10-Q

0001590714-16-000153.txt : 20160510 0001590714-16-000153.hdr.sgml : 20160510 20160509184906 ACCESSION NUMBER: 0001590714-16-000153 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 112 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160510 DATE AS OF CHANGE: 20160509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Platform Specialty Products Corp CENTRAL INDEX KEY: 0001590714 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36272 FILM NUMBER: 161633178 BUSINESS ADDRESS: STREET 1: 1450 CENTREPARK BLVD STREET 2: SUITE 210 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-207-9600 MAIL ADDRESS: STREET 1: 1450 CENTREPARK BLVD STREET 2: SUITE 210 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 10-Q 1 pah10-q2016331document.htm FORM 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 10-Q

_______________

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-36272

_______________

(Exact name of Registrant as specified in its charter)

_______________



Delaware	37-1744899
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1450 Centrepark Boulevard, Suite 210 West Palm Beach, Florida	33401
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (561) 207-9600

_______________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer ý	Accelerated filer ¨	Non-Accelerated filer ¨	Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ¨ No ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date.



Class	May 6, 2016
Common Stock, par value $0.01 per share	229,557,867 shares

Table of Contents



Glossary		Page

	Glossary of Defined Terms	G-1

Part I.	Financial Information

Item 1.	Financial Statements (Unaudited)
	Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015 (Unaudited)	1
	Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2016 and 2015 (Unaudited)	2
	Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015 (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015 (Unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders' Equity for the three months ended March 31, 2016 and 2015 (Unaudited)	5
	Notes to the Condensed Consolidated Financial Statements (Unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	40
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	55
Item 4.	Controls and Procedures	55

Part II.	Other Information

Item 1.	Legal Proceedings	57
Item 1A.	Risk Factors	57
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	58
Item 3.	Defaults Upon Senior Securities	58
Item 4.	Mine Safety Disclosures	58
Item 5.	Other Information	58
Item 6.	Exhibits	59

Signatures		60

Glossary of Defined Terms



Terms		Definitions
Platform; We; Us; Our; the Company		Platform Specialty Products Corporation, a Delaware corporation, and its subsidiaries, collectively, for all periods subsequent to the MacDermid Acquisition.
Acquisitions		Agriphar Acquisition, Alent Acquisition, Arysta Acquisition, CAS Acquisition, MacDermid Acquisition, OMG Acquisition and OMG Malaysia Acquisition, collectively.
Agriphar		Percival and its agrochemical business, Agriphar.
Agriphar Acquisition		Acquisition of a 100% interest in Agriphar, completed on October 1, 2014.
AIs		Active ingredients.
Alent		Alent plc (LSE:ALNT), a formerly public limited company registered in England and Wales.
Alent Acquisition		Acquisition of a 100% interest in Alent completed on December 1, 2015 under the U.K. Companies Act.
Alent EURO Tranche C-2 Term Loan		Tranche C-2 term loans denominated in Euros in an aggregate amount of €300 million borrowed by Platform in connection with the Alent Acquisition.
Alent U.S. Dollar Tranche B-3 Term Loan		Tranche B-3 term loans denominated in U.S. Dollars in an aggregate principal amount of $1.05 billion, borrowed by Platform in connection with the Alent Acquisition.
Amended and Restated Credit Agreement		Platform’s credit agreement dated April 12, 2007, as amended and/or restated on June 7, 2013, October 31, 2013 (Amendment No. 1), August 6, 2014 (Second Amended and Restated Credit Agreement and the further amendments pursuant to Amendment No. 2), October 1, 2014 (Incremental Amendment No. 1), February 13, 2015 (Amendment No. 3) and December 3, 2015 (Amendment No.4).
Amendment No. 1		Amendment No. 1, dated as of October 31, 2013, among, inter alia, Platform (formerly Platform Acquisition Holding Limited), MacDermid Holdings, Matrix Acquisition Corp., MacDermid (as successor to Matrix Acquisition Corp., the borrower), the subsidiaries of the borrower from time to time parties thereto, the lenders from time to time parties thereto and Credit Suisse AG, as administrative agent and as collateral agent, entered into in connection with the MacDermid Acquisition.
Amendment No. 2		Amendment No. 2, dated as of August 6, 2014, among Platform, MacDermid Holdings, MacDermid, the subsidiaries of Platform and MacDermid Holdings from time to time parties thereto, the lenders from time to time parties thereto and Barclays Bank PLC, as administrative agent and collateral agent, entered into in connection with the CAS Acquisition, including the further amendments to the Second Amended and Restated Credit Agreement which became effective upon closing of the CAS acquisition (see Note 8. Debt, Capital Leases, Financial Guarantees and Factoring Arrangements, to the Consolidated Financial Statements).
Amendment No. 3		Amendment No. 3, dated as of February 13, 2015,among Platform, MacDermid Holdings, MAS Holdings, NAIP and certain subsidiaries of Platform and MacDermid Holdings, the lenders from time to time parties thereto and Barclays Bank PLC, entered into in connection with the Arysta Acquisition.
Amendment No. 4		Amendment No. 4, dated as of December 3, 2015, among Platform, MacDermid, MAS Holdings, NAIP, MacDermid Europe and MacDermid Funding, the subsidiaries of Platform from time to time parties thereto, the lenders from time to time parties thereto, and Barclays Bank PLC, as administrative agent and collateral agent, entered into in connection with the Alent Acquisition.
Annual Report		Platform's annual report on Form 10-K for the fiscal year ended December 31, 2015, filed with the SEC on March 11, 2016.
Arysta		Arysta LifeScience Limited, a formerly Irish private limited company.
Arysta Acquisition		Acquisition of a 100% interest in Arysta, completed on February 13, 2015.
Arysta EURO Tranche C-1 Term Loan		Tranche C-1 term loans denominated in Euros in an aggregate amount of €83 million borrowed by Platform in connection with the Arysta Acquisition.
Arysta Seller		Nalozo, L.P., an affiliate of the Original Arysta Seller who became the seller in the Arysta Acquisition pursuant to an amendment to the share purchase agreement dated February 11, 2015.
Arysta U.S. Dollar Tranche B-2 Term Loan		Tranche B-2 term loans denominated in U.S. Dollars in an aggregate principal amount of $500 million borrowed by Platform in connection with the Arysta Acquisition.
ASU		Accounting Standards Update.
Asset-Lite, High-Touch		Platform’s philosophy and business model focused on dedicating extensive resources to research and development and highly technical customer service teams, while limiting investments in fixed assets and capital expenditures.

G-1



Terms		Definitions
Board		Platform’s board of directors.
CAS		The Chemtura AgroSolutions business of Chemtura.
CAS Acquisition		Acquisition of a 100% interest in CAS, completed on November 3, 2014.
CAS EURO Tranche C-1 Term Loan		Tranche C-1 term loans denominated in Euros in an aggregate amount of €205 million borrowed by Platform in connection with the CAS Acquisition.
CAS U.S. Dollar Tranche B Term Loan		Tranche B term loans denominated in U.S. Dollars in an aggregate principal amount of $130 million borrowed by Platform in connection with the CAS Acquisition.
Chemtura		Chemtura Corporation, a Delaware corporation.
Credit Facilities		The First Lien Credit Facility and the Revolving Credit Facility, collectively, available under the Amended and Restated Credit Agreement.
Domestic Pension Plan		MacDermid, Incorporated Employees’ Pension Plan (as amended and restated, effective January 1, 2009), a non-contributory domestic defined benefit pension plan.
EBITDA		Earnings before interest, taxes, depreciation and amortization.
ESPP		Platform Specialty Products Corporation 2014 Employee Stock Purchase Plan, adopted by the Board on March 6, 2014 and approved by Platform’s stockholders at the annual meeting held on June 12, 2014.
Exchange Act		Securities Exchange Act of 1934, as amended.
Exchange Agreement		Exchange Agreement, dated October 25, 2013, between Platform and the fiduciaries of the MacDermid, Incorporated Profit Sharing and Employee Savings Plan.
FASB		Financial Accounting Standard Board.
FCPA		Foreign Corrupt Practices Act of 1977.
February 2015 Notes Offering		Private offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022 and €350 million aggregate principal amount of 6.00% EUR Notes due 2023, completed on February 2, 2015.
First Lien Credit Facility		First lien credit facility available under the Amended and Restated Credit Agreement.
Founder Entities		Mariposa Acquisition, LLC and Berggruen Holdings Ltd. and its affiliates, collectively.
GBP		Platform's Global BioSolutions Portfolio within its Agricultural Solutions segment, which includes biostimulants, innovative nutrition and biocontrol products.
GVAP		Platform’s Global Value Added Portfolio within its Agricultural Solutions segment, which includes products in the herbicides, insecticides, fungicides and seed treatment categories, based on patented or proprietary off-patent AIs.
Incremental Amendment No. 1		Incremental amendment No. 1 to the Amended and Restated Credit Agreement, dated as of October 1, 2014, by and among Platform and MacDermid, as borrowers, MacDermid Holdings, certain subsidiaries of MacDermid Holdings and Platform, Barclays Bank PLC, as collateral agent and administrative agent, and the incremental lender party thereto, entered into in connection with the Agriphar Acquisition.
June 2015 Equity Offering		Underwritten public offering of 18,226,414 shares of its common stock at a public offering price of $26.50 per share, which closed on June 29, 2015, raising gross proceeds of approximately $483 million.
LTCB		Platform's Long Term Cash Bonus plan, established in March 2015.
MacDermid		MacDermid, Incorporated, a Connecticut corporation.
MacDermid Acquisition		Platform’s acquisition on October 31, 2013 of substantially all of the equity of MacDermid Holdings, which, at the time, owned approximately 97% of MacDermid. As a result, Platform became a holding company for the MacDermid business. Platform acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of the Exchange Agreement.
MacDermid Europe		MacDermid European Holdings, B.V., a company organized under the laws of the Netherlands and a subsidiary of Platform.
MacDermid Funding		MacDermid Funding LLC, a limited liability company organized under the laws of Delaware and a subsidiary of Platform.
MacDermid Holdings		MacDermid Holdings, LLC which, at the time of the MacDermid Acquisition, owned approximately 97% of MacDermid, a subsidiary of MacDermid Holdings.
MAS Holdings		MacDermid Agricultural Solutions Holdings B.V., a company organized under the laws of the Netherlands and a subsidiary of Platform.
NAV		Net asset value.

G-2



Terms		Definitions
NAIP		Netherlands Agricultural Investment Partners, LLC, a company organized under the laws of Delaware and a subsidiary of Platform.
NYSE		New York Stock Exchange.
November 2015 Notes Offering		Private offering of $500 million aggregate principal amount of 10.375% senior notes due 2021, completed on November 10, 2015.
OMG		OM Group, Inc. (NYSE:OMG), a Delaware corporation.
OMG Businesses		OMG's Electronic Chemicals and Photomasks businesses, collectively, other than OMG Malaysia.
OMG Malaysia		OMG Electronic Chemicals (M) Sdn Bhd, a subsidiary of OMG located in Malaysia, acquired separately by Platform in the OMG Malaysia Acquisition.
OMG Acquisition		Platform's acquisition of 100% interest in the OMG Businesses completed on October 28, 2015.
OMG Malaysia Acquisition		Platform's acquisition of 100% interest in OMG Malaysia completed on January 31, 2016.
Original Arysta Seller		Nalozo S.à.r.l., a Luxembourg limited liability company and the original seller in the Arysta Acquisition.
PDH		Platform Delaware Holdings, Inc., a subsidiary of Platform.
PDH Common Stock		Shares of common stock of PDH.
Pension Plan		MacDermid, Incorporated Employees’ Pension Plan (as amended and restated, effective January 1, 2009), a non-contributory domestic defined benefit pension plan.
Percival		Percival S.A., a société anonyme incorporated and organized under the laws of Belgium, acquired by Platform on October 1, 2014.
Quarterly Report		This quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2016.
Retaining Holder		Each Holder of an equity interest of MacDermid Holdings immediately prior to the closing of the MacDermid Acquisition, not owned by Platform, who executed a RHSA.
Revolving Credit Facility		Revolving Credit Facility (in U.S. Dollars or multicurrency) available under the Amended and Restated Credit Agreement.
RHSA		Retaining Holder Securityholders’ Agreement dated as of October 31, 2013 entered into by and between Platform and each Retaining Holder pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for shares of PDH Common Stock, at an exchange rate of $11.00 per share plus (i) a proportionate share of the $100 million contingent consideration and (ii) an interest in certain MacDermid pending litigation.
RSUs		Restricted stock units issued by Platform from time to time under the 2013 Plan.
SEC		Securities and Exchange Commission.
Security Agreement		Amended and Restated Pledge and Security Agreement, amended and restated as of October 31, 2013, as amended, supplemented and modified from time to time, entered into by Platform, MacDermid and the guarantors listed therein.
Second Amended and Restated Credit Agreement		Second Amended and Restated Credit Agreement, dated as of August 6, 2014, among, inter alia, Platform, MacDermid Holdings, MacDermid, the subsidiaries of Platform and MacDermid Holdings from time to time parties thereto, the lenders from time to time parties thereto and Barclays Bank PLC, as administrative agent and collateral agent.
Senior Notes		Our 6.00% EUR Notes due 2023, 6.50% USD Notes due 2022 and 10.375% USD Notes due 2021, collectively.
Series A Preferred Stock		2,000,000 shares of Platform’s Series A convertible preferred stock which were automatically converted from ordinary shares held by the Founder Entities upon the Domestication, and which are convertible into shares of Platform’s common stock, on a one-for-one basis, at any time at the option of the Founder Entities.
Series B Convertible Preferred Stock		600,000 shares of Platform’s Series B convertible preferred stock issued to the Arysta Seller in connection with the Arysta Acquisition on February 13, 2015, which are convertible into a maximum of 22,107,590 shares of Platform's common stock at the option of the Arysta Seller.
SERP		Supplemental Executive Retirement Plan for executive officers of Platform.
U.K. Companies Act		The U.K. Companies Act 2006, as amended.
USD Incremental Loan		Incremental term loans under the Incremental Amendment No. 1 to the Amended and Restated Credit Agreement in an aggregate principal amount of $300 million used to finance the Agriphar Acquisition.
U.S. GAAP		Generally accepted accounting principles in the United States.

G-3



Terms		Definitions
2013 Plan		Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan adopted by the Board on October 31, 2013, as amended on December 16, 2013 and approved by Platform’s stockholders at the annual meeting held on June 12, 2014.
401K Plan		MacDermid, Incorporated Profit Sharing and Employee Savings Plan.
6.00% EUR Notes due 2023		Platform’s 6.00% senior notes due 2023 denominated in Euros issued in the February 2015 Notes Offering.
6.50% USD Notes due 2022		Platform’s 6.50% senior notes due 2022 denominated in U.S. Dollars issued in the February 2015 Notes Offering.
10.375% USD Notes due 2021		Platform's 10.375% senior notes due 2021 denominated in U.S. Dollars issued in the November 2015 Notes Offering.

G-4

Part I. Financial Information

Item 1. Financial Statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In millions, except loss per share)



	Three Months Ended March 31,
	2016			2015
Net sales	$	823.8		$	534.8
Cost of sales	467.8			327.7
Gross profit	356.0			207.1
Operating expenses:
Selling, technical, general and administrative	284.0			192.0
Research and development	19.9			12.9
Total operating expenses	303.9			204.9
Operating profit	52.1			2.2
Other (expense) income:
Interest expense, net	(93.8		)	(39.4		)
Loss on derivative contracts	(5.3		)	—
Foreign exchange (loss) gain	(71.1		)	33.9
Other income, net	2.1			1.7
Total other expense	(168.1		)	(3.8		)
Loss before income taxes and non-controlling interests	(116.0		)	(1.6		)
Income tax expense	(18.4		)	(24.7		)
Net loss	(134.4		)	(26.3		)
Net income attributable to the non-controlling interests	(0.4		)	(0.4		)
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)
Loss per share
Basic	$	(0.59	)	$	(0.14	)
Diluted	$	(0.59	)	$	(0.14	)
Weighted average shares outstanding
Basic	229.5			191.9
Diluted	229.5			191.9

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In millions)



	Three Months Ended March 31,
	2016			2015
				(as restated)
Net loss	$	(134.4	)	$	(26.3	)

Other comprehensive income (loss), before tax
Foreign currency translation adjustments:	321.5			(352.5		)

Pension and post-retirement plans:
Tax expense	—			(0.5		)
Pension and post-retirement plan, net of tax	—			(0.5		)

Unrealized loss on available for sale securities:
Unrealized holding loss on available for sale securities	(0.4		)	(0.1		)
Unrealized loss on available for sale securities	(0.4		)	(0.1		)
Tax expense	—			—
Unrealized loss on available for sale securities, net of tax	(0.4		)	(0.1		)

Derivative financial instruments revaluation:
Unrealized hedging loss arising during the period	(11.0		)	—
Derivative financial instruments revaluation	(11.0		)	—
Tax benefit	—			—
Derivative financial instruments revaluation, net of tax	(11.0		)	—
Total other comprehensive income (loss), net of tax	310.1			(353.1		)
Other comprehensive (income) loss attributable to the non-controlling interests	(11.7		)	8.7
Other comprehensive income (loss) attributable to common shareholders	298.4			(344.4		)

Comprehensive income (loss)	164.0			(370.7		)
Comprehensive income attributable to the non-controlling interests	(0.4		)	(0.4		)
Comprehensive income (loss) attributable to common stockholders	$	163.6		$	(371.1	)

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In millions, except share and per share amounts)



	March 31,			December 31,
	2016			2015
Assets
Cash and cash equivalents	$	329.7		$	432.2
Restricted cash	0.8			0.3
Accounts receivable, net of allowance for doubtful accounts of $18.5 and $14.4 at March 31, 2016 and December 31, 2015, respectively	1,172.8			1,023.0
Inventories	612.5			517.5
Note receivable	—			125.0
Prepaid expenses and other current assets	180.3			172.5
Total current assets	2,296.1			2,270.5
Property, plant and equipment, net	496.5			491.6
Goodwill	4,247.9			4,021.9
Intangible assets, net	3,453.6			3,314.3
Other assets	98.6			91.9
Total assets	$	10,592.7		$	10,190.2
Liabilities & Stockholders' Equity
Accounts payable	419.8			450.3
Current installments of long-term debt and revolving credit facilities	188.9			54.7
Accrued salaries, wages and employee benefits	60.8			78.1
Accrued income taxes payable	69.8			65.1
Accrued expenses and other current liabilities	436.3			414.2
Total current liabilities	1,175.6			1,062.4
Long-term debt and capital lease obligations	5,218.4			5,173.6
Long-term retirement benefits, less current portion	81.8			80.5
Long-term deferred income taxes	723.8			678.8
Long-term contingent consideration	73.5			70.7
Other long-term liabilities	223.6			205.0
Total liabilities	7,496.7			7,271.0
Commitments and contingencies (Note 15)
Redeemable preferred stock - Series B	645.9			645.9
Stockholders' Equity
Preferred stock - Series A	—			—
Common stock 400,000,000 shares authorized, 229,523,697 and 229,464,157 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	2.3			2.3
Additional paid-in capital	3,521.7			3,520.4
Accumulated deficit	(667.5		)	(532.7		)
Accumulated other comprehensive loss	(587.7		)	(886.1		)
Total stockholders' equity	2,268.8			2,103.9
Non-controlling interests	181.3			169.4
Total equity	2,450.1			2,273.3
Total liabilities, redeemable preferred shares and equity	$	10,592.7		$	10,190.2

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In millions)



	Three Months Ended March 31,
	2016			2015
				(as restated)
Cash flows from operating activities:
Net cash flows (used in) provided by operating activities	$	(210.4	)	$	2.8
Cash flows from investing activities:
Change in restricted cash	(0.5		)	600.0
Capital expenditures	(11.6		)	(20.8		)
Investment in registrations of products	(7.5		)	(8.4		)
Proceeds from disposal of property, plant and equipment	2.2			—
Settlement of derivatives	(1.1		)	—
Acquisition of businesses, net of acquired cash	(1.2		)	(2,862.1		)
Other, net	(0.2		)	0.2
Net cash flows used in investing activities	(19.9		)	(2,291.1		)
Cash flows from financing activities:
Proceeds from issuance of debt, net of discount and premium	1.2			2,084.0
Change in revolving credit facilities, net	132.5			157.9
Repayments of borrowings	(8.7		)	(3.6		)
Proceeds from issuance of common stock, net	0.2			1.0
Payment of debt financing fees	(0.1		)	(44.6		)
Change in factored liabilities	(3.5		)	4.2
Other, net	(0.9		)	—
Net cash flows provided by financing activities	120.7			2,198.9
Effect of exchange rate changes on cash and cash equivalents	7.1			(10.6		)
Net decrease in cash and cash equivalents	(102.5		)	(100.0		)
Cash and cash equivalents at beginning of period	432.2			397.3
Cash and cash equivalents at end of period	$	329.7		$	297.3
Non-cash Investing Activities
Settlement of Note Receivable in exchange for OMG Malaysia	$	125.0		$	—
Acquisition of OMG Malaysia through the settlement of Note Receivable	$	(125.0	)	$	—

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(Unaudited)

(In millions, except share and per share amounts)



	Preferred Stock			Common Stock
	Shares	Amount		Shares	Amount		Additional Paid-in Capital		Accumulated Deficit			Accumulated Other Comprehensive (Loss) Income			Total Stockholders' Equity			Non- controlling Interest			Total Equity
Balance at December 31, 2015	2,000,000	$	—	229,464,157	$	2.3	$	3,520.4	$	(532.7	)	$	(886.1	)	$	2,103.9		$	169.4		$	2,273.3
Net loss	—	—		—	—		—		(134.8		)	—			(134.8		)	0.4			(134.4		)
Other comprehensive loss, net of taxes	—	—		—	—		—		—			298.4			298.4			11.7			310.1
Issuance of common stock to former non-founder director for exercise of stock options	—	—		7,642	—		—		—			—			—			—			—
Conversion of PDH Common Stock into common stock	—	—		16,499	—		0.2		—			—			0.2			(0.2		)	—
Issuance of common stock under ESPP	—	—		35,399	—		0.2		—			—			0.2			—			0.2
Equity compensation expense	—	—		—	—		0.9		—			—			0.9			—			0.9
Balance at March 31, 2016	2,000,000	$	—	229,523,697	$	2.3	$	3,521.7	$	(667.5	)	$	(587.7	)	$	2,268.8		$	181.3		$	2,450.1

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (continued)

(Unaudited)

(In millions, except share and per share amounts)



	Preferred Stock			Common Stock								Accumulated Other Comprehensive Loss
	Shares	Amount		Shares	Amount		Additional Paid-in Capital		Accumulated Deficit			Accumulated Other Comprehensive Loss			Total Stockholders' Equity			Non- controlling Interest			Total Equity
Balance at December 31, 2014	2,000,000	$	—	182,066,980	$	1.9	$	2,812.4	$	(224.1	)	$	(130.6	)	$	2,459.6		$	93.0		$	2,552.6
Net loss	—	—		—	—		—		(26.7		)	—			(26.7		)	0.4			(26.3		)
Other comprehensive loss, net of taxes (as restated)	—	—		—	—		—		—			(344.4		)	(344.4		)	(8.7		)	(353.1		)
Issuance of common stock to Founder Entities as stock dividend on Series A Preferred Stock declared on 12/31/14	—	—		10,050,290	—		—		—			—			—			—			—
Issuance of common stock to former non-founder director for exercise of stock options	—	—		75,000	—		0.9		—			—			0.9			—			0.9
Conversion of PDH Common Stock into common stock	—	—		21,316	—		0.2		—			—			0.2			(0.2		)	—
Issuance of common stock under ESPP	—	—		7,986	—		0.1		—			—			0.1			—			0.1
Equity compensation expense	—	—		—	—		0.7		—			—			0.7			—			0.7
Acquisition of non-controlling interest with Arysta Acquisition	—	—		—	—		—		—			—			—			24.6			24.6
Balance at March 31, 2015 (as restated)	2,000,000	$	—	192,221,572	$	1.9	$	2,814.3	$	(250.8	)	$	(475.0	)	$	2,090.4		$	109.1		$	2,199.5

See accompanying notes to condensed consolidated financial statements

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Description of the Company and Business

Platform Specialty Products Corporation is a global, diversified producer of high-technology specialty chemical products and provider of technical services. The Company's business involves the formulation of a broad range of solutions-oriented specialty chemicals which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. The Company refers to its products as “dynamic chemistries” due to their intricate chemical compositions which are used in a wide variety of niche markets. As further described in Note 19, Segment Information, the Company operates in two segments: Performance Solutions and Agricultural Solutions.

Until the MacDermid Acquisition on October 31, 2013, the Company had neither engaged in any operations nor generated any income. Following the MacDermid Acquisition, on January 22, 2014, the Company was domesticated in Delaware and on January 23, 2014, its common stock, par value $0.01 per share, began trading on the NYSE under the ticker symbol “PAH.”

Basis of Presentation

These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with U.S. GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report.

The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

Principles of Consolidation

The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation.

Recently Adopted and Pending Accounting Pronouncements

Revenue From Contracts with Customers (Topic 606) - In April 2016, the FASB issued ASU 2016-10, "Identifying Performance Obligations and Licensing." The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.

Compensation - Stock Compensation (Topic 718) - In March 2016, the FASB issued ASU 2016-09, "Improvements to Employee Share-Based Payment Accounting." The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Revenue From Contracts with Customers (Topic 606) - In March 2016, the FASB issued ASU 2016-08, "Principal versus Agent Considerations." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.

Investments - Equity Method and Joint Ventures (Topic 323) - In March 2016, the FASB issued ASU No. 2016-07, "Simplifying the Transition to the Equity Method of Accounting." The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU 2016-06, "Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force)." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU.

Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-05, "Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force)." The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements.

Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU.

Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements.

Revenue from Contracts with Customers (Topic 606) - In August 2015, the FASB issued ASU No. 2015-14, “Deferral of the Effective Date,” which defers the effective date of ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)," for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - In April 2015, the FASB issued ASU No. 2015-05, “Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements.

Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented,therefore, this ASU did not have a material impact on the Company's financial statements.

Presentation of Financial Statements - Going Concern (Subtopic 205-40) - In August 2014, the FASB issued ASU No. 2014-15, "Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern." The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement.

Restatement

As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of $72.8 million occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report. The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million, and therefore further concluded that the previously reported information should be restated. This restatement is included in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included herein.

2. ACQUISITIONS OF BUSINESSES

OMG Malaysia Acquisition

The Company acquired OMG Malaysia to add-on to the OMG Acquisition and further enhance its Performance Solutions segment. Legacy OMG Malaysia, which is highly-synergistic with the legacy OMG Businesses, is included in the Company's Performance Solutions business segment.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Alent Acquisition

On December 1, 2015, Platform completed the Alent Acquisition by acquiring all of the issued shares of Alent for approximately $1.74 billion in cash, net of acquired cash, and 18,419,738 shares of the Company's common stock at $12.56 per share, issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent.

The Company acquired Alent to expand its product capabilities and offerings and improve its geographic outreach in surface treatments. Legacy Alent was a global supplier of specialty chemicals and engineered materials used primarily in electronics, automotive, industrial applications, and high performance consumable products and services. Alent is included in the Company's Performance Solutions business segment.

OMG Acquisition

On October 28, 2015, Platform completed the OMG Acquisition for approximately $239 million, in cash, net of acquired cash, subject to purchase price adjustments.

The Company acquired the highly-synergistic OMG Businesses to bolster its Performance Solutions business segment. Legacy OMG’s Electronic Chemicals business developed, produced and supplied chemicals for electronic and industrial applications. Legacy OMG’s Photomasks products were used by customers to produce semiconductors and related products. The OMG Businesses are included in the Company's Performance Solutions business segment.

Arysta Acquisition

On February 13, 2015, Platform completed the Arysta Acquisition for approximately $3.50 billion, consisting of $2.86 billion in cash, net of acquired cash and closing working capital adjustments, and including Arysta Seller transaction expenses paid by Platform, and the issuance to the Arysta Seller of $600 million of Platform’s Series B Convertible Preferred Stock with a fair value of $646 million.

The Company acquired Arysta to expand its presence in the agrochemical business, complementing the Agriphar and CAS Acquisitions. Legacy Arysta provided products and solutions utilizing globally managed patented and proprietary off-patent agrochemical AIs and biological solutions, or biosolutions, and off-patent agrochemical offerings. Biosolutions includes stimulants, or biostimulants, innovative nutrition and biological control, or biocontrol, products. Arysta is included in the Company's Agricultural Solutions business segment.

Acquisition Net Sales and Net Loss

Since the dates of the respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the three months ended March 31, 2016 and 2015 were as follows:



(amounts in millions)	Three Months Ended March 31, 2016		Three Months Ended March 31, 2015
OMG Malaysia	$	5.5	$	—
Alent	219.6		—
OMG	27.2		—
Arysta	283.6		177.5
Total	$	535.9	$	177.5

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

As the integration continues for (1) the OMG Malaysia, Alent and OMG Acquisitions within the Company's Performance Solutions business segment, and (2) the Arysta, CAS and Agriphar Acquisitions within the Agricultural Solutions segment, discrete revenues reported by these existing businesses are being effected by the integration process and are becoming less comparable to prior periods.

The OMG Malaysia, Alent, OMG and Arysta Acquisitions had net losses for the three months ended March 31, 2016 and 2015 as follows:



(amounts in millions)	Three Months Ended March 31, 2016			Three Months Ended March 31, 2015
OMG Malaysia	$	(0.6	)	$	—
Alent	(1.4		)	—
OMG	(1.0		)	—
Arysta	(70.8		)	(4.3		)
Total	$	(73.8	)	$	(4.3	)

Purchase Price Allocation

The following table summarizes the consideration transferred and transaction costs incurred to acquire OMG Malaysia, Alent and the OMG Businesses, as well as the applicable amounts of identified assets acquired and liabilities assumed at the applicable acquisition date:



(amounts in millions)	OMG Malaysia			Alent			OMG Businesses
Consideration
Cash, net	$	(1.3	)	$	1,507.0		$	239.1
Equity Instruments	—			231.4			—
Note receivable settlement	125.0			—			—
Total Consideration	$	123.7		$	1,738.4		$	239.1

Acquisition costs	$	0.1		$	29.3		$	7.4

Identifiable Assets acquired and Liabilities Assumed
Accounts receivable	$	4.3		$	177.4		$	33.1
- less uncollectible	—			(1.8		)	(1.6		)
Accounts receivable - fair value	4.3			175.6			31.5
Inventories	7.2			116.1			13.2
Other current assets	0.2			29.3			1.6
Property, plant and equipment	4.7			192.2			35.1
Identifiable intangible assets	59.0			682.9			77.9
Other assets	—			37.6			0.2
Current Liabilities	(3.5		)	(181.8		)	(21.5		)
Non-current deferred tax liability	(15.1		)	(138.6		)	(13.6		)
Other long term liabilities	—			(316.9		)	(4.0		)
Total identifiable net assets	56.8			596.4			120.4
Goodwill	66.9			1,142.0			118.7
Total purchase price	$	123.7		$	1,738.4		$	239.1

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

The purchase accounting and purchase price allocation for the OMG Malaysia Acquisition remains open due to the proximity of the acquisition date to quarter-end. The purchase accounting and purchase price allocation for the Alent and OMG Acquisitions is substantially complete with the exception of the following areas: environmental and legal reserves, developed technology intangible assets, asset retirement obligations, or AROs, as well as income taxes for the Alent Acquisition, and developed technology intangible assets and income taxes for the OMG Acquisition. The Company is still gathering information related to these recent acquisitions to finalize their purchase accounting. For more information regarding Alent's environmental reserves, see Note 15, Contingencies, Environmental and Legal Matters, to the Condensed Consolidated Financial Statements.

The excess of the respective cost of the Acquisitions over the net of amounts assigned to the fair values of the assets acquired and the liabilities assumed is recorded as goodwill and represents the value of estimated synergies and the assembled workforces resulting from the Acquisitions. Of the $1.33 billion of goodwill recorded in connection with the OMG Malaysia, Alent and OMG Acquisitions, $83.1 million is expected to be deductible for tax purposes as result of a part of the OMG Malaysia and OMG Acquisitions.

Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows:



	OMG Malaysia			Alent				OMG Businesses			Total
(amounts in millions)	Fair Value		Weighted average useful life (years)	Fair Value			Weighted average useful life (years)	Fair Value		Weighted average useful life (years)	Fair Value		Weighted average useful life (years)
Customer lists	$	45.0	25.0	$	391.4		15.5	$	49.0	24.5	$	485.4	18.0
Developed technology	14.0		10.0	203.3			10.0	28.0		10.0	245.3		10.0
Tradenames	—		—	85.8		⁽¹⁾	20.0	0.9		10.0	86.7		19.1
In process - R&D	—		—	2.4		⁽²⁾	—	—		—	2.4		—
Total	$	59.0	23.3	$	682.9		14.2	$	77.9	21.7	$	819.8	16.3

⁽¹⁾ Includes $81.4 million of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life.

⁽²⁾Excluded from the calculation of weighted average useful life.

Pro Forma Revenue and Earnings

The following unaudited pro forma summary presents consolidated information of the Company for the three months ended March 31, 2016 and 2015, as if the OMG Malaysia, Alent, OMG and Arysta Acquisitions had occurred on January 1, 2015:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Revenue	$	826.7		$	897.2
Net loss attributable to stockholders	$	(119.2	)	$	(64.4	)

For the three months ended March 31, 2016, the Company incurred $11.6 million of acquisition and integration expenses related to the OMG Malaysia, Alent, OMG and Arysta Acquisitions, which have been reflected in the pro forma earnings above, as if they had been incurred in 2015. In addition, for the three months ended March 31, 2015, the Company incurred $22.9 million of acquisition and integration expenses related to the Arysta Acquisition, which have been excluded from the March 31, 2015 pro forma earnings above. These pro forma amounts have been prepared to reflect fair value adjustments to intangible assets and the related amortization expense, net of tax, from January 1, 2015, as well as the effect of the debt instruments used to fund the Arysta and Alent Acquisitions.

3. INVENTORIES

The major components of inventory were as follows:



(amounts in millions)	March 31, 2016		December 31, 2015
Finished goods	$	399.4	$	340.1
Work in process	33.9		28.5
Raw materials and supplies	179.2		148.9
Total inventory, net	$	612.5	$	517.5

In connection with Platform's various acquisitions, the value of inventory was increased at the respective dates of acquisition to reflect fair value. For the three months ended March 31, 2016 and 2015, $12.0 million and $36.1 million, respectively, was charged to "Cost of sales" in the Condensed Consolidated Statements of Operations based on inventory turnover of such various acquisitions.

As of March 31, 2016 and December 31, 2015, the remaining portion of the inventory fair value mark-up totaled $0.5 million and $11.5 million, respectively.

4. PROPERTY, PLANT AND EQUIPMENT

The major components of property, plant and equipment, including equipment under capital leases, were as follows:



(amounts in millions)	March 31, 2016			December 31, 2015
Land and leasehold improvements	$	111.5		$	107.9
Buildings and improvements	149.3			143.8
Machinery, equipment, fixtures and software	283.3			276.8
Assets under capital lease
Land and buildings	8.3			6.4
Machinery and equipment	5.4			5.1
Total Property, plant and equipment	557.8			540.0
Accumulated depreciation	(78.3		)	(64.3		)
Accumulated amortization of capital leases	(6.4		)	(5.5		)
Total accumulated depreciation and amortization	473.1			470.2
Construction in process	23.4			21.4
Property, plant and equipment, net	$	496.5		$	491.6

For the three months ended March 31, 2016 and 2015, the Company recorded depreciation expense of $18.2 million and $8.4 million, respectively.

In March 2016, the Company entered into a sale agreement for a long-lived asset with a net book value of $12.1 million in exchange for a cash payment of $9.3 million, net of estimated selling costs of $0.2 million. As a result, the Company reduced the net book value of the asset by $2.8 million, which was recorded in "Selling, technical, general and administrative expense" in the Condensed Consolidated Statements of Operations. The asset will remain classified as an asset held-for-sale in "Other assets" in the Company's Condensed Consolidated Balance Sheets until the sale has been completed.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

5 . GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill by segment were as follows:



(amounts in millions)	Performance Solutions		Agricultural Solutions		Total
December 31, 2015	$	2,147.2	$	1,874.7	$	4,021.9
Addition from acquisitions	66.9		—		66.9
Purchase accounting adjustments	3.6		0.2		3.8
Foreign currency translation	34.2		121.1		155.3
March 31, 2016	$	2,251.9	$	1,996.0	$	4,247.9

The carrying value of indefinite-lived intangible assets other than goodwill, which consist solely of tradenames, was $377 million and $360 million at March 31, 2016 and December 31, 2015, respectively.

During the three months ended March 31, 2016, the Company found no indications of impairment related to its goodwill and indefinite-lived intangible assets.

Intangible assets subject to amortization were as follows:



		March 31, 2016							December 31, 2015
(amounts in millions)	Weighted average useful life (years)	Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value		Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value
Customer lists	20.5	$	1,250.5	$	(80.3	)	$	1,170.2	$	1,297.2	$	(184.0	)	$	1,113.2
Developed technology	11.8	2,006.0		(119.0		)	1,887.0		2,260.9		(440.4		)	1,820.5
Tradenames	12.4	22.2		(3.7		)	18.5		24.2		(5.4		)	18.8
Non-compete agreements	5.0	1.9		(0.6		)	1.3		1.9		(0.5		)	1.4
Total	15.1	$	3,280.6	$	(203.6	)	$	3,077.0	$	3,584.2	$	(630.3	)	$	2,953.9

For the three months ended March 31, 2016 and 2015, the Company recorded amortization expense on intangible assets of $64.4 million and $39.8 million, respectively.

6. EQUITY COMPENSATION PLANS

In June 2014, the Company’s stockholders approved the 2013 Plan, which is administered by the compensation committee of the Board, except as otherwise expressly provided in the 2013 Plan. The Board approved a maximum of 15,500,000 shares of common stock (subject to increase in accordance with the terms of the 2013 Plan), which were reserved and made available for issuance under the 2013 Plan. As of March 31, 2016, a total of 373,434 shares of common stock had been issued and 2,663,455 awarded RSUs and stock options were outstanding under the 2013 Plan.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)



	Three Months Ended March 31, 2016
	Total		RSUs			Stock Options
	Total		Equity Classified		Liability Classified	Stock Options
Outstanding at December 31, 2015	1,006,436		501,634		329,802	175,000
Granted	1,890,998		1,526,415		—	364,583
Exercised/Issued	(7,642	)	(7,642	)	—	—
Forfeited	(51,337	)	(51,337	)	—	—
Outstanding at March 31, 2016	2,838,455		1,969,070		329,802	539,583

Equity Classified Share Based Payments

During the three months ended March 31, 2016, grants of 1,501,257 RSUs, approved by the Board under the 2013 Plan, were made to certain employees of the Company with grant-date fair values ranging from $8.32 to $15.80 per unit and vesting periods ranging from 33.5 months to 36 months. Of these, 473,657 RSUs are subject to performance conditions that must be achieved in the applicable vesting year, of which 390,324 include a multiplier from zero to 2.0x depending upon return on invested capital benchmarks and 83,333 include a multiplier from zero to 100% based upon an EBITDA target benchmark. The total grants also include 390,324 RSUs that are subject to market conditions, all of which include a multiplier from zero to 3.0x depending upon the relative shareholder return compared to a market benchmark index during a three year performance measurement period. The remaining 637,276 RSUs are subject to service conditions that will vest ratably over the aforementioned vesting periods. During the three months ended March 31, 2016, 51,337 RSUs were forfeited.

On March 17, 2016, the Board approved grants to certain directors of the Company totaling 25,158 RSUs with a grant-date fair value of $8.84. These RSUs will vest on March 17, 2017, provided that they continue to serve as directors of Platform through the vesting date. Each RSU represents a contingent right to receive one share of our common stock. During the three months ended March 31, 2016, 7,642 previously issued RSUs vested and were settled for 7,642 shares of common stock.

As of March 31, 2016, the Board approved 166,667 RSUs under the 2013 Plan which are subject to performance conditions that must be achieved in the applicable vesting year and include a multiplier of zero to 100% based upon EBITDA target benchmarks. As those target EBITDA benchmarks have not yet been established, these RSUs have been excluded from the above grant activity. The EBITDA target benchmarks are expected to be established in 2017 and 2018.

RSUs granted during the three months ended March 31, 2016 had a weighted-average grant-date fair value of $10.82 per unit.

For the three months ended March 31, 2016 and 2015, total compensation expense associated with RSUs classified as equity totaled $0.9 million and $0.7 million, respectively.

Liability Classified Share Based Payments

On March 6, 2014, effective on June 12, 2014 which corresponded to the Company's stockholders' approval of the 2013 Plan, the Board approved grants to certain employees totaling 329,823 RSUs that cliff vest on December 31, 2020. These RSUs are subject to an EBITDA performance condition and a share price market condition. Additionally, the number of shares of common stock to be issued is limited to a maximum cash value, requiring these awards to be classified as liabilities. There were 329,802 RSUs associated with these grants that remained outstanding as of March 31, 2016. The combined undiscounted maximum cash value of all liability-classified RSUs issued is approximately $7.1 million, which is being recognized as compensation expense over the period from grant to the vesting date.

For the three months ended March 31, 2016 and 2015, compensation (income) expense associated with these awards totaled $(0.1) million and $0.3 million, respectively.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Stock Options

On March 16, 2016, certain employees of the Company were granted non-qualified stock options under the 2013 Plan to acquire 364,583 ordinary shares with an exercise price of $7.95 and fair value of $4.32. The exercise price associated with these options was based on the closing stock price on March 15, 2016. They are subject to graded vesting over a three year period and have contractual lives of ten years from the grant date. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model.

The following table provides the assumptions used in valuing the option grants using the Black-Scholes option pricing method:



	Black-Scholes Input Assumptions
Weighted average expected term (years)	6.0
Expected Volatility	53.0		%
Risk-free rate	1.56		%
Expected dividend rate	—		%
Fair value price	$	4.32

Weighted average expected term is calculated based on the simplified method for plain vanilla options as the Company has concluded that its historical share option exercise experience does not provide a reasonable basis upon which to estimate expected term and certain alternative information to assist with estimating it is not easily obtainable. Expected volatility is calculated based on a blend of the implied and historical equity volatility of an index of comparable companies.

For the three months ended March 31, 2016, the Company recognized a de minimis amount of compensation expense associated with stock options.

Long Term Cash Bonus Plan

The Company established the LTCB during the first quarter 2015. As of March 31, 2016, the plan provides participants the right to receive bonuses totaling $12.3 million, a decrease of $3.0 million from December 31, 2015 due to forfeitures. Benefits under the plan vest over periods ranging from 36 to 62.5 months and include EBITDA performance targets, subject to appropriate and equitable adjustments by the compensation committee of the Board to reflect any subsequent acquisition, divestiture or other corporate reorganizations, as necessary. For the three months ended March 31, 2016 and 2015, compensation expense associated with the LTCB totaled $0.2 million and $1.0 million, respectively.

Employee Stock Purchase Plan

Effective March 6, 2014, the Board adopted the ESPP, which was approved by the Company’s stockholders on June 12, 2014. The Board approved a maximum of 5,178,815 shares of common stock, which were reserved and made available for issuance under the ESPP. As of March 31, 2016, a total of 90,898 shares had been issued under the ESPP, and approximately 830 persons were eligible to participate in the ESPP. For the three months ended March 31, 2016, compensation expense associated with the ESPP was de minimis.

7. PENSION AND POST-RETIREMENT PLANS

The components of net periodic pension and post-retirement benefit costs for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016						2015
Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign
Net periodic (benefit) cost:
Service cost	$	—		$	0.4		$	—		$	0.2
Interest cost on the projected benefit obligation	2.5			0.8			1.6			0.5
Expected return on plan assets	(2.9		)	(0.7		)	(2.4		)	(0.5		)
Amortization of prior service cost	—			0.2			—			—
Net periodic (benefit) cost	$	(0.4	)	$	0.7		$	(0.8	)	$	0.2



	Three Months Ended March 31,
(amounts in millions)	2016				2015
Post-retirement Benefits:	Domestic		Foreign		Domestic		Foreign
Net periodic cost:
Interest cost on the projected benefit obligation	$	0.1	$	0.1	$	0.1	$	—
Net periodic cost	$	0.1	$	0.1	$	0.1	$	—

No pension service cost was recognized during the three months ended March 31, 2016 and 2015 under the Domestic Pension Plan, nor will there be in future periods, as benefits in the plan were frozen in connection with the MacDermid Acquisition.

The Company did not make any contributions to the Pension Plan during the three months ended March 31, 2016. The Company expects to make contributions totaling $6.3 million and $0.6 million to the Pension Plan and other post-retirement benefit plans, respectively, during 2016.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

8. DEBT, CAPITAL LEASES, FINANCIAL GUARANTEES AND FACTORING ARRANGEMENTS

The Company’s debt and capital lease obligations consisted of the following:



(amounts in millions)	March 31, 2016			December 31, 2015
Borrowings under lines of credit, weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively	$	149.2		$	16.7

USD Notes, due 2022, interest at 6.50%, net of unamortized premium and debt issuance costs of $18.1million and $18.9 million at March 31, 2016 and December 31, 2015, respectively	1,081.9			1,081.1
EUR Notes, due 2023, interest at 6.00%, net of debt issuance costs of $5.9 million and $6.1 million at March 31, 2016 and December 31, 2015, respectively	392.2			374.0
USD Notes, due 2021, interest at 10.375%, net of debt issuance costs of $12.0 million and $12.5 million at March 31, 2016 and December 31, 2015, respectively	488.0			487.5
First lien secured credit facility, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of debt issuance costs of $0.5 million and $0.6 million at March 31, 2016 and December 31, 2015, respectively	733.7			735.6
USD Incremental Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $5.1 million and $5.4 million at March 31, 2016 and December 31, 2015, respectively	290.4			290.8
CAS U.S. Dollar Tranche B Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $6.1 million and $6.4 million at March 31, 2016 and December 31, 2015, respectively	122.0			121.9
Arysta U.S. Dollar Tranche B-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $13.1 million and $13.9 million at March 31, 2016 and December 31, 2015, respectively	480.7			481.2
Alent U.S. Dollar Tranche B-3 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $38.3 million and $40.5 million at March 31, 2016 and December 31, 2015, respectively	1,001.5			1,001.8
CAS EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount of $0.9 million and $0.9 million at March 31, 2016 and December 31, 2015, respectively	228.8			219.0
Arysta EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $2.0 million and $2.1 million at March 31, 2016 and December 31, 2015, respectively	91.2			87.2
Alent EURO Tranche C-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $11.9 million and $11.9 million at March 31, 2016 and December 31, 2015, respectively	327.7			313.0
Other	20.0			18.5
Total debt and capital lease obligations	5,258.1			5,211.6
Less: current portion debt and capital lease obligations	(39.7		)	(38.0		)
Total long-term debt and capital lease obligations	$	5,218.4		$	5,173.6

The weighted average effective interest rate associated with debt outstanding at March 31, 2016, based on currently applicable interest rates, was 6.92%. This rate includes the effects of interest rate swaps, as well as, the impact of deferred financing fees and original issue discount and premium amortization calculated using the effective interest method.

In August 2015, the Company entered into a series of pay fixed, receiving floating interest rate swaps with respect to a portion of its indebtedness. The swaps effectively fix the floating base rate portion of the interest payments on approximately $1.16 billion of the Company's USD denominated debt and €284 million of its Euro denominated debt at 1.96% and 1.20%, respectively, from September 2015 through June 2020.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Minimum principal payments on long-term debt and capital leases were as follows:



(amounts in millions)	Principal Payments
Year ending December 31,	Principal Payments
2016 - remaining	$	41.1
2017	34.9
2018	34.7
2019	34.6
2020	3,226.6
2021	500.5
Thereafter	1,499.6
Total	$	5,372.0

In order to fund our acquisition activity, we have incurred substantial indebtedness totaling $5.26 billion as of March 31, 2016, with expected interest payments in excess of $300 million per year. Our first significant principal debt payments, totaling $3.23 billion and primarily representing principal payments at maturity associated with all of our outstanding term loans under our Amended and Restated Credit Agreement, are due in 2020. In addition, on April 20, 2017, we may also be required to repurchase each share of Series B Convertible Preferred Stock that has not been previously converted or automatically redeemed. The related potential cash obligation, which varies based on our stock price, corresponds to a maximum amount of $600 million. As of March 31, 2016, this maximum potential obligation was approximately $410 million. We anticipate sufficient cash from operations to fund interest, working capital and other capital expenditures for the foreseeable future and have access to a $500 million line of credit under our Revolving Credit Facility, with current availability of $385 million, as well as availability under various lines of credit and overdraft facilities of $87.4 million. However, any settlement of the Series B Convertible Preferred Stock obligation, working capital shortfalls and future acquisitions may require utilization of our Revolving Credit Facility as well as proceeds from future debt and/or equity offerings. Our long-term liquidity may be impacted by our ability to borrow additional funds, renegotiate existing debt and/or raise equity under terms that are favorable to us.

Amendments to Credit Agreement

Amendment No. 1 -- In connection with the MacDermid Acquisition, on October 31, 2013, MacDermid entered into Amendment No. 1 to the First Lien Credit Agreement and MacDermid paid $373 million in connection with the repayment of the $360 million in principal on the second lien credit facility. Pursuant to Amendment No. 1, Platform became a co-borrower on all obligations under the $50.0 million Revolving Credit Facility and the second term loan and the negative and affirmative covenants contained therein were modified to reflect the new corporate structure. Otherwise, the terms relating to the incremental facility, maturity, indicative margin, LIBOR floor, ranking, guarantors, mandatory prepayments and financial covenants remained unmodified by the amendment. In connection with the MacDermid Acquisition, the first lien term loan was marked to fair value by adding the original discount of $1.8 million to the carrying value at the time.

Amendment No. 2 -- On August 6, 2014, the Company amended and restated its senior secured credit facilities by entering into Amendment No. 2 to the First Lien Credit Facility and the Second Amended and Restated Credit Agreement, and agreeing on the implementation of certain further amendments to the Second Amended and Restated Credit Agreement. Upon consummation of the CAS Acquisition on November 3, 2014, the further amendments became effective, increasing (i) the existing U.S. Dollar revolving credit facility to $87.5 million and (ii) the existing multicurrency revolving credit facility to $87.5 million. On the date of the CAS Acquisition, the Company also borrowed (i) an aggregate principal amount of $130 million under the CAS U.S. Dollar Tranche B Term Loan, (ii) $60.0 million under the U.S. Dollar Revolving Credit Facility, and (iii) €55.0 million under the multicurrency Revolving Credit Facility. The amounts under (ii) and (iii) in the immediately preceding sentence were both settled by December 31, 2014. In addition, an aggregate amount of €205 million was borrowed under the CAS EURO Tranche C-1 Term Loan by MAS Holdings and NAIP, subsidiaries of Platform.

Pursuant to the further amendments, certain additional domestic and foreign subsidiaries of Platform and MacDermid became guarantors under the Amended and Restated Credit Agreement, and certain additional collateral was pledged to secure the Company's obligations incurred under the CAS EURO Tranche C-1 Term Loan and the other loans incurred under the Revolving Credit Facility. With the exception of this collateral package and the interest rate, the CAS EURO Tranche C-1 Term Loan has terms substantially similar to those of Platform’s CAS U.S. Dollar Tranche B Term Loan and bears interest at a rate per annum equal to an applicable

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

margin plus an adjusted Eurocurrency Rate, calculated as set forth in the Amended and Restated Credit Agreement. The CAS EURO Tranche C-1 Term Loan matures on June 7, 2020.

On October 1, 2014, Platform and MacDermid, as borrowers, MacDermid Holdings, certain subsidiaries of MacDermid Holdings and Platform, and Barclays Bank PLC, as collateral and administrative agent and incremental lender, entered into the Incremental Amendment No.1 to the Amended and Restated Credit Agreement for an USD Incremental Loan in an aggregate principal amount of $300 million. Except as set forth in the Incremental Amendment No. 1, such USD Incremental Loan has identical terms as the existing Tranche B term loans and is otherwise subject to the provisions of the Amended and Restated Credit Agreement. The proceeds from the Incremental Amendment No. 1 were used to finance the Agriphar Acquisition.

Amendment No. 3 -- On February 13, 2015, the Company entered into and closed the transactions contemplated by Amendment No. 3 to the Second Amended and Restated Credit Agreement, as amended by Amendment No. 2, which, among other things, provided for (i) a new tranche of term loans denominated in U.S. Dollars in an aggregate principal amount of $500 million, (ii) an increase in the size of the existing Euro Tranche Term Loan by €83.0 million to €287 million, (iii) an increase in the size of the existing U.S. Dollar Revolving Credit Facility by $75.0 million to $163 million, and (iv) an increase in the size of the existing multicurrency Revolving Credit Facility by $75.0 million to $163 million. Concurrently with the closing of the Arysta Acquisition, the Company borrowed (i) an Arysta U.S. Dollar Tranche B-2 Term Loan of $500 million (less original issue discount of 1%), (ii) an additional Arysta EURO Tranche C-1 Term Loan of €83.0 million (less original issue discount of 2%), and (iii) $160 million under the U.S. Dollar Revolving Credit Facility to fund a portion of the cash consideration for the Arysta Acquisition.

Amendment No. 4 -- On December 3, 2015, the Company entered into and closed the transaction contemplated by Amendment No. 4 to the Second Amended and Restated Credit Agreement, as amended by Amendments No. 2 and 3, which, among other things, provided for (i) a new tranche of term loans denominated in U.S. Dollars in an aggregate principal amount of up to $1.05 billion, (ii) a new tranche of new term loans denominated in Euro in an aggregate principal amount of up to €300 million, (iii) an increase in the size of the existing U.S. Dollar revolving credit facility by $87.5 million to $250 million, and (iv) an increase in the size of the existing multicurrency revolving credit facility by $87.5 million to $250 million. Concurrently with the closing of the Alent Acquisition, the additional $1.05 billion of Alent U.S. Dollar Tranche B-3 Term Loans (less original issue discount of 2%), the additional €300 million of Alent EURO Tranche C-2 Term Loans (less original issue discount of 2%) and $115 million under Platform’s multi-currency Revolving Credit Facility were borrowed to fund a portion of the cash consideration for the Alent Acquisition.

Certain additional domestic and foreign subsidiaries of Platform and MacDermid, including certain subsidiaries acquired in the Alent and Arysta Acquisition, have since become guarantors under the Amended and Restated Credit Agreement, with certain of the Company's subsidiaries having pledged collateral in connection therewith.

Each of the Alent U.S. Dollar Tranche B-3 Term Loans and the Alent EURO Tranche C-2 Term Loans bear interest at a rate per annum equal to 5.50% plus an adjusted eurocurrency rate, or 4.50% plus an adjusted base rate, calculated as set forth in the Amended and Restated Credit Agreement. Pursuant to Amendment No. 4, each of the previously existing (i) tranche B term loans, (ii) tranche B-2 term loans, and (iii) EURO tranche C-1 term loans will bear interest at 5.50% per annum plus an adjusted Eurocurrency rate, or 4.50% plus an adjusted base rate, calculated as set forth in the Amended and Restated Credit Agreement. Each tranche of term loans will mature on June 7, 2020.

Loans under our Revolving Credit Facility bear interest at a rate per annum equal to 3.00% plus an adjusted eurocurrency rate, or 2.00% plus an adjusted base rate, each as calculated as set forth in the Amended and Restated Credit Agreement. Amendment No. 4 provided for maturity extension of the revolving loans and commitments held by revolving facility lenders consenting to such extension. The extended Revolving Credit Facility will mature on June 7, 2019. Revolving loans and commitments held by revolving facility lenders, other than the lenders who consent to the extension, will mature on June 7, 2018.

Except as set forth in Amendment No. 4 and above, (i) the Alent U.S. Dollar Tranche B-3 Term Loans shall have identical terms as the existing U.S. Dollar denominated term loans and (ii) the Alent EURO Tranche C-2 Term Loans shall have identical terms as the existing euro denominated term loans and, in each case, shall be otherwise subject to the provisions of the Credit Agreement.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Covenants and Events of Default

The Amended and Restated Credit Agreement contains customary covenants including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. The Revolving Credit Facility also imposes a financial covenant to maintain a first lien net leverage ratio of 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. As of March 31, 2016, the Company was in compliance with the debt covenants contained in its Credit Facilities.

The Amended and Restated Credit Agreement also contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of certain covenants, inaccuracy of representations and warranties, failure to make payment on certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, payment of any outstanding loans under the Amended and Restated Credit Agreement may be accelerated. Borrowings under the Amended and Restated Credit Agreement are also subject to mandatory prepayment from the proceeds of certain dispositions of assets and from certain insurance and condemnation proceeds, excess cash flow and debt incurrences, in each case, subject to customary carve-outs and exceptions.

The Amended and Restated Credit Agreement also contains a yield protection provision wherein the yield on any current indebtedness issued under the Amended and Restated Credit Agreement would be increased to within 50 basis points of the yield on any additional incremental term loan(s), in the event the incremental term loan(s) provided an initial yield, including OID, subject to the yield calculation provisions, as defined, is in excess of 50 basis points of the yield on existing term loan indebtedness.

Guarantees

The obligations of Platform and MacDermid, as borrowers, under the Amended and Restated Credit Agreement are guaranteed by current and future direct and indirect domestic subsidiaries. Certain of Platform's foreign subsidiaries also guarantee the obligations of MAS Holdings, NAIP, MAcDermid Europe and MacDermid Funding with respect to the Arysta EURO Trance C-1Term Loan and the CAS EURO Tranche C-1 Term Loan. Pursuant to the Security Agreement, the Company's obligations under the Amended and Restated Credit Agreement are secured by a security interest in substantially all of the personal property, whether owned on the date the Security Agreement, or entered into or acquired in the future, of Platform and MacDermid, as borrowers, and the guarantors listed in the Security Agreement, including the pledge by Platform, MacDermid and guarantors generally of 100% of the voting common stock and other equity interests in all of their respective domestic subsidiaries and 65% of the voting common stock and other equity interests in all of their respective directly owned non-domestic subsidiaries (in each case, whether existing on the date the Security Agreement or entered into or acquired thereafter), subject to certain exceptions contained in the Amended and Restated Credit Agreement and the Security Agreement.

November 2015 Notes Offering

In connection with the Alent Acquisition, on November 10, 2015, Platform completed the November 2015 Notes Offering of $500 million in aggregate principal amount of 10.375% USD Notes due 2021. The notes are governed by an indenture, dated November 10, 2015, as amended from time to time, bear an interest at a rate of 10.375% and mature on May 1, 2021, unless earlier redeemed. Interest is payable in cash, semi-annually in arrears, on May 1 and November 1 of each year, commencing on May 1, 2016. The proceeds of this offering were used to fund a portion of the cash consideration for the Alent Acquisition.

February 2015 Notes Offering

In connection with the Arysta Acquisition, on February 2, 2015, Platform completed the February Notes Offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022, plus original issue premium of $1.0 million, and €350 million aggregate principal amount of 6.00% EUR Notes due 2023. The Notes are governed by an indenture, dated February 2, 2015, as amended from time to time. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 mature on February 1, 2022 and February 1, 2023, respectively, unless earlier redeemed. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 bear interest at a rate of 6.50% and 6.00% per year, respectively, until maturity. Interest is payable in cash, semi-annually in arrears, on February 1 and August 1 of each year, beginning on August 1, 2015. The proceeds of this offering were used to fund a portion of the cash consideration for the Arysta Acquisition.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Lines of Credit and Other Debt Facilities

The Company carries various lines of credit, short-term debt facilities and overdraft facilities worldwide which are used to fund short-term cash needs. As of March 31, 2016 and December 31, 2015, borrowings under such facilities totaled $149.2 million and $16.7 million, respectively. The Company also had letters of credit outstanding of $27.4 million and $40.0 million as of March 31, 2016 and December 31, 2015, respectively, of which $10.7 million and $11.0 million reduce the borrowings available under the various credit facilities as of March 31, 2016 and December 31, 2015, respectively. As of March 31, 2016 and December 31, 2015, the availability under these facilities was approximately $472 million and $618 million, respectively, net of outstanding letters of credit.

Financial Guarantees and Factoring Arrangements

The Company periodically enters into certain arrangements with vendors and customers under which it provides guarantees to financial institutions for loans entered into between its vendors and customers and the financial institutions, the proceeds of which are used to settle outstanding accounts receivables. The terms of the guarantees are equivalent to the terms of the customer loans. Liabilities for the guarantees are recorded at amounts that approximate fair value, based on the Company’s historical collection experience with vendors and customers that participate in the program and a current assessment of credit exposure. Such liabilities are included in "Accrued expenses and other current liabilities" in the Company's Condensed Consolidated Balance Sheets, and totaled $42.7 million and $46.3 million as of March 31, 2016 and December 31, 2015, respectively. Program income and expenses are recorded in "Interest expense, net" in the Condensed Consolidated Statements of Operations and totaled zero and $0.2 million for the three months ended March 31, 2016 and 2015, respectively.

The Company also utilizes accounts receivable factoring arrangements as a part of its working capital management strategies. Total current capacity under such programs is approximately $263 million as of March 31, 2016. Under these arrangements, factored accounts receivable may be transferred with or without recourse. Factoring transactions qualifying for sales treatment, where the derecognition criteria have been met, totaled $17.9 million as of March 31, 2016. As of December 31, 2015, such transactions totaled $189 million. Account receivable balances related to arrangements not having met the derecognition criteria, whereas the risks and rewards of ownership have not been transferred, remain recorded in "Account receivable" and the related liabilities are included in "Accrued expenses and other current liabilities" in the Company's Condensed Consolidated Balance Sheets, and totaled $30.9 million and $24.8 million as of March 31, 2016 and December 31, 2015, respectively. Factoring fees are recorded in "Interest expense, net" in the Condensed Consolidated Statements of Operations and totaled $0.2 million and $0.7 million for the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, the Company had additional capacity under its factoring arrangements of approximately $56.3 million, subject to the limitations outlined in its Credit Facilities and other agreements governing outstanding debt.

Some of the Company’s subsidiaries in the United States and the Netherlands periodically enter into arrangements for consignment and/or purchase of precious metals with financial institutions. The present and future indebtedness and liability relating to such arrangements are guaranteed by the Company. The Company’s maximum guarantee liability under these arrangements is limited to an aggregate of $18.0 million. No guarantee liability is recorded by the Company for its subsidiary’s debt to financial institutions.

9. DERIVATIVE INSTRUMENTS

In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, interest rates and commodity prices. Derivative financial instruments, such as foreign currency exchange forward contracts, interest rate swaps and commodities futures contracts are used to manage the risks associated with changes in the conditions of those markets. All derivatives are recognized in the Condensed Consolidated Balance Sheets at fair value at the end of each period. The counterparties to the Company’s derivative agreements are primarily major international financial institutions. The Company continually monitors its positions and the credit ratings of its counterparties and does not anticipate nonperformance by the counterparties.

Foreign Currency

The Company conducts a significant portion of its business in currencies other than the U.S. Dollar, the currency in which the unaudited interim Condensed Consolidated Financial Statements are reported, and as a result, the Company’s operating results are affected by foreign currency exchange rate volatility relative to the U.S. Dollar.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

As of March 31, 2016, the Company held foreign currency forward contracts to purchase and sell various currencies primarily with U.S. Dollars and Euro, with lesser amounts traded with Japanese Yen. The Company has not designated any foreign currency exchange forward contracts as eligible for hedge accounting. The total U.S. Dollar equivalent of foreign currency exchange forward contracts held at March 31, 2016 was approximately $289 million, all of which have settlement dates within one year.

The market value of forward contracts are determined using pricing models based upon observable market inputs including both forward and spot prices for the underlying currencies. The change in the net fair value of the foreign currency forward contracts is recorded in "Loss on derivative contracts" on the accompanying Condensed Consolidated Statements of Operations.

Interest Rates

Changes in the fair value of a derivative that is designated as, and meets all the required criteria for, a cash flow hedge are recorded in "Accumulated other comprehensive income (loss)" and reclassified into earnings as the underlying hedged item affects earnings. Amounts reclassified into earnings related to the interest rate swaps are included in interest expense.

Commodities

As part of its risk management policy, the Company enters into commodities futures contracts on an ongoing basis for the purpose of mitigating its exposure to fluctuations in prices of certain metals it uses in the production of its finished goods. The Company held futures contracts to purchase or sell various metals for a notional amount of $21.8 million and $16.5 million as of March 31, 2016 and December 31, 2015, respectively. The change in the net fair value of the commodities futures contracts is recorded in "Loss on derivative contracts" on the accompanying Condensed Consolidated Statements of Operations.

Certain subsidiaries of the Company have entered into supply agreements with a third party that have been deemed to constitute financing agreements with an embedded derivative feature whose fair value is determined by the change in the market value of the underlying metals between delivery date and measurement date. Assets associated with these supply agreements, which serve as the notional of the embedded derivative, have been recorded in "Inventory" and "Current installments of long-term debt and revolving credit facilities" in the Condensed Consolidated Balance Sheets and totaled $14.5 million and $13 million at March 31, 2016 and December 31, 2015, respectively. The fair value of these contracts has been bifurcated and recorded as a derivative liability in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets and totaled $1.2 million and zero at March 31, 2016, and December 31, 2015, respectively.

The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets:



(amounts in millions)		March 31, 2016			December 31, 2015
		U.S. Dollar Amount			U.S. Dollar Amount
Derivatives designated as hedging instruments	Liabilities Balance Sheet location
Interest rate swaps	Other long-term liabilities	$	(23.5	)	$	(12.5	)
Derivatives not designated as hedging instruments:	Assets Balance Sheet location
Foreign exchange and metals contracts	Prepaid expenses and other current assets	4.3			1.1
Foreign exchange contracts	Other Assets	—			1.0
	Liabilities Balance Sheet location
Foreign exchange and metals contracts	Accrued expenses and other current liabilities	(9.5		)	(1.0		)
Net derivative contract liability		$	(28.7	)	$	(11.4	)

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

interest rate swaps were deemed highly effective with no ineffective portions for cash flow hedge accounting purposes during the three months ended March 31, 2016. During the next twelve months, the Company expects to reclassify $10.9 million from Accumulated Other Comprehensive Income to "Interest expense, net" in the Condensed Consolidated Statements of Operations.

For the three months ended March 31, 2016, the Company recorded realized and unrealized losses of $5.3 million in "Loss on derivative contracts" in the Condensed Consolidated Statements of Operations related to foreign exchange and metals derivative contracts. There was no such activity during the three months ended March 31, 2015.

In the normal course of business, the Company enters into contracts with certain counterparties to purchase and sell foreign currency exchange forwards and metal futures that contain master netting arrangements, typically in the form of an ISDA or similar agreement. The right to set-off within these agreements is limited to certain termination events, such as bankruptcy or default of either party to the agreement. The Company has made an accounting policy decision not to offset and reports gross derivative asset and liability balances in the Condensed Consolidated Balance Sheets. The following table presents recognized foreign currency exchange forward and metal future derivative contracts that are subject to master netting arrangements but not offset, as at March 31, 2016, and shows in the 'Net' column what the net impact would be on the Company's Condensed Consolidated Balance Sheets if all set-off rights were exercised.



Financial assets	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross assets		Gross liabilities offset	Net amounts presented		Financial instruments		Cash collateral received
Derivative assets	$	3.3	—	$	3.3	(0.3	)	$	—		$	3.0

Financial liabilities	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross liabilities		Gross assets offset	Net amounts presented		Financial instruments		Cash collateral pledged
Derivative liabilities	$	7.7	—	$	7.7	(2.2	)	$	(1.9	)	$	3.6

Cash balances pledged as collateral and held in accounts with counterparties are recorded in "Prepaid expenses and other current assets" in the Condensed Consolidated Balance Sheets.

10. FAIR VALUE MEASUREMENTS

The Company determines fair value measurements used in its unaudited interim Condensed Consolidated Financial Statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company uses the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.

Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below, with Level 1 having the highest priority, and Level 3 having the lowest.

The three levels of the fair value hierarchy are as follows:


•	Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.


•	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model-derived valuations whose inputs are observable or whose significant valuation drivers are observable.


•	Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Recurring Fair Value Measurements

The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:



			Fair Value Measurement Using
(amounts in millions)	March 31, 2016		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	9.2	$	1.0	$	8.2	$	—
Available for sale equity securities	6.8		6.2		0.6		—
Derivatives	4.3		—		4.3		—
Total	$	20.3	$	7.2	$	13.1	$	—
Liability Category
Long-term contingent consideration	$	73.5	$	—	$	—	$	73.5
Derivatives	33.0		—		33.0		—
Total	$	106.5	$	—	$	33.0	$	73.5



			Fair Value Measurement Using
(amounts in millions)	December 31, 2015		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	59.4	$	2.9	$	56.5	$	—
Available for sale equity securities	6.6		5.8		0.8		—
Derivatives	2.1		—		2.1		—
Total	$	68.1	$	8.7	$	59.4	$	—
Liability Category
Long-term contingent consideration	$	70.7	$	—	$	—	$	70.7
Derivatives	13.5		—		13.5		—
Total	$	84.2	$	—	$	13.5	$	70.7

The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:

Cash equivalents - Cash equivalents comprise money market accounts and certificates of deposits issued by financial institutions. The Company invests in various money market funds which are managed by financial institutions. These funds are not publicly traded, but historically have been highly liquid. The fair values of the money market accounts are determined by the banks based upon the funds’ NAV. All of the money market accounts currently permit daily investments and redemptions at $1.00 NAV and are classified as Level 1 assets. The Company records certificates of deposit at amortized cost in the Condensed Consolidated Balance Sheets. Given the relatively short maturities of these instruments, the Company believes amortized cost approximates fair value. The Company classifies these instruments as Level 2.

Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held. Level 2 equity securities are measured using quoted prices for similar instruments in active markets. Available for sale securities are included in "Other assets" in the Condensed Consolidated Balance Sheets.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Derivatives - Derivative assets and liabilities include foreign currency, metals and interest rate derivatives. The values were determined using pricing models based upon observable market inputs, such as market spot and futures prices on over-the-counter derivative instruments, market interest rates and consideration of counterparty credit risk.

Long-term contingent consideration - The long-term contingent consideration represents a potential liability of up to $100 million tied to achievement of EBITDA and common stock trading price performance metric over a seven-year period ending December 2020 in connection with the MacDermid Acquisition. The common stock performance metric has been satisfied. The fair value of the EBITDA performance metric is derived using the income approach with unobservable inputs, based on future forecasts and present value assumptions which include a discount rate of approximately 1.19% and expected future value of payments of $60.0 million calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Changes in the fair value of the long-term contingent consideration are recorded in "Selling, technical, general and administrative expenses" in the Consolidated Statements of Operations. Relative to the share price metric, an increase or decrease in the discount rate of 1% changes the fair value measure of the metric by approximately $2.0 million. Relative to the EBITDA metric, an increase or a decrease in the discount rate of 1%, within a range of probability between 80% and 100%, changes the fair value measure of the metric by approximately $3.0 million.

The following table provides a reconciliation of the beginning and ending balances for the three months ended March 31, 2016 for instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3):



(amounts in millions)	Long-term contingent consideration
Fair value measurements using significant unobservable inputs (Level 3)	March 31, 2016
Beginning balance	$	70.7
Changes in fair value	2.8
Purchases, sales and settlements ⁽¹⁾	—
Transfers into Level 3	—
Transfers out of Level 3	—
Ending balance	$	73.5

⁽¹⁾ There were no purchases, sales or settlements on a gross basis during the three months ended March 31, 2016.

The Company consistently applies its policy for transfers between fair value hierarchy levels as disclosed in the Company's Annual Report. There were no significant transfers between the fair value hierarchy levels for the three months ended March 31, 2016.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Nonrecurring Fair Value Measurements

The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations:



(amounts in millions)	March 31, 2016				December 31, 2015
	Carrying Value		Fair Value		Carrying Value		Fair Value
USD Notes, due 2022	$	1,081.9	$	932.3	$	1,081.1	$	946.3
EUR Notes, due 2023	392.2		333.1		374.0		326.7
USD Notes, due 2021	488.0		485.0		487.5		500.0
First Lien Credit Facility	733.7		711.8		735.6		710.3
USD Incremental Loan	290.4		286.4		290.8		285.8
CAS U.S. Dollar Tranche B Term Loan	122.0		124.1		121.9		123.9
Arysta U.S. Dollar Tranche B-2 Term Loan	480.7		478.9		481.2		477.7
Alent U.S. Dollar Tranche B-3 Term Loan	1,001.5		1,008.6		1,001.8		1,005.9
CAS EURO Tranche C-1 Term Loan	228.8		223.9		219.0		215.4
Arysta EURO Tranche C-1 Term Loan	91.2		90.8		87.2		87.5
Alent EURO Tranche C-2 Term Loan	327.7		341.5		313.0		321.4
Enthone financing liability	14.5		14.5		13.0		13.0
Capital lease obligations	5.5		5.3		5.5		5.3
Total	$	5,258.1	$	5,036.2	$	5,211.6	$	5,019.2

Carrying values presented above include unamortized premiums, discounts and debt issuance costs.

The following methods and assumptions were used to estimate the fair value of the Company’s long-term debt:

Long-term Debt Instruments - These financial instruments are measured using quoted market prices at the reporting date multiplied by the gross carrying amount of the related debt which excludes unamortized premiums, discounts and debt issuance costs. Such instruments are valued using Level 2 inputs.

11. STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue 5,000,000 shares of preferred stock. The Board has designated 2,000,000 of those shares as "Series A Preferred Stock." As of March 31, 2016 and December 31, 2015, a total of 2,000,000 shares were issued and outstanding. The Board has also designated 600,000 of those shares as "Series B Convertible Preferred Stock," which are redeemable and are presented in the mezzanine section of the Company's Condensed Consolidated Balance Sheets. As of March 31, 2016 and December 31, 2015, a total of 600,000 shares were issued and outstanding. Shares of preferred stock have no voting rights, except in respect of any amendment to the Company's Certificate of Incorporation, as amended, that would alter or change their rights or privileges.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Series A Preferred Stock

The Founder Entities are the current holders of Platform's outstanding 2,000,000 shares of Series A Preferred Stock. Each share of Series A Preferred Stock is convertible into one share of common stock at the option of the holders until December 31, 2020. All outstanding shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (which may be extended by the Board for three additional years).

Holders of Series A Preferred Stock are entitled to receive dividends in the form of shares of common stock. The dividend amount is calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends, which is currently $22.85.

Series B Convertible Preferred Stock

In connection with the Arysta Acquisition, the Company issued to the Arysta Seller 600,000 shares of Series B Convertible Preferred Stock, which have a $1,000 per share liquidation preference. The fair value of these shares, $646 million, was recognized as "Redeemable preferred stock – Series B" in the Condensed Consolidated Balance Sheets. At any time, the Arysta Seller may convert these shares into common stock of Platform at a conversion price of $27.14. Additionally, any shares that have not previously been converted will be automatically redeemed at a $1,000 redemption price in the event of certain mergers or consolidations, the sale of all or substantially all of the Company’s assets or subsidiaries, the sale of certain subsidiaries of the Company or the approval of any plan for the dissolution, liquidation or termination of the Company by its stockholders. Pursuant to the terms of the Arysta share purchase agreement, on April 20, 2017, the Company may be required to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed as described above at the $1,000 redemption price payable in shares of the Company's common stock (22,107,590 shares of common stock valued at $27.14 per share). Upon such repurchase, the Company may also pay to holders of Series B Convertible Preferred Stock in cash any deficit between (i) the 10-day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. To the extent the Arysta Seller continues to own Series B Convertible Preferred Stock, then, if as a result of the March 2013 arbitration matter described in Note 15, Contingencies, Environmental and Legal Matters, to the unaudited interim Condensed Consolidated Financial Statements, the Arysta Seller is obligated to make a payment to us, we may offset any make-whole payment due to the Arysta Seller by any such amount due from the Arysta Seller. If such make whole payment is less than the amount resolved in connection with this arbitration matter, the deficit will be due from the Arysta Seller. Based on Platform's common stock price of $8.60 as of March 31, 2016, the maximum potential make whole payment would total approximately $410 million, assuming no impact from the March 2013 arbitration matter described in Note 15, Contingencies, Environmental and Legal Matters. The holders of Series B Convertible Preferred Stock are also entitled to an incremental payment equal to $4.0 million per month from October 20, 2016 to April 20, 2017, or such earlier date after October 20, 2016 that the then outstanding shares of Series B Convertible Preferred Stock are converted into shares of common stock or automatically redeemed by Platform.

Non-Controlling Interest

In connection with the MacDermid Acquisition, approximately $97.5 million was raised in new equity consisting of shares of PDH Common Stock. Since October 31, 2014, all shares of PDH common stock are convertible, at the option of the holder, into a like number of shares of the Company's common stock, the sale of which is subject to a contractual lock-up of 25% per year over a four-year period, which started on October 31, 2013.

The PDH Common Stock is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at March 31, 2016 and December 31, 2015 and will continue to be until such time as it is fully converted into shares of the Company's common stock. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately 8.8 million, against which 729,417 shares have been issued as of March 31, 2016.

For the three months ended March 31, 2016 and 2015, approximately $(1.2) million and $5.4 million, respectively, of net (loss) income has been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations, representing non-controlling interest of 6.24% and 6.65% at March 31, 2016 and 2015, respectively.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

12. ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME

Changes in each component of accumulated other comprehensive (loss) income, net of tax for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31, 2016
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation			Non-Controlling Interests			Accumulated Other Comprehensive Loss
Balance at December 31, 2015	$	(899.3	)	$	(26.3	)	$	1.2		$	(8.1	)	$	46.4		$	(886.1	)
Other comprehensive (loss) income before reclassifications, net	321.5			—			(0.4		)	(13.9		)	(11.7		)	295.5
Reclassifications, pretax	—			—			—			2.9			—			2.9
Tax benefit reclassified	—			—			—			—			—			—
Balance at March 31, 2016	$	(577.8	)	$	(26.3	)	$	0.8		$	(19.1	)	$	34.7		$	(587.7	)



	Three Months Ended March 31, 2015
	(as restated)
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation		Non-Controlling Interests		Accumulated Other Comprehensive Loss
Balance at December 31, 2014	$	(122.2	)	$	(14.9	)	$	0.1		$	—	$	6.4	$	(130.6	)
Other comprehensive (loss) income before reclassifications, net (as restated)	(352.5		)	—			(0.1		)	—		8.7		(343.9		)
Tax expense reclassified	—			(0.5		)	—			—		—		(0.5		)
Balance at March 31, 2015	$	(474.7	)	$	(15.4	)	$	—		$	—	$	15.1	$	(475.0	)

13. EARNINGS PER SHARE

A computation of the weighted average shares outstanding for the three months ended March 31, 2016 and 2015 follows:



	Three Months Ended March 31,
(amounts in millions, except per share amounts)	2016			2015
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

Basic weighted average common stock outstanding	229.5			191.9
Convertible and performance-based stock ⁽¹⁾	—			—
Dilutive weighted average common stock outstanding	229.5			191.9
Loss per share attributable to common stockholders:
Basic	$	(0.59	)	$	(0.14	)
Diluted	$	(0.59	)	$	(0.14	)

Dividends per share paid to common shareholders	$	—		$	—

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

⁽¹⁾ For the three months ended March 31, 2016 and 2015, no share adjustments are included in the dilutive weighted average shares outstanding computation as their effect would have been anti-dilutive. For more information about such dilutive shares outstanding, refer to the table below.

For the three months ended March 31, 2016 and 2015, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance. These securities may become dilutive in future periods.



	Three Months Ended March 31,
(amounts in thousands)	2016	2015
Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock	—	2,168
Shares issuable upon conversion of PDH Common Stock	8,052	8,619
Shares issuable upon conversion of Series A Preferred Stock	2,000	2,000
Shares issuable upon conversion of Series B Convertible Preferred Stock	22,108	11,299
Shares contingently issuable for the contingent consideration	8,704	1,333
Stock options	—	87
Restricted stock shares and units	—	57
Shares issuable under the ESPP	1	—
	40,865	25,563

14. OPERATING LEASE COMMITMENTS

The Company leases certain land, office space, warehouse space and equipment under agreements which are classified as operating leases for financial statement purposes. Certain of these leases provide for payment of real estate taxes, common area maintenance, insurance and certain other expenses. Lease terms may have escalating rent provisions and rent holidays which are recognized on a straight-line basis over the term of the lease. The leases expire at various dates through 2055.

Total rent expense for operating leases was as follows:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Rent Expense	$	9.1	$	4.3

Minimum non-cancelable operating lease commitments were as follows:



(amounts in millions)	Operating Lease Payment
As of March 31, 2016	Operating Lease Payment
2016, remaining	$	24.7
2017	23.3
2018	15.1
2019	10.3
2020	8.6
2021	7.8
Thereafter	27.9
	$	117.7

The fixed operating lease commitments detailed above assume that the Company continues the leases through their initial lease terms.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

15. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS

Asset Retirement Obligations

The Company has recognized AROs, for properties where it can make a reasonable estimate of the future expenditures necessary to satisfy the related obligations. The Company considers identified legally enforceable obligations, estimated settlement dates and appropriate discount and inflation rates in calculating the fair value of its AROs.

As of March 31, 2016 and December 31, 2015, the Company's ARO reserves, included in other short and long-term liabilities in the Condensed Consolidated Balance Sheets, totaled $18.3 million and $17.5 million, respectively.

Changes in the Company’s AROs were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
AROs, beginning of period	$	17.5		$	18.5
Accretion expense	0.2			0.3
Remeasurements	0.1			—
Payments	(0.2		)	—
Foreign currency adjustments	0.7			(1.4		)
AROs, end of period	$	18.3		$	17.4

Environmental

The Company formulates and distributes specialty chemical products and is therefore subject to extensive domestic and foreign environmental protection laws and regulations, including those governing the management, discharge and disposal of hazardous material and pollutants into the soil, air and water, as well as laws and regulations governing workers' health and safety. As a result, the Company is exposed to risks of liability or claims with respect to environmental clean-up of contaminated facilities or other matters, including those in connection with the disposal or releases of, or exposure to, hazardous materials. The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations. Additional costs could be incurred, including clean-up costs, fines, sanctions, and third-party claims, as a result of violations of or liabilities under environmental laws.

Among other environmental laws, the Company is subject to the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (commonly known as Superfund), under which the Company may be designated as a “potentially responsible party,” or PRP, with respect to clean-up costs associated with sites on the U.S. Environmental Protection Agency National Priority List. The Company conducts studies, individually or jointly with other PRPs, to determine the feasibility of various remedial techniques. It is the Company's policy to record appropriate liabilities for environmental matters when remedial efforts or damage claim payments are probable and the costs can be reasonably estimated. Such liabilities are based on the Company's best estimate of the undiscounted future costs required to complete the remedial work. The recorded liabilities are adjusted periodically as remediation efforts are determined.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties.

In particular, Alent, which the Company acquired in December 2015, had reserved approximately £15.3 million ($22.0 million based on the GBP/USD exchange rate of 1.4362 on March 31, 2016) for potential liability in connection with environmental remediation, clean-up costs, and monitoring of sites that were either closed or disposed of in prior years. These sites are in various stages of environmental management: at some sites, the work is in the early stages of assessment and investigation, while at others, the clean-up remedies have been implemented and the remaining work consists of monitoring the integrity of those remedies. These sites also include federal or state Superfund sites. Because the laws pertaining to Superfund sites generally impose retroactive, strict, joint and several liability, a governmental plaintiff could seek to recover all remediation costs at any such site from any of the PRPs for such site, including us, despite the involvement of other PRPs. The Company is one of several identified PRPs, in

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

the aforementioned Superfund sites. The Company believes that the liability associated with these sites has been apportioned based on the type and amount of waste disposed by each PRP at such disposal site and the number of financially solvent PRPs. In many cases, the nature of future environmental expenditures cannot be quantified with accuracy.

The Company does not currently anticipate any material losses in excess of the reserve amount recorded. However, it is possible that new information about these sites, such as results of investigations, could make it necessary for the the Company to reassess its potential exposure related to these environmental matters. As the settlement of many of the obligations for which provision is made is subject to legal or other regulatory process, the timing of the associated cash outflows is subject to some uncertainty, but the majority of the amounts provided are expected to be utilized over the next five to ten years.

As of March 31, 2016 and December 31, 2015, the Company's environmental reserves totaled $23.8 million and $25.7 million, respectively. Management does not believe it is possible to develop an estimate of the range of reasonably possible environmental loss in excess of the Company's recorded liabilities. As of the date hereof, management believes that any possible losses related to environmental remediation in addition to the amounts recorded as of March 31, 2016 and December 31, 2015 would not be material to the Company’s consolidated financial position, results of operations or cash flows.

Legal Proceedings

From time to time, the Company is involved in various legal proceedings in the normal course of its business. The Company believes that the resolution of these claims, to the extent not covered by insurance, will not individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. As of March 31, 2016 and December 31, 2015, the Company has reserved approximately $12.9 million and $6.5 million, respectively, for its outstanding legal proceedings. The following is a description of certain litigation matters.

Product liability and/or personal injury claims for, or relating to, products the Company sells under its Agricultural Solutions segment are complex in nature and have outcomes that are difficult to predict. Since these products are used in the food chain on a global basis, any such product liability or personal injury claim could lead to litigation in multiple jurisdictions. During 2014, Agricola Colonet, SA de CV claimed that certain Arysta products purchased from a retail distributor in Mexico were contaminated, requiring treated crops to be destroyed. Agricola Colonet, SA de CV is seeking compensation of approximately MXN 182 million ($10.5 million, based on the MXN/ USD exchange rate of 0.0579 on March 31, 2016). The Company believes that it has adequate defenses and intends to vigorously defend against this claim. Under its risk management policies, the Company maintains certain insurance policies under which such claims may be covered.

In March 2013, a claim was filed against Arysta LifeScience Corporation, a subsidiary of the Company, relating to a purchasing optimization agreement entered into in 2011 between Arysta LifeScience Corporation and a consulting firm. The agreement provided for an incentive fee to be paid to the plaintiff based upon savings to Arysta resulting from the plaintiff's work. In addition to fees already received, the plaintiff claims damages, which the Company considers to be immaterial. The Company believes this claim is without merit and that the fees already paid under the agreement exceed or equal the fees owed to the plaintiff. An arbitration hearing was conducted in May 2014, and in May 2015 the tribunal published a partial award, ruling on various issues of principle, but declining to calculate an award amount, rather asking the parties to attempt to agree upon a calculation reflecting the decisions of the tribunal set out in the award. In April 2016, the tribunal awarded the plaintiff $0.1 million pursuant to the agreement. In addition, the tribunal ordered the plaintiff to pay to Arysta LifeScience Corporation the amount of $0.6 million, which represents a portion of Arysta LifeScience Corporation's total legal costs, with each party bearing 50% of the arbitration costs. Finally, the tribunal dismissed any and all other claims in this arbitration. The plaintiff can seek to "correct" the award within 30 days or to vacate the award in a judicial proceeding. We believe that the plaintiff has no grounds for any of these actions.

The $600 million of Series B Convertible Preferred Stock issued in connection with the Arysta Acquisition may be converted into a maximum of 22,107,590 shares of Platform common stock. To the extent that the aggregate value of such shares is less than $600 million (based on a 10-day volume weighted average price), then, such shortfall would be payable in cash by Platform. Such shortfall would however be reduced by a portion, or all, of the amount for which the March 2013 arbitration matter described in the preceding paragraph may be resolved, either by order of the arbitrators or by settlement, pursuant to a formula negotiated by and between the Company and the Arysta Seller.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

site owned and operated by an unaffiliated third party in the state of Pará, Brazil. Arysta Brazil was summoned and has filed its answer in connection with both cases. Proceedings have been suspended indefinitely in order to allow the Pará State Attorney to conduct civil inquiries to determine the extent of contamination and the appropriate remediation, and to identify potentially responsible parties. Damages sought in the private lawsuit include a penalty of BRL 50.0 million ($13.9 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016), plus interest and the cost of remediation. The cost of remediation in the case brought by the city of Ulianopolis was previously estimated by the city to be BRL 70.9 million ($19.8 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016). In addition, 29 former employees of the incineration facility have brought actions naming 80 defendants, including Arysta Brazil, seeking compensation in an aggregate amount of BRL 387 million ($108 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016) for health problems allegedly contracted as a result of their employment at the incineration site.

From time to time, in the ordinary course of our business, we contest tax assessments received by our subsidiaries in various jurisdictions. Our contested tax assessments have been most prevalent in Brazil, where the tax regime is complex, and the administrative and judicial procedures for resolving disputed tax assessments are expensive and time-consuming. In addition, short of simply paying the entire amount demanded, including penalties, interest, and attorney’s fees, it is not possible to settle disputed tax assessments other than by submission for inclusion in formal tax amnesty programs announced by the Brazilian federal or state governments from time to time at irregular intervals. The terms of such amnesty programs vary, but generally offer the possibility of reduced interest and penalties. Historically, Arysta has submitted selected contested tax matters for inclusion in such amnesty programs in Brazil, when it appeared prudent to management to do so. The Company is currently contesting several tax assessments at various stages of the applicable administrative and judicial processes, with a combined amount at issue, including interest and penalties, of approximately BRL 77.6 million ($21.6 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016). Because tax matters in Brazil historically take many years to resolve, it is very difficult to estimate when these matters will be finally resolved. Based on management's judgments, the Company does not expect it will incur a material loss in excess of accrued liabilities.

In July 2014, a federal court jury found in favor of MacDermid Printing Solutions LLC in litigation against Cortron, Inc. The court entered a judgment in the amount of approximately $64.7 million. Cortron, Inc. has appealed the verdict. Accordingly, MacDermid Printing Solutions LLC’s ability to collect on the judgment is uncertain. All proceeds from this litigation are subject to the pending litigation provisions of the Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

In September 2014, the U.S. District Court for the District of New Jersey rendered a summary judgment in favor of MacDermid in this patent litigation with E.I. du Pont de Nemours and Company. The Court issued summary judgment rulings in favor of MacDermid finding certain E.I. du Pont de Nemours and Company’s patents invalid and not infringed. These rulings summarily find against E.I. du Pont de Nemours and Company on all of the patent claims asserted by E.I. du Pont de Nemours and Company in this lawsuit. The ruling, however, leaves the counterclaims made by MacDermid against E.I. du Pont de Nemours and Company in place. E.I. du Pont de Nemours has appealed the summary judgment and accordingly, the final judgment remains uncertain. All proceeds from this litigation are subject to the pending litigation provisions of the Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

In February 2015, MacDermid, as plaintiff, settled a litigation with Cookson Group plc, Enthone Inc., Cookson Electronics and David North, as defendants, for $25.0 million. The litigation related to certain corporate activities that occurred between MacDermid and the defendants in 2006 and 2007. On April 3, 2015, the Company received part of the settlement in the amount of $16.0 million, and placed the remainder, net of legal costs, into escrow for future distribution in accordance with the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

In March and April 2016, a class action lawsuit entitled Dillard v. Platform Specialty Products Corporation, et al. and a shareholder derivative action entitled Tuttelman v. Platform Specialty Products Corporation, et al., respectively, were filed against Platform, certain of its former and current executive officers and, in the case of the derivative action, its directors in the U.S. District Court for the Southern District of Florida alleging that the defendants made material false and misleading statements relating to the Company's business, operational and compliance policies in light of certain matters discovered and reported by the Company itself in connection with a Company internal investigation into certain past business practices of the Company's Arysta West Africa business, as disclosed herein and in the Annual Report. Both actions are seeking unspecified damages. The Company believes these proceedings are without merit and intends to defend them vigorously.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

16. INCOME TAXES

For the three months ended March 31, 2016 and 2015, income tax expense totaled $18.4 million and $24.7 million, respectively. The Company's effective tax rate in the first quarter of 2016 was (15.9)% on pre-tax losses of $116 million, compared to an effective tax rate of (1,547)% on pre-tax losses of $1.6 million in the first quarter of 2015. The difference between the statutory and effective tax rates for the three months ended March 31, 2016 principally relates to the recognition of a $59.6 million valuation allowance on current quarter losses related to net operating losses that may not be recoverable for U.S. and foreign companies.

The amount of unrecognized tax benefits was $118 million and $112 million at March 31, 2016 and December 31, 2015, respectively, of which $92.8 million, if recognized, would reduce the Company's effective tax rate. Accrued interest and penalties related to unrecognized tax benefits were $18.8 million and $17.5 million at March 31, 2016 and December 31, 2015, respectively. The Company recognized interest and penalties of $1.0 million and $0.3 million related to unrecognized tax benefits in the income tax provision for the three months ended March 31, 2016 and 2015, respectively. The unrecognized tax benefits could be reduced by $10.0 million over the next 12 months as a result of the lapse of statutes of limitations in various jurisdictions.

17. RELATED PARTY TRANSACTIONS

RHSA

Immediately prior to the closing of the MacDermid Acquisition, each Retaining Holder entered into a RHSA pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for shares of PDH Common Stock, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder, (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven-year period following the closing of the MacDermid Acquisition. The resulting non-controlling interest percentage for the Retaining Holders was 6.24% at March 31, 2016 and 6.25% at December 31, 2015.

Advisory Services Agreement

The Company is party to an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of our founder directors, whereby Mariposa Capital, LLC is entitled to receive an annual fee equal to $2.0 million, payable in quarterly installments. This agreement is automatically renewed for successive one-year terms unless either party notifies the other party in writing of its intention not to renew no later than 90 days prior to the expiration of the term. For each of the three month periods ended March 31, 2016 and 2015, the Company incurred advisory fees under the agreement totaling $0.5 million.

18. RESTRUCTURING

The Company continuously evaluates all operations to identify opportunities to improve profitability by leveraging existing infrastructure to reduce operating costs and respond to overall economic conditions.

Restructuring expenses were recorded as follows in each of the Company's segments:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Performance Solutions	$	4.2	$	1.5
Agricultural Solutions	0.9		0.1
Total restructuring	$	5.1	$	1.6

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

March 31, 2016 and December 31, 2015, restructuring liabilities totaled $0.4 million and $1.1 million, respectively, and were included in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets.

Restructuring expenses were recorded as follows in the Condensed Consolidated Statements of Operations:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Cost of sales	$	(0.4	)	$	—
Selling, technical, general and administrative	5.5			1.6
Total restructuring	$	5.1		$	1.6

19. SEGMENT INFORMATION

The Company's operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM.

Performance Solutions - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, commercial packaging and printing, electronics, and oil and gas production and drilling. Its products include surface and coating materials, functional conversion coatings, electronics assembly materials, water-based hydraulic control fluids and photopolymers. Performance Solutions products are sold worldwide. In conjunction with the sale of its products, extensive technical service and support is provided to ensure superior performance. Within this segment, the Company provides specialty chemicals to the following industries: Electronics, Commercial Packing and Printing, Industrial, and Offshore. For the electronics industry, the segment designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of the printed circuit boards and other electronic components they manufacture. For the electronics industry, it also develops, manufactures and sells innovative interconnect materials used to assemble printed circuit boards and advanced semiconductor packaging. For the commercial packaging and printing industries, the segment produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment also produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. For the industrials, the segment's dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the offshore industry, the segment produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications.

Agricultural Solutions - The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. It offers to growers diverse crop-protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. The segment also offers a wide variety of proven biosolutions, including biostimulants, innovative nutrition and biocontrol products. It emphasizes on farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. Its Global Value Added Portfolio, or GVAP, consists of agrochemicals in the fungicides, herbicides, insecticides and seed treatment categories, based on patented or proprietary off-patent AIs. Its Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. The segment considers its GVAP and GBP offerings to be key pillars for sustainable growth. In addition, the segment offers regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines.

The Company evaluates the performance of its operating segments based on net sales and adjusted EBITDA. Adjusted EBITDA for each segment is defined as earnings before interest, taxes, depreciation and amortization, as further adjusted for additional items included in earnings that are not representative or indicative of our ongoing business Adjusted EBITDA for each segment also includes an allocation of corporate costs such as corporate salaries, wages, equity compensation expenses and legal costs.

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented.



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Net Sales (from external customers):
Performance Solutions	$	420.0	$	180.3
Agricultural Solutions	403.8		354.5
Consolidated net sales	823.8		534.8
Adjusted EBITDA:
Performance Solutions	$	83.0	$	49.0
Agricultural Solutions	85.4		83.1
Adjusted EBITDA	$	168.4	$	132.1

The following table reconciles Adjusted EBITDA to Net loss attributable to common stockholders:



	Three months ended March 31,
(amounts in millions)	2016			2015
Adjusted EBITDA	$	168.4		$	132.1
Adjustments to reconcile to net loss attributable to common stockholders:
Interest expense, net	(93.8		)	(39.4		)
Depreciation expense	(18.2		)	(8.4		)
Amortization expense	(64.4		)	(39.8		)
Long-term compensation issued in connection with acquisitions	(0.3		)	(1.5		)
Restructuring expenses	(5.1		)	(1.6		)
Manufacturer's profit in inventory purchase accounting adjustments	(12.0		)	(36.1		)
Acquisition and integration costs	(18.9		)	(31.3		)
Non-cash change in fair value of contingent consideration	(2.8		)	(2.7		)
Acquisition put option expiration	—			3.0
Foreign exchange (loss) gains on foreign denominated external and internal debt	(66.1		)	24.1
Other expenses	(2.8		)	—
Net loss before income taxes and non-controlling interests	(116.0		)	(1.6		)
Income tax expense	(18.4		)	(24.7		)
Net income attributable to the non-controlling interests	(0.4		)	(0.4		)
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

20. RESTATEMENT OF UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The tables below present the impact of the restatement on the applicable statements and footnotes as of and for the thee month ended March 31, 2015:

Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As Restated
Other comprehensive income (loss), before tax
Foreign currency translation adjustments:	$	(425.3	)	$	72.8	$	(352.5	)

Total other comprehensive income (loss), net of tax	$	(425.9	)	$	72.8	$	(353.1	)
Other comprehensive income (loss) attributable to common shareholders	(417.2		)	72.8		(344.4		)

Comprehensive income (loss)	$	(443.5	)	$	72.8	$	(370.7	)
Comprehensive income (loss) attributable to common stockholders	(443.9		)	72.8		(371.1		)

Condensed Consolidated Balance Sheet (unaudited)



	March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Assets
Goodwill	$	2,908.9		$	72.8	$	2,981.7
Total Assets	8,067.9			72.8		8,140.7

Stockholders' Equity
Accumulated other comprehensive loss	$	(547.8	)	$	72.8	$	(475.0	)
Total stockholders' equity	2,017.6			72.8		2,090.4
Total equity	2,126.7			72.8		2,199.5
Total liabilities, redeemable preferred shares and stockholders' equity	8,067.9			72.8		8,140.7

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Condensed Consolidated Statement of Cash Flows (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustments			As Restated
Cash flows from operating activities:
Net cash flows (used in) provided by operating activities	$	(70.0	)	$	72.8		$	2.8
Cash flows from investing activities:
Acquisition of businesses, net of acquired cash	$	(2,789.3	)	$	(72.8	)	$	(2,862.1	)
Net cash flows used in investing activities	(2,218.3		)	(72.8		)	(2,291.1		)

Condensed Consolidated Statement of Changes in Stockholder's Equity (unaudited)



	Other Comprehensive loss, net of taxes for the three months ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(417.2	)	$	72.8	$	(344.4	)
Total Stockholders' Equity	(417.2		)	72.8		(344.4		)
Total Equity	(425.9		)	72.8		(353.1		)



	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(547.8	)	$	72.8	$	(475.0	)
Total Stockholders' Equity	2,017.6			72.8		2,090.4
Total Equity	2,126.7			72.8		2,199.5

In addition to the impacts on the above financial statements, the error correction had an impact on disclosures in the following footnotes to the quarterly report for the period ended March 31, 2015.

Note 2, Acquisitions of Businesses



(in millions)	Arysta Purchase Price Allocation
(in millions)	As Previously Reported		Adjustment		As restated
Consideration
Cash, net	$	2,789.1	$	72.8	$	2,861.9

Goodwill	$	1,697.1	$	72.8	$	1,769.9

Total purchase price	$	3,435.0	$	72.8	$	3,507.8

Goodwill recorded in connection with the Arysta, CAS and Agriphar Acquisitions	$	2,151.5	$	72.8	$	2,224.3

PLATFORM SPECIALTY PRODUCTS CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Note 5, Goodwill and Intangible Assets



	Changes in carrying amount of Agricultural Solutions goodwill for the three months ended March 31, 2015
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	1,986.8		72.8		2,059.6

	Changes in carrying amount of Total goodwill
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	2,908.9		72.8		2,981.7

Note 12, Accumulated Other Comprehensive (Loss) Income



	Changes in Other comprehensive income (loss) before reclassifications, net for the three month ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(425.3	)	$	72.8	$	(352.5	)
Accumulated Other Comprehensive Loss	(416.7		)	72.8		(343.9		)

	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(547.5	)	$	72.8	$	(474.7	)
Accumulated Other Comprehensive Loss	(547.8		)	72.8		(475.0		)

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Information

From time to time, Platform may make or publish forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect Platform’s current views with respect to, among other things, future events and performance. These statements may discuss, among other things, Platform’s financial or operational results including earnings guidance, future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; business and management strategies; and the effects of global economic conditions on Platform’s business. Platform generally identifies forward-looking statements by words such as “plans,” “expects,” “is expected,” “is subject to,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” “believes,” “targets,” “aims,” “projects” or words or terms of similar substance or the negative thereof, as well as variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “should,” “would,” “might” or “will” be taken, occur or be achieved. Forward-looking statements are based on beliefs and assumptions made by management using currently available information. These statements are only predictions and are not guarantees of future performance, actions or events. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying beliefs and assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Factors that can cause actual results to differ materially from those reflected in the forward-looking statements include, among others, those discussed in Part I, Item 1A of Platform's Annual Report under the heading "Risk Factors," and elsewhere in this Quarterly Report. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties, and we urge you not to place undue reliance on any forward looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Also, historical results are not necessarily indicative of the results expected for any future period. You are advised to consult any further disclosures we make on related subjects in the Company’s Form 10-K, 10-Q and 8-K reports filed with the SEC.

The following “Executive Overview” section is a brief summary of the significant items addressed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Investors should read the relevant portions of this section for a complete discussion of the items summarized below.

Executive Overview

We are a global, diversified producer of high-technology specialty chemical products. Our business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. We refer to our products as “dynamic chemistries” due to their intricate chemical compositions. Our dynamic chemistries are used in a wide variety of attractive niche markets and we believe that the majority of our operations hold strong positions in the product markets they serve.

Our strategy is to acquire and maintain leading positions in niche sectors of high-growth markets. As our name “Platform Specialty Products Corporation” implies, we continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses on a global basis, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing extensive resources to research and development and highly technical customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially and fiscally prudent. To date, we have completed seven acquisitions: the MacDermid Acquisition on October 31, 2013, the Agriphar Acquisition on October 1, 2014, the CAS Acquisition on November 3, 2014, the Arysta Acquisition on February 13, 2015, the OMG Acquisition on October 28, 2015, the Alent Acquisition on December 1, 2015 and the OMG Malaysia Acquisition on January 31, 2016.

We generate revenue through the formulation and sale of our dynamic chemistries and by providing highly-technical services to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the intricate chemical composition and function of our products are maintained as intended while ensuring that these products are applied safely and effectively by users globally.

We believe that the fragmented nature of the specialty chemical products market will continue to provide significant opportunities for growth. We also believe that our combined company provides a strong platform on which to grow our business and expand our market shares in key geographic markets, particularly in emerging markets. We expect that the Acquisitions will enhance our growth by extending our products breadth, developing higher-margin products and growing internationally. We intend to extend many of our product offerings through the development of new applications for our existing products or through synergistic

combinations. Our goal is to target those geographies with attractive market fundamentals where our strengths in marketing, portfolio development, registration and customer education can add value for our customers.

As previously disclosed in our Annual Report, in connection with the implementation of internal controls at Arysta, a newly acquired subsidiary, we discovered certain payments made to third-party agents in connection with Arysta’s government tender business in West Africa which may be illegal or otherwise inappropriate. We have engaged outside counsel and an outside accounting firm to conduct an internal investigation to review the legality of these and other payments made in Arysta’s West Africa tender business, including Arysta’s compliance with the FCPA. We contacted the SEC and the U.S. Department of Justice to voluntarily inform them of this matter and we are fully cooperating with these governmental authorities as the investigation continues and as they review the matter. Although the internal investigation is still ongoing at the time of this Quarterly Report, based on the results to date, management does not currently believe that the amount of the payments in question, or any revenue or operating income related to those payments, are material to our business, results of operations, financial condition or liquidity.

As previously disclosed in our quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of $72.8 million occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report. We subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million, and therefore further concluded that the previously reported information should no longer be relied upon. As a result, we restated our unaudited Condensed Consolidated Statement of Comprehensive Income, Condensed Consolidated Balance Sheet, Condensed Consolidated Statement of Cash Flows, Condensed Consolidated Statement of Changes in Stockholders' Equity and related notes, for and as of the three months ended March 31, 2015. This restatement is included in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included herein. The error had no impact on the net decrease in cash and cash equivalents for the quarter ended March 31, 2015 and cash balances as of March 31, 2015. Further, the restatement does not impact our quarterly reports on Form 10-Q for the quarters ended June 30, 2015 and September 30, 2015, our Annual Report or our adjusted EBITDA or pro forma adjusted earnings per share, both non-U.S. GAAP measures, as previously reported in Platform's earnings release issued on May 12, 2015 and subsequent earnings releases for the remainder of 2015.

Non-U.S. GAAP Financial Measures

In this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain financial measures related to our business that are “non-U.S. GAAP financial measures” within the meaning of Item 10 of Regulation S-K. Such non-U.S. GAAP financial measures include adjusted net sales change, adjusted cost of sales change, adjusted gross profit change, adjusted selling, technical, general and administrative expense change, adjusted research and development expense change and adjusted operating profit change, in each case adjusted for the Acquisitions for all periods presented and foreign currency translations. We have presented both U.S. GAAP and adjusted financial information to better provide investors with measures that allow them to more readily compare our performance, including, among other things, giving investors additional information regarding our organic performance without giving effect to the Acquisitions and the impact of translating foreign currencies into U.S. Dollars and the impact of currency rate changes on foreign currency denominated transactions. However, these non-U.S. GAAP financial measures should be considered in addition to, and not a substitute for, the financial information that we report in accordance with U.S. GAAP.

Acquisitions

OMG Malaysia Acquisition

On January 31, 2016, we completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments.

We financed the OMG Malaysia Acquisition with the proceeds from the June 2015 Equity Offering.

Alent Acquisition

On December 1, 2015, we completed the Alent Acquisition by acquiring all the issued shares of Alent for approximately $1.74 billion in cash, net of acquired cash, and 18,419,738 shares of our common stock issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent.

We financed the Alent Acquisition with (i) available cash on hand, (ii) the proceeds from the November 2015 Notes Offering of $500 million aggregate principal amount of 10.375% USD Notes due 2021, and (iii) additional borrowings of $1.05 billion (less

original issue discount of 2%) through the establishment of the Alent U.S. Dollar Tranche B-3 Term Loan, approximately €300 million (less original discount of 2%) through the establishment of the Alent EURO Tranche C-2 Term Loan, and $115 million under our increased U.S. Dollar Revolving Credit Facility.

OMG Acquisition

On October 28, 2015, we completed the OMG Acquisition for a total purchase price of approximately $239 million in cash, net of acquired cash, subject to purchase price adjustments.

We financed the OMG Acquisition with the proceeds from the June 2015 Equity Offering.

Arysta Acquisition

On February 13, 2015, we completed the Arysta Acquisition for approximately $3.50 billion. The purchase price consisted of $2.86 billion in cash (net of acquired cash, closing adjustments and including Arysta Seller transaction expenses paid by Platform) and $600 million of Platform's Series B Convertible Preferred Stock issued to the Arysta Seller with a fair market value of $646 million.

We financed the Arysta Acquisition with the proceeds from (1) available cash on hand, (2) the offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022 denominated in U.S. Dollars and €350 million aggregate principal amount of 6.00% EUR Notes due 2023 denominated in Euros (plus original issue premium of $1.0 million), which offering was completed on February 2, 2015, and (3) additional borrowings of $500 million (less original issue discount of 1%) through an incremental term loan denominated in U.S. Dollars, €83 million (less original discount of 2%) through an increase to our existing term loan facility denominated in Euros, and an additional $160 million under our U.S. Dollar Revolving Credit Facility.

CAS Acquisition

On November 3, 2014, we completed the CAS Acquisition for $1.04 billion, consisting of $983 million in cash, net of acquired cash and certain post-closing working capital and other adjustments, and 2,000,000 shares of our common stock.

We financed the CAS Acquisition with a combination of available cash on hand and borrowings under an increase in term loans of approximately $389 million ($256 million of which is denominated in Euros), $60 million under our U.S. Dollar Revolving Credit Facility and €55 million ($68.7 million) under our multicurrency Revolving Credit Facility pursuant to our Amended and Restated Credit Agreement.

Agriphar Acquisition

On October 1, 2014, we completed the Agriphar Acquisition for approximately €300 million ($370 million) consisting of $350 million in cash, net of acquired cash and certain post-closing working capital and other adjustments, and 711,551 restricted shares of our common stock.

We financed the Agriphar Acquisition with proceeds from the Incremental Amendment and available cash on hand.

MacDermid Acquisition

On October 31, 2013, we completed the MacDermid Acquisition, pursuant to which we indirectly acquired substantially all of the equity of MacDermid Holdings which, at the time, owned 97% of MacDermid. As a result, we became a holding company for the MacDermid business. We acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between us and the fiduciaries of the 401K Plan. Concurrently with the closing of the MacDermid Acquisition, we changed our name to “Platform Specialty Products Corporation.” On January 22, 2014, we completed the Domestication, changing our jurisdiction of incorporation from the British Virgin Islands to Delaware, and on January 23, 2014, our common stock began trading on the NYSE under the ticker symbol “PAH.”

The total consideration for the MacDermid Acquisition and the Exchange Agreement was approximately $1.80 billion (including the assumption of $754 million of indebtedness, consisting primarily of MacDermid’s then first lien credit facility), plus (i) up to $100 million of contingent consideration tied to achieving certain EBITDA and stock trading price performance metrics over a seven-year period following the closing of the MacDermid Acquisition and (ii) an interest in certain MacDermid pending litigation which consideration was paid through a combination of both equity interests and cash.

Our Business

We generate revenue through the formulation and sale of our dynamic chemistries to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the chemical composition and function of our dynamic chemistries are maintained as intended.

While our dynamic chemistries typically represent only a small portion of our customers’ costs, we believe that they are critical to our customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for our customers to change suppliers and allow us to retain customers and maintain our market positions.

Business Segments

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM.

Performance Solutions

Our Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in electronics, automotive production, oil and gas production, drilling, and commercial packaging and printing. Our products include surface and coating materials, functional convention coatings, electronic assembly materials, water-based hydraulic control fluids and photopolymers. In conjunction with the sale of these products, we provide extensive technical service and support when necessary to ensure superior performance of their application. Within this segment, we provide specialty chemicals to the following industries: Electronics, Electronics Assembly Materials, Industrial, Offshore and Commercial Packing and Printing. For the Electronics industry, we design and formulate a complete line of proprietary “wet” dynamic chemistries that our customers use to process the surface of printed circuit boards and other electronic components they manufacture. For the Electronics Assembly Materials industry, we develop, manufacture and sell innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. We also offer a small water treatment product line. For the Industrial industry, our dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the Offshore industry, we produce water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. For the Commercial Packaging and Printing industries, we produce photopolymers through an extensive line of flexographic plates, used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, we also produce photopolymer printing plates for the flexographic and letterpress newspaper and publications markets.

Agricultural Solutions

Our Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. We offer to growers diverse crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. We also offer a wide variety of proven biosolutions, including biostimulants, which stimulate plant growth and reproductive development, innovative nutrition, which optimizes the nutrition of plants, and biocontrol products, such as bioinsecticides and biofungicides, which perform the same task as conventional crop protection products without chemical residues. We emphasize farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. Our Global Value Added Portfolio, or GVAP, consists of agrochemicals in the herbicides, insecticides, fungicides and seed treatment categories, based on patented or proprietary off-patent AIs. Our Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. In addition, we offer regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines.

Our business segments include significant foreign operations. There are certain risks associated with our foreign operations. See Part I, Item 1A Risk Factors – “Our substantial international operations subject us to risks not faced by domestic competitors” included in our Annual Report.

We sell our products worldwide. Because our segments may utilize shared facilities and administrative resources and offer products that are distinct from one another, we make decisions about how to manage our operations by reference to each segment and not with respect to the underlying products or geographic regions that comprise each segment.

Results of Operations

The following table summarizes the results of operations for the three months ended March 31, 2016 and 2015:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Net sales	$	823.8		$	534.8
Cost of sales	467.8			327.7
Gross profit	356.0			207.1
Selling, technical, general and administrative	284.0			192.0
Research and development	19.9			12.9
Operating profit	52.1			2.2
Interest, net	(93.8		)	(39.4		)
Other (expense) income	(74.3		)	35.6
Income tax expense	(18.4		)	(24.7		)
Net loss	$	(134.4	)	$	(26.3	)

Three months ended March 31, 2016 versus the three months ended March 31, 2015.

For comparability purposes, changes in net sales, cost of sales, gross profit, selling, technical, general and administrative expense, research and development expense and operating profit are being presented exclusive of the OMG Malaysia, Alent and OMG Acquisitions.

The adjustments were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016
Net sales	$	252.4
Cost of sales	164.4
Gross profit	88.0
Selling, technical, general and administrative	70.7
Research and development	7.0
Operating profit	10.3

In addition, we have also adjusted net sales, cost of sales, gross profit, selling, technical, general and administrative expense, research and development expense and operating profit for changes in foreign currency translations. We believe that the effect of these adjustments provides a more meaningful basis of comparing our results on a year-over-year basis.

Net Sales



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Net sales	$	823.8	$	534.8

Net sales in the first quarter of 2016 totaled $824 million, representing an increase of $289 million, or 54.0%, as compared to the first quarter of 2015.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	76.3
- Acquisitions	252.4
- Foreign Currency Translation	(39.7		)
Total Change	$	289.0

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, net sales increased by $76.3 million, or 14.3%.

Performance Solutions' net sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $175 million, representing a decrease of $5.7 million, or 3.2%, as compared to the first quarter of 2015. The decrease in net sales was driven by slowness in core electronics end-markets served correlated to reduced spending in China telecommunications infrastructure spending, decreases in the price of oil resulting in delay of project startups onshore and offshore alike and industry consolidation in graphic solutions space adversely impacting pricing on sheet photopolymer product offerings used in flexographic printing. The impact of oil prices mentioned above was twofold: (1) reduced demand for offshore production control and drilling fluids in addition to (2) reduced demand for plating chemistry sold into the supply chain for onshore oil production rigs and stripping/cleaning chemistry utilized in polyethylene terephthalate recycling.

Agricultural Solutions' net sales in the first quarter of 2016, adjusted for foreign currency translation, totaled $437 million, representing an increase of $82.0 million, as compared to the first quarter of 2015. The increase was principally due to the exclusion of 2015 sales prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, overall sales were relatively flat with lower volumes substantially offset by favorable pricing. The volume decline was driven by the divestitures in the fourth quarter of 2015 of Toyo Green Co. Ltd. and Toyo Maintenance Co. Ltd. and reduced demand in the North American market in light of lower farmer income. These declines were partially offset by a strong growth of biosolutions products as well as strong growth of our weed resistance management herbicides portfolio. Selling prices were higher than in the first quarter of 2015 predominantly in Africa, Europe and Latin America.

Cost of Sales



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Cost of sales	$	467.8	$	327.7

Cost of sales in the first quarter of 2016 totaled $468 million, or 56.8% of net sales, as compared to $328 million, or 61.3% of net sales, in the first quarter of 2015, representing an increase of $140 million.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	(2.8	)
- Acquisitions	164.4
- Foreign Currency Translation	(21.5		)
Total Change	$	140.1

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, cost of sales decreased by $2.8 million, or 0.9%.

Performance Solutions' cost of sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $81.1 million, as compared to $86.2 million in the first quarter of 2015, representing a decrease of $5.1 million, or 5.9%. The decrease in cost of sales related primarily to lower adjusted sales volume in the first quarter of 2016 coupled with reduced raw material costs and a favorable shift in product mix, which yielded margin expansion for the segment of 1.3% over the comparative prior year period.

Agricultural Solutions' cost of sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $244 million, as compared to $242 million in the first quarter of 2015, representing an increase of $2.3 million. The increase included the impact of purchase accounting related to the step-up of inventory that was sold during the first quarter of 2015 of $36.1 million. Excluding the effect of purchase accounting, cost of sales increased by $38.4 million, largely as a result of the exclusion of 2015 cost of sales prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, cost of sales declined due to lower volumes, favorable raw material procurement trends related to integration activities, and a shift in product mix based on an increased focus on higher margin products.

Gross Profit



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Gross profit	$	356.0	$	207.1

Gross profit in the first quarter of 2016 totaled $356 million, or 43.2% of net sales, as compared to $207 million, or 38.7% of net sales, in the first quarter of 2015, representing an increase of $149 million.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	79.1
- Acquisitions	88.0
- Foreign Currency Translation	(18.2		)
Total Change	$	148.9

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, gross profit increased $79.1 million, or 38.2%.

Performance Solutions' gross profit in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $93.6 million, as compared to $94.2 million in the first quarter of 2015, representing a decrease of $0.6 million, or 0.6%. The decrease in gross profit related to a decrease of $5.7 million in net sales was offset, in part, by a 1.3% of gross margin expansion on $175 million of sales for the three months ended March 31, 2016.

Agricultural Solutions' gross profit in the first quarter of 2016, adjusted for foreign currency translation, totaled $193 million, as compared to $113 million in the first quarter of 2015, representing an increase of $79.7 million. Excluding the effect of purchase accounting on inventory in the first quarter 2015, as noted above, gross profit increased by $43.6 million. The first quarter of 2016 was favorable to the first quarter of 2015 largely as a result of the exclusion of 2015 gross profit prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, gross profit was positively impacted by favorable selling prices, improved raw material procurement trends and product mix as result of our focus on proprietary products and more profitable growing niche markets.

Selling, Technical, General and Administrative Expense



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Selling, technical, general and administrative	$	284.0	$	192.0

Selling, technical, general and administrative expense in the first quarter of 2016 totaled $284 million, or 34.5% of net sales, as compared to $192.0 million, or 35.9% of net sales, in the first quarter of 2015, representing an increase of $92 million.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	34.0
- Acquisitions	70.7
- Foreign Currency Translation	(12.7		)
Total Change	$	92.0

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, selling, technical, general and administrative expense increased by $34.0 million, or 17.7%. The increase was due in part to additional investments we are making in building our corporate infrastructure in support of the demands driven by our substantial growth, including increases in headcount and professional fees, partially offset by lower quarter-over-quarter acquisition-related cost.

Performance Solutions' selling, technical, general and administrative expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, was relatively flat in comparison to the prior year quarter totaling $55.3 million.

Agricultural Solutions' selling, technical, general and administrative expense in the first quarter of 2016, adjusted for foreign currency translation, totaled $127 million, as compared to $108 million in the first quarter of 2015, representing an increase of $18.9 million. The first quarter of 2016 was unfavorable to the first quarter of 2015 largely as a result of the exclusion of 2015 expense activity prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, related expenses in the first quarter of 2016 were lower compared to the first quarter of 2015 as a result of captured integration synergies and stronger control of spending.

Research and Development Expense



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Research and development	$	19.9	$	12.9

Research and development expense in the first quarter of 2016 totaled $19.9 million, or 2.4% of net sales, as compared to $12.9 million, or 2.4% of net sales, in the first quarter of 2015, representing an increase of $7.0 million.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	0.7
- Acquisitions	7.0
- Foreign Currency Translation	(0.7		)
Total Change	$	7.0

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, research and development expense increased by $0.7 million, or 5.4%.

Performance Solutions' research and development expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $5.2 million, as compared to $5.7 million in the first quarter of 2015, representing a decrease of $0.5 million, or 8.8%.

Agricultural Solutions' research and development expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $8.4 million, as compared to $7.2 million in the first quarter of 2015, representing an increase of $1.2 million. Research and development expense was unfavorable compared to the first quarter of 2015 principally as a result of the exclusion of 2015 research and development expense prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, research and development expense was largely unchanged from the first quarter of 2015.

Operating Profit



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Operating profit	$	52.1	$	2.2

Operating profit in the first quarter of 2016 totaled $52.1 million, or 6.3% of net sales, as compared to $2.2 million, or 0.4% of net sales, in the first quarter of 2015, representing an increase of $49.9 million.



	Three Months Ended March 31, 2016
(amounts in millions)	$ Change
Change, adjusted for acquisitions and foreign currency translation	$	44.3
- Acquisitions	10.3
- Foreign Currency Translation	(4.7		)
Total Change	$	49.9

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, operating profit increased by $44.3 million.

Performance Solutions' operating profit in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $33.1 million, as compared to $33.3 million in the first quarter of 2015, representing a decrease of $0.2 million, or 0.6%.

Agricultural Solutions' operating profit (loss) in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $57.5 million, as compared to $(2.0) million in the first quarter of 2015, representing an increase of $59.5 million. The first quarter of 2016 was favorable to the first quarter of 2015 largely as a result of the exclusion of 2015 expense activity prior to the Arysta Acquisition on February 13, 2015 and the impact of inventory purchase accounting in 2015 of $36.1 million. On a comparable basis, the operating profit increased due to favorable price changes and reductions in spending reflected in costs of sales and selling, technical, general and administrative expenses, partially offset by declines in sales volume during the three months ended March 31, 2016.

Partially offsetting the operating profits from the segments was additional investments made in building our corporate infrastructure in support of the demands driven by our substantial growth, including increases in headcount and professional fees, partially offset by lower quarter-over-quarter acquisition-related costs.

Other (Expense) Income



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Interest expense, net	$	(93.8	)	$	(39.4	)
Loss on derivative contracts	(5.3		)	—
Foreign exchange (loss) gain	(71.1		)	33.9
Other income, net	$	2.1		$	1.7
Total other expense	$	(168.1	)	$	(3.8	)

Net interest expense in the first quarter of 2016 totaled $93.8 million, as compared to $39.4 million in the first quarter of 2015, representing an increase of $54.4 million. The increase relates primarily to interest charges resulting from incremental debt facilities used to fund the Alent Acquisition, including the November 2015 Notes Offering, Alent U.S. Dollar Tranche B-3 Term Loans and Alent EURO Tranche C-2 Term Loans, as well as a full quarter's impact in 2016 of the interest expense related to the incremental debt facilities used to fund the Arysta Acquisition, compared to the first quarter of 2015, which, due to the date of this acquisition, included only a partial quarter's impact.

Loss on derivative contracts in the first quarter of 2016 totaled $5.3 million, as compared to zero in the first quarter of 2015. The increase of $5.3 million represents an increase in our use of foreign exchange and metals derivative contracts to better manage our market risks.

Foreign exchange loss in the first quarter of 2016 totaled $71.1 million, as compared to a gain of $33.9 million in the first quarter of 2015. The balance in the first quarter of 2016 includes $66.1 million of foreign exchange losses associated with the remeasurement of foreign denominated external and intercompany debt related to the Acquisitions, compared to a gain of $24.1 million in the first quarter 2015.

Other income, net in the first quarter of 2016 totaled $2.1 million, or 0.3% of net sales, as compared to $1.7 million in the first quarter of 2015, representing an increase of 0.4 million. Other income in 2015 included $3.0 million related to the expiration of an acquisition-related put option on our common stock in connection with the Agriphar Acquisition.

Income Tax



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Income tax expense	$	(18.4	)	$	(24.7	)
Effective tax rate	(15.9		)%	(1,547		)%

The income tax expense for the three months ended March 31, 2016 totaled $18.4 million, as compared to $24.7 million for the three months ended March 31, 2015. Our effective tax rate for the three months ended March 31, 2016 was (15.9)% on pre-tax losses of $116 million, compared to an effective tax rate of (1,547)% on pre-tax loss of $1.6 million for the three months ended March 31, 2015. The difference between the statutory and effective tax rate for the three months ended March 31, 2016 principally relates to the recognition of a $59.6 million valuation allowance on current quarter losses related to net operating losses that may not be recoverable for U.S. and foreign companies. The difference from the statutory to effective tax rates for the three months ended March 31, 2015 resulted principally from the establishment of a $19.0 million valuation allowance on foreign tax credit carryovers as a result of the impact of the Arysta Acquisition and losses that did not produce tax benefits.

Liquidity and Capital Resources

each share of Series B Convertible Preferred Stock that has not been previously converted or automatically redeemed. The related potential cash obligation, which varies based on our stock price, corresponds to a maximum amount of $600 million.

As of March 31, 2016, this maximum potential obligation was approximately $410 million. We anticipate sufficient cash from operations to fund interest, working capital and other capital expenditures for the foreseeable future and have access to a $500 million line of credit under our Revolving Credit Facility, with current availability of $385 million, as well as availability under various lines of credit and overdraft facilities of $87.4 million. However, any settlement of the Series B Convertible Preferred Stock obligation, working capital shortfalls and future acquisitions may require utilization of our Revolving Credit Facility as well as proceeds from future debt and/or equity offerings. Our long-term liquidity may be impacted by our ability to borrow additional funds, renegotiate existing debt and/or raise equity under terms that are favorable to us.

Our primary sources of liquidity during the three months ended March 31, 2016 were borrowings under our Revolving Credit Facility and available cash. Our primary uses of cash and cash equivalents were raw material purchases, salary expenses, capital expenditures, debt service obligations and a business acquisition. We believe that our cash and cash equivalent balance and cash generated from operations will be sufficient to meet our working capital needs, capital expenditures and other business requirements for at least the next twelve months. Pending any future acquisitions, however, we may require additional borrowings against our Revolving Credit Facility as well as future debt and/or equity offerings. At March 31, 2016, we had $330 million in cash and cash equivalents in addition to availability under our lines of credit of $472 million.

Of our $330 million of cash and cash equivalents at March 31, 2016, $309 million was held by our foreign subsidiaries. The majority of the cash held by foreign subsidiaries is generally available for the ongoing needs of our operations. The laws of certain countries may limit our ability to utilize cash resources held in those countries for operations in other countries. However, these laws are not likely to impact our liquidity in a material way. The operations of each foreign subsidiary generally fund such subsidiary’s capital requirements. In the event that other foreign operations or operations within the United States require additional cash, we may transfer cash between and among subsidiaries as needed so long as such transfers are in accordance with law. As of March 31, 2016, we had the ability to repatriate $6.4 million at our discretion from the foreign subsidiaries and branches while the remaining balance of $303 million was held at subsidiaries in which earnings are considered permanently reinvested. Repatriation of some of these funds could be subject to delays and could have potential tax consequences, principally with respect to withholding taxes paid in foreign jurisdictions. If cash is repatriated from jurisdictions in which earnings are considered permanently reinvested we will be required to accrue and pay U.S. income taxes on such repatriations.

On January 31, 2016, the Company completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments. The Company acquired OMG Malaysia to add-on to the OMG Acquisition and further enhance its Performance Solutions segment. See Note 2, Acquisitions of Business, for further detail.

We may from time to time seek to retire or purchase our outstanding debt, including, but not limited to, our Senior Notes, through cash purchases, exchanges for equity securities, or refinancing, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.

The following is a summary of our cash flows provided by (used in) operating, investing and financing activities during the periods indicated:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
				(as restated ⁽¹⁾)
Cash and cash equivalents, beginning of the period	$	432.2		$	397.3
Cash (used in) provided by operating activities	(210.4		)	2.8
Cash used in investing activities	(19.9		)	(2,291.1		)
Cash provided by financing activities	120.7			2,198.9
Exchange rate impact on cash and cash equivalents	7.1			(10.6		)
Cash and cash equivalents, end of the period	$	329.7		$	297.3

⁽¹⁾ The Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2015 was restated as a result of an error related to the Arysta Acquisition. See Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements, to the unaudited interim Condensed Consolidated Financial Statements.

Operating Activities

During the three months ended March 31, 2016, cash used in operating activities totaled $210.4 million. The net loss incurred during the period totaling $134 million was offset by $118 million in non-cash add-backs. The non-cash add-backs were largely related to depreciation and amortization of $82.6 million, foreign exchange losses on the 6.00% EUR Notes due 2023 of $18.0 million, the elimination of manufacturer’s profit in inventory in connection with our Acquisitions of $12.0 million, restructuring charges of $5.0 million, amortization of deferred financing fees of $4.7 million, impairment on an asset held for sale of $2.8 million and other miscellaneous non-cash add-backs of $7.4 million. These non-cash add-backs were partially offset by deferred income taxes of $14.2 million.

Changes in assets and liabilities, net of acquisitions, consumed 137.9 million more cash during the three months ended March 31, 2016 compared to the three month ended March 31, 2015. The major drivers of the unfavorable change in assets and liabilities were increases in inventory due in part to a stronger and earlier growing season in Europe and decreases in accounts payable.

Investing Activities

Cash flows used in investing activities totaled $19.9 million during the three months ended March 31, 2016, as compared to $2.29 billion of cash flows used in investing activities for the same period in 2015. The decrease was primarily due to $2.86 billion of net cash outflows related primarily to the Arysta Acquisition during the three months ended March 31, 2015, which was partially offset by a release of $600 million in restricted cash for this acquisition, compared to $1.2 million of net cash outflows primarily related to the OMG Malaysia Acquisition for the same period during 2016. Additionally, we reduced capital expenditures and investments in product registration rights by an aggregate $10.1 million during the three months ended March 31, 2016 compared to the same period in 2015.

Financing Activities

Cash flows provided by financing activities totaled $121 million during the three months ended March 31, 2016, as compared to $2.20 billion of cash flows provided by financing activities for the same period in 2015. The decrease was primarily due to proceeds of $2.08 billion from borrowings used to fund, in part, the Arysta Acquisition during the three months ended March 31, 2015. We borrowed $25.4 million less cash under our Revolving Credit Facility during the three months ended March 31, 2016 than during to the same period in 2015. Additionally, repayments of borrowings were $8.7 million and $3.6 million for the three months ended March 31, 2016 and 2015, respectively. Partially offsetting the decrease were payments of debt financing fees of $44.6 million associated with the borrowings made during the three months ended March 31, 2015, compared to insignificant payments of this kind for the same period in 2016.

Financial Borrowings

Credit Facilities

As of March 31, 2016, we had $5.26 billion of indebtedness, which included $1.96 billion of Senior Notes and $3.28 billion of term debt arrangements outstanding under our First Lien Credit Facility; $149 million of borrowings under revolver and overdraft lines of credit; and $10.7 million of stand-by letters of credit, which reduce the borrowings available under our Revolving Credit facility. Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $472 million as of March 31, 2016.

Alent Acquisition

In connection with the Alent Acquisition, in November 2015, we completed the November 2015 Notes Offering of $500 million in aggregate principal amount of 10.375% USD Notes due 2021. The notes are governed by an indenture, dated November 10, 2015, as amended from time to time, bear interest at a rate of 10.375% and mature on May 1, 2021, unless earlier redeemed. In addition, we borrowed $1.05 billion under the Alent U.S. Dollar Tranche B-3 Term Loan (less original issue discount of 2%), €300 million under the Alent EURO Tranche C-2 Term Loan (less original issue discount of 2%), and $115 million under our multi-currency Revolving Credit Facility.

Arysta Acquisition

In connection with the Arysta Acquisition, in February 2015, we completed the February 2015 Notes Offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022, plus original issue premium of $1.0 million, and €350 million aggregate principal amount of 6.00% EUR Notes due 2023. The notes are governed by an indenture, dated February 2, 2015, as amended from time to time. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 mature on February 1, 2022 and February 1, 2023, respectively, unless earlier redeemed. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 bear interest at a rate of 6.50% and 6.00% per year, respectively, until maturity. In addition, we borrowed $500 million under the Arysta U.S. Dollar Tranche B-2 Term Loan (less original issue discount of 1%), €83.0 million under the Arysta EURO Tranche C-1 Term Loan (less original issue discount of 2%), and $160 million under our U.S. Dollar Revolving Credit Facility.

CAS Acquisition

In connection with the CAS Acquisition, in August 2014, we borrowed $130 million under the CAS U.S. Dollar Tranche B Term Loan, €205 million under the CAS EURO Tranche C-1 Term Loan, $60.0 million under our U.S. Dollar Revolving Credit Facility, and €55.0 million under our multicurrency Revolving Credit Facility.

Agriphar Acquisition

In connection with the Agriphar Acquisition, in October 2014, we borrowed $300 million under the USD Incremental Loan.

MacDermid Acquisition

In connection with the MacDermid Acquisition, in October 2013, under its First Lien Credit Agreement, MacDermid, with Platform as co-borrower, borrowed $373 million in connection with the repayment of the $360 million in principal on its then second lien credit facility.

Our Credit Facilities contain various covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. In addition, our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. As of March 31, 2016, the Company was in compliance with the debt covenants contained in our Credit Facilities.

Off-Balance Sheet Transactions

We use customary off-balance sheet arrangements, such as operating leases and letters of credit, to finance our business. As a result of ASU No. 2016-02, “Leases,” for fiscal years and interim periods beginning after December 15, 2018, we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions.

There are no other arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Recent Accounting Pronouncements

Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU 2016-06, "Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging ISsues Task Force)." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt instrument that are considered embedded derivatives in debt or hybrid instruments meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU.

guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU.

Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expected this ASU to have a material impact on its financial statements.

Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented, therefore, this ASU did not have a material impact on the Company's financial statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our Annual Report.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting previously disclosed under Item 9A of our Annual Report.

The material weaknesses in our internal control relating to insufficient complement of personnel with an appropriate level of accounting knowledge, experience and training commensurate with our financial reporting requirements, which are described more fully in our Annual Report, continued to exist as of the end of the period covered by this Quarterly Report. These material weaknesses resulted to date in the restatement of the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015 as a result of an error related to the Arysta Acquisition, as described in this Quarterly Report, and the restatement of income taxes in the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended September 30, 2015, as described in our Annual Report.

Our management is actively engaged in implementing the remediation initiatives described in our Annual Report which are designed to address these material weaknesses and, subsequent to the filing of our Annual Report, has specifically:


•	started the implementation of a global consolidation and planning system, which is expected to be completed during the later half of 2016;


•	implemented control processes as it relates to newly-acquired businesses and non-routine transactions;


•	implemented enhanced monitoring controls relating to the financial reporting and performance of Platform's newly-acquired businesses;


•	completed the implementation of a global tax reporting system;


•	enhanced Platform's financial planning and analysis function within its businesses and at the corporate level;


•	added further qualified resources to Platform's corporate and segment staff;


•	enhanced the controllership function in Platform's newly-acquired businesses; and


•	continued its recruiting efforts to hire qualified personnel.

While significant progress has been made, additional time is needed to fully implement and demonstrate the effectiveness of the remediation initiatives and until remediated, the material weaknesses described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. The Company is committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary.

Notwithstanding the aforementioned material weaknesses, our management believes that such unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position, and cash flows at and for the periods presented, each in accordance with U.S. GAAP. Based in part on these additional efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.

Our management has excluded from the evaluation of disclosure controls and procedures as of March 31, 2016 the internal control over financial reporting related to Alent, the OMG Businesses and OMG Malaysia because they were acquired by Platform in purchase business combinations consummated during the fourth quarter of 2015 with respect to Alent and the OMG Businesses and the first quarter of 2016 with respect to OMG Malaysia. Alent's, the OMG Businesses' and OMG Malaysia's total assets, excluding goodwill and intangible assets recognized in purchase accounting, and total revenues represent approximately 24% and 31%, respectively, of the related unaudited interim Condensed Consolidated Financial Statement amounts as of and for the quarter ended March 31, 2016. These acquisitions are material to our results of operations, financial condition and cash flows, and the integration following these business combinations is likely to materially impact the Company's internal control over financial reporting. We are in process of evaluating the internal controls over financial reporting for these acquisitions as required by the above stated Rules.

(b) Changes to Internal Control Over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter covered by this Quarterly Report.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In the ordinary course of our business, we are subject to periodic lawsuits, investigations and claims, including, but not limited to, product liability claims, contractual disputes, premises claims, and employment, and environmental, health and safety matters. Although we cannot predict with certainty the ultimate resolution of lawsuits, investigations and claims asserted against us, we believe that the resolution of these claims, to the extent not covered by insurance, will not individually or in the aggregate, have a material adverse effect on our consolidated financial position, results of operations or cash flows.

For more information regarding certain proceedings and their possible effects on our business, see Note 15, Contingencies, Environmental and Legal Matters, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, under the headings Environmental Liabilities and Legal Proceedings, which sections are incorporated herein by reference.

Item 1A. Risk Factors

Except as set forth below, there have been no material changes to the risk factors set forth in Part I, Item 1A of our Annual Report under the heading "Risk Factors."

We have restated our unaudited interim condensed consolidated financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015.

As further described in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included herein, we previously disclosed in our quarterly report on Form 10-Q for the quarter ended June 30, 2015 an error to goodwill and foreign currency translation adjustment of $72.8 million relating to the Arysta Acquisition, which was corrected as an out-of-period adjustment in such quarterly report. We subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million and therefore further concluded that the previously reported information should no longer be relied upon. As a result, we restated our unaudited interim financial information for our first quarter ended March 31, 2015 in the aforementioned Note 20. If we are required to restate previously issued financial statements for any additional periods, our reputation could be impaired which could cause a loss of investor confidence and adversely materially affect our business, operating results and financial condition.

Volatility of the trading prices of our common stock and/or Senior Notes could adversely affect our security holders.

The trading prices of our common stock and Senior Notes have been highly volatile and could continue to be subject to wide fluctuations in response to various factors, some of which are beyond our control, including, but not limited to:


•	quarterly variations in our operating results;


•	changes in the market’s expectations about our operating results;


•	our operating results failing to meet the expectation of management, securities analysts or investors in a particular period;


•	the failure to remediate identified material weaknesses;


•	changes in financial estimates and recommendations by securities analysts concerning our Company or our industry in general;


•	operating and securities price performance of companies that investors deem comparable to us;


•	news reports and publication of research reports relating to our business or trends in our markets;


•	changes in laws and regulations affecting our businesses;


•	announcements or strategic developments, acquisitions and other material events by us or our competitors;


•	sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur;


•	adverse market reaction to any additional debt we incur in the future;


•	litigation and class action proceedings;


•	the failure to identify and complete acquisitions in the future or unexpected difficulties or developments related to the integration of recently completed, pending or future acquisitions;


•	actions by institutional stockholders;


•	general economic and political conditions such as recessions and acts of war or terrorism; and


•	other matters discussed in this Quarterly Report.

In addition, the stock market in general, and the market for specialty chemicals companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of companies’ stock, including ours, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of particular companies’ securities, securities litigation and class action proceedings have often been instituted against such companies. A shareholder derivative action and a class action lawsuit of these types were filed against us in April and March 2016, respectively. There can be no assurance that the market price of our common stock and/or Senior Notes will not fall in the future due to any of the aforementioned factors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report:



Exhibit Number	Description
3.1(a)	Certificate of Incorporation (filed as Exhibit 3.1 of Post-Effective Amendment No.1 to the Registration Statement on Form S-4 (File No. 333-192778) filed on January 24, 2014, and incorporated herein by reference)
3.1(b)	Certificate of Amendment of Certificate of Incorporation (filed as Exhibit 3.1 of Current Report on Form 8-K filed on June 13, 2014, and incorporated herein by reference)
3.1(c)	Certificate of Designation of Series B Convertible Preferred Stock (filed as Exhibit 3.1 of Current Report on Form 8-K filed on February 17, 2015, and incorporated herein by reference)
3.2	Amended and Restated By-laws (filed as Exhibit 3.2 of the Annual Report on Form 10-K filed on March 31, 2014, and incorporated herein by reference)
10.1	Form of Restricted Stock Unit Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.11 to Platform’s Registration Statement on Form S-4 filed on January 2, 2014, and incorporated herein by reference)
10.2	Form of Performance-Based Restricted Stock Unit Award Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.2 of Current Report on Form 8-K filed on March 25, 2016, and incorporated herein by reference)
10.3	Form of Non-Qualified Stock Option Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.3 of Current Report on Form 8-K filed on March 25, 2016, and incorporated herein by reference)
10.4	Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Appendix A to Platform’s Definitive Proxy Statement, as filed on April 25, 2014, and incorporated herein by reference)
10.5	Platform Specialty Products Corporation 2014 Employee Stock Purchase Plan (filed as Appendix B to Platform’s Definitive Proxy Statement, as filed on April 25, 2014, and incorporated herein by reference)
10.6*	Severance Agreement by and between Scot R. Benson and MacDermid, dated June 6, 2013
10.7	Form of Change in Control Agreement (filed as Exhibit 10.1 of Current Report on Form 8-K filed on April 8, 2016, and incorporated herein by reference)
31.1*	Principal Executive Officer Certification Pursuant to Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Principal Financial Officer Certification Pursuant to Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Principal Executive Officer and Principal Financial Officer Certifications Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101. INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

** Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this May 10, 2016.



	PLATFORM SPECIALTY PRODUCTS CORPORATION

	By:	/s/ Robert L. Worshek
		Name: Robert L. Worshek
		Title: Vice President and Chief Accounting Officer (Principal Accounting Officer)

EXHIBIT INDEX



Exhibit Number	Description
3.1(a)	Certificate of Incorporation (filed as Exhibit 3.1 of Post-Effective Amendment No.1 to the Registration Statement on Form S-4 (File No. 333-192778) filed on January 24, 2014, and incorporated herein by reference)
3.1(b)	Certificate of Amendment of Certificate of Incorporation (filed as Exhibit 3.1 of Current Report on Form 8-K filed on June 13, 2014, and incorporated herein by reference)
3.1(c)	Certificate of Designation of Series B Convertible Preferred Stock (filed as Exhibit 3.1 of Current Report on Form 8-K filed on February 17, 2015, and incorporated herein by reference)
3.2	Amended and Restated By-laws (filed as Exhibit 3.2 of the Annual Report on Form 10-K filed on March 31, 2014, and incorporated herein by reference)
10.1	Form of Restricted Stock Unit Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.11 to Platform’s Registration Statement on Form S-4 filed on January 2, 2014, and incorporated herein by reference)
10.2	Form of Performance-Based Restricted Stock Unit Award Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.2 of Current Report on Form 8-K filed on March 25, 2016, and incorporated herein by reference)
10.3	Form of Non-Qualified Stock Option Agreement – Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Exhibit 10.3 of Current Report on Form 8-K filed on March 25, 2016, and incorporated herein by reference)
10.4	Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (filed as Appendix A to Platform’s Definitive Proxy Statement, as filed on April 25, 2014, and incorporated herein by reference)
10.5	Platform Specialty Products Corporation 2014 Employee Stock Purchase Plan (filed as Appendix B to Platform’s Definitive Proxy Statement, as filed on April 25, 2014, and incorporated herein by reference)
10.6*	Severance Agreement by and between Scot R. Benson and MacDermid, dated June 6, 2013
10.7	Form of Change in Control Agreement (filed as Exhibit 10.1 of Current Report on Form 8-K filed on April 8, 2016, and incorporated herein by reference)
31.1*	Principal Executive Officer Certification Pursuant to Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Principal Financial Officer Certification Pursuant to Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Principal Executive Officer and Principal Financial Officer Certifications Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101. INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

** Furnished herewith.

EX-10.6 2 pah10-q2016331exx106.htm EXHIBIT 10.6 Exhibit

Exhibit 10.6

MacDermid, Incorporated

Scot Benson

[Address]

June 6, 2013

Re: Severance Agreement

Dear Scot:

I write to confirm our agreement regarding severance in the case where your employment with MacDermid is involuntarily terminated without Cause (as defined herein) or within two (2) years after a Change of Control (as defined herein). If your employment with MacDermid is involuntarily terminated without Cause then MacDermid will pay you a severance equal to one (1) year’s base salary, based upon the then most recent year period. In the alternative, if your employment is involuntarily terminated within two (2) years after a Change of Control then you will be paid a severance equal to two (2) year’s base salary and cash bonus, based upon the then most recent two year period. In order to receive either foregoing severance payment, you will be required to execute MacDermid’s standard termination agreement (form attached) containing a full, final general release in favor of MacDermid.

As used in this agreement, Cause and Change of Control shall mean:



	1.	Cause –



	(i)	you are convicted of, or plead guilty or nolo contendere to, any crime constituting a felony or involving dishonesty or moral turpitude;



	(ii)	you engage in any activity that amounts to negligence and that significantly affects the business affairs or reputation of the company;



	(iii)	you willfully fail to perform your duties, or perform your duties in a grossly negligent manner, which failure or performance continues for twenty (20) days after written notice from the company; or



	(iv)	you violate the Company’s standard policies, or the law, and such violation creates a substantial liability (actual or potential) for the company.



	2.	Change of Control –



	(i)	acquisition by any person or group, except for an employee benefit plan sponsored by the company, of beneficial ownership of 50% or more of the company’s voting securities in any combination;



	(ii)	the sale of all or substantially all of the assets of MacDermid; or



	(iii)	individuals, who as of January 1, 2002 are members of MacDermid’s Board of Directors (the “Incumbents”), and any additional individuals (“Additional Directors”) who are recommended to become Directors by a majority of the Incumbents and/or any then previously so recommended and elected Additional Directors, cease for any reason to constitute a majority of the Board of Directors of MacDermid.

Please indicate your acceptance and agreement by countersigning and returning this letter to my attention.

Sincerely,

/s/ John L. Cordani

John L. Cordani

ACCEPTED AND AGREED:

/s/ Scot Benson

Scot Benson

EX-31.1 3 pah10-q2016331exx311.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

I, Rakesh Sachdev, certify that:


1.	I have reviewed this Quarterly Report on Form 10-Q of Platform Specialty Products Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	designated such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:	May 10, 2016

/s/ Rakesh Sachdev
Rakesh Sachdev
Chief Executive Officer

EX-31.2 4 pah10-q2016331exx312.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

I, Sanjiv Khattri, certify that:


1.	I have reviewed this Quarterly Report on Form 10-Q of Platform Specialty Products Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	designated such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:	May 10, 2016

/s/ Sanjiv Khattri
Sanjiv Khattri
Executive Vice President and Chief Financial Officer

EX-32.1 5 pah10-q2016331exx321.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

CERTIFICATION

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Rakesh Sachdev, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Platform Specialty Products Corporation on Form 10-Q for the fiscal quarter ended March 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Platform Specialty Products Corporation.



	Date:	May 10, 2016
	By:	/s/ Rakesh Sachdev
	Name:	Rakesh Sachdev
	Title:	Chief Executive Officer

I, Sanjiv Khattri, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Platform Specialty Products Corporation on Form 10-Q for the fiscal quarter ended March 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Platform Specialty Products Corporation.



	Date:	May 10, 2016
	By:	/s/ Sanjiv Khattri
	Name:	Sanjiv Khattri
	Title:	Executive Vice President and Chief Financial Officer

EX-101.INS 6 pah-20160331.xml XBRL INSTANCE DOCUMENT 0001590714 2016-01-01 2016-03-31 0001590714 2016-05-06 0001590714 2015-01-01 2015-03-31 0001590714 2015-12-31 0001590714 2016-03-31 0001590714 2014-12-31 0001590714 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0001590714 us-gaap:RetainedEarningsMember 2016-03-31 0001590714 us-gaap:ParentMember 2016-01-01 2016-03-31 0001590714 us-gaap:CommonStockMember 2016-01-01 2016-03-31 0001590714 us-gaap:CommonStockMember 2016-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0001590714 us-gaap:PreferredStockMember 2015-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-03-31 0001590714 us-gaap:NoncontrollingInterestMember 2016-03-31 0001590714 us-gaap:ParentMember 2015-12-31 0001590714 us-gaap:PreferredStockMember 2016-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001590714 us-gaap:CommonStockMember 2015-12-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001590714 us-gaap:RetainedEarningsMember 2015-12-31 0001590714 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0001590714 us-gaap:ParentMember 2016-03-31 0001590714 us-gaap:NoncontrollingInterestMember 2015-12-31 0001590714 us-gaap:PreferredStockMember 2014-12-31 0001590714 us-gaap:ParentMember 2015-01-01 2015-03-31 0001590714 us-gaap:PreferredStockMember 2015-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0001590714 us-gaap:RetainedEarningsMember 2015-03-31 0001590714 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-03-31 0001590714 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0001590714 us-gaap:RetainedEarningsMember 2014-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2015-03-31 0001590714 us-gaap:ParentMember 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0001590714 us-gaap:CommonStockMember 2014-12-31 0001590714 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0001590714 us-gaap:CommonStockMember 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2014-12-31 0001590714 us-gaap:ParentMember 2014-12-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0001590714 pah:ArystaMember pah:PriorPeriodErrorRelatedToPurchaseAccountingRelatedToAcquisitionsMember us-gaap:RestatementAdjustmentMember 2015-04-01 2015-06-30 0001590714 2014-01-23 0001590714 pah:ArystaMember 2015-01-01 2015-03-31 0001590714 2015-02-13 0001590714 pah:ArystaMember 2015-02-13 2015-02-13 0001590714 pah:OMGMalaysiaandOMGMember 2016-03-31 0001590714 pah:OMGMalaysiaAlentandOMGMember 2016-01-01 2016-03-31 0001590714 pah:OMGMember 2015-10-28 2015-10-28 0001590714 pah:OMGMalaysiaMember 2016-01-31 2016-01-31 0001590714 pah:OMGMalaysiaAlentOMGandArystaMember 2016-01-01 2016-03-31 0001590714 pah:AlentMember 2015-12-01 2015-12-01 0001590714 pah:AlentMember 2015-12-01 0001590714 pah:OMGMember us-gaap:DevelopedTechnologyRightsMember 2015-10-28 2015-10-28 0001590714 pah:AlentMember us-gaap:InProcessResearchAndDevelopmentMember 2015-12-01 2015-12-01 0001590714 pah:OMGMember us-gaap:InProcessResearchAndDevelopmentMember 2015-10-28 2015-10-28 0001590714 us-gaap:TradeNamesMember 2016-01-01 2016-03-31 0001590714 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-03-31 0001590714 pah:OMGMalaysiaMember us-gaap:CustomerListsMember 2016-01-31 2016-01-31 0001590714 pah:OMGMember us-gaap:CustomerListsMember 2015-10-28 2015-10-28 0001590714 pah:AlentMember us-gaap:CustomerListsMember 2015-12-01 2015-12-01 0001590714 pah:AlentMember us-gaap:TradeNamesMember 2015-12-01 2015-12-01 0001590714 pah:OMGMember us-gaap:TradeNamesMember 2015-10-28 2015-10-28 0001590714 pah:OMGMalaysiaMember us-gaap:TradeNamesMember 2016-01-31 2016-01-31 0001590714 pah:AlentMember us-gaap:DevelopedTechnologyRightsMember 2015-12-01 2015-12-01 0001590714 pah:OMGMalaysiaMember us-gaap:InProcessResearchAndDevelopmentMember 2016-01-31 2016-01-31 0001590714 pah:OMGMalaysiaMember us-gaap:DevelopedTechnologyRightsMember 2016-01-31 2016-01-31 0001590714 us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-03-31 0001590714 us-gaap:CustomerListsMember 2016-01-01 2016-03-31 0001590714 pah:OMGMalaysiaMember 2015-01-01 2015-03-31 0001590714 pah:OMGMember 2015-01-01 2015-03-31 0001590714 pah:ArystaMember 2016-01-01 2016-03-31 0001590714 pah:OMGMalaysiaMember 2016-01-01 2016-03-31 0001590714 pah:AlentMember 2016-01-01 2016-03-31 0001590714 pah:OMGMember 2016-01-01 2016-03-31 0001590714 pah:AlentMember 2015-01-01 2015-03-31 0001590714 pah:OMGMember 2015-10-28 0001590714 pah:OMGMalaysiaMember 2016-01-31 0001590714 pah:OMGMalaysiaAlentOMGandArystaMember 2015-01-01 2015-03-31 0001590714 us-gaap:CostOfSalesMember us-gaap:FairValueAdjustmentToInventoryMember 2015-01-01 2015-03-31 0001590714 us-gaap:FairValueAdjustmentToInventoryMember 2016-03-31 0001590714 us-gaap:CostOfSalesMember us-gaap:FairValueAdjustmentToInventoryMember 2016-01-01 2016-03-31 0001590714 us-gaap:FairValueAdjustmentToInventoryMember 2015-12-31 0001590714 us-gaap:LandAndLandImprovementsMember 2016-03-31 0001590714 pah:ExcludingConstructioninProcessMember 2016-03-31 0001590714 us-gaap:BuildingImprovementsMember 2016-03-31 0001590714 us-gaap:LandAndLandImprovementsMember 2015-12-31 0001590714 pah:LandandBuildingHeldunderCapitalLeasesMember 2016-03-31 0001590714 pah:MachineryEquipmentFixturesandSoftwareMember 2016-03-31 0001590714 pah:ExcludingConstructioninProcessMember 2015-12-31 0001590714 pah:LandandBuildingHeldunderCapitalLeasesMember 2015-12-31 0001590714 pah:MachineryandEquipmentHeldunderCapitalLeasesMember 2016-03-31 0001590714 pah:MachineryandEquipmentHeldunderCapitalLeasesMember 2015-12-31 0001590714 us-gaap:BuildingImprovementsMember 2015-12-31 0001590714 pah:MachineryEquipmentFixturesandSoftwareMember 2015-12-31 0001590714 pah:SaleAgreementforLonglivedAssetMember 2016-03-31 0001590714 pah:SaleAgreementforLonglivedAssetMember 2016-03-01 2016-03-31 0001590714 us-gaap:SellingGeneralAndAdministrativeExpensesMember pah:SaleAgreementforLonglivedAssetMember 2016-03-01 2016-03-31 0001590714 us-gaap:DevelopedTechnologyRightsMember 2016-03-31 0001590714 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0001590714 us-gaap:TradeNamesMember 2016-03-31 0001590714 us-gaap:NoncompeteAgreementsMember 2016-03-31 0001590714 us-gaap:CustomerListsMember 2015-12-31 0001590714 us-gaap:CustomerListsMember 2016-03-31 0001590714 us-gaap:NoncompeteAgreementsMember 2015-12-31 0001590714 us-gaap:TradeNamesMember 2015-12-31 0001590714 us-gaap:NoncompeteAgreementsMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceMaterialsMember 2016-01-01 2016-03-31 0001590714 pah:ArgoSolutionsMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceMaterialsMember 2016-03-31 0001590714 pah:PerformanceMaterialsMember 2015-12-31 0001590714 pah:ArgoSolutionsMember 2016-03-31 0001590714 pah:ArgoSolutionsMember 2015-12-31 0001590714 us-gaap:EmployeeStockOptionMember 2016-03-31 0001590714 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0001590714 us-gaap:EmployeeStockOptionMember pah:The2013PlanMember 2016-03-16 2016-03-16 0001590714 pah:RestrictedStockUnitsGranted17March2015Member pah:The2013PlanMember 2016-01-01 2016-03-31 0001590714 pah:The2013PlanMember 2016-03-16 2016-03-16 0001590714 pah:ServiceRestrictedStockUnitsRSUsMember pah:The2013PlanMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MinimumMember pah:VestingBasedonUnestablishedEBITDATargetBenchmarksMember 2016-01-01 2016-03-31 0001590714 pah:RestrictedStockUnitsGranted6March2014Member pah:The2013PlanMember 2014-03-06 2014-03-06 0001590714 pah:EmployeeStockPurchasePlanMember 2016-01-01 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember 2016-03-31 0001590714 pah:RestrictedStockUnitsRelatedtoMarketConditionsMember pah:The2013PlanMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember pah:CertainEmployeesMember pah:VestingDependingUponReturnonInvestedCapitalBenchmarksMember 2016-01-01 2016-03-31 0001590714 pah:The2013PlanMember 2014-06-30 0001590714 pah:RestrictedStockUnitsGranted6March2014Member pah:The2013PlanMember 2015-01-01 2015-03-31 0001590714 pah:EmployeeStockPurchasePlanMember 2014-03-06 2014-03-06 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember us-gaap:DirectorMember 2016-03-17 2016-03-17 0001590714 pah:RestrictedStockUnitsGranted6March2014Member pah:The2013PlanMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember 2015-12-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MaximumMember pah:VestingBasedonUnestablishedEBITDATargetBenchmarksMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember 2015-01-01 2015-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember us-gaap:MinimumMember pah:CertainEmployeesMember 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember pah:VestingBasedonUnestablishedEBITDATargetBenchmarksMember 2016-03-31 0001590714 pah:RestrictedStockUnitsGranted6March2014Member pah:The2013PlanMember 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001590714 pah:The2013PlanMember 2016-01-01 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember pah:CertainEmployeesMember pah:VestingBasedonEBITDATargetBenchmarksMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember us-gaap:MaximumMember pah:CertainEmployeesMember 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember 2015-01-01 2015-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2016-03-31 0001590714 pah:RestrictedStockUnitsRelatedtoMarketConditionsMember pah:The2013PlanMember us-gaap:MaximumMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MaximumMember pah:CertainEmployeesMember pah:VestingDependingUponReturnonInvestedCapitalBenchmarksMember 2016-01-01 2016-03-31 0001590714 pah:RestrictedStockUnitsRelatedtoMarketConditionsMember pah:The2013PlanMember us-gaap:MinimumMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MinimumMember pah:CertainEmployeesMember pah:VestingDependingUponReturnonInvestedCapitalBenchmarksMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MinimumMember pah:CertainEmployeesMember pah:VestingBasedonEBITDATargetBenchmarksMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceRestrictedStockUnitsRSUsMember pah:The2013PlanMember us-gaap:MaximumMember pah:CertainEmployeesMember pah:VestingBasedonEBITDATargetBenchmarksMember 2016-01-01 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember us-gaap:MinimumMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 us-gaap:DeferredBonusMember pah:LongTermCashBonusPlanLTCBMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember pah:The2013PlanMember us-gaap:MaximumMember pah:CertainEmployeesMember 2016-01-01 2016-03-31 0001590714 us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-03-31 0001590714 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-01-01 2016-03-31 0001590714 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember pah:ForeignMember 2016-01-01 2016-03-31 0001590714 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember pah:DomesticMember 2016-01-01 2016-03-31 0001590714 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember pah:ForeignMember 2015-01-01 2015-03-31 0001590714 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember pah:DomesticMember 2015-01-01 2015-03-31 0001590714 pah:PensionAndSERPBenefitsMember pah:ForeignMember 2015-01-01 2015-03-31 0001590714 pah:PensionAndSERPBenefitsMember pah:DomesticMember 2015-01-01 2015-03-31 0001590714 pah:PensionAndSERPBenefitsMember pah:ForeignMember 2016-01-01 2016-03-31 0001590714 pah:PensionAndSERPBenefitsMember pah:DomesticMember 2016-01-01 2016-03-31 0001590714 us-gaap:PensionPlansDefinedBenefitMember pah:DomesticMember 2015-01-01 2015-03-31 0001590714 us-gaap:PensionPlansDefinedBenefitMember pah:DomesticMember 2016-01-01 2016-03-31 0001590714 pah:EuroTracncheTermLoansMember 2015-12-31 0001590714 pah:TrancheBTermLoanMember 2016-03-31 0001590714 pah:TrauncheB2TermLoanMember 2016-03-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember 2016-03-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:USDIncrementalLoansMember 2015-12-31 0001590714 pah:USDNotesMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:TrauncheB2TermLoanMember 2015-12-31 0001590714 pah:EuroNotesMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember 2016-03-31 0001590714 pah:FirstLienTermLoanMember us-gaap:SecuredDebtMember 2015-12-31 0001590714 pah:USDIncrementalLoansMember 2016-03-31 0001590714 pah:EuroTrauncheB2TermLoanMember 2016-03-31 0001590714 pah:EuroNotesMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember 2015-12-31 0001590714 pah:EuroTracncheTermLoansMember 2016-03-31 0001590714 pah:TrancheBTermLoanMember 2015-12-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember 2015-12-31 0001590714 pah:FirstLienTermLoanMember us-gaap:SecuredDebtMember 2016-03-31 0001590714 pah:USDNotesMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:EuroTrauncheB2TermLoanMember 2015-12-31 0001590714 pah:USDNotesMember us-gaap:NotesPayableToBanksMember 2015-02-02 0001590714 pah:NewTrancheB2TermLoanMember 2015-02-13 0001590714 us-gaap:MaximumMember pah:RedeemableSeriesBPreferredStockMember us-gaap:ScenarioForecastMember 2017-04-20 2017-04-20 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-12-03 2015-12-03 0001590714 pah:EuroNotesMember us-gaap:NotesPayableToBanksMember 2015-02-02 0001590714 country:US 2016-01-01 2016-03-31 0001590714 pah:SecondLienTermLoanMember 2013-10-31 2013-10-31 0001590714 pah:ArystaMember pah:EuroTracncheTermLoansMember 2015-02-13 0001590714 us-gaap:BankOverdraftsMember 2016-03-31 0001590714 us-gaap:OtherOperatingIncomeExpenseMember 2015-01-01 2015-03-31 0001590714 pah:USDNotesMember us-gaap:InterestRateSwapMember us-gaap:NotesPayableToBanksMember 2015-08-31 0001590714 us-gaap:MinimumMember 2016-01-01 2016-03-31 0001590714 pah:EuroTracncheTermLoansMember 2015-02-13 0001590714 us-gaap:OtherOperatingIncomeExpenseMember 2016-01-01 2016-03-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:EurodollarMember 2015-12-03 2015-12-03 0001590714 pah:ChemturaMember us-gaap:RevolvingCreditFacilityMember 2014-11-03 2014-11-03 0001590714 pah:EuroTracncheTermLoansMember 2015-02-13 2015-02-13 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember 2015-12-03 0001590714 us-gaap:FinancialGuaranteeMember 2016-03-31 0001590714 pah:AlentMember pah:AlentU.S.DollarTrancheB3TermLoanMember 2015-12-03 0001590714 pah:EuroNotesMember us-gaap:InterestRateSwapMember us-gaap:NotesPayableToBanksMember 2015-08-31 0001590714 pah:RevolvingCreditFacilityMultiCurrencyMember 2015-12-03 0001590714 pah:EuroTracncheTermLoansMember 2015-12-03 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:SeniorNotesMember 2015-11-10 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:BaseRateMember 2015-12-03 2015-12-03 0001590714 us-gaap:RevolvingCreditFacilityMember 2016-01-01 2016-03-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2016-03-31 0001590714 pah:SecondLienTermLoanMember 2013-10-31 0001590714 pah:ChemturaMember pah:RevolvingCreditFacilityMultiCurrencyMember 2014-11-03 0001590714 2015-01-01 2015-12-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-12-31 0001590714 pah:RevolvingCreditFacilityMultiCurrencyMember 2015-12-03 2015-12-03 0001590714 pah:AlentMember pah:EuroTracncheTermLoansMember 2015-12-03 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2015-12-03 2015-12-03 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2015-12-03 2015-12-03 0001590714 us-gaap:MaximumMember 2016-01-01 2016-03-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:BaseRateMember 2015-12-03 2015-12-03 0001590714 pah:FirstLienTermLoanMember 2014-11-03 0001590714 pah:ChemturaMember pah:NewTrancheBTermLoansMember 2014-11-03 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-12-03 0001590714 us-gaap:FinancialGuaranteeMember 2015-12-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-02-13 2015-02-13 0001590714 pah:FirstLienTermLoanMember 2013-10-31 0001590714 pah:ArystaMember pah:NewTrancheB2TermLoanMember 2015-02-13 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-12-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:EurodollarMember 2015-12-03 2015-12-03 0001590714 us-gaap:RevolvingCreditFacilityMember 2015-02-13 0001590714 pah:RevolvingCreditFacilityMultiCurrencyMember 2015-02-13 2015-02-13 0001590714 pah:RevolvingCreditFacilityMultiCurrencyMember 2015-02-13 0001590714 us-gaap:RevolvingCreditFacilityMember pah:FirstLienTermLoanMember 2013-10-31 0001590714 pah:BarclaysBankPLCMember 2014-10-01 0001590714 pah:ChemturaMember us-gaap:RevolvingCreditFacilityMember 2014-11-03 0001590714 pah:EuroTrauncheB2TermLoanMember 2016-01-01 2016-03-31 0001590714 pah:TrancheBTermLoanMember 2016-01-01 2016-03-31 0001590714 pah:TrauncheB2TermLoanMember 2016-01-01 2016-03-31 0001590714 pah:EuroTracncheTermLoansMember 2016-01-01 2016-03-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember 2016-01-01 2016-03-31 0001590714 pah:FirstLienTermLoanMember us-gaap:SecuredDebtMember 2016-01-01 2016-03-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember 2016-01-01 2016-03-31 0001590714 pah:USDIncrementalLoansMember 2016-01-01 2016-03-31 0001590714 pah:ForeignExchangeForwardandCommodityContractsMember 2016-03-31 0001590714 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-01-01 2016-03-31 0001590714 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001590714 us-gaap:CommodityContractMember 2015-12-31 0001590714 us-gaap:InventoriesMember 2016-03-31 0001590714 us-gaap:LiabilityMember 2015-12-31 0001590714 us-gaap:ForeignExchangeForwardMember 2016-03-31 0001590714 us-gaap:ForeignExchangeContractMember 2015-01-01 2015-03-31 0001590714 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-01-01 2015-03-31 0001590714 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2016-03-31 0001590714 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2016-01-01 2016-03-31 0001590714 us-gaap:ForeignExchangeContractMember 2016-01-01 2016-03-31 0001590714 us-gaap:CommodityContractMember 2016-03-31 0001590714 us-gaap:ForeignExchangeForwardMember 2015-12-31 0001590714 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001590714 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001590714 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001590714 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001590714 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001590714 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001590714 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001590714 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyTwoMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:ArystaEUROTrauncheTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:CASEUROTracncheC1TermLoansMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyTwoMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:EuroNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:EuroNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:USDIncrementalLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:ArystaEUROTrauncheTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:EuroNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:USDIncrementalLoansMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:CASU.S.DollarTrancheBTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:FirstLienTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2016-03-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyTwoMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:CASU.S.DollarTrancheBTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:EuroNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:FirstLienTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2015-12-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:CASEUROTracncheC1TermLoansMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyOneMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2016-03-31 0001590714 pah:AlentU.S.DollarTrancheB3TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:USDNotesdueTwoThousandAndTwentyTwoMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:NotesPayableToBanksMember 2015-12-31 0001590714 pah:FirstLienTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2015-12-31 0001590714 pah:AlentEuroTrancheC2TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:CASEUROTracncheC1TermLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001590714 pah:ArystaEUROTrauncheTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:CASU.S.DollarTrancheBTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:CASU.S.DollarTrancheBTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:USDIncrementalLoansMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:ArystaU.S.DollarTrauncheB2TermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-03-31 0001590714 pah:USDIncrementalLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 pah:FirstLienTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2016-03-31 0001590714 pah:ArystaEUROTrauncheTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001590714 pah:CASEUROTracncheC1TermLoansMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001590714 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001590714 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001590714 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001590714 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001590714 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001590714 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001590714 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001590714 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001590714 pah:MacDermidMember 2016-03-31 0001590714 pah:MacDermidMember 2016-01-01 2016-03-31 0001590714 pah:FounderEntitiesMember us-gaap:SeriesAPreferredStockMember 2016-01-01 2016-03-31 0001590714 pah:RedeemableSeriesBPreferredStockMember 2016-03-31 0001590714 pah:ArystaMember 2016-03-31 0001590714 pah:ArystaMember 2015-10-27 0001590714 pah:PDHMember 2016-01-01 2016-03-31 0001590714 pah:PDHMember 2016-03-31 0001590714 pah:ArystaMember 2015-02-13 0001590714 pah:MacDermidMember 2015-03-31 0001590714 pah:FounderEntitiesMember us-gaap:SeriesAPreferredStockMember 2016-03-31 0001590714 pah:ArystaMember 2014-10-20 2014-10-20 0001590714 pah:MacDermidMember 2015-01-01 2015-03-31 0001590714 us-gaap:SeriesAPreferredStockMember 2016-03-31 0001590714 us-gaap:SeriesAPreferredStockMember 2016-01-01 2016-03-31 0001590714 pah:RedeemableSeriesBPreferredStockMember 2015-12-31 0001590714 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-01 2016-03-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2016-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-03-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-03-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-03-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-12-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-12-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-03-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-12-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-03-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-12-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2014-12-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-03-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-12-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember 2015-03-31 0001590714 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2014-12-31 0001590714 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001590714 pah:SharesIssuableUponConversionOfFounderPreferredSharesMember 2016-01-01 2016-03-31 0001590714 pah:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2015-01-01 2015-03-31 0001590714 pah:SharesIssuableUponConversionOfFounderPreferredSharesMember 2015-01-01 2015-03-31 0001590714 pah:ContingentlyIssuableForTheContingentConsiderationMember 2015-01-01 2015-03-31 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001590714 pah:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2016-01-01 2016-03-31 0001590714 us-gaap:StockOptionMember 2015-01-01 2015-03-31 0001590714 us-gaap:StockOptionMember 2016-01-01 2016-03-31 0001590714 pah:SharesIssuableUponConversionOfSeriesBPreferredSharesMember 2015-01-01 2015-03-31 0001590714 pah:SharesIssuableUnderEmployeeStockPurchasePlanMember 2015-01-01 2015-03-31 0001590714 pah:SharesIssuableUponConversionOfSeriesBPreferredSharesMember 2016-01-01 2016-03-31 0001590714 pah:ContingentlyIssuableSharesForTheFounderPreferredShareDividendRightMember 2016-01-01 2016-03-31 0001590714 pah:ContingentlyIssuableForTheContingentConsiderationMember 2016-01-01 2016-03-31 0001590714 pah:ContingentlyIssuableSharesForTheFounderPreferredShareDividendRightMember 2015-01-01 2015-03-31 0001590714 pah:SharesIssuableUnderEmployeeStockPurchasePlanMember 2016-01-01 2016-03-31 0001590714 pah:ArystaMember us-gaap:PendingLitigationMember pah:HealthProblemsFromEmploymentSiteMember 2016-01-01 2016-03-31 0001590714 pah:AlentMember 2016-03-31 0001590714 pah:ArystaMember us-gaap:PendingLitigationMember 2009-06-01 2009-06-30 0001590714 pah:ArystaLifeScienceCorporationMember us-gaap:SubsequentEventMember 2016-04-01 2016-04-30 0001590714 pah:AlentMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001590714 pah:ArystaMember us-gaap:PendingLitigationMember 2016-01-01 2016-03-31 0001590714 us-gaap:SettledLitigationMember 2015-02-01 2015-02-28 0001590714 pah:AgricolaColonetSAdeCVMember us-gaap:PendingLitigationMember 2016-01-01 2016-03-31 0001590714 pah:AgricolaColonetSAdeCVMember us-gaap:PendingLitigationMember 2014-01-01 2014-12-31 0001590714 pah:AlentMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001590714 pah:ArystaMember us-gaap:PendingLitigationMember 2011-11-01 2011-11-30 0001590714 pah:MacDermidMember us-gaap:PendingLitigationMember 2014-07-01 2014-07-31 0001590714 pah:ArystaMember us-gaap:SeriesBPreferredStockMember 2015-02-13 2015-02-13 0001590714 us-gaap:SettledLitigationMember 2015-04-03 2015-04-03 0001590714 pah:NetOperatingLossMember 2016-01-01 2016-03-31 0001590714 pah:MariposaCapitalMember 2016-01-01 2016-03-31 0001590714 pah:MacDermidMember 2015-12-31 0001590714 pah:AnnualFeesMember pah:MariposaCapitalMember 2016-01-01 2016-03-31 0001590714 pah:MariposaCapitalMember 2015-01-01 2015-03-31 0001590714 pah:AgriculturalSolutionsMember 2015-01-01 2015-03-31 0001590714 pah:AgriculturalSolutionsMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceApplicationsMember 2016-01-01 2016-03-31 0001590714 pah:PerformanceApplicationsMember 2015-01-01 2015-03-31 0001590714 us-gaap:OtherCurrentLiabilitiesMember 2016-03-31 0001590714 us-gaap:OtherCurrentLiabilitiesMember 2015-12-31 0001590714 pah:SellingTechnicalGeneralAndAdministrativeMember 2016-01-01 2016-03-31 0001590714 us-gaap:CostOfSalesMember 2015-01-01 2015-03-31 0001590714 us-gaap:CostOfSalesMember 2016-01-01 2016-03-31 0001590714 pah:SellingTechnicalGeneralAndAdministrativeMember 2015-01-01 2015-03-31 0001590714 pah:ArgoSolutionsMember 2015-01-01 2015-03-31 0001590714 pah:PerformanceMaterialsMember 2015-01-01 2015-03-31 0001590714 us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 pah:ArgoSolutionsMember us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 pah:ArgoSolutionsMember us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 pah:ArgoSolutionsMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 pah:ArgoSolutionsMember 2015-03-31 0001590714 pah:ArgoSolutionsMember us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 us-gaap:ParentMember us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 us-gaap:ParentMember us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 us-gaap:ParentMember us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 us-gaap:ParentMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 pah:ArystaMember us-gaap:ScenarioPreviouslyReportedMember 2015-01-01 2015-03-31 0001590714 pah:ArystaCASAgripharMember 2015-03-31 0001590714 pah:ArystaMember 2015-03-31 0001590714 pah:ArystaMember us-gaap:RestatementAdjustmentMember 2015-01-01 2015-03-31 0001590714 pah:ArystaMember us-gaap:RestatementAdjustmentMember 2015-03-31 0001590714 pah:ArystaCASAgripharMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 pah:ArystaMember us-gaap:ScenarioPreviouslyReportedMember 2015-03-31 0001590714 pah:ArystaCASAgripharMember us-gaap:RestatementAdjustmentMember 2015-03-31 xbrli:pure iso4217:USD xbrli:shares pah:segment iso4217:USD iso4217:EUR pah:person xbrli:shares iso4217:GBP pah:employee iso4217:MXN iso4217:USD iso4217:GBP iso4217:USD pah:defendant iso4217:BRL iso4217:USD iso4217:BRL iso4217:MXN false --12-31 Q1 2016 2016-03-31 10-Q 0001590714 229557867 Large Accelerated Filer Platform Specialty Products Corp 13000000 16500000 14500000 21811268 289000000 284000000 1160000000 24800000 30900000 56300000 263000000 189000000 17900000 5500000 6400000 0.25 0 200000 11.00 0 0 125000000 0 125000000 2000000 3000000 60000000 P7Y 3000000 0 1800000 1600000 0 177400000 33100000 4300000 P10D 8800000 729417 70700000 73500000 27.14 27.14 1 P3Y 1.0 6.25 4000000 P10Y P5Y 200000 0 700000 200000 1.00 0.01 1.00 0.8 24100000 -66100000 155300000 121100000 34200000 85800000 75000000 75000000 83000000 87500000 87500000 300000000 11000000 10700000 0.5 P30D 200000 5173600000 5218400000 5211600000 5258100000 83000000 300000000 1499600000 500500000 19800000 70900000 410000000 77600000 21600000 36100000 12000000 830 P4Y 132100000 168400000 27900000 7800000 0 -2800000 618000000 472000000 18000000 8400000 7500000 4200000 -3500000 P1Y P90D 25700000 23800000 1600000 5100000 1 2.0 0 0 3 0 1 0 P3Y 7642 51337 1890998 3000000 12300000 1006436 2838455 1 0.65

450300000

419800000

1023000000

1172800000

22000000

15300000

65100000

69800000

64300000

78300000

-130600000

-14900000

100000

-122200000

6400000

-475000000

-15400000

-474700000

72800000

-547500000

15100000

72800000

-547800000

-886100000

-26300000

-8100000

1200000

-899300000

46400000

-587700000

-26300000

-19100000

800000

-577800000

34700000

P14Y2M12D

P15Y6M

P10Y

P20Y

P21Y8M12D

P24Y6M

P10Y

P23Y3M18D

P25Y

P10Y

P16Y3M18D

P18Y

P10Y

P19Y1M6D

3520400000

3521700000

39800000

64400000

700000

900000

300000

700000

1000000

-100000

900000

200000

14400000

18500000

39800000

64400000

25563000

1333000

2168000

2000000

8619000

11299000

57000

87000

8704000

1000

2000000

8052000

22108000

40865000

18500000

17400000

17500000

18300000

300000

200000

-1400000

700000

100000

8140700000

72800000

8067900000

10190200000

10592700000

2270500000

2296100000

36100000

12000000

8700000

59400000

68100000

7200000

13100000

20300000

9300000

5800000

800000

6600000

6200000

600000

6800000

97500000

646000000

231400000

18419738

83100000

12.56

-64400000

-119200000

897200000

826700000

29300000

7400000

100000

31300000

22900000

11600000

18900000

3500000000

1738400000

239100000

123700000

600000000

2700000

2800000

100000000

70700000

100000000

73500000

-4300000

-1400000

-70800000

-600000

-1000000

-73800000

177500000

219600000

283600000

5500000

27200000

535900000

596400000

120400000

56800000

29300000

1600000

200000

175600000

31500000

4300000

181800000

21500000

3500000

138600000

13600000

15100000

682900000

77900000

59000000

116100000

13200000

7200000

316900000

4000000

37600000

200000

192200000

35100000

4700000

3507800000

72800000

3435000000

1738400000

239100000

123700000

18500000

20000000

397300000

297300000

432200000

329700000

-100000000

-102500000

10050290

400000000

229464157

229523697

229464157

229523697

2300000

-371100000

72800000

-443900000

163600000

400000

-370700000

72800000

-443500000

164000000

21400000

23400000

600000000

200000

-200000

200000

-200000

200000

22107590

21316

16499

327700000

467800000

0.02

0.03

0.045

0.055

0.045

0.055

0.045

374000000

326700000

487500000

500000000

1081100000

946300000

392200000

333100000

488000000

485000000

1081900000

932300000

350000000

1100000000

360000000

500000000

0.055

0.0600

0.055

0.065

0.10375

0.06

0.065

0.10375

300000000

1800000

0.02

0.01

0.02

11900000

40500000

6100000

900000

2100000

600000

6400000

13900000

5400000

18900000

12500000

11900000

38300000

5900000

900000

2000000

500000

6100000

13100000

5100000

18100000

12000000

1000000

678800000

723800000

200000

600000

6300000

2400000

500000

2900000

700000

100000

1600000

500000

100000

2500000

800000

100000

-800000

200000

100000

-400000

700000

200000

400000

8400000

18200000

2100000

3300000

4300000

1100000

4300000

-11400000

-28700000

1000000

300000

1900000

2200000

3300000

3000000

7700000

3600000

0.012

0.0196

13500000

7700000

33000000

1000000

9500000

1200000

12500000

23500000

5300000

P1Y

-0.14

-0.59

-0.14

-0.59

-10600000

7100000

-15.469

-0.159

78100000

60800000

7100000

0.0119

-2800000

70700000

73500000

P15Y1M6D

P20Y6M

P11Y9M18D

P5Y

P12Y4M24D

630300000

184000000

440400000

500000

5400000

203600000

80300000

119000000

600000

3700000

3584200000

1297200000

2260900000

1900000

24200000

3280600000

1250500000

2006000000

1900000

22200000

2953900000

1113200000

1820500000

1400000

18800000

3077000000

1170200000

1887000000

1300000

18500000

682900000

391400000

203300000

77900000

49000000

28000000

900000

59000000

45000000

14000000

819800000

485400000

245300000

86700000

0.0579

1.4362

0.2786

33900000

-71100000

2981700000

2224300000

72800000

2151500000

1769900000

72800000

1697100000

2059600000

72800000

1986800000

72800000

2908900000

4021900000

1874700000

2147200000

4247900000

1996000000

2251900000

1142000000

118700000

66900000

1769900000

72800000

1697100000

72800000

1697100000

66900000

1330000000

66900000

3800000

200000

3600000

207100000

356000000

46300000

42700000

2800000

5400000

-1200000

-1600000

-116000000

24700000

18400000

-600000000

500000

360000000

377000000

81400000

2400000

3314300000

3453600000

-39400000

-93800000

10900000

11500000

500000

340100000

399400000

517500000

612500000

148900000

179200000

28500000

33900000

4300000

9100000

40000000

27400000

7271000000

7496700000

8140700000

72800000

8067900000

10190200000

10592700000

1062400000

1175600000

13500000

70700000

84200000

33000000

73500000

106500000

87400000.0

385000000

160000000

115000000

500000000

50000000.0

87500000.0

163000000

287000000

250000000

300000000

64700000

25000000

600000

313000000

321400000

1001800000

1005900000

87200000

87500000

481200000

477700000

219000000

215400000

121900000

123900000

374000000

219000000

87200000

735600000

710300000

735600000

121900000

481200000

290800000

285800000

1081100000

487500000

5211600000

5019200000

327700000

341500000

1001500000

1008600000

91200000

90800000

480700000

478900000

228800000

223900000

122000000

124100000

392200000

228800000

91200000

733700000

711800000

733700000

122000000

480700000

290400000

286400000

1081900000

488000000

5258100000

5036200000

130000000

205000000

500000000

1050000000

5500000

5300000

5500000

5300000

38000000

39700000

5372000000

3230000000

3226600000

34600000

34700000

34900000

41100000

54700000

188900000

5173600000

5218400000

0.0692

16000000

100000

182000000

10500000

13900000

50000000

108000000

387000000

6500000

12900000

169400000

181300000

0.0665

0.0625

0.0624

2900000

56500000

59400000

1000000

8200000

9200000

2198900000

120700000

-2291100000

-72800000

-2218300000

-19900000

2800000

72800000

-70000000

-210400000

-26700000

-134800000

400000

-26700000

-134800000

125000000

24600000

-3800000

-168100000

125000000

204900000

303900000

2200000

83100000

49000000

52100000

85400000

83000000

117700000

8600000

10300000

15100000

23300000

24700000

414200000

436300000

91900000

98600000

-100000

-400000

-343900000

-100000

-352500000

72800000

-425300000

8700000

72800000

-416700000

-13900000

-400000

321500000

295500000

-11700000

-11000000

-352500000

72800000

-425300000

72800000

321500000

-353100000

-344400000

72800000

-417200000

-8700000

-344400000

72800000

-417200000

72800000

-425900000

310100000

298400000

11700000

298400000

-8700000

11700000

-344400000

72800000

-417200000

298400000

-500000

500000

11000000

500000

-11000000

-100000

-400000

205000000

223600000

13000000

14500000

1700000

2100000

1100000

-200000

200000

2862100000

72800000

2789300000

1200000

600000000

44600000

100000

2860000000

1507000000

239100000

-1300000

2861900000

72800000

2789100000

20800000

11600000

80500000

81800000

22.85

1000

5000000

2000000

172500000

180300000

2084000000

1200000

1000000

200000

55000000

60000000

-900000

157900000

132500000

2200000

500000

-26300000

400000

-26700000

-134400000

400000

-134800000

540000000

6400000

276800000

5100000

143800000

107900000

557800000

8300000

283300000

5400000

149300000

111500000

491600000

470200000

496500000

12100000

473100000

-2900000

2000000

3600000

8700000

373000000

12900000

19900000

300000

800000

1600000

100000

1500000

5500000

-400000

900000

4200000

5100000

1100000

400000

-532700000

-667500000

534800000

354500000

180300000

823800000

403800000

420000000

192000000

284000000

1500000

300000

P3Y

P36M

P33M15D

P62M15D

P36M

329823

25158

473657

83333

390324

7642

390324

637276

1501257

373434

8.84

10.82

329802

0.5300

0.0156

7642

51337

1526415

501634

1969070

2663455

5178815

15500000

166667

364583

4.32

175000

539583

90898

7.95

8.60

4.32

0.01

P10Y

P6Y

15.80

8.32

182066980

2000000

192221572

2000000

229464157

2000000

229523697

2000000

16700000

149200000

0.0428

0.0343

10000000

7986

35399

75000

7642

100000

200000

900000

2090400000

72800000

2017600000

2103900000

2268800000

2552600000

-130600000

2812400000

1900000

93000000

2459600000

-224100000

2199500000

-475000000

72800000

-547800000

2814300000

1900000

109100000

2090400000

72800000

2017600000

-250800000

72800000

2126700000

2273300000

-886100000

3520400000

2300000

169400000

2103900000

-532700000

2450100000

-587700000

3521700000

2300000

181300000

2268800000

-667500000

645900000

600000

112000000

118000000

17500000

18800000

300000

1000000

92800000

59600000

191900000

229500000

191900000

229500000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RESTATEMENT OF UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;"> occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report.  The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;">, and therefore further concluded that the previously reported information should be restated.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tables below present the impact of the restatement on the applicable statements and footnotes as of and for the thee month ended March 31, 2015: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;"> As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other comprehensive income (loss), before tax</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(352.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other comprehensive income (loss), net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(353.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other comprehensive income (loss) attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(443.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(370.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Comprehensive income (loss) attributable to common stockholders</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(443.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(371.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheet (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,908.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,981.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,067.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,140.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stockholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,017.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,090.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,126.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,199.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities, redeemable preferred shares and stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,067.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,140.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Cash Flows (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;"> As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash flows (used in) provided by operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition of businesses, net of acquired cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,789.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,862.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash flows used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,218.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,291.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Changes in Stockholder's Equity (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Comprehensive loss, net of taxes for the three months ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(353.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,017.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,090.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,126.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,199.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the impacts on the above financial statements, the error correction had an impact on disclosures in the following footnotes to the quarterly report for the period ended March 31, 2015.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 2, Acquisitions of Businesses</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Arysta Purchase Price Allocation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,789.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,861.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,435.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,507.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill recorded in connection with the Arysta, CAS and Agriphar Acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,151.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,224.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 5, Goodwill and Intangible Assets</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in carrying amount of Agricultural Solutions goodwill for the three months ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Additions from acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,986.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,059.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in carrying amount of Total goodwill</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Additions from acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,908.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,981.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 12, Accumulated Other Comprehensive (Loss) Income</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in Other comprehensive income (loss) before reclassifications, net for the three month ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign Currency Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(352.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(416.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(343.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign Currency Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(474.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with U.S. GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company and Business</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform Specialty Products Corporation is a global, diversified producer of high-technology specialty chemical products and provider of technical services. The Company's business involves the formulation of a broad range of solutions-oriented specialty chemicals which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. The Company refers to its products as “dynamic chemistries” due to their intricate chemical compositions which are used in a wide variety of niche markets. As further described in Note 19, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Information</font><font style="font-family:inherit;font-size:10pt;">, the Company operates in two segments: Performance Solutions and Agricultural Solutions.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Until the MacDermid Acquisition on October 31, 2013, the Company had neither engaged in any operations nor generated any income.  Following the MacDermid Acquisition, on January 22, 2014, the Company was domesticated in Delaware and on January 23, 2014, its common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share, began trading on the NYSE under the ticker symbol “PAH.”</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with U.S. GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted and Pending Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue From Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In April 2016, the FASB issued ASU 2016-10, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Identifying Performance Obligations and Licensing.</font><font style="font-family:inherit;font-size:10pt;">" The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation - Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:10pt;"> - In March 2016, the FASB issued ASU 2016-09, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Improvements to Employee Share-Based Payment Accounting.</font><font style="font-family:inherit;font-size:10pt;">" The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue From Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU 2016-08, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principal versus Agent Considerations</font><font style="font-family:inherit;font-size:10pt;">." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments - Equity Method and Joint Ventures (Topic 323) </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU No. 2016-07, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Transition to the Equity Method of Accounting.</font><font style="font-family:inherit;font-size:10pt;">" The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivatives and Hedging (Topic 815)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU 2016-06, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force)</font><font style="font-family:inherit;font-size:10pt;">." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivatives and Hedging (Topic 815) </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU No. 2016-05, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force).</font><font style="font-family:inherit;font-size:10pt;">" The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases (Topic 842) </font><font style="font-family:inherit;font-size:10pt;">- In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Leases.”</font><font style="font-family:inherit;font-size:10pt;"> The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Instruments - Overall (Subtopic 825.10) -</font><font style="font-family:inherit;font-size:10pt;"> In January 2016, the FASB issued ASU No. 2016-1, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Recognition and Measurement of Financial Assets and Financial Liabilities.”</font><font style="font-family:inherit;font-size:10pt;"> This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">- In August 2015, the FASB issued ASU No. 2015-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Deferral of the Effective Date,”</font><font style="font-family:inherit;font-size:10pt;"> which defers the effective date of ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Revenue from Contracts with Customers (Topic 606),"</font><font style="font-family:inherit;font-size:10pt;"> for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font><font style="font-family:inherit;font-size:10pt;"> - In April 2015, the FASB issued ASU No. 2015-05, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.”</font><font style="font-family:inherit;font-size:10pt;"> This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Statement – Extraordinary and Unusual Items (Subtopic 225-20)</font><font style="font-family:inherit;font-size:10pt;"> - In January 2015, the FASB issued ASU No. 2015-1, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.”</font><font style="font-family:inherit;font-size:10pt;">  This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items.  The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016.  The Company did not have any extraordinary or unusual income statement items recorded for any periods presented,therefore, this ASU did not have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Presentation of Financial Statements - Going Concern (Subtopic 205-40) </font><font style="font-family:inherit;font-size:10pt;">- In August 2014, the FASB issued ASU No. 2014-15, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern</font><font style="font-family:inherit;font-size:10pt;">."  The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern.  The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted.  The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation – Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:10pt;"> - In June 2014, the FASB issued ASU No. 2014-12, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).”</font><font style="font-family:inherit;font-size:10pt;">  The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.  The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015.  The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restatement</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;"> occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report.  The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;">, and therefore further concluded that the previously reported information should be restated. This restatement is included in Note 20, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) </font><font style="font-family:inherit;font-size:10pt;">to the unaudited interim Condensed Consolidated Financial Statements included herein.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma summary presents consolidated information of the Company for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, as if the OMG Malaysia, Alent, OMG and Arysta Acquisitions had occurred on January 1, 2015:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">826.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">897.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACQUISITIONS OF BUSINESSES</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">OMG Malaysia Acquisition</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 31, 2016, the Company completed the OMG Malaysia Acquisition for approximately </font><font style="font-family:inherit;font-size:10pt;">$124 million</font><font style="font-family:inherit;font-size:10pt;">, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company acquired OMG Malaysia to add-on to the OMG Acquisition and further enhance its Performance Solutions segment. Legacy OMG Malaysia, which is highly-synergistic with the legacy OMG Businesses, is included in the Company's Performance Solutions business segment.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Alent Acquisition</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2015, Platform completed the Alent Acquisition by acquiring all of the issued shares of Alent for approximately </font><font style="font-family:inherit;font-size:10pt;">$1.74 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash, net of acquired cash, and </font><font style="font-family:inherit;font-size:10pt;">18,419,738</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock at </font><font style="font-family:inherit;font-size:10pt;">$12.56</font><font style="font-family:inherit;font-size:10pt;"> per share, issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company acquired Alent to expand its product capabilities and offerings and improve its geographic outreach in surface treatments. Legacy Alent was a global supplier of specialty chemicals and engineered materials used primarily in electronics, automotive, industrial applications, and high performance consumable products and services. Alent is included in the Company's Performance Solutions business segment. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">OMG Acquisition</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 28, 2015, Platform completed the OMG Acquisition for approximately </font><font style="font-family:inherit;font-size:10pt;">$239 million</font><font style="font-family:inherit;font-size:10pt;">, in cash, net of acquired cash, subject to purchase price adjustments.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company acquired the highly-synergistic OMG Businesses to bolster its Performance Solutions business segment. Legacy OMG’s Electronic Chemicals business developed, produced and supplied chemicals for electronic and industrial applications. Legacy OMG’s Photomasks products were used by customers to produce semiconductors and related products. The OMG Businesses are included in the Company's Performance Solutions business segment. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Arysta Acquisition</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 13, 2015, Platform completed the Arysta Acquisition for approximately </font><font style="font-family:inherit;font-size:10pt;">$3.50 billion</font><font style="font-family:inherit;font-size:10pt;">, consisting of </font><font style="font-family:inherit;font-size:10pt;">$2.86 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash, net of acquired cash and closing working capital adjustments, and including Arysta Seller transaction expenses paid by Platform, and the issuance to the Arysta Seller of </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;"> of Platform’s Series B Convertible Preferred Stock with a fair value of </font><font style="font-family:inherit;font-size:10pt;">$646 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company acquired Arysta to expand its presence in the agrochemical business, complementing the Agriphar and CAS Acquisitions. Legacy Arysta provided products and solutions utilizing globally managed patented and proprietary off-patent agrochemical AIs and biological solutions, or biosolutions, and off-patent agrochemical offerings. Biosolutions includes stimulants, or biostimulants, innovative nutrition and biological control, or biocontrol, products. Arysta is included in the Company's Agricultural Solutions business segment. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisition Net Sales and Net Loss</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the dates of the respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">283.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">535.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As the integration continues for (1) the OMG Malaysia, Alent and OMG Acquisitions within the Company's Performance Solutions business segment, and (2) the Arysta, CAS and Agriphar Acquisitions within the Agricultural Solutions segment, discrete revenues reported by these existing businesses are being effected by the integration process and are becoming less comparable to prior periods. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The OMG Malaysia, Alent, OMG and Arysta Acquisitions had net losses for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(73.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase Price Allocation</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the consideration transferred and transaction costs incurred to acquire OMG Malaysia, Alent and the OMG Businesses, as well as the applicable amounts of identified assets acquired and liabilities assumed at the applicable acquisition date:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Alent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Businesses</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,507.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity Instruments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">231.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Note receivable settlement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquisition costs</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Identifiable Assets acquired and Liabilities Assumed</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> - less uncollectible</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable - fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">192.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Identifiable intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(181.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-current deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(138.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(316.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">596.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">120.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase accounting and purchase price allocation for the OMG Malaysia Acquisition remains open due to the proximity of the acquisition date to quarter-end. The purchase accounting and purchase price allocation for the Alent and OMG Acquisitions is substantially complete with the exception of the following areas: environmental and legal reserves, developed technology intangible assets, asset retirement obligations, or AROs, as well as income taxes for the Alent Acquisition, and developed technology intangible assets and income taxes for the OMG Acquisition. The Company is still gathering information related to these recent acquisitions to finalize their purchase accounting. For more information regarding Alent's environmental reserves, see Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies, Environmental and Legal Matters, </font><font style="font-family:inherit;font-size:10pt;">to the Condensed Consolidated Financial Statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of the respective cost of the Acquisitions over the net of amounts assigned to the fair values of the assets acquired and the liabilities assumed is recorded as goodwill and represents the value of estimated synergies and the assembled workforces resulting from the Acquisitions. Of the </font><font style="font-family:inherit;font-size:10pt;">$1.33 billion</font><font style="font-family:inherit;font-size:10pt;"> of goodwill recorded in connection with the OMG Malaysia, Alent and OMG Acquisitions, </font><font style="font-family:inherit;font-size:10pt;">$83.1 million</font><font style="font-family:inherit;font-size:10pt;"> is expected to be deductible for tax purposes as result of a part of the OMG Malaysia and OMG Acquisitions.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="28" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Alent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Businesses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Customer lists</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">391.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">485.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Developed technology</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">203.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">245.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tradenames</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">86.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In process - R&D</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">819.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Includes </font><font style="font-family:inherit;font-size:10pt;">$81.4 million</font><font style="font-family:inherit;font-size:10pt;"> of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Excluded from the calculation of weighted average useful life. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pro Forma Revenue and Earnings</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma summary presents consolidated information of the Company for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, as if the OMG Malaysia, Alent, OMG and Arysta Acquisitions had occurred on January 1, 2015:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">826.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">897.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to stockholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company incurred </font><font style="font-family:inherit;font-size:10pt;">$11.6 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition and integration expenses related to the OMG Malaysia, Alent, OMG and Arysta Acquisitions, which have been reflected in the pro forma earnings above, as if they had been incurred in 2015. In addition, for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended March 31, 2015, the Company incurred </font><font style="font-family:inherit;font-size:10pt;">$22.9 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition and integration expenses related to the Arysta Acquisition, which have been excluded from the March 31, 2015 pro forma earnings above. These pro forma amounts have been prepared to reflect fair value adjustments to intangible assets and the related amortization expense, net of tax, from January 1, 2015, as well as the effect of the debt instruments used to fund the Arysta and Alent Acquisitions.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A computation of the weighted average shares outstanding for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(134.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basic weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">229.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible and performance-based stock </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">229.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss per share attributable to common stockholders:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends per share paid to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> share adjustments are included in the dilutive weighted average shares outstanding computation as their effect would have been anti-dilutive. For more information about such dilutive shares outstanding, refer to the table below.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance. These securities may become dilutive in future periods.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of PDH Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,052</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of Series A Preferred Stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of Series B Convertible Preferred Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,299</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares contingently issuable for the contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted stock shares and units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable under the ESPP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,865</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,563</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines fair value measurements used in its unaudited interim Condensed Consolidated Financial Statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company uses the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below, with Level 1 having the highest priority, and Level 3 having the lowest.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The three levels of the fair value hierarchy are as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model-derived valuations whose inputs are observable or whose significant valuation drivers are observable.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recurring Fair Value Measurements</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">other observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Asset Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Available for sale equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivatives</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Liability Category</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivatives</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">106.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">active markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">other observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Asset Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Available for sale equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivatives</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Liability Category</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivatives</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash equivalents -</font><font style="font-family:inherit;font-size:10pt;"> Cash equivalents comprise money market accounts and certificates of deposits issued by financial institutions. The Company invests in various money market funds which are managed by financial institutions. These funds are not publicly traded, but historically have been highly liquid. The fair values of the money market accounts are determined by the banks based upon the funds’ NAV. All of the money market accounts currently permit daily investments and redemptions at </font><font style="font-family:inherit;font-size:10pt;">$1.00</font><font style="font-family:inherit;font-size:10pt;"> NAV and are classified as Level 1 assets. The Company records certificates of deposit at amortized cost in the Condensed Consolidated Balance Sheets. Given the relatively short maturities of these instruments, the Company believes amortized cost approximates fair value. The Company classifies these instruments as Level 2.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Available for sale equity securities </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">-</font><font style="font-family:inherit;font-size:10pt;"> Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held. Level 2 equity securities are measured using quoted prices for similar instruments in active markets. Available for sale securities are included in "Other assets" in the Condensed Consolidated Balance Sheets.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivatives</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> -</font><font style="font-family:inherit;font-size:10pt;"> Derivative assets and liabilities include foreign currency, metals and interest rate derivatives. The values were determined using pricing models based upon observable market inputs, such as market spot and futures prices on over-the-counter derivative instruments, market interest rates and consideration of counterparty credit risk. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Long-term contingent consideration </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">-</font><font style="font-family:inherit;font-size:10pt;"> The long-term contingent consideration represents a potential liability of up to </font><font style="font-family:inherit;font-size:10pt;">$100 million</font><font style="font-family:inherit;font-size:10pt;"> tied to achievement of EBITDA and common stock trading price performance metric over a </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;">-year period ending December 2020 in connection with the MacDermid Acquisition. The common stock performance metric has been satisfied. The fair value of the EBITDA performance metric is derived using the income approach with unobservable inputs, based on future forecasts and present value assumptions which include a discount rate of approximately </font><font style="font-family:inherit;font-size:10pt;">1.19%</font><font style="font-family:inherit;font-size:10pt;"> and expected future value of payments of </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Changes in the fair value of the long-term contingent consideration are recorded in "Selling, technical, general and administrative expenses" in the Consolidated Statements of Operations. Relative to the share price metric, an increase or decrease in the discount rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> changes the fair value measure of the metric by approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">. Relative to the EBITDA metric, an increase or a decrease in the discount rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">, within a range of probability between </font><font style="font-family:inherit;font-size:10pt;">80%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">, changes the fair value measure of the metric by approximately </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending balances for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> for instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term contingent consideration</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair value measurements using significant unobservable inputs (Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchases, sales and settlements </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transfers into Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transfers out of Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchases, sales or settlements on a gross basis during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company consistently applies its policy for transfers between fair value hierarchy levels as disclosed in the Company's Annual Report. There were no significant transfers between the fair value hierarchy levels for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonrecurring Fair Value Measurements</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Notes, due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,081.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">932.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,081.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">946.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">EUR Notes, due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">392.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">333.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">374.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">326.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Notes, due 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">488.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">485.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">487.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First Lien Credit Facility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">733.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">711.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">735.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">710.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Incremental Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">286.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CAS U.S. Dollar Tranche B Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">124.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta U.S. Dollar Tranche B-2 Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">480.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">478.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">481.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">477.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent U.S. Dollar Tranche B-3 Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,001.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,008.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,001.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,005.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CAS EURO Tranche C-1 Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">223.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">215.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta EURO Tranche C-1 Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent EURO Tranche C-2 Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">327.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">341.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">313.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">321.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Enthone financing liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,258.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,036.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,211.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,019.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying values presented above include unamortized premiums, discounts and debt issuance costs.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following methods and assumptions were used to estimate the fair value of the Company’s long-term debt:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Long-term Debt Instruments</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">-</font><font style="font-family:inherit;font-size:10pt;"> These financial instruments are measured using quoted market prices at the reporting date multiplied by the gross carrying amount of the related debt which excludes unamortized premiums, discounts and debt issuance costs. Such instruments are valued using Level 2 inputs.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending balances for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> for instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Long-term contingent consideration</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair value measurements using significant unobservable inputs (Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchases, sales and settlements </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transfers into Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transfers out of Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> purchases, sales or settlements on a gross basis during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Adopted and Pending Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue From Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In April 2016, the FASB issued ASU 2016-10, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Identifying Performance Obligations and Licensing.</font><font style="font-family:inherit;font-size:10pt;">" The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation - Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:10pt;"> - In March 2016, the FASB issued ASU 2016-09, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Improvements to Employee Share-Based Payment Accounting.</font><font style="font-family:inherit;font-size:10pt;">" The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue From Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU 2016-08, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principal versus Agent Considerations</font><font style="font-family:inherit;font-size:10pt;">." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments - Equity Method and Joint Ventures (Topic 323) </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU No. 2016-07, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Transition to the Equity Method of Accounting.</font><font style="font-family:inherit;font-size:10pt;">" The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivatives and Hedging (Topic 815)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU 2016-06, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force)</font><font style="font-family:inherit;font-size:10pt;">." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivatives and Hedging (Topic 815) </font><font style="font-family:inherit;font-size:10pt;">- In March 2016, the FASB issued ASU No. 2016-05, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force).</font><font style="font-family:inherit;font-size:10pt;">" The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases (Topic 842) </font><font style="font-family:inherit;font-size:10pt;">- In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Leases.”</font><font style="font-family:inherit;font-size:10pt;"> The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Instruments - Overall (Subtopic 825.10) -</font><font style="font-family:inherit;font-size:10pt;"> In January 2016, the FASB issued ASU No. 2016-1, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Recognition and Measurement of Financial Assets and Financial Liabilities.”</font><font style="font-family:inherit;font-size:10pt;"> This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">- In August 2015, the FASB issued ASU No. 2015-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Deferral of the Effective Date,”</font><font style="font-family:inherit;font-size:10pt;"> which defers the effective date of ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">“Revenue from Contracts with Customers (Topic 606),"</font><font style="font-family:inherit;font-size:10pt;"> for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font><font style="font-family:inherit;font-size:10pt;"> - In April 2015, the FASB issued ASU No. 2015-05, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.”</font><font style="font-family:inherit;font-size:10pt;"> This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Statement – Extraordinary and Unusual Items (Subtopic 225-20)</font><font style="font-family:inherit;font-size:10pt;"> - In January 2015, the FASB issued ASU No. 2015-1, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.”</font><font style="font-family:inherit;font-size:10pt;">  This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items.  The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016.  The Company did not have any extraordinary or unusual income statement items recorded for any periods presented,therefore, this ASU did not have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Presentation of Financial Statements - Going Concern (Subtopic 205-40) </font><font style="font-family:inherit;font-size:10pt;">- In August 2014, the FASB issued ASU No. 2014-15, "</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern</font><font style="font-family:inherit;font-size:10pt;">."  The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern.  The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted.  The Company does not expect this ASU to have a material impact on its financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation – Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:10pt;"> - In June 2014, the FASB issued ASU No. 2014-12, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).”</font><font style="font-family:inherit;font-size:10pt;">  The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.  The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015.  The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restatement</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;"> occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report.  The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by </font><font style="font-family:inherit;font-size:10pt;">$72.8 million</font><font style="font-family:inherit;font-size:10pt;">, and therefore further concluded that the previously reported information should be restated. This restatement is included in Note 20, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) </font><font style="font-family:inherit;font-size:10pt;">to the unaudited interim Condensed Consolidated Financial Statements included herein.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="28" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Alent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Businesses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Customer lists</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">391.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">485.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Developed technology</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">203.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">245.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tradenames</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">86.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In process - R&D</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">819.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> Includes </font><font style="font-family:inherit;font-size:10pt;">$81.4 million</font><font style="font-family:inherit;font-size:10pt;"> of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;">Excluded from the calculation of weighted average useful life. </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance. These securities may become dilutive in future periods.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of PDH Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,052</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of Series A Preferred Stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable upon conversion of Series B Convertible Preferred Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,299</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares contingently issuable for the contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted stock shares and units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issuable under the ESPP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,865</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,563</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the dates of the respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">283.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">535.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The OMG Malaysia, Alent, OMG and Arysta Acquisitions had net losses for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OMG</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(73.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in the Company’s AROs were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">AROs, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Remeasurements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">AROs, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s debt and capital lease obligations consisted of the following:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.1304347826087%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Borrowings under lines of credit, <br clear="none"/>weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Notes, due 2022, <br clear="none"/>interest at 6.50%, net of unamortized premium and debt issuance costs of $18.1million and $18.9 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,081.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,081.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">EUR Notes, due 2023, <br clear="none"/>interest at 6.00%, net of debt issuance costs of $5.9 million and $6.1 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">392.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">374.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Notes, due 2021, <br clear="none"/>interest at 10.375%, net of debt issuance costs of $12.0 million and $12.5 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">488.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">487.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First lien secured credit facility, due 2020,<br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of debt issuance costs of $0.5 million and $0.6 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">733.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">735.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">USD Incremental Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $5.1 million and $5.4 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CAS U.S. Dollar Tranche B Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $6.1 million and $6.4 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta U.S. Dollar Tranche B-2 Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $13.1 million and $13.9 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">480.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">481.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent U.S. Dollar Tranche B-3 Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $38.3 million and $40.5 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,001.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,001.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CAS EURO Tranche C-1 Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount of $0.9 million and $0.9 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Arysta EURO Tranche C-1 Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $2.0 million and $2.1 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Alent EURO Tranche C-2 Term Loan, due 2020, <br clear="none"/>interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $11.9 million and $11.9 million at March 31, 2016 and December 31, 2015, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">327.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">313.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total debt and capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,258.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,211.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current portion debt and capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total long-term debt and capital lease obligations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,218.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,173.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A computation of the weighted average shares outstanding for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(134.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basic weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">229.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible and performance-based stock </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">229.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss per share attributable to common stockholders:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends per share paid to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> For the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> share adjustments are included in the dilutive weighted average shares outstanding computation as their effect would have been anti-dilutive.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tables below present the impact of the restatement on the applicable statements and footnotes as of and for the thee month ended March 31, 2015: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;"> As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other comprehensive income (loss), before tax</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(352.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other comprehensive income (loss), net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(353.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other comprehensive income (loss) attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(443.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(370.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Comprehensive income (loss) attributable to common stockholders</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(443.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(371.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Balance Sheet (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,908.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,981.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,067.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,140.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stockholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,017.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,090.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,126.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,199.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities, redeemable preferred shares and stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,067.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,140.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Cash Flows (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;"> As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash flows (used in) provided by operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition of businesses, net of acquired cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,789.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,862.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash flows used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,218.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,291.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidated Statement of Changes in Stockholder's Equity (unaudited) </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Comprehensive loss, net of taxes for the three months ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(417.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(344.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(353.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,017.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,090.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,126.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,199.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the impacts on the above financial statements, the error correction had an impact on disclosures in the following footnotes to the quarterly report for the period ended March 31, 2015.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 2, Acquisitions of Businesses</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Arysta Purchase Price Allocation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,789.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,861.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,435.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,507.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill recorded in connection with the Arysta, CAS and Agriphar Acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,151.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,224.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 5, Goodwill and Intangible Assets</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in carrying amount of Agricultural Solutions goodwill for the three months ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Additions from acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,986.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,059.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in carrying amount of Total goodwill</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Additions from acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,697.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,769.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at March 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,908.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,981.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Note 12, Accumulated Other Comprehensive (Loss) Income</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in Other comprehensive income (loss) before reclassifications, net for the three month ended March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign Currency Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(425.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(352.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(416.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(343.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at March 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As restated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign Currency Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(474.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(547.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(475.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average useful life (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount and Foreign Exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization and</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Book</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount and Foreign Exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization and</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Book</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Customer lists</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,250.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(80.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,170.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,297.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(184.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,113.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11.8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,006.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,887.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,260.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(440.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,820.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tradenames</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-compete agreements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,280.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(203.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,077.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,584.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(630.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,953.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum non-cancelable operating lease commitments were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Lease </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Payment</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of March 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2016, remaining</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Performance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Agricultural Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,147.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,874.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,021.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Addition from acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase accounting adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,251.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,996.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,247.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The major components of inventory were as follows: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">340.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Raw materials and supplies</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">179.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">148.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total inventory, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">612.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">517.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum principal payments on long-term debt and capital leases were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90338164251207%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal Payments</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year ending December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2016 - remaining</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,226.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,499.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">   Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,372.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the consideration transferred and transaction costs incurred to acquire OMG Malaysia, Alent and the OMG Businesses, as well as the applicable amounts of identified assets acquired and liabilities assumed at the applicable acquisition date:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Malaysia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Alent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">OMG Businesses</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,507.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity Instruments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">231.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Note receivable settlement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquisition costs</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Identifiable Assets acquired and Liabilities Assumed</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">177.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> - less uncollectible</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable - fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">192.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Identifiable intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(181.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-current deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(138.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(316.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">596.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">120.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">239.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total rent expense for operating leases was as follows: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Rent Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Options</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Equity </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classified</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liability Classified</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,006,436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">501,634</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">329,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,890,998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,526,415</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">364,583</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercised/Issued </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,642</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,642</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(51,337</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(51,337</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Outstanding at March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,838,455</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,969,070</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">329,802</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">539,583</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the assumptions used in valuing the option grants using the Black-Scholes option pricing method:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Black-Scholes Input Assumptions</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average expected term (years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expected Volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Risk-free rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expected dividend rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance Solutions</font><font style="font-family:inherit;font-size:10pt;"> - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, commercial packaging and printing, electronics, and oil and gas production and drilling. Its products include surface and coating materials, functional conversion coatings, electronics assembly materials, water-based hydraulic control fluids and photopolymers. Performance Solutions products are sold worldwide. In conjunction with the sale of its products, extensive technical service and support is provided to ensure superior performance. Within this segment, the Company provides specialty chemicals to the following industries: Electronics, Commercial Packing and Printing, Industrial, and Offshore. For the electronics industry, the segment designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of the printed circuit boards and other electronic components they manufacture. For the electronics industry, it also develops, manufactures and sells innovative interconnect materials used to assemble printed circuit boards and advanced semiconductor packaging. For the commercial packaging and printing industries, the segment produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment also produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. For the industrials, the segment's dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the offshore industry, the segment produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Agricultural Solutions</font><font style="font-family:inherit;font-size:10pt;"> - The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. It offers to growers diverse crop-protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. The segment also offers a wide variety of proven biosolutions, including biostimulants, innovative nutrition and biocontrol products.  It emphasizes on farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">agrochemicals. Its Global Value Added Portfolio, or GVAP, consists of agrochemicals in the fungicides, herbicides, insecticides and seed treatment categories, based on patented or proprietary off-patent AIs.  Its Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. The segment considers its GVAP and GBP offerings to be key pillars for sustainable growth.  In addition, the segment offers regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates the performance of its operating segments based on net sales and adjusted EBITDA. Adjusted EBITDA for each segment is defined as earnings before interest, taxes, depreciation and amortization, as further adjusted for additional items included in earnings that are not representative or indicative of our ongoing business Adjusted EBITDA for each segment also includes an allocation of corporate costs such as corporate salaries, wages, equity compensation expenses and legal costs. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net Sales (from external customers):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Performance Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">420.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Agricultural Solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">403.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">354.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consolidated net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">823.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">534.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Performance Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Agricultural Solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">168.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles Adjusted EBITDA to Net loss attributable to common stockholders: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;"> (amounts in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">168.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Adjustments to reconcile to net loss attributable to common stockholders:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(93.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term compensation issued in connection with acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restructuring expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Manufacturer's profit in inventory purchase accounting adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(36.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash change in fair value of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition put option expiration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange (loss) gains on foreign denominated external and internal debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(66.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net loss before income taxes and non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(116.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to the non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(134.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS’ EQUITY</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is authorized to issue </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock. The Board has designated </font><font style="font-family:inherit;font-size:10pt;">2,000,000</font><font style="font-family:inherit;font-size:10pt;"> of those shares as "Series A Preferred Stock." As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, a total of </font><font style="font-family:inherit;font-size:10pt;">2,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares were issued and outstanding. The Board has also designated </font><font style="font-family:inherit;font-size:10pt;">600,000</font><font style="font-family:inherit;font-size:10pt;"> of those shares as "Series B Convertible Preferred Stock," which are redeemable and are presented in the mezzanine section of the Company's Condensed Consolidated Balance Sheets. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, a total of </font><font style="font-family:inherit;font-size:10pt;">600,000</font><font style="font-family:inherit;font-size:10pt;"> shares were issued and outstanding. Shares of preferred stock have no voting rights, except in respect of any amendment to the Company's Certificate of Incorporation, as amended, that would alter or change their rights or privileges.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Series A Preferred Stock</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Founder Entities are the current holders of Platform's outstanding </font><font style="font-family:inherit;font-size:10pt;">2,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Series A Preferred Stock. Each share of Series A Preferred Stock is convertible into one share of common stock at the option of the holders until December 31, 2020. All outstanding shares of Series A Preferred Stock will be automatically converted into shares of common stock on a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (which may be extended by the Board for </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> additional years).</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of Series A Preferred Stock are entitled to receive dividends in the form of shares of common stock. The dividend amount is calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends, which is currently </font><font style="font-family:inherit;font-size:10pt;">$22.85</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Series B Convertible Preferred Stock</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Arysta Acquisition, the Company issued to the Arysta Seller </font><font style="font-family:inherit;font-size:10pt;">600,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Series B Convertible Preferred Stock, which have a </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> per share liquidation preference. The fair value of these shares, </font><font style="font-family:inherit;font-size:10pt;">$646 million</font><font style="font-family:inherit;font-size:10pt;">, was recognized as "Redeemable preferred stock – Series B" in the Condensed Consolidated Balance Sheets. At any time, the Arysta Seller may convert these shares into common stock of Platform at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$27.14</font><font style="font-family:inherit;font-size:10pt;">. Additionally, any shares that have not previously been converted will be automatically redeemed at a </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> redemption price in the event of certain mergers or consolidations, the sale of all or substantially all of the Company’s assets or subsidiaries, the sale of certain subsidiaries of the Company or the approval of any plan for the dissolution, liquidation or termination of the Company by its stockholders. Pursuant to the terms of the Arysta share purchase agreement, on April 20, 2017, the Company may be required to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed as described above at the </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> redemption price payable in shares of the Company's common stock (</font><font style="font-family:inherit;font-size:10pt;">22,107,590</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock valued at </font><font style="font-family:inherit;font-size:10pt;">$27.14</font><font style="font-family:inherit;font-size:10pt;"> per share). Upon such repurchase, the Company may also pay to holders of Series B Convertible Preferred Stock in cash any deficit between (i) the </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">-day volume weighted price of Platform’s common stock prior to such repurchase and (ii) </font><font style="font-family:inherit;font-size:10pt;">$27.14</font><font style="font-family:inherit;font-size:10pt;"> per share. To the extent the Arysta Seller continues to own Series B Convertible Preferred Stock, then, if as a result of the March 2013 arbitration matter described in Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies, Environmental and Legal Matters</font><font style="font-family:inherit;font-size:10pt;">, to the unaudited interim Condensed Consolidated Financial Statements, the Arysta Seller is obligated to make a payment to us, we may offset any make-whole payment due to the Arysta Seller by any such amount due from the Arysta Seller. If such make whole payment is less than the amount resolved in connection with this arbitration matter, the deficit will be due from the Arysta Seller. Based on Platform's common stock price of </font><font style="font-family:inherit;font-size:10pt;">$8.60</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the maximum potential make whole payment would total approximately </font><font style="font-family:inherit;font-size:10pt;">$410 million</font><font style="font-family:inherit;font-size:10pt;">, assuming no impact from the March 2013 arbitration matter described in Note 15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies, Environmental and Legal Matters</font><font style="font-family:inherit;font-size:10pt;">. The holders of Series B Convertible Preferred Stock are also entitled to an incremental payment equal to </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> per month from October 20, 2016 to April 20, 2017, or such earlier date after October 20, 2016 that the then outstanding shares of Series B Convertible Preferred Stock are converted into shares of common stock or automatically redeemed by Platform.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-Controlling Interest</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the MacDermid Acquisition, approximately </font><font style="font-family:inherit;font-size:10pt;">$97.5 million</font><font style="font-family:inherit;font-size:10pt;"> was raised in new equity consisting of shares of PDH Common Stock. Since October 31, 2014, all shares of PDH common stock are convertible, at the option of the holder, into a like number of shares of the Company's common stock, the sale of which is subject to a contractual lock-up of </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> per year over a </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-year period, which started on October 31, 2013.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The PDH Common Stock is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and will continue to be until such time as it is fully converted into shares of the Company's common stock. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately </font><font style="font-family:inherit;font-size:10pt;">8.8 million</font><font style="font-family:inherit;font-size:10pt;">, against which </font><font style="font-family:inherit;font-size:10pt;">729,417</font><font style="font-family:inherit;font-size:10pt;"> shares have been issued as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$(1.2) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of net (loss) income has been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations, representing non-controlling interest of </font><font style="font-family:inherit;font-size:10pt;">6.24%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">6.65%</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>

EX-101.SCH 7 pah-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2413402 - Disclosure - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Accumulated Other Comprehensive (Loss) Income link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Acquisitions of Businesses link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Acquisitions of Businesses - Acquisition Net Sales and Net Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Acquisitions of Businesses - Identifiable Intangible Assets Acquired (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Acquisitions of Businesses - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2403406 - Disclosure - Acquisitions of Businesses - Pro Forma Revenue and Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Acquisitions of Businesses - Purchase Price Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Acquisitions of Businesses (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Contingencies, Environmental and Legal Matters link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Contingencies, Environmental and Legal Matters - Changes in AROs (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Contingencies, Environmental and Legal Matters - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Contingencies, Environmental and Legal Matters (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Amendments to Credit Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Covenants and Guarantees (Details) link:presentationLink link:calculationLink link:definitionLink 2409408 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Financial Guarantees and Factoring Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Minimum Principal Payments on Long-term Debt and Capital Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2409407 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Note Offerings, Lines of Credit and Other Debt Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Summary of Debt and Capital Leases Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Derivative Instruments link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Derivative Instruments - Derivative Assets and Liability Offsetting (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Derivative Instruments - Fair Value of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Derivative Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Derivative Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Earnings Per Share - Anti-dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Earnings Per Share - Computation of Weighted Average Shares Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Equity Compensation Plans link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Equity Compensation Plans - Activity in Payment Awards (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Equity Compensation Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Equity Compensation Plans - Stock Options Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Equity Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Fair Value Measurements - Level 3 Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Fair Value Measurements - Nonrecurring Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Goodwill and Intangible Assets - Intangible Assets Subject to Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2417401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Inventories - Major Components of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Operating Lease Commitments link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Operating Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Operating Lease Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Pension and Post-Retirement Plans link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Pension and Post-Retirement Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Pension and Post-Retirement Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Pension and Post-Retirement Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements link:presentationLink link:calculationLink link:definitionLink 2423409 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Accumulated Other Comprehensive (Loss) Income (Details) link:presentationLink link:calculationLink link:definitionLink 2423407 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Acquisitions of Businesses (Details) link:presentationLink link:calculationLink link:definitionLink 2423404 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2423405 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 2423406 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Changes in Stockholder's Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2423403 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2423408 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2423402 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2323301 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Restructuring (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Segment Information - Financial Information by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Net Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 pah-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 pah-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 pah-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Inventory Disclosure [Abstract] Finished goods Inventory, Finished Goods, Gross Work in process Inventory, Work in Process, Gross Raw materials and supplies Inventory, Raw Materials and Supplies, Gross Total inventory, net Inventory, Net Segment Reporting [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Accounting Changes and Error Corrections [Abstract] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Prior Period Error Related To Purchase Accounting Related To Acquisitions Prior Period Error Related To Purchase Accounting Related To Acquisitions [Member] Prior Period Error Related To Purchase Accounting Related To Acquisitions [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Arysta Arysta [Member] Arysta [Member] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Adjustment Restatement Adjustment [Member] Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Foreign currency translation adjustments: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Recently Adopted and Pending Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Revision Reclassification, Policy [Policy Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Inventories Inventories [Member] Liability Liability [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 6.50% USD Notes due 2022 USD Notes [Member] USD Notes [Member] EUR Notes, due 2023 Euro Notes [Member] Euro Notes [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Notes Payable to Banks Notes Payable to Banks [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Forward Foreign Exchange Forward [Member] Commodity Contract Commodity Contract [Member] Interest Rate Swap Interest Rate Swap [Member] Foreign Exchange Contract Foreign Exchange Contract [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Derivative notional amount Derivative, Notional Amount Derivative term Derivative, Term of Contract Interest rate swap rate Derivative, Fixed Interest Rate Derivative liability, current Derivative Liability, Current Unrealized losses recorded to other comprehensive income related to foreign currency hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Gain (loss) to be reclassified during next 12 months Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Loss on derivative contracts Derivative, Loss on Derivative Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] OMG Malaysia, Alent, OMG and Arysta OMG Malaysia, Alent, OMG and Arysta [Member] OMG Malaysia, Alent, OMG and Arysta [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Revenue Business Acquisition, Pro Forma Revenue Net loss attributable to stockholders Business Acquisition, Pro Forma Net Income (Loss) Statement of Comprehensive Income [Abstract] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive income (loss), before tax Other comprehensive income (loss) income, before tax Pension and post-retirement plans: Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments and Tax [Abstract] Tax expense Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax Pension and post-retirement plan, net of tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax Unrealized loss on available for sale securities: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Reclassification Adjustments and Tax [Abstract] Unrealized loss on available for sale securities Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax Tax expense Other Comprehensive Income (Loss), Available-for-sale Securities, Tax Unrealized loss on available for sale securities, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Derivative financial instruments revaluation: Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax [Abstract] Unrealized hedging loss arising during the period Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Derivative financial instruments revaluation Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Tax benefit Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Derivative financial instruments revaluation, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Other comprehensive (income) loss attributable to the non-controlling interests Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive income attributable to the non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income (loss) attributable to common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Reported Value Measurement [Member] Reported Value Measurement [Member] Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Secured Debt [Member] Secured Debt [Member] USD Notes, due 2022 USD Notes due Two Thousand And Twenty Two [Member] USD Notes due Two Thousand And Twenty Two [Member] USD Notes, due 2021 USD Notes due Two Thousand And Twenty One [Member] USD Notes due Two Thousand And Twenty One [Member] First Lien Credit Facility First Lien Term Loan [Member] First lien term loan. USD Incremental Loan USD Incremental Loans [Member] Represents USD incremental loans. CAS U.S. Dollar Tranche B Term Loan CAS U.S. Dollar Tranche B Term Loan [Member] CAS U.S. Dollar Tranche B Term Loan [Member] Arysta U.S. Dollar Tranche B-2 Term Loan Arysta U.S. Dollar Traunche B-2 Term Loan [Member] Arysta U.S. Dollar Traunche B-2 Term Loan [Member] Alent U.S. Dollar Tranche B-3 Term Loan Alent U.S. Dollar Tranche B-3 Term Loan [Member] Alent U.S. Dollar Tranche B-3 Term Loan [Member] CAS EURO Tranche C-1 Term Loan CAS EURO Tracnche C-1 Term Loans [Member] CAS EURO Tracnche C-1 Term Loans [Member] Arysta EURO Tranche C-1 Term Loan Arysta EURO Traunche Term Loan [Member] Arysta EURO Traunche Term Loan [Member] Alent EURO Tranche C-2 Term Loan Alent Euro Tranche C-2 Term Loan [Member] New Euro Tranche C-2 Term Loan [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gross debt, long term Long-term Debt, Gross Long term debt Long-term Debt Enthone financing liability Other Long-term Debt Total Long-term Debt and Capital Lease Obligations Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets [Member] Other Assets Other Assets [Member] Other Current Liabilities Other Current Liabilities [Member] Derivative liability, noncurrent Derivative Liability, Noncurrent Derivative assets, current Derivative Asset, Current Derivative assets, noncurrent Derivative Asset, Noncurrent Derivative liability, current Total derivative contracts Derivative Assets (Liabilities), at Fair Value, Net Equity [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Accumulated Net Unrealized Investment Gain (Loss) [Member] Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Beginning balance Accumulated Other Comprehensive Income (Loss), Net of Tax Other comprehensive (loss) income before reclassifications, net Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Reclassifications, pretax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Tax benefit reclassified Other Comprehensive Income (Loss), Tax Ending balance Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Preferred Stock [Member] Preferred Stock [Member] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) [Member] AOCI Attributable to Parent [Member] Parent [Member] Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance, shares (in Shares) Shares, Outstanding Beginning balance, stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Other comprehensive loss, net of taxes Issuance of common stock to Founder Entities as stock dividend on Series A Preferred Stock declared on 12/31/14 (in shares) Common Stock Dividends, Shares Issuance of common stock to former non-founder director for exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Issuance of common stock to former non-founder director for exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Conversion of PDH Common Stock into common stock (in shares) Conversion of Stock, Shares Issued Conversion of PDH Common Stock into common stock Conversion of Stock, Amount Issued Issuance of common stock under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Equity compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Acquisition of non-controlling interest with Arysta Acquisition Noncontrolling Interest, Increase from Business Combination Ending balance, shares (in Shares) Ending balance, stockholders' equity Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Earnings Per Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Contingently Issuable Shares For The Founder Preferred Share Dividend Right Contingently Issuable Shares For The Founder Preferred Share Dividend Right [Member] Represents contingently issuable for the founder preferred share dividend right. Shares Issuable Upon Conversion of PDH Non-controlling Interest Shares Issuable Upon Conversion Of PDH Non Controlling Interest [Member] Represents shares issuable upon conversion of the PDH non-controlling interest. Shares Issuable Upon Conversion Of Founder Preferred Shares Shares Issuable Upon Conversion Of Founder Preferred Shares [Member] Represents shares issuable upon conversion of founder preferred shares. Shares Issuable Upon Conversion Of Series B Preferred Shares Shares Issuable Upon Conversion Of Series B Preferred Shares [Member] Shares Issuable Upon Conversion Of Series B Preferred Shares [Member] Contingently Issuable for the Contingent Consideration Contingently Issuable For The Contingent Consideration [Member] Information on the number of shares contingently issuable for the contingent consideration. Equity Option Equity Option [Member] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Shares Issuable Under Employee Stock Purchase Plan Shares Issuable Under Employee Stock Purchase Plan [Member] Shares Issuable Under Employee Stock Purchase Plan [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Weighted-average securities not included in computation of diluted shares outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Employee Stock Option Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Weighted average expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected dividend rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Fair value price (in dollars per share) Share Price Summary of Impact of the restatement on the applicable statements and footnotes Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Total [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Total [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Total [Roll Forward] Total, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Outstanding, Number Total, Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Granted Share-based Compensation Arrangement by Share-based Payment Award, Granted Total, Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Exercised Total, Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Forfeited EX-101.PRE 11 pah-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 platformspecialtylogoa06.jpg begin 644 platformspecialtylogoa06.jpg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htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2016	May. 06, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Platform Specialty Products Corp
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding (in shares)		229,557,867
Amendment Flag	false
Entity Central Index Key	0001590714
Entity Filer Category	Large Accelerated Filer
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Net sales	$ 823.8	$ 534.8
Cost of sales	467.8	327.7
Gross profit	356.0	207.1
Operating expenses:
Selling, technical, general and administrative	284.0	192.0
Research and development	19.9	12.9
Total operating expenses	303.9	204.9
Operating profit	52.1	2.2
Other (expense) income:
Interest expense, net	(93.8)	(39.4)
Loss on derivative contracts	(5.3)	0.0
Foreign exchange (loss) gain	(71.1)	33.9
Other income, net	2.1	1.7
Total other expense	(168.1)	(3.8)
Loss before income taxes and non-controlling interests	(116.0)	(1.6)
Income tax expense	(18.4)	(24.7)
Net loss	(134.4)	(26.3)
Net income attributable to the non-controlling interests	(0.4)	(0.4)
Net loss attributable to common stockholders	$ (134.8)	$ (26.7)
Loss per share
Basic (in usd per share)	$ (0.59)	$ (0.14)
Diluted (in usd per share)	$ (0.59)	$ (0.14)
Weighted average shares outstanding
Basic (in Shares)	229.5	191.9
Diluted (in Shares)	229.5	191.9

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net loss	$ (134.4)	$ (26.3)
Other comprehensive income (loss), before tax
Foreign currency translation adjustments:	321.5	(352.5)
Pension and post-retirement plans:
Tax expense	0.0	(0.5)
Pension and post-retirement plan, net of tax	0.0	(0.5)
Unrealized loss on available for sale securities:
Unrealized loss on available for sale securities	(0.4)	(0.1)
Tax expense	0.0	0.0
Unrealized loss on available for sale securities, net of tax	(0.4)	(0.1)
Derivative financial instruments revaluation:
Unrealized hedging loss arising during the period	(11.0)	0.0
Derivative financial instruments revaluation	(11.0)	0.0
Tax benefit	0.0	0.0
Derivative financial instruments revaluation, net of tax	(11.0)	0.0
Total other comprehensive income (loss), net of tax	310.1	(353.1)
Other comprehensive (income) loss attributable to the non-controlling interests	(11.7)	8.7
Total other comprehensive income (loss), net of tax	298.4	(344.4)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Comprehensive income (loss)	164.0	(370.7)
Comprehensive income attributable to the non-controlling interests	(0.4)	(0.4)
Comprehensive income (loss) attributable to common stockholders	$ 163.6	$ (371.1)

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Assets
Cash and cash equivalents	$ 329.7	$ 432.2
Restricted cash	0.8	0.3
Accounts receivable, net of allowance for doubtful accounts of $18.5 and $14.4 at March 31, 2016 and December 31, 2015, respectively	1,172.8	1,023.0
Inventories	612.5	517.5
Note receivable	0.0	125.0
Prepaid expenses and other current assets	180.3	172.5
Total current assets	2,296.1	2,270.5
Property, plant and equipment, net	496.5	491.6
Goodwill	4,247.9	4,021.9
Intangible assets, net	3,453.6	3,314.3
Other assets	98.6	91.9
Total assets	10,592.7	10,190.2
Liabilities & Stockholders' Equity
Accounts payable	419.8	450.3
Current installments of long-term debt and revolving credit facilities	188.9	54.7
Accrued salaries, wages and employee benefits	60.8	78.1
Accrued income taxes payable	69.8	65.1
Accrued expenses and other current liabilities	436.3	414.2
Total current liabilities	1,175.6	1,062.4
Long-term debt and capital lease obligations	5,218.4	5,173.6
Long-term retirement benefits, less current portion	81.8	80.5
Long-term deferred income taxes	723.8	678.8
Long-term contingent consideration	73.5	70.7
Other long-term liabilities	223.6	205.0
Total liabilities	$ 7,496.7	$ 7,271.0
Commitments and contingencies
Redeemable preferred stock - Series B	$ 645.9	$ 645.9
Stockholders' Equity
Preferred stock - Series A	0.0	0.0
Common stock 400,000,000 shares authorized, 229,523,697 and 229,464,157 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	2.3	2.3
Additional paid-in capital	3,521.7	3,520.4
Accumulated deficit	(667.5)	(532.7)
Accumulated other comprehensive loss	(587.7)	(886.1)
Total stockholders' equity	2,268.8	2,103.9
Non-controlling interests	181.3	169.4
Total equity	2,450.1	2,273.3
Total liabilities, redeemable preferred shares and equity	$ 10,592.7	$ 10,190.2

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 18.5	$ 14.4
Common shares authorized (in shares)	400,000,000	400,000,000
Common shares issued (in shares)	229,523,697	229,464,157
Common shares outstanding (in shares)	229,523,697	229,464,157

XML 18 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net cash flows (used in) provided by operating activities	$ (210.4)	$ 2.8
Cash flows from investing activities:
Change in restricted cash	(0.5)	600.0
Capital expenditures	(11.6)	(20.8)
Investment in registrations of products	(7.5)	(8.4)
Proceeds from disposal of property, plant and equipment	2.2	0.0
Settlement of derivatives	(1.1)	0.0
Acquisition of businesses, net of acquired cash	(1.2)	(2,862.1)
Other, net	(0.2)	0.2
Net cash flows used in investing activities	(19.9)	(2,291.1)
Cash flows from financing activities:
Proceeds from issuance of debt, net of discount and premium	1.2	2,084.0
Change in revolving credit facilities, net	132.5	157.9
Repayments of borrowings	(8.7)	(3.6)
Proceeds from issuance of common stock, net	0.2	1.0
Payment of debt financing fees	(0.1)	(44.6)
Change in factored liabilities	(3.5)	4.2
Other, net	(0.9)	0.0
Net cash flows provided by financing activities	120.7	2,198.9
Effect of exchange rate changes on cash and cash equivalents	7.1	(10.6)
Net decrease in cash and cash equivalents	(102.5)	(100.0)
Cash and cash equivalents at beginning of period	432.2	397.3
Cash and cash equivalents at end of period	329.7	297.3
Non-cash Investing Activities
Settlement of Note Receivable in exchange for OMG Malaysia	125.0	0.0
Acquisition of OMG Malaysia through the settlement of Note Receivable	$ (125.0)	$ 0.0

XML 19 R7.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Stockholders' Equity Statement - USD ($) $ in Millions	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Parent [Member]	Noncontrolling Interest [Member]
Beginning balance, shares (in Shares) at Dec. 31, 2014		2,000,000	182,066,980
Beginning balance, stockholders' equity at Dec. 31, 2014	$ 2,552.6	$ 0.0	$ 1.9	$ 2,812.4	$ (224.1)	$ (130.6)	$ 2,459.6	$ 93.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(26.3)				(26.7)		(26.7)	0.4
Other comprehensive loss, net of taxes	(353.1)					(344.4)	(344.4)	(8.7)
Issuance of common stock to Founder Entities as stock dividend on Series A Preferred Stock declared on 12/31/14 (in shares)			10,050,290
Issuance of common stock to former non-founder director for exercise of stock options (in shares)			75,000
Issuance of common stock to former non-founder director for exercise of stock options	0.9			0.9			0.9
Conversion of PDH Common Stock into common stock (in shares)			21,316
Conversion of PDH Common Stock into common stock				0.2			0.2	(0.2)
Issuance of common stock under ESPP (in shares)			7,986
Issuance of common stock under ESPP	0.1			0.1			0.1
Equity compensation expense	0.7			0.7			0.7
Acquisition of non-controlling interest with Arysta Acquisition	24.6							24.6
Ending balance, shares (in Shares) at Mar. 31, 2015		2,000,000	192,221,572
Ending balance, stockholders' equity at Mar. 31, 2015	2,199.5	$ 0.0	$ 1.9	2,814.3	(250.8)	(475.0)	2,090.4	109.1
Beginning balance, shares (in Shares) at Dec. 31, 2015		2,000,000	229,464,157
Beginning balance, stockholders' equity at Dec. 31, 2015	2,273.3	$ 0.0	$ 2.3	3,520.4	(532.7)	(886.1)	2,103.9	169.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(134.4)				(134.8)		(134.8)	0.4
Other comprehensive loss, net of taxes	$ 310.1					298.4	298.4	11.7
Issuance of common stock to former non-founder director for exercise of stock options (in shares)	0		7,642
Conversion of PDH Common Stock into common stock (in shares)			16,499
Conversion of PDH Common Stock into common stock				0.2			0.2	(0.2)
Issuance of common stock under ESPP (in shares)			35,399
Issuance of common stock under ESPP	$ 0.2			0.2			0.2
Equity compensation expense	0.9			0.9			0.9
Ending balance, shares (in Shares) at Mar. 31, 2016		2,000,000	229,523,697
Ending balance, stockholders' equity at Mar. 31, 2016	$ 2,450.1	$ 0.0	$ 2.3	$ 3,521.7	$ (667.5)	$ (587.7)	$ 2,268.8	$ 181.3

XML 20 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Significant Accounting Policies	BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Description of the Company and Business Platform Specialty Products Corporation is a global, diversified producer of high-technology specialty chemical products and provider of technical services. The Company's business involves the formulation of a broad range of solutions-oriented specialty chemicals which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. The Company refers to its products as “dynamic chemistries” due to their intricate chemical compositions which are used in a wide variety of niche markets. As further described in Note 19, Segment Information, the Company operates in two segments: Performance Solutions and Agricultural Solutions. Until the MacDermid Acquisition on October 31, 2013, the Company had neither engaged in any operations nor generated any income. Following the MacDermid Acquisition, on January 22, 2014, the Company was domesticated in Delaware and on January 23, 2014, its common stock, par value $0.01 per share, began trading on the NYSE under the ticker symbol “PAH.” Basis of Presentation These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with U.S. GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report. The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Principles of Consolidation The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation. Recently Adopted and Pending Accounting Pronouncements Revenue From Contracts with Customers (Topic 606) - In April 2016, the FASB issued ASU 2016-10, "Identifying Performance Obligations and Licensing." The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU. Compensation - Stock Compensation (Topic 718) - In March 2016, the FASB issued ASU 2016-09, "Improvements to Employee Share-Based Payment Accounting." The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Revenue From Contracts with Customers (Topic 606) - In March 2016, the FASB issued ASU 2016-08, "Principal versus Agent Considerations." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU. Investments - Equity Method and Joint Ventures (Topic 323) - In March 2016, the FASB issued ASU No. 2016-07, "Simplifying the Transition to the Equity Method of Accounting." The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU 2016-06, "Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force)." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-05, "Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force)." The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements. Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU. Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements. Revenue from Contracts with Customers (Topic 606) - In August 2015, the FASB issued ASU No. 2015-14, “Deferral of the Effective Date,” which defers the effective date of ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)," for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU. Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - In April 2015, the FASB issued ASU No. 2015-05, “Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements. Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented,therefore, this ASU did not have a material impact on the Company's financial statements. Presentation of Financial Statements - Going Concern (Subtopic 205-40) - In August 2014, the FASB issued ASU No. 2014-15, "Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern." The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement. Restatement As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of $72.8 million occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report. The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million, and therefore further concluded that the previously reported information should be restated. This restatement is included in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included herein.

XML 21 R9.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses

3 Months Ended

Mar. 31, 2016

Business Combinations [Abstract]

Acquisitions of Businesses

ACQUISITIONS OF BUSINESSES

OMG Malaysia Acquisition

Alent Acquisition

OMG Acquisition

On October 28, 2015, Platform completed the OMG Acquisition for approximately $239 million, in cash, net of acquired cash, subject to purchase price adjustments.

Arysta Acquisition

Acquisition Net Sales and Net Loss

Since the dates of the respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the three months ended March 31, 2016 and 2015 were as follows:



(amounts in millions)	Three Months Ended March 31, 2016		Three Months Ended March 31, 2015
OMG Malaysia	$	5.5	$	—
Alent	219.6		—
OMG	27.2		—
Arysta	283.6		177.5
Total	$	535.9	$	177.5

The OMG Malaysia, Alent, OMG and Arysta Acquisitions had net losses for the three months ended March 31, 2016 and 2015 as follows:



(amounts in millions)	Three Months Ended March 31, 2016			Three Months Ended March 31, 2015
OMG Malaysia	$	(0.6	)	$	—
Alent	(1.4		)	—
OMG	(1.0		)	—
Arysta	(70.8		)	(4.3		)
Total	$	(73.8	)	$	(4.3	)

Purchase Price Allocation



(amounts in millions)	OMG Malaysia			Alent			OMG Businesses
Consideration
Cash, net	$	(1.3	)	$	1,507.0		$	239.1
Equity Instruments	—			231.4			—
Note receivable settlement	125.0			—			—
Total Consideration	$	123.7		$	1,738.4		$	239.1

Acquisition costs	$	0.1		$	29.3		$	7.4

Identifiable Assets acquired and Liabilities Assumed
Accounts receivable	$	4.3		$	177.4		$	33.1
- less uncollectible	—			(1.8		)	(1.6		)
Accounts receivable - fair value	4.3			175.6			31.5
Inventories	7.2			116.1			13.2
Other current assets	0.2			29.3			1.6
Property, plant and equipment	4.7			192.2			35.1
Identifiable intangible assets	59.0			682.9			77.9
Other assets	—			37.6			0.2
Current Liabilities	(3.5		)	(181.8		)	(21.5		)
Non-current deferred tax liability	(15.1		)	(138.6		)	(13.6		)
Other long term liabilities	—			(316.9		)	(4.0		)
Total identifiable net assets	56.8			596.4			120.4
Goodwill	66.9			1,142.0			118.7
Total purchase price	$	123.7		$	1,738.4		$	239.1

Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows:



	OMG Malaysia			Alent				OMG Businesses			Total
(amounts in millions)	Fair Value		Weighted average useful life (years)	Fair Value			Weighted average useful life (years)	Fair Value		Weighted average useful life (years)	Fair Value		Weighted average useful life (years)
Customer lists	$	45.0	25.0	$	391.4		15.5	$	49.0	24.5	$	485.4	18.0
Developed technology	14.0		10.0	203.3			10.0	28.0		10.0	245.3		10.0
Tradenames	—		—	85.8		⁽¹⁾	20.0	0.9		10.0	86.7		19.1
In process - R&D	—		—	2.4		⁽²⁾	—	—		—	2.4		—
Total	$	59.0	23.3	$	682.9		14.2	$	77.9	21.7	$	819.8	16.3

⁽¹⁾ Includes $81.4 million of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life.

⁽²⁾Excluded from the calculation of weighted average useful life.

Pro Forma Revenue and Earnings



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Revenue	$	826.7		$	897.2
Net loss attributable to stockholders	$	(119.2	)	$	(64.4	)

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1524-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4934-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4926-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=73530397&loc=SL65897772-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

XML 22 R10.htm IDEA: XBRL DOCUMENT

Inventories

3 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

The major components of inventory were as follows:



(amounts in millions)	March 31, 2016		December 31, 2015
Finished goods	$	399.4	$	340.1
Work in process	33.9		28.5
Raw materials and supplies	179.2		148.9
Total inventory, net	$	612.5	$	517.5

As of March 31, 2016 and December 31, 2015, the remaining portion of the inventory fair value mark-up totaled $0.5 million and $11.5 million, respectively.

XML 23 R11.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

PROPERTY, PLANT AND EQUIPMENT

The major components of property, plant and equipment, including equipment under capital leases, were as follows:



(amounts in millions)	March 31, 2016			December 31, 2015
Land and leasehold improvements	$	111.5		$	107.9
Buildings and improvements	149.3			143.8
Machinery, equipment, fixtures and software	283.3			276.8
Assets under capital lease
Land and buildings	8.3			6.4
Machinery and equipment	5.4			5.1
Total Property, plant and equipment	557.8			540.0
Accumulated depreciation	(78.3		)	(64.3		)
Accumulated amortization of capital leases	(6.4		)	(5.5		)
Total accumulated depreciation and amortization	473.1			470.2
Construction in process	23.4			21.4
Property, plant and equipment, net	$	496.5		$	491.6

For the three months ended March 31, 2016 and 2015, the Company recorded depreciation expense of $18.2 million and $8.4 million, respectively.

XML 24 R12.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill by segment were as follows:



(amounts in millions)	Performance Solutions		Agricultural Solutions		Total
December 31, 2015	$	2,147.2	$	1,874.7	$	4,021.9
Addition from acquisitions	66.9		—		66.9
Purchase accounting adjustments	3.6		0.2		3.8
Foreign currency translation	34.2		121.1		155.3
March 31, 2016	$	2,251.9	$	1,996.0	$	4,247.9

During the three months ended March 31, 2016, the Company found no indications of impairment related to its goodwill and indefinite-lived intangible assets.

Intangible assets subject to amortization were as follows:



		March 31, 2016							December 31, 2015
(amounts in millions)	Weighted average useful life (years)	Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value		Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value
Customer lists	20.5	$	1,250.5	$	(80.3	)	$	1,170.2	$	1,297.2	$	(184.0	)	$	1,113.2
Developed technology	11.8	2,006.0		(119.0		)	1,887.0		2,260.9		(440.4		)	1,820.5
Tradenames	12.4	22.2		(3.7		)	18.5		24.2		(5.4		)	18.8
Non-compete agreements	5.0	1.9		(0.6		)	1.3		1.9		(0.5		)	1.4
Total	15.1	$	3,280.6	$	(203.6	)	$	3,077.0	$	3,584.2	$	(630.3	)	$	2,953.9

For the three months ended March 31, 2016 and 2015, the Company recorded amortization expense on intangible assets of $64.4 million and $39.8 million, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 25 R13.htm IDEA: XBRL DOCUMENT

Equity Compensation Plans

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Compensation Plans

EQUITY COMPENSATION PLANS



	Three Months Ended March 31, 2016
	Total		RSUs			Stock Options
	Total		Equity Classified		Liability Classified	Stock Options
Outstanding at December 31, 2015	1,006,436		501,634		329,802	175,000
Granted	1,890,998		1,526,415		—	364,583
Exercised/Issued	(7,642	)	(7,642	)	—	—
Forfeited	(51,337	)	(51,337	)	—	—
Outstanding at March 31, 2016	2,838,455		1,969,070		329,802	539,583

Equity Classified Share Based Payments

RSUs granted during the three months ended March 31, 2016 had a weighted-average grant-date fair value of $10.82 per unit.

For the three months ended March 31, 2016 and 2015, total compensation expense associated with RSUs classified as equity totaled $0.9 million and $0.7 million, respectively.

Liability Classified Share Based Payments

For the three months ended March 31, 2016 and 2015, compensation (income) expense associated with these awards totaled $(0.1) million and $0.3 million, respectively.

Stock Options

The following table provides the assumptions used in valuing the option grants using the Black-Scholes option pricing method:



	Black-Scholes Input Assumptions
Weighted average expected term (years)	6.0
Expected Volatility	53.0		%
Risk-free rate	1.56		%
Expected dividend rate	—		%
Fair value price	$	4.32

For the three months ended March 31, 2016, the Company recognized a de minimis amount of compensation expense associated with stock options.

Long Term Cash Bonus Plan

Employee Stock Purchase Plan

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 26 R14.htm IDEA: XBRL DOCUMENT

Pension and Post-Retirement Plans

3 Months Ended

Mar. 31, 2016

Compensation and Retirement Disclosure [Abstract]

Pension and Post-Retirement Plans

PENSION AND POST-RETIREMENT PLANS

The components of net periodic pension and post-retirement benefit costs for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016						2015
Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign
Net periodic (benefit) cost:
Service cost	$	—		$	0.4		$	—		$	0.2
Interest cost on the projected benefit obligation	2.5			0.8			1.6			0.5
Expected return on plan assets	(2.9		)	(0.7		)	(2.4		)	(0.5		)
Amortization of prior service cost	—			0.2			—			—
Net periodic (benefit) cost	$	(0.4	)	$	0.7		$	(0.8	)	$	0.2



	Three Months Ended March 31,
(amounts in millions)	2016				2015
Post-retirement Benefits:	Domestic		Foreign		Domestic		Foreign
Net periodic cost:
Interest cost on the projected benefit obligation	$	0.1	$	0.1	$	0.1	$	—
Net periodic cost	$	0.1	$	0.1	$	0.1	$	—

XML 27 R15.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements

DEBT, CAPITAL LEASES, FINANCIAL GUARANTEES AND FACTORING ARRANGEMENTS

The Company’s debt and capital lease obligations consisted of the following:



(amounts in millions)	March 31, 2016			December 31, 2015
Borrowings under lines of credit, weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively	$	149.2		$	16.7

USD Notes, due 2022, interest at 6.50%, net of unamortized premium and debt issuance costs of $18.1million and $18.9 million at March 31, 2016 and December 31, 2015, respectively	1,081.9			1,081.1
EUR Notes, due 2023, interest at 6.00%, net of debt issuance costs of $5.9 million and $6.1 million at March 31, 2016 and December 31, 2015, respectively	392.2			374.0
USD Notes, due 2021, interest at 10.375%, net of debt issuance costs of $12.0 million and $12.5 million at March 31, 2016 and December 31, 2015, respectively	488.0			487.5
First lien secured credit facility, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of debt issuance costs of $0.5 million and $0.6 million at March 31, 2016 and December 31, 2015, respectively	733.7			735.6
USD Incremental Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $5.1 million and $5.4 million at March 31, 2016 and December 31, 2015, respectively	290.4			290.8
CAS U.S. Dollar Tranche B Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $6.1 million and $6.4 million at March 31, 2016 and December 31, 2015, respectively	122.0			121.9
Arysta U.S. Dollar Tranche B-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $13.1 million and $13.9 million at March 31, 2016 and December 31, 2015, respectively	480.7			481.2
Alent U.S. Dollar Tranche B-3 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $38.3 million and $40.5 million at March 31, 2016 and December 31, 2015, respectively	1,001.5			1,001.8
CAS EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount of $0.9 million and $0.9 million at March 31, 2016 and December 31, 2015, respectively	228.8			219.0
Arysta EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $2.0 million and $2.1 million at March 31, 2016 and December 31, 2015, respectively	91.2			87.2
Alent EURO Tranche C-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $11.9 million and $11.9 million at March 31, 2016 and December 31, 2015, respectively	327.7			313.0
Other	20.0			18.5
Total debt and capital lease obligations	5,258.1			5,211.6
Less: current portion debt and capital lease obligations	(39.7		)	(38.0		)
Total long-term debt and capital lease obligations	$	5,218.4		$	5,173.6

Minimum principal payments on long-term debt and capital leases were as follows:



(amounts in millions)	Principal Payments
Year ending December 31,	Principal Payments
2016 - remaining	$	41.1
2017	34.9
2018	34.7
2019	34.6
2020	3,226.6
2021	500.5
Thereafter	1,499.6
Total	$	5,372.0

Amendments to Credit Agreement

Covenants and Events of Default

Guarantees

November 2015 Notes Offering

February 2015 Notes Offering

Lines of Credit and Other Debt Facilities

Financial Guarantees and Factoring Arrangements

XML 28 R16.htm IDEA: XBRL DOCUMENT

Derivative Instruments

3 Months Ended

Mar. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

DERIVATIVE INSTRUMENTS

Foreign Currency

Interest Rates

Commodities

The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets:



(amounts in millions)		March 31, 2016			December 31, 2015
		U.S. Dollar Amount			U.S. Dollar Amount
Derivatives designated as hedging instruments	Liabilities Balance Sheet location
Interest rate swaps	Other long-term liabilities	$	(23.5	)	$	(12.5	)
Derivatives not designated as hedging instruments:	Assets Balance Sheet location
Foreign exchange and metals contracts	Prepaid expenses and other current assets	4.3			1.1
Foreign exchange contracts	Other Assets	—			1.0
	Liabilities Balance Sheet location
Foreign exchange and metals contracts	Accrued expenses and other current liabilities	(9.5		)	(1.0		)
Net derivative contract liability		$	(28.7	)	$	(11.4	)

For the three months ended March 31, 2016, the Company recorded unrealized losses of $11.0 million in "Other comprehensive income (loss)" related to interest rate swaps. There was no such activity during the three months ended March 31, 2015. The interest rate swaps were deemed highly effective with no ineffective portions for cash flow hedge accounting purposes during the three months ended March 31, 2016. During the next twelve months, the Company expects to reclassify $10.9 million from Accumulated Other Comprehensive Income to "Interest expense, net" in the Condensed Consolidated Statements of Operations.



Financial assets	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross assets		Gross liabilities offset	Net amounts presented		Financial instruments		Cash collateral received
Derivative assets	$	3.3	—	$	3.3	(0.3	)	$	—		$	3.0

Financial liabilities	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross liabilities		Gross assets offset	Net amounts presented		Financial instruments		Cash collateral pledged
Derivative liabilities	$	7.7	—	$	7.7	(2.2	)	$	(1.9	)	$	3.6

Cash balances pledged as collateral and held in accounts with counterparties are recorded in "Prepaid expenses and other current assets" in the Condensed Consolidated Balance Sheets.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 29 R17.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

The three levels of the fair value hierarchy are as follows:


•	Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.


•	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model-derived valuations whose inputs are observable or whose significant valuation drivers are observable.


•	Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.

Recurring Fair Value Measurements

The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:



			Fair Value Measurement Using
(amounts in millions)	March 31, 2016		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	9.2	$	1.0	$	8.2	$	—
Available for sale equity securities	6.8		6.2		0.6		—
Derivatives	4.3		—		4.3		—
Total	$	20.3	$	7.2	$	13.1	$	—
Liability Category
Long-term contingent consideration	$	73.5	$	—	$	—	$	73.5
Derivatives	33.0		—		33.0		—
Total	$	106.5	$	—	$	33.0	$	73.5



			Fair Value Measurement Using
(amounts in millions)	December 31, 2015		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	59.4	$	2.9	$	56.5	$	—
Available for sale equity securities	6.6		5.8		0.8		—
Derivatives	2.1		—		2.1		—
Total	$	68.1	$	8.7	$	59.4	$	—
Liability Category
Long-term contingent consideration	$	70.7	$	—	$	—	$	70.7
Derivatives	13.5		—		13.5		—
Total	$	84.2	$	—	$	13.5	$	70.7

The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:



(amounts in millions)	Long-term contingent consideration
Fair value measurements using significant unobservable inputs (Level 3)	March 31, 2016
Beginning balance	$	70.7
Changes in fair value	2.8
Purchases, sales and settlements ⁽¹⁾	—
Transfers into Level 3	—
Transfers out of Level 3	—
Ending balance	$	73.5

⁽¹⁾ There were no purchases, sales or settlements on a gross basis during the three months ended March 31, 2016.

Nonrecurring Fair Value Measurements

The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations:



(amounts in millions)	March 31, 2016				December 31, 2015
	Carrying Value		Fair Value		Carrying Value		Fair Value
USD Notes, due 2022	$	1,081.9	$	932.3	$	1,081.1	$	946.3
EUR Notes, due 2023	392.2		333.1		374.0		326.7
USD Notes, due 2021	488.0		485.0		487.5		500.0
First Lien Credit Facility	733.7		711.8		735.6		710.3
USD Incremental Loan	290.4		286.4		290.8		285.8
CAS U.S. Dollar Tranche B Term Loan	122.0		124.1		121.9		123.9
Arysta U.S. Dollar Tranche B-2 Term Loan	480.7		478.9		481.2		477.7
Alent U.S. Dollar Tranche B-3 Term Loan	1,001.5		1,008.6		1,001.8		1,005.9
CAS EURO Tranche C-1 Term Loan	228.8		223.9		219.0		215.4
Arysta EURO Tranche C-1 Term Loan	91.2		90.8		87.2		87.5
Alent EURO Tranche C-2 Term Loan	327.7		341.5		313.0		321.4
Enthone financing liability	14.5		14.5		13.0		13.0
Capital lease obligations	5.5		5.3		5.5		5.3
Total	$	5,258.1	$	5,036.2	$	5,211.6	$	5,019.2

Carrying values presented above include unamortized premiums, discounts and debt issuance costs.

The following methods and assumptions were used to estimate the fair value of the Company’s long-term debt:

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 30 R18.htm IDEA: XBRL DOCUMENT

Stockholders' Equity	3 Months Ended
Stockholders' Equity	Mar. 31, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity	STOCKHOLDERS’ EQUITY Preferred Stock The Company is authorized to issue 5,000,000 shares of preferred stock. The Board has designated 2,000,000 of those shares as "Series A Preferred Stock." As of March 31, 2016 and December 31, 2015, a total of 2,000,000 shares were issued and outstanding. The Board has also designated 600,000 of those shares as "Series B Convertible Preferred Stock," which are redeemable and are presented in the mezzanine section of the Company's Condensed Consolidated Balance Sheets. As of March 31, 2016 and December 31, 2015, a total of 600,000 shares were issued and outstanding. Shares of preferred stock have no voting rights, except in respect of any amendment to the Company's Certificate of Incorporation, as amended, that would alter or change their rights or privileges. Series A Preferred Stock The Founder Entities are the current holders of Platform's outstanding 2,000,000 shares of Series A Preferred Stock. Each share of Series A Preferred Stock is convertible into one share of common stock at the option of the holders until December 31, 2020. All outstanding shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (which may be extended by the Board for three additional years). Holders of Series A Preferred Stock are entitled to receive dividends in the form of shares of common stock. The dividend amount is calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends, which is currently $22.85. Series B Convertible Preferred Stock In connection with the Arysta Acquisition, the Company issued to the Arysta Seller 600,000 shares of Series B Convertible Preferred Stock, which have a $1,000 per share liquidation preference. The fair value of these shares, $646 million, was recognized as "Redeemable preferred stock – Series B" in the Condensed Consolidated Balance Sheets. At any time, the Arysta Seller may convert these shares into common stock of Platform at a conversion price of $27.14. Additionally, any shares that have not previously been converted will be automatically redeemed at a $1,000 redemption price in the event of certain mergers or consolidations, the sale of all or substantially all of the Company’s assets or subsidiaries, the sale of certain subsidiaries of the Company or the approval of any plan for the dissolution, liquidation or termination of the Company by its stockholders. Pursuant to the terms of the Arysta share purchase agreement, on April 20, 2017, the Company may be required to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed as described above at the $1,000 redemption price payable in shares of the Company's common stock (22,107,590 shares of common stock valued at $27.14 per share). Upon such repurchase, the Company may also pay to holders of Series B Convertible Preferred Stock in cash any deficit between (i) the 10-day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. To the extent the Arysta Seller continues to own Series B Convertible Preferred Stock, then, if as a result of the March 2013 arbitration matter described in Note 15, Contingencies, Environmental and Legal Matters, to the unaudited interim Condensed Consolidated Financial Statements, the Arysta Seller is obligated to make a payment to us, we may offset any make-whole payment due to the Arysta Seller by any such amount due from the Arysta Seller. If such make whole payment is less than the amount resolved in connection with this arbitration matter, the deficit will be due from the Arysta Seller. Based on Platform's common stock price of $8.60 as of March 31, 2016, the maximum potential make whole payment would total approximately $410 million, assuming no impact from the March 2013 arbitration matter described in Note 15, Contingencies, Environmental and Legal Matters. The holders of Series B Convertible Preferred Stock are also entitled to an incremental payment equal to $4.0 million per month from October 20, 2016 to April 20, 2017, or such earlier date after October 20, 2016 that the then outstanding shares of Series B Convertible Preferred Stock are converted into shares of common stock or automatically redeemed by Platform. Non-Controlling Interest In connection with the MacDermid Acquisition, approximately $97.5 million was raised in new equity consisting of shares of PDH Common Stock. Since October 31, 2014, all shares of PDH common stock are convertible, at the option of the holder, into a like number of shares of the Company's common stock, the sale of which is subject to a contractual lock-up of 25% per year over a four-year period, which started on October 31, 2013. The PDH Common Stock is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at March 31, 2016 and December 31, 2015 and will continue to be until such time as it is fully converted into shares of the Company's common stock. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately 8.8 million, against which 729,417 shares have been issued as of March 31, 2016. For the three months ended March 31, 2016 and 2015, approximately $(1.2) million and $5.4 million, respectively, of net (loss) income has been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations, representing non-controlling interest of 6.24% and 6.65% at March 31, 2016 and 2015, respectively.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 31 R19.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive (Loss) Income

3 Months Ended

Mar. 31, 2016

Equity [Abstract]

Accumulated Other Comprehensive (Loss) Income

ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME

Changes in each component of accumulated other comprehensive (loss) income, net of tax for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31, 2016
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation			Non-Controlling Interests			Accumulated Other Comprehensive Loss
Balance at December 31, 2015	$	(899.3	)	$	(26.3	)	$	1.2		$	(8.1	)	$	46.4		$	(886.1	)
Other comprehensive (loss) income before reclassifications, net	321.5			—			(0.4		)	(13.9		)	(11.7		)	295.5
Reclassifications, pretax	—			—			—			2.9			—			2.9
Tax benefit reclassified	—			—			—			—			—			—
Balance at March 31, 2016	$	(577.8	)	$	(26.3	)	$	0.8		$	(19.1	)	$	34.7		$	(587.7	)



	Three Months Ended March 31, 2015
	(as restated)
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation		Non-Controlling Interests		Accumulated Other Comprehensive Loss
Balance at December 31, 2014	$	(122.2	)	$	(14.9	)	$	0.1		$	—	$	6.4	$	(130.6	)
Other comprehensive (loss) income before reclassifications, net (as restated)	(352.5		)	—			(0.1		)	—		8.7		(343.9		)
Tax expense reclassified	—			(0.5		)	—			—		—		(0.5		)
Balance at March 31, 2015	$	(474.7	)	$	(15.4	)	$	—		$	—	$	15.1	$	(475.0	)

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

XML 32 R20.htm IDEA: XBRL DOCUMENT

Earnings Per Share

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

A computation of the weighted average shares outstanding for the three months ended March 31, 2016 and 2015 follows:



	Three Months Ended March 31,
(amounts in millions, except per share amounts)	2016			2015
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

Basic weighted average common stock outstanding	229.5			191.9
Convertible and performance-based stock ⁽¹⁾	—			—
Dilutive weighted average common stock outstanding	229.5			191.9
Loss per share attributable to common stockholders:
Basic	$	(0.59	)	$	(0.14	)
Diluted	$	(0.59	)	$	(0.14	)

Dividends per share paid to common shareholders	$	—		$	—



	Three Months Ended March 31,
(amounts in thousands)	2016	2015
Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock	—	2,168
Shares issuable upon conversion of PDH Common Stock	8,052	8,619
Shares issuable upon conversion of Series A Preferred Stock	2,000	2,000
Shares issuable upon conversion of Series B Convertible Preferred Stock	22,108	11,299
Shares contingently issuable for the contingent consideration	8,704	1,333
Stock options	—	87
Restricted stock shares and units	—	57
Shares issuable under the ESPP	1	—
	40,865	25,563

XML 33 R21.htm IDEA: XBRL DOCUMENT

Operating Lease Commitments

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Operating Lease Commitments

OPERATING LEASE COMMITMENTS

Total rent expense for operating leases was as follows:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Rent Expense	$	9.1	$	4.3

Minimum non-cancelable operating lease commitments were as follows:



(amounts in millions)	Operating Lease Payment
As of March 31, 2016	Operating Lease Payment
2016, remaining	$	24.7
2017	23.3
2018	15.1
2019	10.3
2020	8.6
2021	7.8
Thereafter	27.9
	$	117.7

The fixed operating lease commitments detailed above assume that the Company continues the leases through their initial lease terms.

XML 34 R22.htm IDEA: XBRL DOCUMENT

Contingencies, Environmental and Legal Matters

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Contingencies, Environmental and Legal Matters

CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS

Asset Retirement Obligations

Changes in the Company’s AROs were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
AROs, beginning of period	$	17.5		$	18.5
Accretion expense	0.2			0.3
Remeasurements	0.1			—
Payments	(0.2		)	—
Foreign currency adjustments	0.7			(1.4		)
AROs, end of period	$	18.3		$	17.4

Environmental

Legal Proceedings

In June 2009, a lawsuit was filed by a private individual against Arysta LifeScience do Brasil Industria Química e Agropecuária Ltda, or Arysta Brazil, and 25 other defendants, and in November 2011, a claim was filed against Arysta Brazil and 5 other defendants by the city of Ulianopolis, in each case in connection with materials sent by Arysta Brazil and others to an incineration site owned and operated by an unaffiliated third party in the state of Pará, Brazil. Arysta Brazil was summoned and has filed its answer in connection with both cases. Proceedings have been suspended indefinitely in order to allow the Pará State Attorney to conduct civil inquiries to determine the extent of contamination and the appropriate remediation, and to identify potentially responsible parties. Damages sought in the private lawsuit include a penalty of BRL 50.0 million ($13.9 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016), plus interest and the cost of remediation. The cost of remediation in the case brought by the city of Ulianopolis was previously estimated by the city to be BRL 70.9 million ($19.8 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016). In addition, 29 former employees of the incineration facility have brought actions naming 80 defendants, including Arysta Brazil, seeking compensation in an aggregate amount of BRL 387 million ($108 million, based on the BRL/USD exchange rate of 0.2786 on March 31, 2016) for health problems allegedly contracted as a result of their employment at the incineration site.

XML 35 R23.htm IDEA: XBRL DOCUMENT

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES For the three months ended March 31, 2016 and 2015, income tax expense totaled $18.4 million and $24.7 million, respectively. The Company's effective tax rate in the first quarter of 2016 was (15.9)% on pre-tax losses of $116 million, compared to an effective tax rate of (1,547)% on pre-tax losses of $1.6 million in the first quarter of 2015. The difference between the statutory and effective tax rates for the three months ended March 31, 2016 principally relates to the recognition of a $59.6 million valuation allowance on current quarter losses related to net operating losses that may not be recoverable for U.S. and foreign companies. The amount of unrecognized tax benefits was $118 million and $112 million at March 31, 2016 and December 31, 2015, respectively, of which $92.8 million, if recognized, would reduce the Company's effective tax rate. Accrued interest and penalties related to unrecognized tax benefits were $18.8 million and $17.5 million at March 31, 2016 and December 31, 2015, respectively. The Company recognized interest and penalties of $1.0 million and $0.3 million related to unrecognized tax benefits in the income tax provision for the three months ended March 31, 2016 and 2015, respectively. The unrecognized tax benefits could be reduced by $10.0 million over the next 12 months as a result of the lapse of statutes of limitations in various jurisdictions.

XML 36 R24.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions	RELATED PARTY TRANSACTIONS RHSA Immediately prior to the closing of the MacDermid Acquisition, each Retaining Holder entered into a RHSA pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for shares of PDH Common Stock, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder, (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven-year period following the closing of the MacDermid Acquisition. The resulting non-controlling interest percentage for the Retaining Holders was 6.24% at March 31, 2016 and 6.25% at December 31, 2015. Advisory Services Agreement The Company is party to an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of our founder directors, whereby Mariposa Capital, LLC is entitled to receive an annual fee equal to $2.0 million, payable in quarterly installments. This agreement is automatically renewed for successive one-year terms unless either party notifies the other party in writing of its intention not to renew no later than 90 days prior to the expiration of the term. For each of the three month periods ended March 31, 2016 and 2015, the Company incurred advisory fees under the agreement totaling $0.5 million.

XML 37 R25.htm IDEA: XBRL DOCUMENT

Restructuring

3 Months Ended

Mar. 31, 2016

Restructuring and Related Activities [Abstract]

Restructuring

RESTRUCTURING

Restructuring expenses were recorded as follows in each of the Company's segments:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Performance Solutions	$	4.2	$	1.5
Agricultural Solutions	0.9		0.1
Total restructuring	$	5.1	$	1.6

The restructuring plans initiated within the Performance Solutions segment primarily relate to headcount reductions associated with the integration of the Alent, OMG and OMG Malaysia Acquisitions. The restructuring plans initiated within the Agricultural Solutions segment primarily relate to cost saving opportunities associated with the integration of the Arysta, CAS and Agriphar Acquisitions. There are no material additional costs expected to be incurred related to these discrete restructuring plans. As of March 31, 2016 and December 31, 2015, restructuring liabilities totaled $0.4 million and $1.1 million, respectively, and were included in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets.

Restructuring expenses were recorded as follows in the Condensed Consolidated Statements of Operations:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Cost of sales	$	(0.4	)	$	—
Selling, technical, general and administrative	5.5			1.6
Total restructuring	$	5.1		$	1.6

XML 38 R26.htm IDEA: XBRL DOCUMENT

Segment Information

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented.



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Net Sales (from external customers):
Performance Solutions	$	420.0	$	180.3
Agricultural Solutions	403.8		354.5
Consolidated net sales	823.8		534.8
Adjusted EBITDA:
Performance Solutions	$	83.0	$	49.0
Agricultural Solutions	85.4		83.1
Adjusted EBITDA	$	168.4	$	132.1

The following table reconciles Adjusted EBITDA to Net loss attributable to common stockholders:



	Three months ended March 31,
(amounts in millions)	2016			2015
Adjusted EBITDA	$	168.4		$	132.1
Adjustments to reconcile to net loss attributable to common stockholders:
Interest expense, net	(93.8		)	(39.4		)
Depreciation expense	(18.2		)	(8.4		)
Amortization expense	(64.4		)	(39.8		)
Long-term compensation issued in connection with acquisitions	(0.3		)	(1.5		)
Restructuring expenses	(5.1		)	(1.6		)
Manufacturer's profit in inventory purchase accounting adjustments	(12.0		)	(36.1		)
Acquisition and integration costs	(18.9		)	(31.3		)
Non-cash change in fair value of contingent consideration	(2.8		)	(2.7		)
Acquisition put option expiration	—			3.0
Foreign exchange (loss) gains on foreign denominated external and internal debt	(66.1		)	24.1
Other expenses	(2.8		)	—
Net loss before income taxes and non-controlling interests	(116.0		)	(1.6		)
Income tax expense	(18.4		)	(24.7		)
Net income attributable to the non-controlling interests	(0.4		)	(0.4		)
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 39 R27.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements

3 Months Ended

Mar. 31, 2016

Accounting Changes and Error Corrections [Abstract]

Restatement of Unaudited Interim Condensed Consolidated Financial Statements

RESTATEMENT OF UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The tables below present the impact of the restatement on the applicable statements and footnotes as of and for the thee month ended March 31, 2015:

Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As Restated
Other comprehensive income (loss), before tax
Foreign currency translation adjustments:	$	(425.3	)	$	72.8	$	(352.5	)

Total other comprehensive income (loss), net of tax	$	(425.9	)	$	72.8	$	(353.1	)
Other comprehensive income (loss) attributable to common shareholders	(417.2		)	72.8		(344.4		)

Comprehensive income (loss)	$	(443.5	)	$	72.8	$	(370.7	)
Comprehensive income (loss) attributable to common stockholders	(443.9		)	72.8		(371.1		)

Condensed Consolidated Balance Sheet (unaudited)



	March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Assets
Goodwill	$	2,908.9		$	72.8	$	2,981.7
Total Assets	8,067.9			72.8		8,140.7

Stockholders' Equity
Accumulated other comprehensive loss	$	(547.8	)	$	72.8	$	(475.0	)
Total stockholders' equity	2,017.6			72.8		2,090.4
Total equity	2,126.7			72.8		2,199.5
Total liabilities, redeemable preferred shares and stockholders' equity	8,067.9			72.8		8,140.7

Condensed Consolidated Statement of Cash Flows (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustments			As Restated
Cash flows from operating activities:
Net cash flows (used in) provided by operating activities	$	(70.0	)	$	72.8		$	2.8
Cash flows from investing activities:
Acquisition of businesses, net of acquired cash	$	(2,789.3	)	$	(72.8	)	$	(2,862.1	)
Net cash flows used in investing activities	(2,218.3		)	(72.8		)	(2,291.1		)

Condensed Consolidated Statement of Changes in Stockholder's Equity (unaudited)



	Other Comprehensive loss, net of taxes for the three months ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(417.2	)	$	72.8	$	(344.4	)
Total Stockholders' Equity	(417.2		)	72.8		(344.4		)
Total Equity	(425.9		)	72.8		(353.1		)



	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(547.8	)	$	72.8	$	(475.0	)
Total Stockholders' Equity	2,017.6			72.8		2,090.4
Total Equity	2,126.7			72.8		2,199.5

In addition to the impacts on the above financial statements, the error correction had an impact on disclosures in the following footnotes to the quarterly report for the period ended March 31, 2015.

Note 2, Acquisitions of Businesses



(in millions)	Arysta Purchase Price Allocation
(in millions)	As Previously Reported		Adjustment		As restated
Consideration
Cash, net	$	2,789.1	$	72.8	$	2,861.9

Goodwill	$	1,697.1	$	72.8	$	1,769.9

Total purchase price	$	3,435.0	$	72.8	$	3,507.8

Goodwill recorded in connection with the Arysta, CAS and Agriphar Acquisitions	$	2,151.5	$	72.8	$	2,224.3

Note 5, Goodwill and Intangible Assets



	Changes in carrying amount of Agricultural Solutions goodwill for the three months ended March 31, 2015
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	1,986.8		72.8		2,059.6

	Changes in carrying amount of Total goodwill
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	2,908.9		72.8		2,981.7

Note 12, Accumulated Other Comprehensive (Loss) Income



	Changes in Other comprehensive income (loss) before reclassifications, net for the three month ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(425.3	)	$	72.8	$	(352.5	)
Accumulated Other Comprehensive Loss	(416.7		)	72.8		(343.9		)

	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(547.5	)	$	72.8	$	(474.7	)
Accumulated Other Comprehensive Loss	(547.8		)	72.8		(475.0		)

- Definition

The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.

+ References + Details

XML 40 R28.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with U.S. GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report. The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.
Principles of Consolidation	Principles of Consolidation The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation.
Recently Adopted and Pending Accounting Pronouncements	Recently Adopted and Pending Accounting Pronouncements Revenue From Contracts with Customers (Topic 606) - In April 2016, the FASB issued ASU 2016-10, "Identifying Performance Obligations and Licensing." The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU. Compensation - Stock Compensation (Topic 718) - In March 2016, the FASB issued ASU 2016-09, "Improvements to Employee Share-Based Payment Accounting." The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Revenue From Contracts with Customers (Topic 606) - In March 2016, the FASB issued ASU 2016-08, "Principal versus Agent Considerations." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU. Investments - Equity Method and Joint Ventures (Topic 323) - In March 2016, the FASB issued ASU No. 2016-07, "Simplifying the Transition to the Equity Method of Accounting." The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU 2016-06, "Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force)." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-05, "Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force)." The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements. Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU. Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements. Revenue from Contracts with Customers (Topic 606) - In August 2015, the FASB issued ASU No. 2015-14, “Deferral of the Effective Date,” which defers the effective date of ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)," for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU. Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - In April 2015, the FASB issued ASU No. 2015-05, “Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements. Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented,therefore, this ASU did not have a material impact on the Company's financial statements. Presentation of Financial Statements - Going Concern (Subtopic 205-40) - In August 2014, the FASB issued ASU No. 2014-15, "Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern." The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement.
Revision	Restatement As previously disclosed in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of $72.8 million occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report. The Company subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million, and therefore further concluded that the previously reported information should be restated. This restatement is included in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included herein.

XML 41 R29.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses (Tables)

3 Months Ended

Mar. 31, 2016

Business Combinations [Abstract]

Schedule of Business Acquisitions, by Acquisition

Since the dates of the respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the three months ended March 31, 2016 and 2015 were as follows:



(amounts in millions)	Three Months Ended March 31, 2016		Three Months Ended March 31, 2015
OMG Malaysia	$	5.5	$	—
Alent	219.6		—
OMG	27.2		—
Arysta	283.6		177.5
Total	$	535.9	$	177.5

The OMG Malaysia, Alent, OMG and Arysta Acquisitions had net losses for the three months ended March 31, 2016 and 2015 as follows:



(amounts in millions)	Three Months Ended March 31, 2016			Three Months Ended March 31, 2015
OMG Malaysia	$	(0.6	)	$	—
Alent	(1.4		)	—
OMG	(1.0		)	—
Arysta	(70.8		)	(4.3		)
Total	$	(73.8	)	$	(4.3	)

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed



(amounts in millions)	OMG Malaysia			Alent			OMG Businesses
Consideration
Cash, net	$	(1.3	)	$	1,507.0		$	239.1
Equity Instruments	—			231.4			—
Note receivable settlement	125.0			—			—
Total Consideration	$	123.7		$	1,738.4		$	239.1

Acquisition costs	$	0.1		$	29.3		$	7.4

Identifiable Assets acquired and Liabilities Assumed
Accounts receivable	$	4.3		$	177.4		$	33.1
- less uncollectible	—			(1.8		)	(1.6		)
Accounts receivable - fair value	4.3			175.6			31.5
Inventories	7.2			116.1			13.2
Other current assets	0.2			29.3			1.6
Property, plant and equipment	4.7			192.2			35.1
Identifiable intangible assets	59.0			682.9			77.9
Other assets	—			37.6			0.2
Current Liabilities	(3.5		)	(181.8		)	(21.5		)
Non-current deferred tax liability	(15.1		)	(138.6		)	(13.6		)
Other long term liabilities	—			(316.9		)	(4.0		)
Total identifiable net assets	56.8			596.4			120.4
Goodwill	66.9			1,142.0			118.7
Total purchase price	$	123.7		$	1,738.4		$	239.1

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows:



	OMG Malaysia			Alent				OMG Businesses			Total
(amounts in millions)	Fair Value		Weighted average useful life (years)	Fair Value			Weighted average useful life (years)	Fair Value		Weighted average useful life (years)	Fair Value		Weighted average useful life (years)
Customer lists	$	45.0	25.0	$	391.4		15.5	$	49.0	24.5	$	485.4	18.0
Developed technology	14.0		10.0	203.3			10.0	28.0		10.0	245.3		10.0
Tradenames	—		—	85.8		⁽¹⁾	20.0	0.9		10.0	86.7		19.1
In process - R&D	—		—	2.4		⁽²⁾	—	—		—	2.4		—
Total	$	59.0	23.3	$	682.9		14.2	$	77.9	21.7	$	819.8	16.3

⁽¹⁾ Includes $81.4 million of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life.

⁽²⁾Excluded from the calculation of weighted average useful life.

Schedule of Acquired Indefinite-lived Intangible Assets by Major Class

Identifiable intangible assets recorded in conjunction with the Acquisitions were as follows:



	OMG Malaysia			Alent				OMG Businesses			Total
(amounts in millions)	Fair Value		Weighted average useful life (years)	Fair Value			Weighted average useful life (years)	Fair Value		Weighted average useful life (years)	Fair Value		Weighted average useful life (years)
Customer lists	$	45.0	25.0	$	391.4		15.5	$	49.0	24.5	$	485.4	18.0
Developed technology	14.0		10.0	203.3			10.0	28.0		10.0	245.3		10.0
Tradenames	—		—	85.8		⁽¹⁾	20.0	0.9		10.0	86.7		19.1
In process - R&D	—		—	2.4		⁽²⁾	—	—		—	2.4		—
Total	$	59.0	23.3	$	682.9		14.2	$	77.9	21.7	$	819.8	16.3

⁽¹⁾ Includes $81.4 million of indefinite-lived Tradenames which have been excluded from the calculation of weighted average useful life.

⁽²⁾Excluded from the calculation of weighted average useful life.

Business Acquisition, Pro Forma Information



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Revenue	$	826.7		$	897.2
Net loss attributable to stockholders	$	(119.2	)	$	(64.4	)

XML 42 R30.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

3 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

The major components of inventory were as follows:



(amounts in millions)	March 31, 2016		December 31, 2015
Finished goods	$	399.4	$	340.1
Work in process	33.9		28.5
Raw materials and supplies	179.2		148.9
Total inventory, net	$	612.5	$	517.5

XML 43 R31.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

The major components of property, plant and equipment, including equipment under capital leases, were as follows:



(amounts in millions)	March 31, 2016			December 31, 2015
Land and leasehold improvements	$	111.5		$	107.9
Buildings and improvements	149.3			143.8
Machinery, equipment, fixtures and software	283.3			276.8
Assets under capital lease
Land and buildings	8.3			6.4
Machinery and equipment	5.4			5.1
Total Property, plant and equipment	557.8			540.0
Accumulated depreciation	(78.3		)	(64.3		)
Accumulated amortization of capital leases	(6.4		)	(5.5		)
Total accumulated depreciation and amortization	473.1			470.2
Construction in process	23.4			21.4
Property, plant and equipment, net	$	496.5		$	491.6

XML 44 R32.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The changes in the carrying amount of goodwill by segment were as follows:



(amounts in millions)	Performance Solutions		Agricultural Solutions		Total
December 31, 2015	$	2,147.2	$	1,874.7	$	4,021.9
Addition from acquisitions	66.9		—		66.9
Purchase accounting adjustments	3.6		0.2		3.8
Foreign currency translation	34.2		121.1		155.3
March 31, 2016	$	2,251.9	$	1,996.0	$	4,247.9

Schedule of Finite-Lived Intangible Assets

Intangible assets subject to amortization were as follows:



		March 31, 2016							December 31, 2015
(amounts in millions)	Weighted average useful life (years)	Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value		Gross Carrying Amount and Foreign Exchange		Accumulated Amortization and Foreign Exchange			Net Book Value
Customer lists	20.5	$	1,250.5	$	(80.3	)	$	1,170.2	$	1,297.2	$	(184.0	)	$	1,113.2
Developed technology	11.8	2,006.0		(119.0		)	1,887.0		2,260.9		(440.4		)	1,820.5
Tradenames	12.4	22.2		(3.7		)	18.5		24.2		(5.4		)	18.8
Non-compete agreements	5.0	1.9		(0.6		)	1.3		1.9		(0.5		)	1.4
Total	15.1	$	3,280.6	$	(203.6	)	$	3,077.0	$	3,584.2	$	(630.3	)	$	2,953.9

XML 45 R33.htm IDEA: XBRL DOCUMENT

Equity Compensation Plans (Tables)

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Restricted Stock Units Award Activity



	Three Months Ended March 31, 2016
	Total		RSUs			Stock Options
	Total		Equity Classified		Liability Classified	Stock Options
Outstanding at December 31, 2015	1,006,436		501,634		329,802	175,000
Granted	1,890,998		1,526,415		—	364,583
Exercised/Issued	(7,642	)	(7,642	)	—	—
Forfeited	(51,337	)	(51,337	)	—	—
Outstanding at March 31, 2016	2,838,455		1,969,070		329,802	539,583

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table provides the assumptions used in valuing the option grants using the Black-Scholes option pricing method:



	Black-Scholes Input Assumptions
Weighted average expected term (years)	6.0
Expected Volatility	53.0		%
Risk-free rate	1.56		%
Expected dividend rate	—		%
Fair value price	$	4.32

XML 46 R34.htm IDEA: XBRL DOCUMENT

Pension and Post-Retirement Plans (Tables)

3 Months Ended

Mar. 31, 2016

Compensation and Retirement Disclosure [Abstract]

Schedule of Net Benefit Costs

The components of net periodic pension and post-retirement benefit costs for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016						2015
Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign
Net periodic (benefit) cost:
Service cost	$	—		$	0.4		$	—		$	0.2
Interest cost on the projected benefit obligation	2.5			0.8			1.6			0.5
Expected return on plan assets	(2.9		)	(0.7		)	(2.4		)	(0.5		)
Amortization of prior service cost	—			0.2			—			—
Net periodic (benefit) cost	$	(0.4	)	$	0.7		$	(0.8	)	$	0.2



	Three Months Ended March 31,
(amounts in millions)	2016				2015
Post-retirement Benefits:	Domestic		Foreign		Domestic		Foreign
Net periodic cost:
Interest cost on the projected benefit obligation	$	0.1	$	0.1	$	0.1	$	—
Net periodic cost	$	0.1	$	0.1	$	0.1	$	—

XML 47 R35.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements (Tables)

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Schedule of Debt

The Company’s debt and capital lease obligations consisted of the following:



(amounts in millions)	March 31, 2016			December 31, 2015
Borrowings under lines of credit, weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively	$	149.2		$	16.7

USD Notes, due 2022, interest at 6.50%, net of unamortized premium and debt issuance costs of $18.1million and $18.9 million at March 31, 2016 and December 31, 2015, respectively	1,081.9			1,081.1
EUR Notes, due 2023, interest at 6.00%, net of debt issuance costs of $5.9 million and $6.1 million at March 31, 2016 and December 31, 2015, respectively	392.2			374.0
USD Notes, due 2021, interest at 10.375%, net of debt issuance costs of $12.0 million and $12.5 million at March 31, 2016 and December 31, 2015, respectively	488.0			487.5
First lien secured credit facility, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of debt issuance costs of $0.5 million and $0.6 million at March 31, 2016 and December 31, 2015, respectively	733.7			735.6
USD Incremental Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $5.1 million and $5.4 million at March 31, 2016 and December 31, 2015, respectively	290.4			290.8
CAS U.S. Dollar Tranche B Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $6.1 million and $6.4 million at March 31, 2016 and December 31, 2015, respectively	122.0			121.9
Arysta U.S. Dollar Tranche B-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $13.1 million and $13.9 million at March 31, 2016 and December 31, 2015, respectively	480.7			481.2
Alent U.S. Dollar Tranche B-3 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $38.3 million and $40.5 million at March 31, 2016 and December 31, 2015, respectively	1,001.5			1,001.8
CAS EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount of $0.9 million and $0.9 million at March 31, 2016 and December 31, 2015, respectively	228.8			219.0
Arysta EURO Tranche C-1 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $2.0 million and $2.1 million at March 31, 2016 and December 31, 2015, respectively	91.2			87.2
Alent EURO Tranche C-2 Term Loan, due 2020, interest at the greater of 5.50% or LIBOR plus 4.50%, net of unamortized discount and debt issuance costs of $11.9 million and $11.9 million at March 31, 2016 and December 31, 2015, respectively	327.7			313.0
Other	20.0			18.5
Total debt and capital lease obligations	5,258.1			5,211.6
Less: current portion debt and capital lease obligations	(39.7		)	(38.0		)
Total long-term debt and capital lease obligations	$	5,218.4		$	5,173.6

Schedule of Maturities of Long-term Debt

Minimum principal payments on long-term debt and capital leases were as follows:



(amounts in millions)	Principal Payments
Year ending December 31,	Principal Payments
2016 - remaining	$	41.1
2017	34.9
2018	34.7
2019	34.6
2020	3,226.6
2021	500.5
Thereafter	1,499.6
Total	$	5,372.0

XML 48 R36.htm IDEA: XBRL DOCUMENT

Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets:



(amounts in millions)		March 31, 2016			December 31, 2015
		U.S. Dollar Amount			U.S. Dollar Amount
Derivatives designated as hedging instruments	Liabilities Balance Sheet location
Interest rate swaps	Other long-term liabilities	$	(23.5	)	$	(12.5	)
Derivatives not designated as hedging instruments:	Assets Balance Sheet location
Foreign exchange and metals contracts	Prepaid expenses and other current assets	4.3			1.1
Foreign exchange contracts	Other Assets	—			1.0
	Liabilities Balance Sheet location
Foreign exchange and metals contracts	Accrued expenses and other current liabilities	(9.5		)	(1.0		)
Net derivative contract liability		$	(28.7	)	$	(11.4	)

Offsetting Assets

The following table presents recognized foreign currency exchange forward and metal future derivative contracts that are subject to master netting arrangements but not offset, as at March 31, 2016, and shows in the 'Net' column what the net impact would be on the Company's Condensed Consolidated Balance Sheets if all set-off rights were exercised.



Financial assets	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross assets		Gross liabilities offset	Net amounts presented		Financial instruments		Cash collateral received
Derivative assets	$	3.3	—	$	3.3	(0.3	)	$	—		$	3.0

Financial liabilities	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross liabilities		Gross assets offset	Net amounts presented		Financial instruments		Cash collateral pledged
Derivative liabilities	$	7.7	—	$	7.7	(2.2	)	$	(1.9	)	$	3.6

Offsetting Liabilities



Financial assets	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross assets		Gross liabilities offset	Net amounts presented		Financial instruments		Cash collateral received
Derivative assets	$	3.3	—	$	3.3	(0.3	)	$	—		$	3.0

Financial liabilities	Amounts offset					Amounts not offset					Net
March 31, 2016	Gross liabilities		Gross assets offset	Net amounts presented		Financial instruments		Cash collateral pledged
Derivative liabilities	$	7.7	—	$	7.7	(2.2	)	$	(1.9	)	$	3.6

XML 49 R37.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value, Assets Measured on Recurring Basis

The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:



			Fair Value Measurement Using
(amounts in millions)	March 31, 2016		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	9.2	$	1.0	$	8.2	$	—
Available for sale equity securities	6.8		6.2		0.6		—
Derivatives	4.3		—		4.3		—
Total	$	20.3	$	7.2	$	13.1	$	—
Liability Category
Long-term contingent consideration	$	73.5	$	—	$	—	$	73.5
Derivatives	33.0		—		33.0		—
Total	$	106.5	$	—	$	33.0	$	73.5



			Fair Value Measurement Using
(amounts in millions)	December 31, 2015		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	$	59.4	$	2.9	$	56.5	$	—
Available for sale equity securities	6.6		5.8		0.8		—
Derivatives	2.1		—		2.1		—
Total	$	68.1	$	8.7	$	59.4	$	—
Liability Category
Long-term contingent consideration	$	70.7	$	—	$	—	$	70.7
Derivatives	13.5		—		13.5		—
Total	$	84.2	$	—	$	13.5	$	70.7

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation



(amounts in millions)	Long-term contingent consideration
Fair value measurements using significant unobservable inputs (Level 3)	March 31, 2016
Beginning balance	$	70.7
Changes in fair value	2.8
Purchases, sales and settlements ⁽¹⁾	—
Transfers into Level 3	—
Transfers out of Level 3	—
Ending balance	$	73.5

⁽¹⁾ There were no purchases, sales or settlements on a gross basis during the three months ended March 31, 2016.

Fair Value Measurements, Nonrecurring

The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations:



(amounts in millions)	March 31, 2016				December 31, 2015
	Carrying Value		Fair Value		Carrying Value		Fair Value
USD Notes, due 2022	$	1,081.9	$	932.3	$	1,081.1	$	946.3
EUR Notes, due 2023	392.2		333.1		374.0		326.7
USD Notes, due 2021	488.0		485.0		487.5		500.0
First Lien Credit Facility	733.7		711.8		735.6		710.3
USD Incremental Loan	290.4		286.4		290.8		285.8
CAS U.S. Dollar Tranche B Term Loan	122.0		124.1		121.9		123.9
Arysta U.S. Dollar Tranche B-2 Term Loan	480.7		478.9		481.2		477.7
Alent U.S. Dollar Tranche B-3 Term Loan	1,001.5		1,008.6		1,001.8		1,005.9
CAS EURO Tranche C-1 Term Loan	228.8		223.9		219.0		215.4
Arysta EURO Tranche C-1 Term Loan	91.2		90.8		87.2		87.5
Alent EURO Tranche C-2 Term Loan	327.7		341.5		313.0		321.4
Enthone financing liability	14.5		14.5		13.0		13.0
Capital lease obligations	5.5		5.3		5.5		5.3
Total	$	5,258.1	$	5,036.2	$	5,211.6	$	5,019.2

XML 50 R38.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income (Tables)

3 Months Ended

Mar. 31, 2016

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

Changes in each component of accumulated other comprehensive (loss) income, net of tax for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31, 2016
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation			Non-Controlling Interests			Accumulated Other Comprehensive Loss
Balance at December 31, 2015	$	(899.3	)	$	(26.3	)	$	1.2		$	(8.1	)	$	46.4		$	(886.1	)
Other comprehensive (loss) income before reclassifications, net	321.5			—			(0.4		)	(13.9		)	(11.7		)	295.5
Reclassifications, pretax	—			—			—			2.9			—			2.9
Tax benefit reclassified	—			—			—			—			—			—
Balance at March 31, 2016	$	(577.8	)	$	(26.3	)	$	0.8		$	(19.1	)	$	34.7		$	(587.7	)



	Three Months Ended March 31, 2015
	(as restated)
(amounts in millions)	Foreign Currency Translation Adjustments			Pension and Post-retirement Plans			Unrealized Gain on Available for Sale Securities			Derivative Financial Instrument Revaluation		Non-Controlling Interests		Accumulated Other Comprehensive Loss
Balance at December 31, 2014	$	(122.2	)	$	(14.9	)	$	0.1		$	—	$	6.4	$	(130.6	)
Other comprehensive (loss) income before reclassifications, net (as restated)	(352.5		)	—			(0.1		)	—		8.7		(343.9		)
Tax expense reclassified	—			(0.5		)	—			—		—		(0.5		)
Balance at March 31, 2015	$	(474.7	)	$	(15.4	)	$	—		$	—	$	15.1	$	(475.0	)

XML 51 R39.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

A computation of the weighted average shares outstanding for the three months ended March 31, 2016 and 2015 follows:



	Three Months Ended March 31,
(amounts in millions, except per share amounts)	2016			2015
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

Basic weighted average common stock outstanding	229.5			191.9
Convertible and performance-based stock ⁽¹⁾	—			—
Dilutive weighted average common stock outstanding	229.5			191.9
Loss per share attributable to common stockholders:
Basic	$	(0.59	)	$	(0.14	)
Diluted	$	(0.59	)	$	(0.14	)

Dividends per share paid to common shareholders	$	—		$	—

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share



	Three Months Ended March 31,
(amounts in thousands)	2016	2015
Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock	—	2,168
Shares issuable upon conversion of PDH Common Stock	8,052	8,619
Shares issuable upon conversion of Series A Preferred Stock	2,000	2,000
Shares issuable upon conversion of Series B Convertible Preferred Stock	22,108	11,299
Shares contingently issuable for the contingent consideration	8,704	1,333
Stock options	—	87
Restricted stock shares and units	—	57
Shares issuable under the ESPP	1	—
	40,865	25,563

XML 52 R40.htm IDEA: XBRL DOCUMENT

Operating Lease Commitments (Tables)

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of Rent Expense

Total rent expense for operating leases was as follows:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Rent Expense	$	9.1	$	4.3

Schedule of Future Minimum Rental Payments for Operating Leases

Minimum non-cancelable operating lease commitments were as follows:



(amounts in millions)	Operating Lease Payment
As of March 31, 2016	Operating Lease Payment
2016, remaining	$	24.7
2017	23.3
2018	15.1
2019	10.3
2020	8.6
2021	7.8
Thereafter	27.9
	$	117.7

XML 53 R41.htm IDEA: XBRL DOCUMENT

Contingencies, Environmental and Legal Matters (Tables)

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of Change in Asset Retirement Obligation

Changes in the Company’s AROs were as follows:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
AROs, beginning of period	$	17.5		$	18.5
Accretion expense	0.2			0.3
Remeasurements	0.1			—
Payments	(0.2		)	—
Foreign currency adjustments	0.7			(1.4		)
AROs, end of period	$	18.3		$	17.4

XML 54 R42.htm IDEA: XBRL DOCUMENT

Restructuring (Tables)

3 Months Ended

Mar. 31, 2016

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs

Restructuring expenses were recorded as follows in the Condensed Consolidated Statements of Operations:



	Three Months Ended March 31,
(amounts in millions)	2016			2015
Cost of sales	$	(0.4	)	$	—
Selling, technical, general and administrative	5.5			1.6
Total restructuring	$	5.1		$	1.6

Restructuring expenses were recorded as follows in each of the Company's segments:



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Performance Solutions	$	4.2	$	1.5
Agricultural Solutions	0.9		0.1
Total restructuring	$	5.1	$	1.6

XML 55 R43.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented.



	Three Months Ended March 31,
(amounts in millions)	2016		2015
Net Sales (from external customers):
Performance Solutions	$	420.0	$	180.3
Agricultural Solutions	403.8		354.5
Consolidated net sales	823.8		534.8
Adjusted EBITDA:
Performance Solutions	$	83.0	$	49.0
Agricultural Solutions	85.4		83.1
Adjusted EBITDA	$	168.4	$	132.1

The following table reconciles Adjusted EBITDA to Net loss attributable to common stockholders:



	Three months ended March 31,
(amounts in millions)	2016			2015
Adjusted EBITDA	$	168.4		$	132.1
Adjustments to reconcile to net loss attributable to common stockholders:
Interest expense, net	(93.8		)	(39.4		)
Depreciation expense	(18.2		)	(8.4		)
Amortization expense	(64.4		)	(39.8		)
Long-term compensation issued in connection with acquisitions	(0.3		)	(1.5		)
Restructuring expenses	(5.1		)	(1.6		)
Manufacturer's profit in inventory purchase accounting adjustments	(12.0		)	(36.1		)
Acquisition and integration costs	(18.9		)	(31.3		)
Non-cash change in fair value of contingent consideration	(2.8		)	(2.7		)
Acquisition put option expiration	—			3.0
Foreign exchange (loss) gains on foreign denominated external and internal debt	(66.1		)	24.1
Other expenses	(2.8		)	—
Net loss before income taxes and non-controlling interests	(116.0		)	(1.6		)
Income tax expense	(18.4		)	(24.7		)
Net income attributable to the non-controlling interests	(0.4		)	(0.4		)
Net loss attributable to common stockholders	$	(134.8	)	$	(26.7	)

XML 56 R44.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Tables)

3 Months Ended

Mar. 31, 2016

Accounting Changes and Error Corrections [Abstract]

Summary of Impact of the restatement on the applicable statements and footnotes

The tables below present the impact of the restatement on the applicable statements and footnotes as of and for the thee month ended March 31, 2015:

Condensed Consolidated Statement of Comprehensive Income (Loss) (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As Restated
Other comprehensive income (loss), before tax
Foreign currency translation adjustments:	$	(425.3	)	$	72.8	$	(352.5	)

Total other comprehensive income (loss), net of tax	$	(425.9	)	$	72.8	$	(353.1	)
Other comprehensive income (loss) attributable to common shareholders	(417.2		)	72.8		(344.4		)

Comprehensive income (loss)	$	(443.5	)	$	72.8	$	(370.7	)
Comprehensive income (loss) attributable to common stockholders	(443.9		)	72.8		(371.1		)

Condensed Consolidated Balance Sheet (unaudited)



	March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Assets
Goodwill	$	2,908.9		$	72.8	$	2,981.7
Total Assets	8,067.9			72.8		8,140.7

Stockholders' Equity
Accumulated other comprehensive loss	$	(547.8	)	$	72.8	$	(475.0	)
Total stockholders' equity	2,017.6			72.8		2,090.4
Total equity	2,126.7			72.8		2,199.5
Total liabilities, redeemable preferred shares and stockholders' equity	8,067.9			72.8		8,140.7

Condensed Consolidated Statement of Cash Flows (unaudited)



	Three Months Ended March 31, 2015
(in millions)	As Previously Reported			Adjustments			As Restated
Cash flows from operating activities:
Net cash flows (used in) provided by operating activities	$	(70.0	)	$	72.8		$	2.8
Cash flows from investing activities:
Acquisition of businesses, net of acquired cash	$	(2,789.3	)	$	(72.8	)	$	(2,862.1	)
Net cash flows used in investing activities	(2,218.3		)	(72.8		)	(2,291.1		)

Condensed Consolidated Statement of Changes in Stockholder's Equity (unaudited)



	Other Comprehensive loss, net of taxes for the three months ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(417.2	)	$	72.8	$	(344.4	)
Total Stockholders' Equity	(417.2		)	72.8		(344.4		)
Total Equity	(425.9		)	72.8		(353.1		)



	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Accumulated Other Comprehensive Loss	$	(547.8	)	$	72.8	$	(475.0	)
Total Stockholders' Equity	2,017.6			72.8		2,090.4
Total Equity	2,126.7			72.8		2,199.5

In addition to the impacts on the above financial statements, the error correction had an impact on disclosures in the following footnotes to the quarterly report for the period ended March 31, 2015.

Note 2, Acquisitions of Businesses



(in millions)	Arysta Purchase Price Allocation
(in millions)	As Previously Reported		Adjustment		As restated
Consideration
Cash, net	$	2,789.1	$	72.8	$	2,861.9

Goodwill	$	1,697.1	$	72.8	$	1,769.9

Total purchase price	$	3,435.0	$	72.8	$	3,507.8

Goodwill recorded in connection with the Arysta, CAS and Agriphar Acquisitions	$	2,151.5	$	72.8	$	2,224.3

Note 5, Goodwill and Intangible Assets



	Changes in carrying amount of Agricultural Solutions goodwill for the three months ended March 31, 2015
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	1,986.8		72.8		2,059.6

	Changes in carrying amount of Total goodwill
(in millions)	As Previously Reported		Adjustment		As restated
Additions from acquisitions	$	1,697.1	$	72.8	$	1,769.9
Balance at March 31, 2015	2,908.9		72.8		2,981.7

Note 12, Accumulated Other Comprehensive (Loss) Income



	Changes in Other comprehensive income (loss) before reclassifications, net for the three month ended March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(425.3	)	$	72.8	$	(352.5	)
Accumulated Other Comprehensive Loss	(416.7		)	72.8		(343.9		)

	Balance at March 31, 2015
(in millions)	As Previously Reported			Adjustment		As restated
Foreign Currency Translation Adjustments	$	(547.5	)	$	72.8	$	(474.7	)
Accumulated Other Comprehensive Loss	(547.8		)	72.8		(475.0		)

XML 57 R45.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Details) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2016 USD ($) segment $ / shares	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Jan. 23, 2014 $ / shares
Business Acquisition [Line Items]
Number of operating segments \| segment	2
Share price (in usd per share) \| $ / shares	$ 8.60			$ 0.01
Foreign currency translation adjustments	$ 321.5		$ (352.5)
Adjustment
Business Acquisition [Line Items]
Foreign currency translation adjustments			$ 72.8
Prior Period Error Related To Purchase Accounting Related To Acquisitions \| Adjustment \| Arysta
Business Acquisition [Line Items]
Foreign currency translation adjustments		$ 72.8

XML 58 R46.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions					3 Months Ended
	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Feb. 13, 2015	Mar. 31, 2016	Mar. 31, 2015
Business Acquisition [Line Items]
Equity Instruments				$ 646.0
Goodwill acquired					$ 66.9	$ 1,769.9
Acquisition costs					18.9	31.3
OMG Malaysia [Member]
Business Acquisition [Line Items]
Total Consideration	$ 123.7
Equity Instruments	0.0
Acquisition costs	$ 0.1
Alent
Business Acquisition [Line Items]
Total Consideration		$ 1,738.4
Business acquisition, shares of common stock issued (in shares)		18,419,738
Business acquisition, price per share of common stock acquired (in dollars per share)		$ 12.56
Equity Instruments		$ 231.4
Acquisition costs		$ 29.3
Arysta
Business Acquisition [Line Items]
Total Consideration				3,500.0
Cash, net				2,860.0
Common stock restricted shares				600.0
Equity Instruments				$ 646.0
Acquisition costs						$ 22.9
OMG Malaysia, Alent and OMG
Business Acquisition [Line Items]
Goodwill acquired					1,330.0
OMG Malaysia and OMG
Business Acquisition [Line Items]
Goodwill, expected to be tax deductible					83.1
OMG
Business Acquisition [Line Items]
Total Consideration			$ 239.1
Equity Instruments			0.0
Acquisition costs			$ 7.4
OMG Malaysia, Alent, OMG and Arysta
Business Acquisition [Line Items]
Acquisition costs					$ 11.6

XML 59 R47.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses - Acquisition Net Sales and Net Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Business Acquisition [Line Items]
Revenues	$ 535.9	$ 177.5
Net loss attributable to stockholders	(73.8)	(4.3)
OMG Malaysia [Member]
Business Acquisition [Line Items]
Revenues	5.5	0.0
Net loss attributable to stockholders	(0.6)	0.0
Alent
Business Acquisition [Line Items]
Revenues	219.6	0.0
Net loss attributable to stockholders	(1.4)	0.0
OMG
Business Acquisition [Line Items]
Revenues	27.2	0.0
Net loss attributable to stockholders	(1.0)	0.0
Arysta
Business Acquisition [Line Items]
Revenues	283.6	177.5
Net loss attributable to stockholders	$ (70.8)	$ (4.3)

XML 60 R48.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses - Purchase Price Allocation (Details) - USD ($) $ in Millions				3 Months Ended
	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Feb. 13, 2015
Consideration
Equity Instruments							$ 646.0
Note receivable settlement				$ 125.0	$ 0.0
Acquisition costs				18.9	31.3
Identifiable Assets acquired and Liabilities Assumed
Goodwill				$ 4,247.9	$ 2,981.7	$ 4,021.9
OMG Malaysia [Member]
Consideration
Cash, net	$ (1.3)
Equity Instruments	0.0
Note receivable settlement	125.0
Total Consideration	123.7
Acquisition costs	0.1
Identifiable Assets acquired and Liabilities Assumed
Note receivable settlement	4.3
- less uncollectible	0.0
Accounts receivable	4.3
Inventories	7.2
Other current assets	0.2
Property, plant and equipment	4.7
Identifiable intangible assets	59.0
Other assets	0.0
Current Liabilities	(3.5)
Non-current deferred tax liability	(15.1)
Other long term liabilities	0.0
Total identifiable net assets	56.8
Goodwill	66.9
Total purchase price	$ 123.7
Alent
Consideration
Cash, net		$ 1,507.0
Equity Instruments		231.4
Note receivable settlement		0.0
Total Consideration		1,738.4
Acquisition costs		29.3
Identifiable Assets acquired and Liabilities Assumed
Note receivable settlement		177.4
- less uncollectible		(1.8)
Accounts receivable		175.6
Inventories		116.1
Other current assets		29.3
Property, plant and equipment		192.2
Identifiable intangible assets		682.9
Other assets		37.6
Current Liabilities		(181.8)
Non-current deferred tax liability		(138.6)
Other long term liabilities		(316.9)
Total identifiable net assets		596.4
Goodwill		1,142.0
Total purchase price		$ 1,738.4
OMG
Consideration
Cash, net			$ 239.1
Equity Instruments			0.0
Note receivable settlement			0.0
Total Consideration			239.1
Acquisition costs			7.4
Identifiable Assets acquired and Liabilities Assumed
Note receivable settlement			33.1
- less uncollectible			(1.6)
Accounts receivable			31.5
Inventories			13.2
Other current assets			1.6
Property, plant and equipment			35.1
Identifiable intangible assets			77.9
Other assets			0.2
Current Liabilities			(21.5)
Non-current deferred tax liability			(13.6)
Other long term liabilities			(4.0)
Total identifiable net assets			120.4
Goodwill			118.7
Total purchase price			$ 239.1

XML 61 R49.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses - Identifiable Intangible Assets Acquired (Details) - USD ($) $ in Millions				3 Months Ended
	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Mar. 31, 2016	Dec. 31, 2015
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 819.8
Weighted average useful life (years)				16 years 3 months 18 days
Indefinite-lived Tradenames				$ 377.0	$ 360.0
Customer Lists [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 485.4
Weighted average useful life (years)				18 years
Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 245.3
Weighted average useful life (years)				10 years
Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 86.7
Weighted average useful life (years)				19 years 1 month 6 days
In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value				$ 2.4
OMG Malaysia [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 59.0
Weighted average useful life (years)	23 years 3 months 18 days
OMG Malaysia [Member] \| Customer Lists [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 45.0
Weighted average useful life (years)	25 years
OMG Malaysia [Member] \| Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 14.0
Weighted average useful life (years)	10 years
OMG Malaysia [Member] \| Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 0.0
OMG Malaysia [Member] \| In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value	$ 0.0
Alent
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 682.9
Weighted average useful life (years)		14 years 2 months 12 days
Indefinite-lived Tradenames		$ 81.4
Alent \| Customer Lists [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 391.4
Weighted average useful life (years)		15 years 6 months
Alent \| Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 203.3
Weighted average useful life (years)		10 years
Alent \| Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)		20 years
Intangible assets acquired		$ 85.8
Alent \| In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value		$ 2.4
OMG
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 77.9
Weighted average useful life (years)			21 years 8 months 12 days
OMG \| Customer Lists [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 49.0
Weighted average useful life (years)			24 years 6 months
OMG \| Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 28.0
Weighted average useful life (years)			10 years
OMG \| Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 0.9
Weighted average useful life (years)			10 years
OMG \| In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value			$ 0.0

XML 62 R50.htm IDEA: XBRL DOCUMENT

Acquisitions of Businesses - Pro Forma Revenue and Earnings (Details) - OMG Malaysia, Alent, OMG and Arysta - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Business Acquisition [Line Items]
Revenue	$ 826.7	$ 897.2
Net loss attributable to stockholders	$ (119.2)	$ (64.4)

XML 63 R51.htm IDEA: XBRL DOCUMENT

Inventories - Major Components of Inventory (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Inventory Disclosure [Abstract]
Finished goods	$ 399.4	$ 340.1
Work in process	33.9	28.5
Raw materials and supplies	179.2	148.9
Total inventory, net	$ 612.5	$ 517.5

XML 64 R52.htm IDEA: XBRL DOCUMENT

Inventories - Narrative (Details) - Fair Value Adjustment to Inventory [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Inventory [Line Items]
Inventory adjustments	$ 0.5		$ 11.5
Cost of Sales
Inventory [Line Items]
Fair value of assets	$ 12.0	$ 36.1

XML 65 R53.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	$ 557.8	$ 557.8		$ 540.0
Accumulated depreciation	(78.3)	(78.3)		(64.3)
Accumulated amortization of capital leases	(6.4)	(6.4)		(5.5)
Construction in process	23.4	23.4		21.4
Property, plant and equipment, net	496.5	496.5		491.6
Depreciation expense		18.2	$ 8.4
Land and leasehold improvements
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	111.5	111.5		107.9
Buildings and improvements
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	149.3	149.3		143.8
Machinery, equipment, fixtures and software
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	283.3	283.3		276.8
Land and buildings under capital lease
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	8.3	8.3		6.4
Machinery and equipment under capital lease
Property, Plant and Equipment [Line Items]
Total Property, plant and equipment	5.4	5.4		5.1
Excluding Construction in Process [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	473.1	473.1		$ 470.2
Sale Agreement for Long-lived Asset
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	12.1	12.1
Long lived asset held for sale, fair value	9.3	$ 9.3
Estimated selling expense	0.2
Sale Agreement for Long-lived Asset \| Selling, General and Administrative Expenses [Member]
Property, Plant and Equipment [Line Items]
Reduction in net book value of the asset	$ 2.8

XML 66 R54.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 4,021.9
Addition from acquisitions	66.9	$ 1,769.9
Purchase accounting adjustments	3.8
Foreign currency translation	155.3
Goodwill, Ending Balance	4,247.9	2,981.7
Performance Materials
Goodwill [Roll Forward]
Goodwill, Beginning Balance	2,147.2
Addition from acquisitions	66.9
Purchase accounting adjustments	3.6
Foreign currency translation	34.2
Goodwill, Ending Balance	2,251.9
ArgoSolutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	1,874.7
Addition from acquisitions	0.0	1,769.9
Purchase accounting adjustments	0.2
Foreign currency translation	121.1
Goodwill, Ending Balance	$ 1,996.0	$ 2,059.6

XML 67 R55.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Carrying value of indefinite-lived intangible assets other than goodwill	$ 377.0		$ 360.0
Amortization of expense of intangible assets	$ 64.4	$ 39.8

XML 68 R56.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Intangible Assets Subject to Amortization (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	15 years 1 month 6 days
Gross Carrying Amount and Foreign Exchange	$ 3,280.6	$ 3,584.2
Accumulated Amortization and Foreign Exchange	(203.6)	(630.3)
Net Book Value	$ 3,077.0	2,953.9
Customer Lists [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	20 years 6 months
Gross Carrying Amount and Foreign Exchange	$ 1,250.5	1,297.2
Accumulated Amortization and Foreign Exchange	(80.3)	(184.0)
Net Book Value	$ 1,170.2	1,113.2
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	11 years 9 months 18 days
Gross Carrying Amount and Foreign Exchange	$ 2,006.0	2,260.9
Accumulated Amortization and Foreign Exchange	(119.0)	(440.4)
Net Book Value	$ 1,887.0	1,820.5
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	12 years 4 months 24 days
Gross Carrying Amount and Foreign Exchange	$ 22.2	24.2
Accumulated Amortization and Foreign Exchange	(3.7)	(5.4)
Net Book Value	$ 18.5	18.8
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	5 years
Gross Carrying Amount and Foreign Exchange	$ 1.9	1.9
Accumulated Amortization and Foreign Exchange	(0.6)	(0.5)
Net Book Value	$ 1.3	$ 1.4

XML 69 R57.htm IDEA: XBRL DOCUMENT

Equity Compensation Plans - Narrative (Details) $ / shares in Units, $ in Millions				3 Months Ended
	Mar. 17, 2016 $ / shares shares	Mar. 16, 2016 $ / shares shares	Mar. 06, 2014 shares	Mar. 31, 2016 USD ($) person $ / shares shares	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($) shares	Jun. 30, 2014 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Options, Granted (in shares)				364,583
The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock that may be subject to grant awards (in shares)							15,500,000
Awards granted (in shares)				373,434
Stock Options, Granted (in shares)		364,583
Options granted, exercise price (in dollars per share) \| $ / shares		$ 7.95
Options granted, weighted average grant date fair value (in dollars per share) \| $ / shares		$ 4.32
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum approved shares of common stock for ESPP (in shares)			5,178,815
Total number of shares issued under ESPP (in shares)				90,898
Persons eligible to participate \| person				830
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)				1,969,070		501,634
Forfeited (in shares)				51,337
Weighted average grant date fair value (in dollars per share) \| $ / shares				$ 10.82
RSUs, Liability Classified, outstanding (in shares)				329,802		329,802
Restricted Stock Units (RSUs) \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)				2,663,455
Compensation expense \| $				$ 0.9	$ 0.7
Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				1,501,257
Restricted Stock Units (RSUs) \| Director \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)	25,158
Weighted average grant date fair value (in dollars per share) \| $ / shares	$ 8.84
Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				473,657
Market Conditions \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				390,324
Share multiplier performance period (in years)				3 years
Restricted Stock Units Related to Service Conditions \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				637,276
Restricted Stock Units Granted 17 March 2015 \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				7,642
Restricted Stock Units Granted 6 March 2014 \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)			329,823
Compensation expense \| $				$ (0.1)	0.3
RSUs, Liability Classified, outstanding (in shares)				329,802
Combined undiscounted maximum cash value of all RSUs \| $				$ 7.1
Employee Stock Option \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in months)		3 years
Award expiration period (in years)		10 years
Minimum \| Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value range (in usd per share) \| $ / shares				$ 8.32
Vesting period (in months)				33 months 15 days
Minimum \| Market Conditions \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				0
Maximum \| Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value range (in usd per share) \| $ / shares				$ 15.80
Vesting period (in months)				36 months
Maximum \| Market Conditions \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				3
Deferred Bonus \| Long Term Cash Bonus Plan (LTCB)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $				$ 0.2	$ 1.0
Allotted bonus total amount \| $				$ 12.3		$ 3.0
Deferred Bonus \| Minimum \| Long Term Cash Bonus Plan (LTCB)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in months)				36 months
Deferred Bonus \| Maximum \| Long Term Cash Bonus Plan (LTCB)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in months)				62 months 15 days
Vesting Depending Upon Return on Invested Capital Benchmarks \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				390,324
Vesting Depending Upon Return on Invested Capital Benchmarks \| Minimum \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				0
Vesting Depending Upon Return on Invested Capital Benchmarks \| Maximum \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				2.0
Vesting Based on EBITDA Target Benchmarks \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				83,333
Vesting Based on EBITDA Target Benchmarks \| Minimum \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				0
Vesting Based on EBITDA Target Benchmarks \| Maximum \| Performance Restricted Stock Units (RSUs) \| Certain Employees \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				1
Vesting Based on Unestablished EBITDA Target Benchmarks \| Performance Restricted Stock Units (RSUs) \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock that may be subject to grant awards (in shares)				166,667
Vesting Based on Unestablished EBITDA Target Benchmarks \| Minimum \| Performance Restricted Stock Units (RSUs) \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				0
Vesting Based on Unestablished EBITDA Target Benchmarks \| Maximum \| Performance Restricted Stock Units (RSUs) \| The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier				1

XML 70 R58.htm IDEA: XBRL DOCUMENT

Equity Compensation Plans - Activity in Payment Awards (Details) - shares	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Total [Roll Forward]
Total, beginning balance (in shares)	1,006,436
Total, Granted (in shares)	1,890,998
Total, Exercised (in shares)	(7,642)
Total, Forfeited (in shares)	(51,337)
Total, ending balance (in shares)	2,838,455
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Stock Options, beginning balance (in shares)	175,000
Stock Options, Granted (in shares)	364,583
Stock Options, Exercised (in shares)	0
Stock Options, Forfeited (in shares)	0
Stock Options, ending balance (in shares)	539,583
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares)	501,634
Granted (in shares)	1,526,415
Exercised (in shares)	(7,642)
Forfeited (in shares)	(51,337)
Ending balance (in shares)	1,969,070
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
RSUs, Liability Classified, outstanding (in shares)	329,802	329,802

XML 71 R59.htm IDEA: XBRL DOCUMENT

Equity Compensation Plans - Stock Options Valuation Assumptions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2016	Jan. 23, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value price (in dollars per share)	$ 8.60	$ 0.01
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected term (years)	6 years
Expected Volatility	53.00%
Risk-free rate	1.56%
Expected dividend rate	0.00%
Fair value price (in dollars per share)	$ 4.32

XML 72 R60.htm IDEA: XBRL DOCUMENT

Pension and Post-Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Other Postretirement Benefits \| Domestic
Defined Benefit Plan Disclosure [Line Items]
Interest cost on the projected benefit obligation	$ 0.1	$ 0.1
Net periodic (benefit) cost	0.1	0.1
Other Postretirement Benefits \| Foreign
Defined Benefit Plan Disclosure [Line Items]
Interest cost on the projected benefit obligation	0.1	0.0
Net periodic (benefit) cost	0.1	0.0
Pension And SERP Benefits \| Domestic
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.0	0.0
Interest cost on the projected benefit obligation	2.5	1.6
Expected return on plan assets	(2.9)	(2.4)
Amortization of prior service cost	0.0	0.0
Net periodic (benefit) cost	(0.4)	(0.8)
Pension And SERP Benefits \| Foreign
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.4	0.2
Interest cost on the projected benefit obligation	0.8	0.5
Expected return on plan assets	(0.7)	(0.5)
Amortization of prior service cost	0.2	0.0
Net periodic (benefit) cost	$ 0.7	$ 0.2

XML 73 R61.htm IDEA: XBRL DOCUMENT

Pension and Post-Retirement Plans - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Contributions by employer	$ 0
Expected contributions in current year	6,300,000
Other Postretirement Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected contributions in current year	600,000
Domestic \| Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 0	$ 0

XML 74 R62.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Summary of Debt and Capital Leases Outstanding (Details) € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 03, 2015 USD ($)	Feb. 02, 2015	Nov. 03, 2014 EUR (€)
Debt Instrument [Line Items]
Borrowings under lines of credit, weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively	$ 149.2	$ 16.7
Other	20.0	18.5
Total debt and capital lease obligations	5,258.1	5,211.6
Less: current portion debt and capital lease obligations	(39.7)	(38.0)
Total long-term debt and capital lease obligations	$ 5,218.4	$ 5,173.6
Weighted average interest rate, short term debt	3.43%	4.28%
6.50% USD Notes due 2022 \| Notes Payable to Banks
Debt Instrument [Line Items]
Long term debt	$ 1,081.9	$ 1,081.1
Stated interest rate	6.50%			6.50%
Unamortized discount (premium) and debt issuance costs, net	$ 18.1	18.9
EUR Notes, due 2023 \| Notes Payable to Banks
Debt Instrument [Line Items]
Long term debt	$ 392.2	374.0
Stated interest rate	6.00%			6.00%
Unamortized discount (premium) and debt issuance costs, net	$ 5.9	6.1
USD Notes, due 2021 \| Notes Payable to Banks
Debt Instrument [Line Items]
Long term debt	$ 488.0	487.5
Stated interest rate	10.375%
Unamortized discount (premium) and debt issuance costs, net	$ 12.0	12.5
First Lien Credit Facility
Debt Instrument [Line Items]
Long term debt \| €					€ 205
First Lien Credit Facility \| Secured Debt [Member]
Debt Instrument [Line Items]
Long term debt	$ 733.7	735.6
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 0.5	0.6
USD Incremental Loan
Debt Instrument [Line Items]
Long term debt	$ 290.4	290.8
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 5.1	5.4
Tranche B Term Loan
Debt Instrument [Line Items]
Long term debt	$ 122.0	121.9
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 6.1	6.4
Traunche B-2 Term Loan
Debt Instrument [Line Items]
Long term debt	$ 480.7	481.2
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 13.1	13.9
Alent U.S. Dollar Tranche B-3 Term Loan
Debt Instrument [Line Items]
Long term debt	$ 1,001.5	1,001.8	$ 1,050.0
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 38.3	40.5
Euro Tracnche Term Loans
Debt Instrument [Line Items]
Long term debt	$ 228.8	219.0
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 0.9	0.9
Euro Traunche B-2 Term Loan
Debt Instrument [Line Items]
Long term debt	$ 91.2	87.2
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 2.0	2.1
Alent EURO Tranche C-2 Term Loan
Debt Instrument [Line Items]
Long term debt	$ 327.7	313.0
Stated interest rate	5.50%
Spread on variable rate	4.50%
Unamortized discount (premium) and debt issuance costs, net	$ 11.9	$ 11.9

XML 75 R63.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Narrative (Details) € in Millions		3 Months Ended
	Apr. 20, 2017 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 03, 2015 USD ($)	Aug. 31, 2015 USD ($)	Aug. 31, 2015 EUR (€)	Feb. 13, 2015 USD ($)
Debt Instrument [Line Items]
Effective interest rate		6.92%
Total debt and capital lease obligations		$ 5,258,100,000	$ 5,211,600,000
Periodic interest payments (in excess of)		300,000,000
First significant payment due in 2020		3,226,600,000
Whole payment amount		410,000,000
Interest Rate Swap \| Notes Payable to Banks \| 6.50% USD Notes due 2022
Debt Instrument [Line Items]
Derivative notional amount					$ 1,160,000,000
Interest rate swap rate					1.96%	1.96%
Interest Rate Swap \| Notes Payable to Banks \| EUR Notes, due 2023
Debt Instrument [Line Items]
Derivative notional amount \| €						€ 284
Interest rate swap rate					1.20%	1.20%
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum capacity		500,000,000		$ 250,000,000			$ 163,000,000
Current borrowing capacity		385,000,000
Bank Overdrafts
Debt Instrument [Line Items]
Current borrowing capacity		$ 87,400,000.0
Maximum \| Forecast \| Redeemable Series B Preferred Stock
Debt Instrument [Line Items]
Payments for repurchase of convertible preferred stock	$ 600,000,000

XML 76 R64.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Minimum Principal Payments on Long-term Debt and Capital Leases (Details) $ in Millions	Mar. 31, 2016 USD ($)
Debt Disclosure [Abstract]
2016 - remaining	$ 41.1
2017	34.9
2018	34.7
2019	34.6
2020	3,226.6
2021	500.5
Thereafter	1,499.6
Total	$ 5,372.0

XML 77 R65.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Amendments to Credit Agreement (Details)							3 Months Ended
	Dec. 03, 2015 USD ($)	Feb. 13, 2015 USD ($)	Feb. 13, 2015 EUR (€)	Nov. 03, 2014 USD ($)	Nov. 03, 2014 EUR (€)	Oct. 31, 2013 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 03, 2015 EUR (€)	Feb. 13, 2015 EUR (€)	Nov. 03, 2014 EUR (€)	Oct. 01, 2014 USD ($)
Second Lien Term Loan
Debt Instrument [Line Items]
Repayments of long-term debt						$ 373,000,000
Debt face amount						360,000,000
First Lien Credit Facility
Debt Instrument [Line Items]
Original issue discount percentage						1,800,000
Long term debt \| €											€ 205,000,000
New Tranche B-2 Term Loan
Debt Instrument [Line Items]
Long term debt		$ 500,000,000
Euro Tracnche Term Loans
Debt Instrument [Line Items]
Maximum capacity \| €									€ 300,000,000	€ 287,000,000
Long term debt							$ 228,800,000	$ 219,000,000
Line of credit facility increase (decrease) \| €			€ 83,000,000
Spread on variable rate							4.50%
Alent U.S. Dollar Tranche B-3 Term Loan
Debt Instrument [Line Items]
Long term debt	$ 1,050,000,000						$ 1,001,500,000	$ 1,001,800,000
Spread on variable rate							4.50%
Alent U.S. Dollar Tranche B-3 Term Loan \| Eurodollar
Debt Instrument [Line Items]
Spread on variable rate	5.50%
Alent U.S. Dollar Tranche B-3 Term Loan \| Base Rate
Debt Instrument [Line Items]
Spread on variable rate	4.50%
Arysta U.S. Dollar Tranche B-2 Term Loan \| Eurodollar
Debt Instrument [Line Items]
Spread on variable rate	5.50%
Arysta U.S. Dollar Tranche B-2 Term Loan \| Base Rate
Debt Instrument [Line Items]
Spread on variable rate	4.50%
Chemtura \| New Tranche B Term Loans
Debt Instrument [Line Items]
Long term debt				$ 130,000,000
Arysta \| New Tranche B-2 Term Loan
Debt Instrument [Line Items]
Original issue discount percentage		0.01
Long term debt		500,000,000
Arysta \| Euro Tracnche Term Loans
Debt Instrument [Line Items]
Original issue discount percentage \| €										0.02
Increase in Euro tranche term loan facility \| €										€ 83,000,000
Alent \| Euro Tracnche Term Loans
Debt Instrument [Line Items]
Original issue discount percentage \| €									0.02
Increase in Euro tranche term loan facility \| €									€ 300,000,000
Alent \| Alent U.S. Dollar Tranche B-3 Term Loan
Debt Instrument [Line Items]
Original issue discount percentage	$ 0.02
Long term debt	1,050,000,000
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum capacity	250,000,000	163,000,000					$ 500,000,000
Line of credit facility increase (decrease)	87,500,000	75,000,000
Borrowed under U.S. Dollar revolving credit facility for acquisition	$ 115,000,000	160,000,000
Revolving Credit Facility \| Eurodollar
Debt Instrument [Line Items]
Spread on variable rate	3.00%
Revolving Credit Facility \| Base Rate
Debt Instrument [Line Items]
Spread on variable rate	2.00%
Revolving Credit Facility \| First Lien Credit Facility
Debt Instrument [Line Items]
Maximum capacity						$ 50,000,000.0
Revolving Credit Facility \| Chemtura
Debt Instrument [Line Items]
Maximum capacity				87,500,000.0
Proceeds from line of credits				60,000,000	€ 55,000,000
Revolving Credit Facility, Multi Currency
Debt Instrument [Line Items]
Maximum capacity	$ 250,000,000	163,000,000
Line of credit facility increase (decrease)	$ 87,500,000	$ 75,000,000
Revolving Credit Facility, Multi Currency \| Chemtura
Debt Instrument [Line Items]
Maximum capacity				$ 87,500,000.0
Barclays Bank PLC
Debt Instrument [Line Items]
Second amendment increase in credit facility												$ 300,000,000

XML 78 R66.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Covenants and Guarantees (Details)	3 Months Ended
	Mar. 31, 2016
Debt Instrument [Line Items]
Voting capital stock pledged of domestic subsidiaries	100.00%
Voting capital stock pledged of non-domestic subsidiaries	65.00%
Minimum
Debt Instrument [Line Items]
Ratio of debt to EBITDA	6.25
Maximum
Debt Instrument [Line Items]
Ratio of debt to EBITDA	1.0

XML 79 R67.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Note Offerings, Lines of Credit and Other Debt Facilities (Details) € in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Nov. 10, 2015 USD ($)	Feb. 02, 2015 USD ($)	Feb. 02, 2015 EUR (€)
Debt Instrument [Line Items]
Borrowings under lines of credit, weighted average interest rate of 3.43% and 4.28% at March 31, 2016 and December 31, 2015, respectively	$ 149,200,000	$ 16,700,000
Overdraft facility capacity	$ 472,000,000	618,000,000
Senior Notes \| 10.375% USD Notes due 2021
Debt Instrument [Line Items]
Debt face amount			$ 500,000,000
Stated interest rate			10.375%
Notes Payable to Banks \| 10.375% USD Notes due 2021
Debt Instrument [Line Items]
Stated interest rate	10.375%
Notes Payable to Banks \| 6.50% USD Notes due 2022
Debt Instrument [Line Items]
Stated interest rate	6.50%			6.50%	6.50%
Gross debt, long term				$ 1,100,000,000
Notes Payable to Banks \| EUR Notes, due 2023
Debt Instrument [Line Items]
Stated interest rate	6.00%			6.00%	6.00%
Original issue premium				$ 1,000,000
Gross debt, long term \| €					€ 350
Revolving Credit Facility
Debt Instrument [Line Items]
Outstanding letters of credit	$ 27,400,000	40,000,000
Reduction in borrowings	$ 10,700,000	$ 11,000,000

XML 80 R68.htm IDEA: XBRL DOCUMENT

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Financial Guarantees and Factoring Arrangements (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Factoring agreements total current capacity	$ 263,000,000
Factoring agreements qualifying for sales treatment	17,900,000		$ 189,000,000
Factoring agreements recorded in accounts receivable	30,900,000		24,800,000
Factoring agreements, additional capacity	56,300,000
Overdraft facility capacity	472,000,000		618,000,000
Financial Guarantee
Debt Instrument [Line Items]
Financial guarantees	42,700,000		$ 46,300,000
Other Operating Income (Expense)
Debt Instrument [Line Items]
Factoring agreement program expense	0	$ 200,000
Factoring fees	200,000	$ 700,000
UNITED STATES
Debt Instrument [Line Items]
Overdraft facility capacity	$ 18,000,000

XML 81 R69.htm IDEA: XBRL DOCUMENT

Derivative Instruments - Narrative (Details) € in Millions	3 Months Ended
Derivative Instruments - Narrative (Details) € in Millions	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($)	Aug. 31, 2015 USD ($)	Aug. 31, 2015 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Loss on derivative contracts	$ (5,300,000)	$ 0
Foreign Exchange Forward
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	21,811,268		$ 16,500,000
Foreign Exchange Forward \| Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	$ 289,000,000
Derivative term	1 year
Commodity Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, current	$ 1,200,000		0
Interest Rate Swap \| Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized losses recorded to other comprehensive income related to foreign currency hedges	11,000,000	0
Gain (loss) to be reclassified during next 12 months	10,900,000
Foreign Exchange Contract
Derivative Instruments, Gain (Loss) [Line Items]
Loss on derivative contracts	(5,300,000)	$ 0
6.50% USD Notes due 2022 \| Notes Payable to Banks \| Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount				$ 1,160,000,000
Interest rate swap rate				1.96%	1.96%
EUR Notes, due 2023 \| Notes Payable to Banks \| Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount \| €					€ 284
Interest rate swap rate				1.20%	1.20%
Inventories
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	$ 14,500,000
Liability
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount			$ 13,000,000

XML 82 R70.htm IDEA: XBRL DOCUMENT

Derivative Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Total derivative contracts	$ (28.7)	$ (11.4)
Other Noncurrent Liabilities \| Interest Rate Swap \| Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, noncurrent	(23.5)	(12.5)
Prepaid Expenses and Other Current Assets \| Foreign Exchange Contract \| Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets, current	4.3	1.1
Other Assets \| Foreign Exchange Contract \| Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets, noncurrent	0.0	1.0
Other Current Liabilities \| Foreign Exchange Contract \| Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, current	$ (9.5)	$ (1.0)

XML 83 R71.htm IDEA: XBRL DOCUMENT

Derivative Instruments - Derivative Assets and Liability Offsetting (Details) - Foreign Exchange Forward and Commodity Contracts $ in Millions	Mar. 31, 2016 USD ($)
Derivative Asset, Fair Value, Amount Offset Against Collateral [Abstract]
Gross assets	$ 3.3
Gross liabilities offset	0.0
Net amounts presented	3.3
Financial instruments	(0.3)
Cash collateral received	0.0
Net	3.0
Derivative Liability, Fair Value, Amount Offset Against Collateral [Abstract]
Gross liabilities	7.7
Gross assets offset	0.0
Net amounts presented	7.7
Financial instruments	(2.2)
Cash collateral pledged	(1.9)
Net	$ 3.6

XML 84 R72.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Estimate of Fair Value Measurement
Asset Category
Cash equivalents	$ 9.2	$ 59.4
Available for sale equity securities	6.8	6.6
Derivatives	4.3	2.1
Total	20.3	68.1
Liability Category
Long-term contingent consideration	73.5	70.7
Derivatives	33.0	13.5
Total	106.5	84.2
Fair Value, Inputs, Level 1
Asset Category
Cash equivalents	1.0	2.9
Available for sale equity securities	6.2	5.8
Derivatives	0.0	0.0
Total	7.2	8.7
Liability Category
Long-term contingent consideration	0.0	0.0
Derivatives	0.0	0.0
Total	0.0	0.0
Fair Value, Inputs, Level 2
Asset Category
Cash equivalents	8.2	56.5
Available for sale equity securities	0.6	0.8
Derivatives	4.3	2.1
Total	13.1	59.4
Liability Category
Long-term contingent consideration	0.0	0.0
Derivatives	33.0	13.5
Total	33.0	13.5
Fair Value, Inputs, Level 3
Asset Category
Cash equivalents	0.0	0.0
Available for sale equity securities	0.0	0.0
Derivatives	0.0	0.0
Total	0.0	0.0
Liability Category
Long-term contingent consideration	73.5	70.7
Derivatives	0.0	0.0
Total	$ 73.5	$ 70.7

XML 85 R73.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Narrative (Details)	3 Months Ended
Fair Value Measurements - Narrative (Details)	Mar. 31, 2016 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
NAV Redemptions	$ 1.00
Percentage change in rate affecting component measurement	1.00%
Measurement component change affected by change in discount rate	$ 2,000,000
EBITDA metric, measurement component change affected by change in discount rate	3,000,000
Mac Dermid
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term contingent consideration	$ 100,000,000
Price performance metrics period	7 years
EBITDA related earnout include a discount rate	1.19%
Business acquisition expected future value payments	$ 60,000,000
Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs, EBITDA Probability Range	80.00%
Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs, EBITDA Probability Range	100.00%

XML 86 R74.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Level 3 Reconciliation (Details)	3 Months Ended
	Mar. 31, 2016 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 70,700,000
Changes in fair value	2,800,000
Purchases, sales and settlements	0
Transfers into Level 3	0
Transfers out of Level 3	0
Ending balance	$ 73,500,000

XML 87 R75.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Nonrecurring Fair Value Measurements (Details) € in Millions, $ in Millions	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 03, 2015 USD ($)	Feb. 02, 2015 EUR (€)	Nov. 03, 2014 EUR (€)
First Lien Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt \| €					€ 205
USD Incremental Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	$ 290.4	$ 290.8
Alent U.S. Dollar Tranche B-3 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	1,001.5	1,001.8	$ 1,050.0
Alent EURO Tranche C-2 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	327.7	313.0
Notes Payable to Banks \| EUR Notes, due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term \| €				€ 350
Long term debt	392.2	374.0
Notes Payable to Banks \| USD Notes, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	488.0	487.5
Secured Debt [Member] \| First Lien Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	733.7	735.6
Reported Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	5,258.1	5,211.6
Enthone financing liability	14.5	13.0
Total	5.5	5.5
Reported Value Measurement [Member] \| USD Incremental Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	290.4	290.8
Reported Value Measurement [Member] \| CAS U.S. Dollar Tranche B Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	122.0	121.9
Reported Value Measurement [Member] \| Arysta U.S. Dollar Tranche B-2 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	480.7	481.2
Reported Value Measurement [Member] \| Alent U.S. Dollar Tranche B-3 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	1,001.5	1,001.8
Reported Value Measurement [Member] \| CAS EURO Tranche C-1 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	228.8	219.0
Reported Value Measurement [Member] \| Arysta EURO Tranche C-1 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	91.2	87.2
Reported Value Measurement [Member] \| Alent EURO Tranche C-2 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	327.7	313.0
Reported Value Measurement [Member] \| Notes Payable to Banks \| USD Notes, due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	1,081.9	1,081.1
Reported Value Measurement [Member] \| Notes Payable to Banks \| EUR Notes, due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	392.2	374.0
Reported Value Measurement [Member] \| Notes Payable to Banks \| USD Notes, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	488.0	487.5
Reported Value Measurement [Member] \| Secured Debt [Member] \| First Lien Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	733.7	735.6
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	5,036.2	5,019.2
Enthone financing liability	14.5	13.0
Total	5.3	5.3
Estimate of Fair Value Measurement \| USD Incremental Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	286.4	285.8
Estimate of Fair Value Measurement \| CAS U.S. Dollar Tranche B Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	124.1	123.9
Estimate of Fair Value Measurement \| Arysta U.S. Dollar Tranche B-2 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	478.9	477.7
Estimate of Fair Value Measurement \| Alent U.S. Dollar Tranche B-3 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	1,008.6	1,005.9
Estimate of Fair Value Measurement \| CAS EURO Tranche C-1 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	223.9	215.4
Estimate of Fair Value Measurement \| Arysta EURO Tranche C-1 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	90.8	87.5
Estimate of Fair Value Measurement \| Alent EURO Tranche C-2 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	341.5	321.4
Estimate of Fair Value Measurement \| Notes Payable to Banks \| USD Notes, due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	932.3	946.3
Estimate of Fair Value Measurement \| Notes Payable to Banks \| EUR Notes, due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	333.1	326.7
Estimate of Fair Value Measurement \| Notes Payable to Banks \| USD Notes, due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross debt, long term	485.0	500.0
Estimate of Fair Value Measurement \| Secured Debt [Member] \| First Lien Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term debt	$ 711.8	$ 710.3

XML 88 R76.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details) $ / shares in Units, $ in Millions			3 Months Ended
	Feb. 13, 2015 USD ($) shares	Oct. 20, 2014 shares	Mar. 31, 2016 USD ($) $ / shares shares	Mar. 31, 2015 USD ($)	Dec. 31, 2015 shares	Oct. 27, 2015 USD ($)	Jan. 23, 2014 $ / shares
Class of Stock [Line Items]
Number of preferred shares authorized in amendment (in shares)			5,000,000
Equity Instruments \| $	$ 646.0
Conversion price (in usd per share) \| $ / shares			$ 27.14
Share price (in usd per share) \| $ / shares			$ 8.60				$ 0.01
Whole payment amount \| $			$ 410.0
Total number of shares of common stock originally issuable upon the exchange of PDH common stock pursuant to the RHSA (in shares)			8,800,000
Arysta
Class of Stock [Line Items]
Equity Instruments \| $	$ 646.0
Conversion price (in usd per share) \| $ / shares			$ 27.14
Dividend Payable, Aggregate Monthly Amount \| $						$ 4.0
Volume weighted average price period (in days)	10 days
Maximum share conversion (in shares)	22,107,590	22,107,590
Mac Dermid
Class of Stock [Line Items]
Equity Instruments \| $			$ 97.5
Net income allocated to Retaining Holders \| $			$ (1.2)	$ 5.4
Noncontrolling interest percentage			6.24%	6.65%	6.25%
PDH
Class of Stock [Line Items]
Rate PDH Common stock that may be exchanged for shares of common stock			25.00%
Period during which PDH Common stock that may be exchanged for shares of common stock (in years)			4 years
Common stock issued in connection with exchange of PDH common stock (in shares)			729,417
Redeemable Series B Preferred Stock
Class of Stock [Line Items]
Temporary equity designated (in shares)			600,000
Temporary equity issued (in shares)			600,000		600,000
Liquidation preference per share \| $ / shares			$ 1,000
Temporary equity outstanding (in shares)			600,000		600,000
Series A Preferred Stock
Class of Stock [Line Items]
Number of preferred shares authorized in amendment (in shares)			2,000,000
Preferred shares, shares issued (in shares)			2,000,000		2,000,000
Dividend price (in usd per share) \| $ / shares			$ 22.85
Series A Preferred Stock \| Founders Entities
Class of Stock [Line Items]
Preferred shares, shares outstanding (in shares)			2,000,000
Conversion ratio			1
Extension period for conversion			3 years

XML 89 R77.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	$ (886.1)	$ (130.6)
Other comprehensive (loss) income before reclassifications, net	295.5	(343.9)
Reclassifications, pretax	2.9
Tax benefit reclassified	0.0	(0.5)
Ending balance	(587.7)	(475.0)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	(899.3)	(122.2)
Other comprehensive (loss) income before reclassifications, net	321.5	(352.5)
Reclassifications, pretax	0.0
Tax benefit reclassified	0.0	0.0
Ending balance	(577.8)	(474.7)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	(26.3)	(14.9)
Other comprehensive (loss) income before reclassifications, net	0.0	0.0
Reclassifications, pretax	0.0
Tax benefit reclassified	0.0	(0.5)
Ending balance	(26.3)	(15.4)
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	1.2	0.1
Other comprehensive (loss) income before reclassifications, net	(0.4)	(0.1)
Reclassifications, pretax	0.0
Tax benefit reclassified	0.0	0.0
Ending balance	0.8	0.0
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	(8.1)	0.0
Other comprehensive (loss) income before reclassifications, net	(13.9)	0.0
Reclassifications, pretax	2.9
Tax benefit reclassified	0.0	0.0
Ending balance	(19.1)	0.0
Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance	46.4	6.4
Other comprehensive (loss) income before reclassifications, net	(11.7)	8.7
Reclassifications, pretax	0.0
Tax benefit reclassified	0.0	0.0
Ending balance	$ 34.7	$ 15.1

XML 90 R78.htm IDEA: XBRL DOCUMENT

Earnings Per Share - Computation of Weighted Average Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Net income attributable to common shareholders	$ (134.8)	$ (26.7)
Basic weighted average common shares outstanding (in shares)	229.5	191.9
Convertible and performance-based stock	0.0	0.0
Dilutive weighted average common stock outstanding (in shares)	229.5	191.9
Basic (in usd per share)	$ (0.59)	$ (0.14)
Diluted (in usd per share)	(0.59)	(0.14)
Dividends per share paid to common shareholders (in dollars per share)	$ 0	$ 0

XML 91 R79.htm IDEA: XBRL DOCUMENT

Earnings Per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	40,865	25,563
Contingently Issuable Shares For The Founder Preferred Share Dividend Right
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	2,168
Shares Issuable Upon Conversion of PDH Non-controlling Interest
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	8,052	8,619
Shares Issuable Upon Conversion Of Founder Preferred Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	2,000	2,000
Shares Issuable Upon Conversion Of Series B Preferred Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	22,108	11,299
Contingently Issuable for the Contingent Consideration
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	8,704	1,333
Equity Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	87
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	57
Shares Issuable Under Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	1	0

XML 92 R80.htm IDEA: XBRL DOCUMENT

Operating Lease Commitments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Total rent expense	$ 9.1	$ 4.3
2016, remaining	24.7
2017	23.3
2018	15.1
2019	10.3
2020	8.6
2021	7.8
Thereafter	27.9
Total	$ 117.7

XML 93 R81.htm IDEA: XBRL DOCUMENT

Contingencies, Environmental and Legal Matters - Changes in AROs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Loss Contingency Accrual [Roll Forward]
AROs, beginning of period	$ 17.5	$ 18.5
Accretion expense	0.2	0.3
Remeasurements	0.1	0.0
Payments	(0.2)	0.0
Foreign currency adjustments	0.7	(1.4)
AROs, end of period	$ 18.3	$ 17.4

XML 94 R82.htm IDEA: XBRL DOCUMENT

Contingencies, Environmental and Legal Matters - Narrative (Details) £ in Millions, MXN in Millions, BRL in Millions, $ in Millions				1 Months Ended					3 Months Ended		12 Months Ended
	Apr. 03, 2015 USD ($)	Feb. 13, 2015 USD ($) shares	Oct. 20, 2014 shares	Apr. 30, 2016 USD ($)	Feb. 28, 2015 USD ($)	Jul. 31, 2014 USD ($)	Nov. 30, 2011 defendant	Jun. 30, 2009 defendant	Mar. 31, 2016 USD ($) employee defendant	Mar. 31, 2016 BRL employee defendant	Dec. 31, 2014 MXN	Mar. 31, 2016 GBP (£)	Mar. 31, 2016 MXN / $	Mar. 31, 2016 £ / $	Mar. 31, 2016 BRL / $	Mar. 31, 2016 BRL	Dec. 31, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Loss Contingencies [Line Items]
Asset retirement obligations									$ 18.3								$ 17.5	$ 17.4	$ 18.5
Potential litigation loss exchange rate													0.0579	1.4362	0.2786
Reserves for environmental matters									23.8								25.7
Estimate of possible loss in legal proceedings									12.9								$ 6.5
Contest of tax assessment									21.6							BRL 77.6
Settled Litigation
Loss Contingencies [Line Items]
Amount awarded	$ 16.0
Legal settlement					$ 25.0
Arysta \| Pending Litigation
Loss Contingencies [Line Items]
Compensation sought									13.9	BRL 50.0
Number of defendants \| defendant							5	25
Remediation amount sought									19.8	70.9
Agricola Colonet, SA de CV \| Pending Litigation
Loss Contingencies [Line Items]
Compensation sought									10.5		MXN 182.0
Arysta
Loss Contingencies [Line Items]
Series B preferred stock issued		$ 600.0
Maximum share conversion (in shares) \| shares		22,107,590	22,107,590
Maximum share conversion amount		$ 600.0
Volume weighted average price period (in days)		10 days
Arysta \| Series B Preferred Stock
Loss Contingencies [Line Items]
Series B preferred stock issued		$ 600.0
Health Problems From Employment Site \| Arysta \| Pending Litigation
Loss Contingencies [Line Items]
Compensation sought									$ 108.0	BRL 387.0
Number of defendants \| defendant									80	80
Number of former employees \| employee									29	29
Alent
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies									$ 22.0			£ 15.3
Mac Dermid \| Pending Litigation
Loss Contingencies [Line Items]
Legal settlement						$ 64.7
Minimum \| Alent
Loss Contingencies [Line Items]
Estimated period to resolve contingency (in years)									5 years	5 years
Maximum \| Alent
Loss Contingencies [Line Items]
Estimated period to resolve contingency (in years)									10 years	10 years
Subsequent Event \| Arysta LifeScience Corporation
Loss Contingencies [Line Items]
Amount awarded				$ 0.1
Litigation expense				$ 0.6
Litigation expense, percent				50.00%
Period for petition to correct or vacate the award (in days)				30 days

XML 95 R83.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Valuation Allowance [Line Items]
Income tax expense	$ 18.4	$ 24.7
Effective income tax rate	(15.90%)	(1546.90%)
Loss before income taxes and non-controlling interests	$ (116.0)	$ (1.6)
Unrecognized tax benefit	118.0		$ 112.0
Reduction in effective tax rate	92.8
Accrued interest and penalties related to unrecognized tax benefits	18.8		$ 17.5
Interest and penalties recognized	1.0	$ 0.3
Possible reduction in tax benefits from lapse of applicable statute of limitations	10.0
Net Operating Loss [Member]
Valuation Allowance [Line Items]
Change in valuation allowance	$ 59.6

XML 96 R84.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details) - USD ($)	3 Months Ended
Related Party Transactions (Details) - USD ($)	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Mac Dermid
Related Party Transaction [Line Items]
Price exchange rate (in usd per share)	$ 11.00
Contingent purchase payable	$ 100,000,000
Price performance metrics period (in years)	7 years
Noncontrolling interest percentage	6.24%	6.65%	6.25%
Mariposa Capital
Related Party Transaction [Line Items]
Automatic renewal period (in years)	1 year
Agreement renewal period (in days)	90 days
Advisory fees	$ 500,000	$ 500,000
Annual Fees \| Mariposa Capital
Related Party Transaction [Line Items]
Annual fee	$ 2,000,000

XML 97 R85.htm IDEA: XBRL DOCUMENT

Restructuring (Details) - USD ($) $ in Millions	3 Months Ended
Restructuring (Details) - USD ($) $ in Millions	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 5.1	$ 1.6
Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	(0.4)	0.0
Selling, Technical, General And Administrative
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	5.5	1.6
Performance Applications
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	4.2	1.5
Agricultural Solutions
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	0.9	$ 0.1
Other Current Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring liabilities	$ 0.4		$ 1.1

XML 98 R86.htm IDEA: XBRL DOCUMENT

Segment Information - Financial Information by Reportable Segment (Details) $ in Millions	3 Months Ended
	Mar. 31, 2016 USD ($) segment	Mar. 31, 2015 USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments \| segment	2
Net Sales (from external customers):
Net Sales	$ 823.8	$ 534.8
Adjusted EBITDA:
Operating profit	52.1	2.2
Adjusted EBITDA	168.4	132.1
Performance Materials
Net Sales (from external customers):
Net Sales	420.0	180.3
Adjusted EBITDA:
Operating profit	83.0	49.0
ArgoSolutions
Net Sales (from external customers):
Net Sales	403.8	354.5
Adjusted EBITDA:
Operating profit	$ 85.4	$ 83.1

XML 99 R87.htm IDEA: XBRL DOCUMENT

Segment Information - Reconciliation of Adjusted EBITDA to Net Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting [Abstract]
Adjusted EBITDA	$ 168.4	$ 132.1
Interest expense, net	(93.8)	(39.4)
Depreciation expense	(18.2)	(8.4)
Amortization expense	(64.4)	(39.8)
Long-term compensation issued in connection with acquisitions	(0.3)	(1.5)
Restructuring expenses	(5.1)	(1.6)
Manufacturer's profit in inventory purchase accounting adjustments	(12.0)	(36.1)
Acquisition and integration costs	(18.9)	(31.3)
Non-cash change in fair value of contingent consideration	(2.8)	(2.7)
Acquisition put option expiration	0.0	3.0
Foreign exchange (loss) gains on foreign denominated external and internal debt	(66.1)	24.1
Other expenses	(2.8)	0.0
Loss before income taxes and non-controlling interests	(116.0)	(1.6)
Income tax expense	(18.4)	(24.7)
Net income attributable to the non-controlling interests	(0.4)	(0.4)
Net loss attributable to common stockholders	$ (134.8)	$ (26.7)

XML 100 R88.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:	$ 321.5		$ (352.5)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:			$ 72.8
Prior Period Error Related To Purchase Accounting Related To Acquisitions \| Arysta \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:		$ 72.8

XML 101 R89.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:	$ 321.5	$ (352.5)
Total other comprehensive income (loss), net of tax	310.1	(353.1)
Other comprehensive income (loss) attributable to common shareholders	298.4	(344.4)
Comprehensive income (loss)	164.0	(370.7)
Comprehensive income (loss) attributable to common stockholders	$ 163.6	(371.1)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:		(425.3)
Total other comprehensive income (loss), net of tax		(425.9)
Other comprehensive income (loss) attributable to common shareholders		(417.2)
Comprehensive income (loss)		(443.5)
Comprehensive income (loss) attributable to common stockholders		(443.9)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Foreign currency translation adjustments:		72.8
Total other comprehensive income (loss), net of tax		72.8
Other comprehensive income (loss) attributable to common shareholders		72.8
Comprehensive income (loss)		72.8
Comprehensive income (loss) attributable to common stockholders		$ 72.8

XML 102 R90.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	$ 4,247.9	$ 4,021.9	$ 2,981.7
Total Assets	10,592.7	10,190.2	8,140.7
Accumulated other comprehensive loss	(587.7)	(886.1)	(475.0)	$ (130.6)
Total stockholders' equity	2,268.8	2,103.9	2,090.4
Total equity	2,450.1	2,273.3	2,199.5	$ 2,552.6
Total liabilities, redeemable preferred shares and stockholders' equity	$ 10,592.7	$ 10,190.2	8,140.7
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill			2,908.9
Total Assets			8,067.9
Accumulated other comprehensive loss			(547.8)
Total stockholders' equity			2,017.6
Total equity			2,126.7
Total liabilities, redeemable preferred shares and stockholders' equity			8,067.9
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill			72.8
Total Assets			72.8
Accumulated other comprehensive loss			72.8
Total stockholders' equity			72.8
Total equity			72.8
Total liabilities, redeemable preferred shares and stockholders' equity			$ 72.8

XML 103 R91.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows (used in) provided by operating activities	$ (210.4)	$ 2.8
Acquisition of businesses, net of acquired cash	(1.2)	(2,862.1)
Net cash flows used in investing activities	$ (19.9)	(2,291.1)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows (used in) provided by operating activities		(70.0)
Acquisition of businesses, net of acquired cash		(2,789.3)
Net cash flows used in investing activities		(2,218.3)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows (used in) provided by operating activities		72.8
Acquisition of businesses, net of acquired cash		(72.8)
Net cash flows used in investing activities		$ (72.8)

XML 104 R92.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Changes in Stockholder's Equity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes	$ 310.1	$ (353.1)
Total equity	2,450.1	2,199.5	$ 2,273.3	$ 2,552.6
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		(425.9)
Total equity		2,126.7
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		72.8
Total equity		72.8
Accumulated Other Comprehensive Income (Loss) [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes	298.4	(344.4)
Total equity	(587.7)	(475.0)	(886.1)	(130.6)
Accumulated Other Comprehensive Income (Loss) [Member] \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		(417.2)
Total equity		(547.8)
Accumulated Other Comprehensive Income (Loss) [Member] \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		72.8
Total equity		72.8
Parent [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes	298.4	(344.4)
Total equity	$ 2,268.8	2,090.4	$ 2,103.9	$ 2,459.6
Parent [Member] \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		(417.2)
Total equity		2,017.6
Parent [Member] \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive loss, net of taxes		72.8
Total equity		$ 72.8

XML 105 R93.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Acquisitions of Businesses (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2016	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	$ 2,981.7	$ 4,247.9	$ 4,021.9
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	2,908.9
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	72.8
Arysta
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash, net	2,861.9
Goodwill	1,769.9
Total purchase price	3,507.8
Arysta \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash, net	2,789.1
Goodwill	1,697.1
Total purchase price	3,435.0
Arysta \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash, net	72.8
Goodwill	72.8
Total purchase price	72.8
Arysta, CAS, Agriphar
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	2,224.3
Arysta, CAS, Agriphar \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	2,151.5
Arysta, CAS, Agriphar \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Goodwill	$ 72.8

XML 106 R94.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Goodwill and Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions	$ 66.9	$ 1,769.9
Goodwill	4,247.9	2,981.7	$ 4,021.9
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions		1,697.1
Goodwill		2,908.9
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions		72.8
Goodwill		72.8
ArgoSolutions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions	0.0	1,769.9
Goodwill	$ 1,996.0	2,059.6	$ 1,874.7
ArgoSolutions \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions		1,697.1
Goodwill		1,986.8
ArgoSolutions \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Addition from acquisitions		72.8
Goodwill		$ 72.8

XML 107 R95.htm IDEA: XBRL DOCUMENT

Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net	$ 295.5	$ (343.9)
Accumulated other comprehensive loss	(587.7)	(475.0)	$ (886.1)	$ (130.6)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net		(416.7)
Accumulated other comprehensive loss		(547.8)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net		72.8
Accumulated other comprehensive loss		72.8
Accumulated Translation Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net	321.5	(352.5)
Accumulated other comprehensive loss	$ (577.8)	(474.7)	$ (899.3)	$ (122.2)
Accumulated Translation Adjustment [Member] \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net		(425.3)
Accumulated other comprehensive loss		(547.5)
Accumulated Translation Adjustment [Member] \| Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income before reclassifications, net		72.8
Accumulated other comprehensive loss		$ 72.8

EXCEL 108 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
&PO=V]R:W-H965TU3 !X;"]W;W)K&UL4$L! A0#% @ 3):I2(R'1^.B 0 L0, !D M ( !R%4 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 3):I2*(EKC7+ 0 X 0 !D ( ! M5EL 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 3):I2&!0DF.G 0 L0, !D ( !1V$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2$6Z<2"E M 0 L0, !D ( !]F8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2'6(N2>_ 0 >P0 !D M ( !L&P 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ 3):I2.4%E;6Q 0 %@0 !D ( !:G( M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M3):I2(K8-_BF 0 L0, !D ( !#'@ 'AL+W=O0 >&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2%8)V V) P M?Q$ !D ( !1'X 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2 .U8^JK! 6AT !D M ( !UXH 'AL+W=OH! #@! &0 @ &YCP >&PO=V]R:W-H M965T&UL4$L! M A0#% @ 3):I2"! F:/_ 0 H@4 !D ( !^I, 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I M2%WW1![T 0 +P4 !D ( !,)T 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2)B:CCK6 @ ;0L M !D ( !>:D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2/_1T_ = @ P@8 !D M ( !"K( 'AL+W=O'2#*4% 0(P &0 @ %>M >&PO=V]R:W-H965T M&UL4$L! A0# M% @ 3):I2 (5.H0& @ $P8 !D ( !=;T 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2%L7 M]S,A P S0T !D ( !H,< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2'GAMWY! @ \0< !D M ( !B=$ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 3):I2.N@Y>5A @ ]0@ !D ( ! M6=H 'AL+W=O&PO=V]R:W-H965T(P8 "XH 9 M " 1G? !X;"]W;W)K&UL4$L! A0#% M @ 3):I2#]]WNGV P 010 !D ( !<^4 'AL+W=O&UL4$L! A0#% @ 3):I2&_#K"C7 M @ T0P !D ( !C_ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2!F:-N(Z!0 MAP !D M ( !C/@ 'AL+W=O&PO=V]R M:W-H965T1R=@( T) M 9 " <0 0!X;"]W;W)K&UL M4$L! A0#% @ 3):I2+: "0N( @ Z D !D ( !<0,! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M3):I2#>VR/D9 @ ; 8 !D ( != P! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2 9!GU1X @ MY @ !D ( !-Q4! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 3):I2*_I<-OZ @ @PP !D M ( !&!\! 'AL+W=O&PO=V]R:W-H M965T XML 110 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 112 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 453 434 1 false 143 0 false 15 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.platformspecialtyproducts.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 3 false false R4.htm 1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 4 false false R5.htm 1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 1005000 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity Statement Sheet http://www.platformspecialtyproducts.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityStatement Condensed Consolidated Statements of Changes in Stockholders' Equity Statement Statements 7 false false R8.htm 2102100 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://www.platformspecialtyproducts.com/role/BasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 2103100 - Disclosure - Acquisitions of Businesses Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinesses Acquisitions of Businesses Notes 9 false false R10.htm 2104100 - Disclosure - Inventories Sheet http://www.platformspecialtyproducts.com/role/Inventories Inventories Notes 10 false false R11.htm 2105100 - Disclosure - Property, Plant and Equipment Sheet http://www.platformspecialtyproducts.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 11 false false R12.htm 2106100 - Disclosure - Goodwill and Intangible Assets Sheet http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 12 false false R13.htm 2107100 - Disclosure - Equity Compensation Plans Sheet http://www.platformspecialtyproducts.com/role/EquityCompensationPlans Equity Compensation Plans Notes 13 false false R14.htm 2108100 - Disclosure - Pension and Post-Retirement Plans Sheet http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlans Pension and Post-Retirement Plans Notes 14 false false R15.htm 2109100 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangements Debt, Capital Leases, Financial Guarantees and Factoring Arrangements Notes 15 false false R16.htm 2110100 - Disclosure - Derivative Instruments Sheet http://www.platformspecialtyproducts.com/role/DerivativeInstruments Derivative Instruments Notes 16 false false R17.htm 2111100 - Disclosure - Fair Value Measurements Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 2112100 - Disclosure - Stockholders' Equity Sheet http://www.platformspecialtyproducts.com/role/StockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 2113100 - Disclosure - Accumulated Other Comprehensive (Loss) Income Sheet http://www.platformspecialtyproducts.com/role/AccumulatedOtherComprehensiveLossIncome Accumulated Other Comprehensive (Loss) Income Notes 19 false false R20.htm 2114100 - Disclosure - Earnings Per Share Sheet http://www.platformspecialtyproducts.com/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 2115100 - Disclosure - Operating Lease Commitments Sheet http://www.platformspecialtyproducts.com/role/OperatingLeaseCommitments Operating Lease Commitments Notes 21 false false R22.htm 2116100 - Disclosure - Contingencies, Environmental and Legal Matters Sheet http://www.platformspecialtyproducts.com/role/ContingenciesEnvironmentalAndLegalMatters Contingencies, Environmental and Legal Matters Notes 22 false false R23.htm 2117100 - Disclosure - Income Taxes Sheet http://www.platformspecialtyproducts.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2119100 - Disclosure - Related Party Transactions Sheet http://www.platformspecialtyproducts.com/role/RelatedPartyTransactions Related Party Transactions Notes 24 false false R25.htm 2120100 - Disclosure - Restructuring Sheet http://www.platformspecialtyproducts.com/role/Restructuring Restructuring Notes 25 false false R26.htm 2121100 - Disclosure - Segment Information Sheet http://www.platformspecialtyproducts.com/role/SegmentInformation Segment Information Notes 26 false false R27.htm 2123100 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatements Restatement of Unaudited Interim Condensed Consolidated Financial Statements Notes 27 false false R28.htm 2202201 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.platformspecialtyproducts.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.platformspecialtyproducts.com/role/BasisOfPresentationAndSignificantAccountingPolicies 28 false false R29.htm 2303301 - Disclosure - Acquisitions of Businesses (Tables) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesTables Acquisitions of Businesses (Tables) Tables http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinesses 29 false false R30.htm 2304301 - Disclosure - Inventories (Tables) Sheet http://www.platformspecialtyproducts.com/role/InventoriesTables Inventories (Tables) Tables http://www.platformspecialtyproducts.com/role/Inventories 30 false false R31.htm 2305301 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.platformspecialtyproducts.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.platformspecialtyproducts.com/role/PropertyPlantAndEquipment 31 false false R32.htm 2306301 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssets 32 false false R33.htm 2307301 - Disclosure - Equity Compensation Plans (Tables) Sheet http://www.platformspecialtyproducts.com/role/EquityCompensationPlansTables Equity Compensation Plans (Tables) Tables http://www.platformspecialtyproducts.com/role/EquityCompensationPlans 33 false false R34.htm 2308301 - Disclosure - Pension and Post-Retirement Plans (Tables) Sheet http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlansTables Pension and Post-Retirement Plans (Tables) Tables http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlans 34 false false R35.htm 2309301 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements (Tables) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsTables Debt, Capital Leases, Financial Guarantees and Factoring Arrangements (Tables) Tables http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangements 35 false false R36.htm 2310301 - Disclosure - Derivative Instruments (Tables) Sheet http://www.platformspecialtyproducts.com/role/DerivativeInstrumentsTables Derivative Instruments (Tables) Tables http://www.platformspecialtyproducts.com/role/DerivativeInstruments 36 false false R37.htm 2311301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.platformspecialtyproducts.com/role/FairValueMeasurements 37 false false R38.htm 2313301 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.platformspecialtyproducts.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.platformspecialtyproducts.com/role/AccumulatedOtherComprehensiveLossIncome 38 false false R39.htm 2314301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.platformspecialtyproducts.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.platformspecialtyproducts.com/role/EarningsPerShare 39 false false R40.htm 2315301 - Disclosure - Operating Lease Commitments (Tables) Sheet http://www.platformspecialtyproducts.com/role/OperatingLeaseCommitmentsTables Operating Lease Commitments (Tables) Tables http://www.platformspecialtyproducts.com/role/OperatingLeaseCommitments 40 false false R41.htm 2316301 - Disclosure - Contingencies, Environmental and Legal Matters (Tables) Sheet http://www.platformspecialtyproducts.com/role/ContingenciesEnvironmentalAndLegalMattersTables Contingencies, Environmental and Legal Matters (Tables) Tables http://www.platformspecialtyproducts.com/role/ContingenciesEnvironmentalAndLegalMatters 41 false false R42.htm 2320301 - Disclosure - Restructuring (Tables) Sheet http://www.platformspecialtyproducts.com/role/RestructuringTables Restructuring (Tables) Tables http://www.platformspecialtyproducts.com/role/Restructuring 42 false false R43.htm 2321301 - Disclosure - Segment Information (Tables) Sheet http://www.platformspecialtyproducts.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.platformspecialtyproducts.com/role/SegmentInformation 43 false false R44.htm 2323301 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Tables) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsTables Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Tables) Tables http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatements 44 false false R45.htm 2402402 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details) Sheet http://www.platformspecialtyproducts.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails Basis of Presentation and Significant Accounting Policies (Details) Details http://www.platformspecialtyproducts.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies 45 false false R46.htm 2403402 - Disclosure - Acquisitions of Businesses - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesNarrativeDetails Acquisitions of Businesses - Narrative (Details) Details 46 false false R47.htm 2403403 - Disclosure - Acquisitions of Businesses - Acquisition Net Sales and Net Loss (Details) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesAcquisitionNetSalesAndNetLossDetails Acquisitions of Businesses - Acquisition Net Sales and Net Loss (Details) Details 47 false false R48.htm 2403404 - Disclosure - Acquisitions of Businesses - Purchase Price Allocation (Details) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesPurchasePriceAllocationDetails Acquisitions of Businesses - Purchase Price Allocation (Details) Details 48 false false R49.htm 2403405 - Disclosure - Acquisitions of Businesses - Identifiable Intangible Assets Acquired (Details) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesIdentifiableIntangibleAssetsAcquiredDetails Acquisitions of Businesses - Identifiable Intangible Assets Acquired (Details) Details 49 false false R50.htm 2403406 - Disclosure - Acquisitions of Businesses - Pro Forma Revenue and Earnings (Details) Sheet http://www.platformspecialtyproducts.com/role/AcquisitionsOfBusinessesProFormaRevenueAndEarningsDetails Acquisitions of Businesses - Pro Forma Revenue and Earnings (Details) Details 50 false false R51.htm 2404402 - Disclosure - Inventories - Major Components of Inventory (Details) Sheet http://www.platformspecialtyproducts.com/role/InventoriesMajorComponentsOfInventoryDetails Inventories - Major Components of Inventory (Details) Details 51 false false R52.htm 2404403 - Disclosure - Inventories - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/InventoriesNarrativeDetails Inventories - Narrative (Details) Details 52 false false R53.htm 2405402 - Disclosure - Property, Plant and Equipment (Details) Sheet http://www.platformspecialtyproducts.com/role/PropertyPlantAndEquipmentDetails Property, Plant and Equipment (Details) Details http://www.platformspecialtyproducts.com/role/PropertyPlantAndEquipmentTables 53 false false R54.htm 2406402 - Disclosure - Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) Sheet http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) Details 54 false false R55.htm 2406403 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 55 false false R56.htm 2406404 - Disclosure - Goodwill and Intangible Assets - Intangible Assets Subject to Amortization (Details) Sheet http://www.platformspecialtyproducts.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsSubjectToAmortizationDetails Goodwill and Intangible Assets - Intangible Assets Subject to Amortization (Details) Details 56 false false R57.htm 2407402 - Disclosure - Equity Compensation Plans - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/EquityCompensationPlansNarrativeDetails Equity Compensation Plans - Narrative (Details) Details 57 false false R58.htm 2407403 - Disclosure - Equity Compensation Plans - Activity in Payment Awards (Details) Sheet http://www.platformspecialtyproducts.com/role/EquityCompensationPlansActivityInPaymentAwardsDetails Equity Compensation Plans - Activity in Payment Awards (Details) Details 58 false false R59.htm 2407404 - Disclosure - Equity Compensation Plans - Stock Options Valuation Assumptions (Details) Sheet http://www.platformspecialtyproducts.com/role/EquityCompensationPlansStockOptionsValuationAssumptionsDetails Equity Compensation Plans - Stock Options Valuation Assumptions (Details) Details 59 false false R60.htm 2408402 - Disclosure - Pension and Post-Retirement Plans (Details) Sheet http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlansDetails Pension and Post-Retirement Plans (Details) Details http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlansTables 60 false false R61.htm 2408403 - Disclosure - Pension and Post-Retirement Plans - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/PensionAndPostRetirementPlansNarrativeDetails Pension and Post-Retirement Plans - Narrative (Details) Details 61 false false R62.htm 2409402 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Summary of Debt and Capital Leases Outstanding (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsSummaryOfDebtAndCapitalLeasesOutstandingDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Summary of Debt and Capital Leases Outstanding (Details) Details 62 false false R63.htm 2409403 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsNarrativeDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Narrative (Details) Details http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsTables 63 false false R64.htm 2409404 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Minimum Principal Payments on Long-term Debt and Capital Leases (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsMinimumPrincipalPaymentsOnLongTermDebtAndCapitalLeasesDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Minimum Principal Payments on Long-term Debt and Capital Leases (Details) Details 64 false false R65.htm 2409405 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Amendments to Credit Agreement (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsAmendmentsToCreditAgreementDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Amendments to Credit Agreement (Details) Details 65 false false R66.htm 2409406 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Covenants and Guarantees (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsCovenantsAndGuaranteesDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Covenants and Guarantees (Details) Details 66 false false R67.htm 2409407 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Note Offerings, Lines of Credit and Other Debt Facilities (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsNoteOfferingsLinesOfCreditAndOtherDebtFacilitiesDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Note Offerings, Lines of Credit and Other Debt Facilities (Details) Details 67 false false R68.htm 2409408 - Disclosure - Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Financial Guarantees and Factoring Arrangements (Details) Sheet http://www.platformspecialtyproducts.com/role/DebtCapitalLeasesFinancialGuaranteesAndFactoringArrangementsFinancialGuaranteesAndFactoringArrangementsDetails Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Financial Guarantees and Factoring Arrangements (Details) Details 68 false false R69.htm 2410402 - Disclosure - Derivative Instruments - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/DerivativeInstrumentsNarrativeDetails Derivative Instruments - Narrative (Details) Details 69 false false R70.htm 2410403 - Disclosure - Derivative Instruments - Fair Value of Derivative Instruments (Details) Sheet http://www.platformspecialtyproducts.com/role/DerivativeInstrumentsFairValueOfDerivativeInstrumentsDetails Derivative Instruments - Fair Value of Derivative Instruments (Details) Details 70 false false R71.htm 2410404 - Disclosure - Derivative Instruments - Derivative Assets and Liability Offsetting (Details) Sheet http://www.platformspecialtyproducts.com/role/DerivativeInstrumentsDerivativeAssetsAndLiabilityOffsettingDetails Derivative Instruments - Derivative Assets and Liability Offsetting (Details) Details 71 false false R72.htm 2411402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueDetails Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) Details 72 false false R73.htm 2411403 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 73 false false R74.htm 2411404 - Disclosure - Fair Value Measurements - Level 3 Reconciliation (Details) Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurementsLevel3ReconciliationDetails Fair Value Measurements - Level 3 Reconciliation (Details) Details 74 false false R75.htm 2411405 - Disclosure - Fair Value Measurements - Nonrecurring Fair Value Measurements (Details) Sheet http://www.platformspecialtyproducts.com/role/FairValueMeasurementsNonrecurringFairValueMeasurementsDetails Fair Value Measurements - Nonrecurring Fair Value Measurements (Details) Details 75 false false R76.htm 2412401 - Disclosure - Stockholders' Equity (Details) Sheet http://www.platformspecialtyproducts.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.platformspecialtyproducts.com/role/StockholdersEquity 76 false false R77.htm 2413402 - Disclosure - Accumulated Other Comprehensive Income (Details) Sheet http://www.platformspecialtyproducts.com/role/AccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Details) Details http://www.platformspecialtyproducts.com/role/AccumulatedOtherComprehensiveIncomeTables 77 false false R78.htm 2414402 - Disclosure - Earnings Per Share - Computation of Weighted Average Shares Outstanding (Details) Sheet http://www.platformspecialtyproducts.com/role/EarningsPerShareComputationOfWeightedAverageSharesOutstandingDetails Earnings Per Share - Computation of Weighted Average Shares Outstanding (Details) Details 78 false false R79.htm 2414403 - Disclosure - Earnings Per Share - Anti-dilutive Securities (Details) Sheet http://www.platformspecialtyproducts.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails Earnings Per Share - Anti-dilutive Securities (Details) Details 79 false false R80.htm 2415402 - Disclosure - Operating Lease Commitments (Details) Sheet http://www.platformspecialtyproducts.com/role/OperatingLeaseCommitmentsDetails Operating Lease Commitments (Details) Details http://www.platformspecialtyproducts.com/role/OperatingLeaseCommitmentsTables 80 false false R81.htm 2416402 - Disclosure - Contingencies, Environmental and Legal Matters - Changes in AROs (Details) Sheet http://www.platformspecialtyproducts.com/role/ContingenciesEnvironmentalAndLegalMattersChangesInArosDetails Contingencies, Environmental and Legal Matters - Changes in AROs (Details) Details 81 false false R82.htm 2416403 - Disclosure - Contingencies, Environmental and Legal Matters - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/ContingenciesEnvironmentalAndLegalMattersNarrativeDetails Contingencies, Environmental and Legal Matters - Narrative (Details) Details 82 false false R83.htm 2417401 - Disclosure - Income Taxes (Details) Sheet http://www.platformspecialtyproducts.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.platformspecialtyproducts.com/role/IncomeTaxes 83 false false R84.htm 2419401 - Disclosure - Related Party Transactions (Details) Sheet http://www.platformspecialtyproducts.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.platformspecialtyproducts.com/role/RelatedPartyTransactions 84 false false R85.htm 2420402 - Disclosure - Restructuring (Details) Sheet http://www.platformspecialtyproducts.com/role/RestructuringDetails Restructuring (Details) Details http://www.platformspecialtyproducts.com/role/RestructuringTables 85 false false R86.htm 2421402 - Disclosure - Segment Information - Financial Information by Reportable Segment (Details) Sheet http://www.platformspecialtyproducts.com/role/SegmentInformationFinancialInformationByReportableSegmentDetails Segment Information - Financial Information by Reportable Segment (Details) Details 86 false false R87.htm 2421403 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Net Loss (Details) Sheet http://www.platformspecialtyproducts.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToNetLossDetails Segment Information - Reconciliation of Adjusted EBITDA to Net Loss (Details) Details 87 false false R88.htm 2423402 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Narrative (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsNarrativeDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Narrative (Details) Details http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsTables 88 false false R89.htm 2423403 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Comprehensive Income (Loss) (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsCondensedConsolidatedStatementOfComprehensiveIncomeLossDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Comprehensive Income (Loss) (Details) Details 89 false false R90.htm 2423404 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Balance Sheet (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsCondensedConsolidatedBalanceSheetDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Balance Sheet (Details) Details 90 false false R91.htm 2423405 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Cash Flows (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsCondensedConsolidatedStatementOfCashFlowsDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Cash Flows (Details) Details 91 false false R92.htm 2423406 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Changes in Stockholder's Equity (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsCondensedConsolidatedStatementOfChangesInStockholdersEquityDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Changes in Stockholder's Equity (Details) Details 92 false false R93.htm 2423407 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Acquisitions of Businesses (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsAcquisitionsOfBusinessesDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Acquisitions of Businesses (Details) Details 93 false false R94.htm 2423408 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Goodwill and Intangible Assets (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsGoodwillAndIntangibleAssetsDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Goodwill and Intangible Assets (Details) Details 94 false false R95.htm 2423409 - Disclosure - Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Accumulated Other Comprehensive (Loss) Income (Details) Sheet http://www.platformspecialtyproducts.com/role/RestatementOfUnauditedInterimCondensedConsolidatedFinancialStatementsAccumulatedOtherComprehensiveLossIncomeDetails Restatement of Unaudited Interim Condensed Consolidated Financial Statements - Accumulated Other Comprehensive (Loss) Income (Details) Details 95 false false All Reports Book All Reports pah-20160331.xml pah-20160331.xsd pah-20160331_cal.xml pah-20160331_def.xml pah-20160331_lab.xml pah-20160331_pre.xml true true ZIP 114 0001590714-16-000153-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001590714-16-000153-xbrl.zip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�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�?3\X?3\\Z;P;=H_[W;/NP=&@ MTWU__.KO0AWXPO%E_9C(-1C-;AZR^XN5O M@Q3>X*DG?4F"R NF(6PO'K$*C!_$@QKOE.Z[&@O&/6P*SJ,9O)AE$<_\ (?$ M!CB1-IC@9GWLNN,;VX8OY5CM2VP)CE.U)382#S-?L"\A3T=Q,OE)TM,S_!N/ M?,;#$.$7P%=$19R%#(^2V;4,_( G@9!MQD[@(O,GQA.1/QF7Q5)8],O6B8/I M\2GP)8"'3^$!L<_BI,6"$:SXKPQ^]5MLE,03N@X?A:/M[\:!-Z9?3A7(6'R= M\B JM@/+OS+^.LK"<(9_R]D^;J+MOT+)!>&,LL$4]A>*?GO<-N__STJ-?I'':&[X;#]SG#Z_8.3XZV MSO!Z!^MG> M%=V?G[ZY:[/3DRX>KDX_LX_G)Y?EEB[W_<'%R7[.3BC+T_.;WZ_/7#Q>_LY"O\_OOYI_.+J\O&_M+[&WW[9E_?D.A.24;#Y_&_ MX0IVSM.>=H]"73[_-9\HC0)T!7A.B"ST6?-E^EMH5/+(<2TY(H-3>0(UJZ70 M?QZ8%\0X%7STLA0UU(UVQ_K?NG?$8>7]6'DF/#&Y%DD5,9_2TF'7 MVF=45D"=>DVU[ W]8B^CZEV<)*2.2C"C ?D8ZGQD8'I@]@;I_4Q"'24HMF#K M)?Q&*-M0R)0E9"&/6+]]T/^1]..#=F_XXT+7CD/Z6XX!12^/%HX6FPHP)6]% M.+/%AUS6I\OZ7%=2_,%QN[=]:+JL^'HQ]MKI(8X_.OZX%?YX6(>^1WO!'AOB MF[@G0$L.Q:VSR97-MT?EV<,,T)DB_F9 (NZ MU[O?B"]L=K#-#]N#SH]JOC<8[UG$)S$ ^C]@X4\3,0FR"9GK%/,*I,RH$:<7 MRY2\!3]TA^VN=MG2=?C#,2M^6;/IOWJ'ZAV9I]5M=8;=#0S4VA7%J$'LHW9V MXYX2U_KG&^\*<37$ZMBN7#[_X^N<7.ZO*I<[AER^3_X.3&F+\O>PW:V?^&T8 M(^@?]^QY=G>%VNM'V,V5F$VCAZ,#>^TM=H4>G+EJUUQ](#'%%(O=3KM_-'A< M,'9[[4Y5,L(O@_J)QEU1G@^&0XLM<'9==6X0GVBNE-T=TCJR.*=VUTGK:7(9 M3GSO9._[( %9&@8B8E)X62)\G?7%1MS#TJ-9(90[K55D,A8XW"2"PR\H>P?H M4<;2HX\?WGW^RJ9A)ME!Q(%;37$&]2Z0U=*2U3M&^;Q+\ M].22_=&^;+,SK"=/V%4"PA,D\CMV)9))307ZX;Q /ZRC0&\8<^GV>B[8Y1Z"$^]1ZSWZRS6^\-VORK6#SIU3!9K M&(OIMCJ=KKW4E5WA)?5C&\V5QHVD"&N^ZUVA"&=.O]1W??['U\^%M#U]T]VV MM%797,?SV5S.5%Y?4*PW=$$Q9RK723CO#&EUCUUM@S.5U^ "KYO8?LA(7BBH MZKE2XQ?CP;%%)]RN,)#Z\8KFBN"&D;NY^DM= M).VN:/?]WI&+,3O#N4Y2>V=(J]MWAK,SG&W*\\\@@).UT-P:IK!LTV?5L4AY MCX!F5PBP?K368!&V6^34'5ILP;$GY+1.PW6X#4EG!9WHV\) K*L8ZX8?GRSJ MM,W[:730Z@V&KG^K,^5J)0=WA[BZ77M],W:>N!IJS-E#F(]"RK?,RY($';!3 M=('&T;8DW&XIHZ_[Q^L:K70_;$K\>BIPMH:"3YDA7#.Z;+# VS5:L]G7U-&: MLPJ?;!6&,6X' Y96I><3,'7=6P]677;VQA!M#"(!)O\HF7O"L:E MC+V XZ5W03I6&F&EA"]!XSJHHQZQDQGFRF95GM]@UJ*T^BZ/< M/Q3.&)].0R F))3*EF6+W7%I9U.'[>/>CU:>U&;L:AQ(=2A!Y(69+R0E!ZJ3 MHU2^ZM').SZ%S[D08PK\MNCZ83+FGNZ*/1(+=V$=!Q",/3W,DX*FH\,? M].#7D!(&1361L)C3J?(,R1 "R'TLI 0)9/XJ')M%:R:B'0<^VUK%-19/\%\ MB-A)=@,/UHF.N+/3&, 8S9B@??FXOYAQ)N$A@LYBRF< U^_"Q\1(3P2W!-XP M!FC!AR4GI>A+)U$R>EKNQ,2CA1/&#)=K ' DI"1\R.\LP!S2.VF!Q:L0]=5K MC,<1(N1K@*5B'V&)] %4D<3?@PE<#P^S@KH_=-O=0W:MTDFM/#'?@3Z$GR3# MALB@&<83P%E$P<)PM?(^Q9:&_<.#7WO#HN.AM:W@V9YG2;QD!Y:8:[=]?&B' M#]D#:K<-Y&R)O9NIQRTV2N()NQ335&4H(]$"NH "=#-F_\PBE7UMCP-M0X9_ M"J)@ BQXFH L"*; ITTB?LR!@Q(A0=G.1G$(=I5\NS%@>,0P[X6%\:J*E51P M>9WEA]_-M41Q,N%A],(7;,\)3T!.JD7R+(WS'Y2A2[_)M_N'7>5V[W(7IP"ST]8.E[NK57:!J@4-8T:,&P5*S1-W??>'M M+[W_:;:^7[KZ+?*$P)OWA+P&S2Z+2./(A9U\2FRKV%/?V.LV MXCA+@/\PD!?8TTO!O.!B_U)P["^:8Z\WD+$9J-8"I1=@_6\PVT%#)SO5+%A: M+\3KXS==G[^/ZL#>@-XUX:")1#>V?%E67:,:]TD96%/2:WW\IB]PBZX#3M:[ M1W8WD&BY 82IE;.TF9J/!=[UE&2F72U][Q^X-NM.X#^!:)[2[&OOTI6!FEQ- MMQ-!JU/34WCO#HL@-QC3B:"5B:;WE,38_1-!K5[OT%7,."GT!()ZBDV]JU)H MT.FXGO%.#*V*+E?P%\%'Z7:Z@NR*L.JV#HZ/UY4#^02P[36][@A9+@_^&(G= M2SY1I!;F MD40WEA)&!^V>Y8113CFY5IZUWD1U2@(6WS&;4645SZ7H!A'\U4.8V]K/#_U. MQVY*ZQ2P:P8TTV;L,R#7*$A@!Q(0.A@!#\/F#$4.#.4GYIMKV<:C?KO7MXQ' ME/X>3'@"E[)$3.%T8.FXY"6IF#QE$YYF\+390B$%#T,\0J0^LYR"LC;#F$>2 M 7%BSU^XX 0>YV.Q!KS]*Z #/>44*#)(V,AJ6IBK>@)P"QEV0\:X+#&="0=PA3)FUP) #)P)>0^P*P!W M!K2'^>R">V,FQ[AC .*ERKI_QT[CB"0ERL O25[><)G&WC>6CN$XX&86Q2D\ M6418QW ;Q)F$D_34C5@C MPP ^[,2=[2(?L(8%]GW"="%3E,XU0H3NAQ.39* MHF$+XP!6=\MI447E"1ZDI)7 CCW1@GE7VG3T"/[1, MX ")DZ;PTQ2+9G+ EF=6'A<5^ZRCZN&@:QWJ_R<82E_D,E@UDHV GP;8[890 MD-+>8V"^JC*_$/"Y$ '$C)-OR&3R9' J],'^IL4O*'F $0'/$I@LMHP,";@=P4,: "$L .[G M)WR4LI&"@:YBLK/3X5';;M4,T,(_XCL!BX9-1S,F19J&) 7STJ"51$*%:<_1 MAAS'23H"":#JX7*\+Q5E27)*RR>6I0 U70JGQ?J]Z&6>$_ =3PB0 $2]^BUY MU<8O0(#X?$([6#D\2YJR%+6KLM8C#.!2'R_&A5WGE7ZPV^N9TO(U.@"Q@F$( MQE\AB6&_R"HD5M)$XB9.45$!9A!(4FW,]20\0/FK5J40"]\NE7Q%@3SBMW%" MS )>E,G&%MJHKV::_')'$VEG2N&##<^K9;9V/[_YFNV=7<1MMAA->A;#?O,& MM410R2*LZ4(1C=P8J?H3]\X V0*?G92$2&KD9R^-C7$4_99Q;:5&&3X MY/=DI'P$:;IP@D3_Y=.F/+!4 ?=#_ZAO5]0%R\$&BK,R27+N:&GYAY8E=1 9 M5A1L )S(!^8&)Z,%EA91,Y "7[($YYE0O>S9 "_T^ 28 M-P#GC>)\J %$R@8K>QGE[,P:@ :=MF4(/2!3 $@&O H[LO@#\'5.I=CX P?5 M,9FH[QX(_X@C^X([4PY\B&Y(!!P'U0E.8A\L]]P&&X54GTQ/O$,C9AJK(N8T MR3P47VCVX_UW("A4L;02$&0YD8T;Z_IC.$\\+Y0^A>:5&\PM]#"!"49+5$5U M+3WT9A3&,0C^A$7E':GOI6X E_ M3&/B"C*;3+C95@&G8QO\ )=T 0Q'U9Z9,%^R%"VHBGX.+<4D.374>!W\K)IJ MY&KY'^W+-CO#HF%0RPO!,"[%W,<#?B.-T;:V9#0>&0S6M[DJQ=V[/>T!SXO#U?UT M?N6V@YP!3^!6Y4Z=8O\;TFXP5")P^""IE2#8Q]IS0UK7_$C! \/547ZJQ \J M-&*9,LRF+QW+C \UP8+8JP1S_X1FA-$GN.(?H'N@)XB@?G'RX4N+ K,!P#MO M/I1;/NTEOLJ&Z%]TGVG>+1>9K4*R&[XL/YZ Y X\I??'8,G<1/?":,Z\UR*X MM"F,\WF"1K)D5=3> S0D^(CG#QJ*?Z-, :55S;4T,@W3(@+_"*X8R)(K4\J_ MKR**2Q[S$+'_7V[H8,1Y6NHX@33W,N7>-^P@E[^PTMJJM0I>8U!.F8A&@@$P M#AD @O!$'7XLA7EJFCI[W:-?Y2J"AI9W+7@BF3E=E>O.6(A3491-T+$)>\)P M1F1VB%,&J!JWBG_Q$=L!D-BVJ62?2F]?-]>7EQ$H1C]RA(TV77\XC2_8P3_Z+U]*S\QJ.!_&1\^),@ MTUT>Z5F]QG:#HX0CSUI%7U12(^ M?# NJIA,A6MR)8RA8!W@!#9",Q])B()\:#/:I.U<$L#E"QP70,7-"P-?;,"].W%H< 7O1>7">@ M#,Q8M]]ZM $D2OXPELJ#RH E1))[2H:CUE$SECPPIR$"Y9 +1ISOE#1RFW;&\.^;5O/EJ^DT@GSR/YI/.$X M5K+(K9W.#T?6[6]K_JONH=TP8N[&N%W],%;T(+CC>)X.=!I'9>/J(OZ$DH:< MWEK72&8@)^YW,0OL$0>,40.K!HB4@=_\>Y^ M?>R1;&I1W+<[ ZM%)KF8F-\_?;T7!F2=;'COAD2Q[?AYB35P?\C8FOII/Q9N M#1][ ]LG\4)KP!W'5JR!$#GZ@C%@:)XU97^X ;7XY99)OU2-9>/4SG4L_RRR89QV-#1_0 M?:=6$P1:>OH6R;-EL44J$5)ZN %-?,8R!PT5T0'?]@1F'L0OS#Q096MZ50M# MDBK+A!=3U;+.0C!BFM4B LH$Q^06WH0R)P?TIDF0*G_C6(3D@BRO*]P-*@>+,C'RIBV8?(EY M0L5K="X.??W6-XR-<7+[-5.$BY@FN^_+MQG&\A]]46RV\]L*QA MP]G&/8E@\WA$*7G7,1;/Y!4S*RM\+^6FAU;>VJ$T44BM8>0 ']>1K\93,M06";2KNJ*\+$:G3H@@4C^G\5LW. M'+$S,>)@:C=UMW3?U8)I;61U;&KIA (Q+YZ+'%4O:; /7 M8@ 81%U?&JUE?$R-#:XSNIL28.$E%*/"@$;1C.0:IT;30S*5Z4TELWE.9&MI MAQH:_ H/IR8791>Q_,=\N5B&B\W%S&P\U8-K- *6JV9^5PL"X^2&1[J?!_D+ MO$P_G'ODUB+S'SCS#=XK>:CRWVFZ*O::K;X,_P1@F,:ZQYH [;/<6VV0_2\FPI:YUE[32 M?-:"$$:OO_],8A5[9.J@FM'A,"]\Q5)M$][ @#/490U$),^:FKD+'[!3RBT/ M<_:"K+7(6*>KGN_O03B^GLVM^OS=AZNS$Z-W$RC8DQC+,81'>>*!1+D":G.2 MDI9A2 +0KI&1X4=/%?(WJ,]7&0C'ZAIR8DVF0-U4;Y8'2:B3S;*&!W ]ECE7 M*3$0LNG%%*N+ F(Z2^2!*$2CKT2CZO2CA(.H!/,!FZ(X>F,T&RD"T*W2C /, M' EDF[=!'"X4:!>'@W< L\T2[E'7K:+9(B^9ZAU/D'8"?-J(!R%542%K_"98 ML8JH](B20,(N;\E\"],6&#K1MR2;IMY,%V\ 3=V2L:8@T"IO_#/S;\K&$DH, MT!X >DD<&MI47BA.E5B>-O_H6A!N]%P#L"UF0 X1V6P,:?:$Q*>M>*JZ%12V M:0O1ST]]#-\1 Z*:EZ>R'&SP1)ABL(UE/3?*(H:BK,$X9%,8TF8EJ/2Z30?> MEU\'AY E1,'*?H(%3B*%,J5FH/NAJAYX(7:U0G&+A*[KW>!^N: 2E\LW5!^> MW(HW"'5Z1E'VUMP>5B_B 9S- C13 =2IC@84F U6J.H0@T>L+D/%$) V[YI7 M$9\4$_2?C&UW<89FLBC2#BB@A=PAJ678U](,$<56)/?VE")&:44-,/BFCB_F*?Y++8ZC$38J7*QE8 MW;-9SM[2M>R?3O+"3 P23,57ZW]G#.JV!W8>&$@4S+)RY;2,E':6\4 MGD:HE(6Y)2[,F4\W(L( =CBSE_EOS:^NS^HV5IZ#> ):,U/MH$M7B>ZJF9^Z MRF4M#CI(5S6^G"8*@?DX63Q( M%90807.@?JZJDYI!EMICUWU\P6G)FB%2G\S\$KQJ7:P4;J1/N=MK](UOL"QL( M*/CB9 6D)*7RR"TY5J-:0MG)P80<%_AO2T6] MZ4D+@>]:P@CY5!EQ_,1GJF]'KXOJ*N6&PH;"0"3F+(4/A6HCT>U!75;0_0-6 M/+!3,0G>8("?I#FB#>BLG&*B^@6J^5$!600,\7J<.](B,0-FO^;RQ8JZA_.M M%O)^-GE[[;FV"ON;.7D/HRZ:(>P+HUZ2LAD;/2%ZCS#JXL)U\>ANN]NQ/.)F M_1SZT%Z*U@)_AA.A'):Y=/1I BPEF]@$_#K*;*P\RBP(L%Q]LAGLL&9U@9%? MQ8Z^%@ 7*TOO15)_2'CKQ]>?2@KCHOY'9N@6^6&4842E::CME)UZZ,=^RS ; MP]E#RH@[,]MG=E_F9@U%B#V?B<4T3#U";PZ%2[S'%)2P2)-\D3Z]A*A4N0KU M"3=_K2K9UP($;*1U[(6+%;='Z>S3NCWF"U&DYK8G&*[ S#'&6 MF0I-W7<1#\G3-W"8 /KO[IE7U5*CF=3,(PKS&EWH[YUE=12@@7(;XV)P/&'A?+FTPL+-1.\E=+1PB,[ /*P#;.BJ: "FM%F@?'[9[] MOO66%G?8MMU%S108*M&PTF-^S#%-,<7<+V,&G)EI8LU$ZMD>^V81\ ?6>\4W M9,1P@QA%57L'X"K6;8GR.I8ISVI=N6WD!"K/=']8@_WJ(9&@*98AZUSJ+DYX M40CN,'Q-&.YTC34 F/IM+(Y"A9^EJ*B'ZQH"?%1;U>.P:W<6V#R_QDH$FH1J MY+#.ZQT[9ZV]+THURD0UY9OB7AJ3Q7N"*=*5K(UKD=[AO'=,\%_^UMRQMORYK84\YD4;4LVQJ6"[KA225'D1W**=]#!1O"XR)W7./A 7$">6;I,7T'C6N MMV1YQCS"5CFTWDARJW2C&0<2T=G38TUTV QKL\!T+RHNE@.;WCSE23'(7"?% MP%)N$JYRRGB9IBBED#+/BM=:";PHEJI"Y1*-Q]" 6Y8%R=0OLVK$\]+,/F8 M*L>D,&O3\I<8][_*EU/F]IUBWGF$$#DU*VW>\9!2#"_'0J1YNIM5T_6@5U\= M]>"P;7EXK3.@UJQ>?M$$!M2!C894B4-.$R:;0*HI_,GZ$A+H!G$L)8E+S&2; MY/5"GZ?:7ROMT\9_1!+7[#A_Z-CV,^7L/!TG L?P1ND819MO"XC-().U$<3. M:%_DV -=)81+Y#*] TT=K7Y6%#&T>D@4([FB>G07)]\H3U=76T]XQ-7%C 8< MB1M5!7"%M%R(3[@:3*G"NB)_KI;F6/JS%LNJ9[G+?E/$#U84&C9LY3Q;^IQ1 MTUN"!+H6D$K31X(&P9&:!EP&_P7=E41 EDA4K$J+I5++COUV )>I8PD.! :6 M#BI=(GBJ6]!A6K2NM<6GW41J#*X'&\+J2=7@XAKU\8G ,@J[SOZC]O&^HH5% M[]':-1-B$16\LHP'0[MH .!E)XJD3(JZ5B: GFVO+,$*@XWB-.^T"-C^ %EH MPM&-7I) ?E-*4R+N>**,3JQW2.0XF"H2PD<3&1GTW-(3[:NJW.+"7Q46;[[P M';6@^AWK_,":NM@[:-OUP#D/_=I-J%(HCA:<*PVPFNR;*#:M)\N^#F<]K=5Z M:DJTJMH;!M,?S)G,5:WG+_#3- -"X*H!VA0D"X7B07,$"U_9:LLC M%$6:)37(,4O[*UTXJ$59D(="2?4SFV!670,+C0,,*.7SJ9? ;,*!0K*)4?=? MOM$,OE9>%DB%IEJ#-LL$[15L#"TG50 0+N*E^PQDJ154 4?GCI17H%85>I3/ M>&^ ZV%JRS__[9=,OKGA?/H6,T3/ HF300 7KH"8WH6Q]^WO__U??RLO2< D M0)[^ 5Z4J"YW)Y'_#^'? &Z<(+LGSK#D.6J2U/?TJQC]]NK]&7+L?W7_?74& M^HX//P ??=,[&IX' U.NN>=SLGP^.#LN-\]ZQX'1^_^OL!S^V#FHG%0KERL/V*#EI'<03; MQY)/ IEF\]6;&ZL=J:^+V2V:-$XU:31U>XLE!T /&5$F0XTL&('V!D\T"E$0 M,W)>1G4U"@0T*H;4Y:)-M]$8NJ4S-C0C"2*=.(*_9A'/_$ UPT$/X.0^HBQ3 MB@P_@2)K7!\Z_2AC A;'R+0"355>J!_'12'AZ&.3#[);=4L=& M0WV\%3FE&_NVV32SLWY,4(8LV: L-SWGK$9LMK8 F@5Y@* H-'@\%"F '1<9 MM27*E'R.6'QE?B6UH\Z26$_SP9)%M,;RM)V$^[ED^"<8KQ'JTO\6T1P7A!40 MP_(%XK-JU1\]=+J+>X$G" !Y0.%#X,5CZL14MC_.4YDH$FAV0S<2F "L3WDE M@1GD3/4HUI:3_J);EYHY85Q)*@6SY(YTR2: M)=Q3:H_63Q2NS2,Q=K<3F$!';H^,)B2B4D@1F=@78%>K9+<,V[3&UT!K>;"4 MGAU$TZS2"AWV."Y>1#0^C5.M9Q8N1S)T0PJ2EE2?ZTD*^[4FAEFRAI*EG1$K ML!K3QD3/\\=84K-S0[DJ+GZ5I_(A]1*#H*[C3_-&[YHR4[CJOR)=-G5SN?&E MZF\?G0H-_"@?;S?E@%;!=Q4TQ, @137"6.D'RPR;^9:+?%Y!JC0>5=BN[A2D M89#C&-^I<#Q_53%A9K[PMUA#WMJ?NKJN01!TVR!E;,\PK49 L9K?'-A!CIYU M=/SH#2W7W.FS/9\?.:)V8&GJ6+=]?%BWIG'^^-(+:AER*:6HT<4O' M29S=C-7 'AKRU6B6=%KU6E1%'#>EE.HF+RNJJLX%F"@W!"A5*E5!=UXL4HE M*K8P5;SH_*UUU/FH[(GG91,]L4JG+0!A)F*,0Y-N19X0^SH$&?KS*YUWX85< M2K $<]X)>E:DJN;DO(P?JQF:L*J)-J9D<3D.NBHRL>Y[I)$^4F%\IE=I+BDC MF(LT-S>=\1[Y?%JZT)JZL]RZ-#,LTRJ+\@F*-(29EV8Z/AA$N29K-.O7X:<@19]E M0=$@A=%E8DC_41 %$DB!W<2Q#^IB$CJ.S38!EB=--R2ML;F90JN:>@_3=X.LO U-\9Z?TEU-[K@5 M58-'9M,I=DLOPPQJ\!=V(4I\8LPSI8&4:J\HN\2TX#U]Z=GHMT%?CI^B\-B?KU&%IR\P:8(?"K%V_R#B2>X&6-1 M2?$)XSNXE.BW5]WN*Y;$=_I+;@X^"S(?@4R^V_>AA66CO(M:+I=T:J%_N?#OUO';!\ MF(EYY"VSR,8617$D7OV"ERZU51Q6.JRTCY6Y".:>]]N$GB- MC_['.'G[/YXGQ&A4*S_)\?. ?/R *E=6.U9R""DM3^4R%WYP6X1?(U#7CB,L M!QSLOTY0VR""F@V:*_$5%L8>9=TXK*R3G-H@$)L N-H RV'O;,.1T' \4E,BRT1*(ZO+X5-]'5/U0)X?;(/ _HX) M@2QN^76OWUXY#K#JMDLL;\S1N\P"QQT<=UC@#MV>XPY/X0[.A?DL%^9\UYZE M;LR'$W.=_>[\F&O 4ETYYER86W;"B55=SZ&<3X<@3D"6X/"V7&$M3F78K/%?3TR:W:, MY=0,/CM9;^/0;&<])O9I;E?$E2,*1Q2.*)PWL9;Q8F>$.L?B [CXM-[7#BEK M)"H?:Q^R*YZ3U\?VR@Q>#+-=KD]P5.NHUA[5VG1X.JIUSM+5W5T7(ETV#JJ< M^N$,>^=4W;ZE[[#G*5R_#US?CS,<5_&2_GCU0"9KU<(KPZ@!Y<2]8?MHXW#9 M9H+%TFT?. :T'M/D%YHTM>SZC04G#-C4SVE>F$3SWE8 M.DZ$8!/XRU@R$?G"M_+8)DSE,^??%A,@LR@1<'3_@8\XTU[8&_;\ ["-CMV! MC#B44F7\XMCB1(Q%)-7X.O@NV&OSD,?": M<,;$:*3&,*H9PQ&>7/D;#B2DJ?,XV-WC%;",@)&S]([$=[FP*AR%0R6X=Q9(#Q@,"&7$F2!+6[2:1_;Y2:C))ZP M$\_+)IGB%XJUG%98RP?%6F!'KXINFSHFV,(Y[8]-O;4_/=V)Y%TAKGM$2\1OD\:%L>]XWB^2,LDL71,C_SHQ.B[Z,54Z"/'L@16?9.)^TW(^T;SNDMWA@\W) 46 MPX6@F@#"2H6O4H1A@.L%-\8A]N#P[8<#"90"@X0GC-XF@^X!: M2&LCXQN7+47Z)AZ-:'?J.;B%_'( @F0A/$039[Y];"(<1$2\3-RJ]2ATE^R: M1]^2;)K"AF$%OACQ+$QQ72(@\8LPF^'#<,WFPJZ,(\#!]A/N(S0K^A^P$GBN M+[Q XKNQ0QX\"38 ^R!HJN'6DMTDR*<,AD'M(NB2(AH&2Z64[))Q.X0#$I-35D B *0N(NST&?7 D620<,_R=4. MDP5 +T"K.1D076@#1GP7">"9\#?'^Q;F$#5\&OJ$)S=!I!;)LS3.?U"^/_IE M#0/3>STK ]-[6YY8WG$SPYMZNSNZQM[>[*-KU.:?5RFQ^=F!SXXW69\B^!Z4 M[L@+0%U\S<@^=+4QGK-4L1C5_46KU^ DP;!ABUB[IH%CNH4-!A8*EE>;0 MX[UK=/]8 R@"6\?Z]A?]Z@4_-^/P&3,.:V"YK;FG:'WJE1Y#M?K7*?7M M#?+8^4ZR#>(\]>+C&P5<30C+]4!W!%8; G-"W EQQV,@9>K6,\C,,KAU>.7SF\7XE<,KAU>-2U^K7:WA M5FJQGSN=PSW$]5W/M^%YM<&^^YGH:XD 6Q_GV%OOJ!3]7^W>QN#CZJX=U3G)[B1[A0%UV\>. 3D&Y!B08T!;*L9^2FK5?IL6 M1LSB%YJZN>SZC2W, -J+9Y=:!S5%'XL1O3KVB+-LC8@D#HP=B]#'>;%Z3G ^ MJ;DZH1FGYQ8#V'&.^9=$3'G@,_%]BE-BU2SFF"84JW&]J4XU>FRH^=QTX(<1 M07_^VR^9?'/#^?1M&9CY4(;W3R+_'[!;@/2)&A\..S@+I!?&,DO$%<#\71A[ MW_[^W__UM^(YQ9\_CW &+BR4QC-_59/53V.9RLLQ0.$=AQU\X3-Z4?$H&C8, M7[Z*T6^OWI]AMN2_NO^^.H/-^_ #]](W9]W3P^%PT#D[Z@P&9^^[![WNP7&_ M>]8].!KT3CKGK_X^AU'F.3\R)W89%3\9(7L'4VM5-,NC:.?_^N/#U;_9Z>=/ M7\XO+D^N/GR^8%\^GEQ<;HS(UC0<_9]9)#!%]J R"+UP3Q_]*N&A@"9C 6. M1N?3:0(JB$]7PWU]]@6(H,7NQH$WQIGAW)\$48 3JN&BZQE=YQEHB5\F09H* M&L..?WT7\\1OX81L,4724[1X%T@4JZ.LPG_ M'DPR&HN^<$;/@55WT!IT.JU.9[']R',>QR22)&8S$D +@1F]MH8]!U$7B)P ML+QF<8E/[(:8',( 9['+'(H%0'[.#X-&66/.6D(0P7GC-%?]E@Q0F< MF,SHJ2!X@0'.@_9$6@/@FN>' \!PF+JMU?:/^JV#_L%:SWK,<7ZYB.@0]!%9 M>6&O=7@(RQ\,["R?X\!Z6-_7RS^4L%3+CZ=(SWID>IRE,H6_ ?NZ!Y46M[8M M5FF\JV*?U':8^AHFI7?M3$H_&+QP;G"OT5.3W>KW9?4-J;"JG7>H7&YWWPM- MK\8)*+V?X&]CR42N!M@_[Z,W#6 8W:I>.+!U9.K+<7JYJ[[@U[*R_8,>1I2/+F@"N"639/1HL3:IS9+F[ M [_65YSQ>\*WW:&O+G35&AYW6L?'0UNPV!4:J1\Y-$M"-9HF!KW#UH$]IY.C M"4<3#:>)-70B)Q_%XD72.'_\D$5 M\]32(5 3ZGI]U#H\<*US7.>*&@LO1W>.[NJ"/H[NFDUWKMNKBS Y G,$5BL" MV_M8T?LX&8G 8K1H[:5<6]0]/P+L^X)T?9]CI+4>\772I]%K# M_G!I#\&-0W%7Z+I!)-QD,;IN FU$5GWK^/"XU3FREU?_;!#O1>*](VU'V@VM M8W.$[0C;$78-"'O0/[:9<^H(>U4C>\?&L5B>%*&^XN5O@Q3>X.F$5]6EJ^PM MQ&C("*,I(RP?,]+43=-]9UF"?@5L9+^PC^<\+\4&P%:>Q"8Q=1$6U$78RB/7 M.Y[A!NLR[Q8TL45IJQP>HJ>6J)$B2X89M-3( YJFD<;, M _;+@XB)R32,9T(4(SGT,!4UL(,@\ 8'![$1#Q)VR\,,+H5?<=H/&R7QQ YL M?ABV^XO:X;/@ INSLZ3NH#VT-#=E"J>114%*@RAN!5 ]0 ]^#&)_'=#L]]N6 MIFAHDK4%TR5]GUZPK#9CGPEII6C96=_!4;]U:)- :9"7,1T'SGR$ SEP>(T7 M1WZ@II&D8YZR"4@#=BT8]\:!N"VG!@&)@P"C*1TYZLQ 3+>08M70'#MG<]QI M]7N6AL<$D1=F.+<'=A6F 6P *, >@O]')'&]N$6OW?EN9T6^F H]DF8:1RP1 M:99$##X%$1X_X(7'IZC4 *Y$WGC"DV_2WA2>8;_5[R^J\PX)5I+PG<1R#!SOA^;D4 M*,=PRA08Y@2F#%TJ2G% :! .X>KQ8+>"7!PMJ(U6]'* M8^[)H'P^#I')-\I3QA\>]EIWQ\;G2&=*=(_4R;4,@[Y@L6_1"\X.#7"^W 2WYI, NWMH1[8KMBI%OOB<*\5SQP;_ M+<:B$@.#(YG1/-\@RD3.Z02.5*V(,Y_3J4::$N=K&0H.*N*<4:1K"#SAWMFY;6#ZBM=EL7@WOK>;$+>7T M=BRVP\/6X:%-D;O$]:IMF/6Y@@A;EYI(MN1$_0RDM=C:]QC:4@V53LV+!WQ-6"W MDOIP_&"E!>E,FRSWK8XP2WR? F(INPTPQW@U(@\*7L(2^#!L-H,@"-ZHEIFY M(4J#Q6E2944J5KD(C:[F3*7C"O\-'$+";\2Z-:QNISVT);)T&.'Y![CFLWD? M)ZN=A1UXV)L]OFRFQ_/4'.6.0R^*B"1'GDZD&4E4:>7_S]ZW-C=N(^U^WOT5 M*)_DK%,E*Z+NFDE2)=]VYZVYQ7;RGOT(4Y#%'8I4"-(>[Z\_W0 I41?;NH 2 M2?76)I%D7L!F/T\W&MUHWW8XZJUR[I4FV[.U:'!YA5Z@5A-^J%5[#(YR M82PYDSL,K6-T:!7P["42(3CW+O!F49E.?UW*7UC5'JE\*0S3F7Y;D46SPL1P MJ-\I3B?_)X))FU77?XM]*]L/\,7[BFK J;F^?^0VBW684[YC]B#Y&X2#T@M MD:\54)@MF9N-(*@%P.A=?:&54K\W/VQ=\U-G:PTIO51$! MCR?0DP##DXN!?/2P<0^3#PMXDK$EVW?XF+ M5D,_8**6^(9U*!O^[J<+BU;,HV(_$D1]KXZ'N8HC;3]2KM2R6/$"N J32.SY M+"5)-;;4*U* @2O 0-T5?1"WL@Z=JF78.L2K21+4 H44"-M_\. @I1DKC?8T MFJ[#YMI1U^YYS#,+0:B,;0ZY:T;=M;EW?@IS:'\L?GK18UL@%Y-.VFFM:OV4 M7S>M06[:^F[:^BV=<_QL"XLN[204]W;F(!K39(+N^=[97Q$,4!D-;=U]+9B5 MH3*T\#;:HD&;87>1S?V@8R%#CK5GJ$\/J2" M+((;35-IF[%KLB#)U?R;Z,\3V&P=O(OS&FS7EVB)M9K%+V.JP:VT$_2\Z.J" MP@Y2B^3*[.JX+PHOD=!VDA/AR!^\VYOD MEEI,SPLN=:NYBJI:E([4=_E MA-O)]Q6O[,X9@]0^BR=VX\/T>''D,!]^<#P]2!Z%?O*#KI93OSPY@W#T#M5\JTM\Y+Y:?_ M&R_FL60Q;[8,*H(Q.U7.RR;[[4T?I/Z6-F>V?<[K C1=P-NN9M_&LH3EMWDV M$5DVC(G1]:>/&>08$\X"6P6#4*MA#D,%WM9T.1V'S-F&(KQQY+>S(0;C Y@$ MD]EZ9:^H:LO<5GDE[ F3+1C+A+FI38.[.3"C&F2&O8)![/^:WPR5 '7,UNUZ M%LY5L7G36K71WDK9SE5V%=4/>[-M^=_4=>4:$TU1:8>HW:7]1OC(D0PTR(Y< MM0(YM]0HG?$D7M362R2J0&CB&.Y[*]E,#P"5Y"5<,]1IL?"5<'')"%!&. M V[N8.GQ/5X)!X'5>,F='J?!@I,,4EOC,E^B:C>3%"? M2]>H9IW9MO]L:A]T^ YA<($YC^>^%TF5A5+4YYRN$Z>6TZ=50*@?'^\NSM,U M,T,G %C_%?$ H(]ZU-*53J;R![*M*%59F9@T-%T&!_2#T77 M;#QU^P>K;CQ##H%K(ZL;3-=I5&MF4PQ51L="3KG5 A53E=SQS@-1H%*MSX4G MAFCI9GE?ZNWIU'3,M\EP1S1#*:RFJA?;=<,[M*4K0%>D[.N:05F92^['C&V8 MB*%7@*68=I>2+\NJKOS@EMW%2*#&;"@:3U7&OF. QGG"J M'7+Y(W=<90MQ6H]53LJ,SCP7%&Z1?&4>%R:;&FVO5NGV#&UW%+\A+,]7FR+$ M167SPJ[H8D/S56;=AKE-?J5*2T>5$L "#NH/[O21S$I"D6SD$:L/^3)[]AM0 M[HH,9T&1U\U?\OF7GR-Y]L#YY-VE(['. +S7+\.+U'UOA IJ7?@RE*HD6U5D M)P79=V :SET@GM_^_K=?DDM=\0!W()1?1:#.F!ZD4OKARXT8_GIR?8F2^MWZ M]]WE"7,&\ .WP[/S>JW>;-3Z5Y?]RRNKWNGT^]U>P[JTFIU.M]^^.OEMP:2E MI?E&TO*JH/?&%K'>G+>()D/EZNM2MN55_^;SA\__O&5?KV[8[;_Z-U=[,_?& MUP'Z2J>C4*MT/,UZ6@Q7)[8M5?<[)$K)E?-N;'84%W_(C&LQUJ""8E1>9%!6 MT3525M%I'%-91MWDEHARKV6E]RI5<%/VK)>S:\* MKBOM@JCHR[[6KE)=#B#-5/94+YA*G+;% 3A9P4W[Q$1M)QZOU,=';55GDH^J MJ>+HO,D>V?N676%IF)1T8R5=NP4YY8N^E/CW683,]:5D/ P#YS[2,P7*O44ZO1K"Z'S \FSHV2\ N@J9NX M7T4AU]RY!$2>1)X'(<]ZN[J\33]QY[ZYLR#A@D7>3,+@W5^IYY*E;]X@W3QS)DN4]6V;DF" M6]P+3Y/1Y 5I@K#>+Z7NS*[2GH1Q-%'/V>!"&[(H[5>R-M#+@N?\3Z2*8R() M%65!!4T#UW:?+ATW4I5'Y9D)FLHF*,DT<0]!ZL,COD#@+JZ!/$Z4[F>">10H M+<@:4W:K<1\QZ2F57OIV^M/K12''Y.F:7%\J"Z#RAYWB6C<"14E D>7LKUML M^Z,6_0Y)+K0[ZX:D53Z4A=)2BY@F1 Q4) :RFL1 ^4CN M++CGH^+<8G!(YLF'((P13*%XQ)PG(!Y8QX]XN?5?D?H=X'E;U\ETUJR3V69@M&^[F>'F;Y/E MBIGQ>+X9 <7Y?ZEV3/C=27I'QLT$!B\FYZ_8'SR]K;AN3.D$3*C.(NS)C]P! M&W'LDX:-&+@7.F?)U>-V!6,_F&\/R>_A\DQ&]F@VD.7[8LN9(;9S\'4_0]VH M4H"34-CV,^H\8H+2,H%JD*CV7$?<2&%'<*PCX@8?V/5T$8@+6_8/]&+B*A3> M"YM'4JBSYL!W+^91AQW2DH-7-'2;C>598)NUD2.PCPTV >!//!BH3K/8JQ6[ ML*F.L*F+ *+O1@(NG'JV,7_&^_GC%*W TPTCU:XM;M"7,61?PF?JPG,^^S%M M0=_.QQ;T]4)O K_?T1[2?MTN"W:!)XV@7]]]KVO3>##D1])L.';[?7^ M9N4<;:.=\[W>RT&HI(>TG?O^H]6W>AHTFY"XS[JS9ES6>.WKCH]7\'Q8H?'0MHS5R)0%#S3EV\'H%&H^EQ,4UBO@FF4N MH++ LT!(+)8=(V@=.[1H5K6V@3MGZ2W&,S)V109>O6+5C 4[R@*P_&&I6":J MP("PK$J]1W,MFFN96%X;QFFJJ6Q ^"B=@0A4NB*YA*_%/#JU[/<7*@M "X3% M8IFR,D++JC0:#8(6S;;6-'&ZR<0$+581R\ +D+I1%JSD#Q;%LC8%1D776)_P MLH"!)DTOZXN\0IHBT12) @2?7!T55\-&N5;MMMY7L4-2$%0G6Q+"/A>BF[J55IM=(GCUP/GEWQ0,/U$Q^%8&:6-W!XYZ[OOWMM[__[9?D MH&ON!']R-Q)]*44H/PDNHT ,OGB??2_ +94"N 3VTI/3TU4"!GRY$<-?3ZXO M<8.#WZU_WUV>,&< /W [/*O7K5;[PNITNNUN'?Y[V>M>]QK6I=5LUUJ TI/? M%EY%6JQO;$BTZDWF@R\]3O[?S7C+7QP<2P9@-Q'VH+F'S">X!PD#S))Q[ M#\^GTF/>Z*^[LS37>$USS'A,.UY99K:\:K8.N^?4@;>\HH>GAR__PQ<^"KRO M?:S@.B[:M:VVL>H<8/N@7.T'M.Y6J!1XW79Z2;J6Z-JEL,7X7@1+ZI;MCE2D M@QMT-J+MTN94]B*>FZT[9]KKX-2$/5],;2PH0Q J"X0PM,1RJ*JDC<>HC43H M1.@$H3T3>MD2$>9&8-47(MAGZA=S"VY_W%ZRSWXH9(4-(@'SI;JQ;=RV6J,\ MX()<;KK,O:F1%Y9>)[&:OQ(/HB^B+Z(OK:F^_5;)/O==25H/L-CUW]<;,0'MM$^Z9/ M]E8CL8RS+TRCL-&K5ZG;PQYL6LEL?FGQT&B8\$!X M*#H>ZNTJ;;9F8OZ1HXA*WM;M-W% U@9:=KM%[1>!S6[7G$4J_291!4)A<6U8 M>:#5(F@1M A:64"K4S6WR0U!BZ!%T$JV#*W5R&IE-%>#-WYT\[%K)Y A^^@( MCUT$8N"$[)K;CNN$SQ3_>-]I-"C^0?% B@+"L*K5P)#P0'A+[T*H:VQ6$ M\$!X*#H>K)JY++>RX('6BW9=+_K@V8$8P]6YRS[Z?)-FID<7'ZCW:E5J9DJA MMQP9L=) J]LF:!&T"%K96"UC@06"%D&+H#6S6BV"5K:3M6.;DUWT;]D?U=LJ MN\0MWP-V%W#/'@EVSNYPM_VLIF@% YY5KU,R.04'*3@XQ4.3BHT(#X2'*1X, M[B5&>" \%!X/#<*#D?E(CN;_AYVH](-G&?+5K:SE;+$#YK=FKD(:MM) J]/=PVZR!"V"UO%!JVN9V^F'H$70(FC-K%:'',)L)W!'-T]S MX:HO3-,:M*@TOPUNS3)76UL6E.4/4,6U4P5$1)>J, @1A(@Y&T%U>H0(0L0, M$2U:7#(R-\E1+.#P67!7?]Q\F(F@1M+* 5HLJ:[.=MAW;["Q._=OO!*U@L.L9S)$H"[CR MAZ/BFJ>BP<%@#3K!@>!0<#AT.V0=" X$AQD<*.W&Q$PD1S/_/&2]+! <%B"@\&)#L&! MX$!P*!T<:/%H%XVZX!,'^R&!]*5@_CV,@X>.[\E,@@1^,!!!(CIK\IU)WW4& M[/_4U/]*$T1H&0Q\;RNRLL"[0$@NKAD\'F ::RM(P"1@$C#)8A(P"9BE!B99 MS!RMEM4.,2,UHDWJVY-0 [KWW8&^SIT/D\]L%*P!"C;PHWM73#5L&^S%%\4C MEE7VX%)5I_VP=P'N65[&2:U2;W7--1%Z4VQ[T*'#LQN%I8F]B+WVPEZU1MO@ MKN3$7L1>Q%[$7GOSO2S+W#Z[Q%[$7L1>Q%[[\[VL'OE>F<7%?@XY//[*XU=\ M_N7G2)X]<#YY=\V=X$_N1J(OI0CE)\%E%(C!%^^S[P7"CH( E.V<2T?>@2#. M7=_^]MO?__;+FZ??K#X7A.VA1&_$\->3Z\MZS6K_;OW[[O*$.0/X@=OA6;W7 M:+=;O4[[LM>N6Y?-3OVRV6M8EU:S7>OV+>ODMX4WE);VG3,6DGT63^S&'_.7 MV3-UNNMXXFRDXVM6O?;C(L*L]@)KJ1]2:O&?2(;.\-FH9MR-!!OZ+M@!3'M7 M[U:R22 D5BR'6*CLCT%GGS6C=^M6Y[U,\N2YRQQ/AD$TAH-EA7'U:ACW!M/\ M>0>N%HYXR'@@V#A^:0R^#^%]LD=\HU$?0>PV\GWS57HR1F$(_@( MSQ1SC(T=4R92O$L^O%_DC-F@TM'K&>^T5ZY3K!\ UV-JMGY\F]E6 MONOYA3Z]V*.GAR_*PQ>D<"QWLYCI<1(&O<6\)<\DE@E(]3<\^AWF MCSOVHEJ>\K$?@>,.3CR#Z[B84_Y3%DR7A:KNQ(39*^\G'MBCF:@;5H6]- ?' MJ2DQZ/[M[Q%JY>^1'\+T>Q(XMD#8KSO)WNL@N1TZCX*->?!-A*\7N1QJB*01F>Q*)HVUR:1L]=DS(9G,AE=W&0C;#U3Y]3MX18Z^&3?;6,2ZC?$C$6.)I=D]LO"T8M4&B.-/A4QH( M_P?"OT5;]Q'^"?]'B_\NV7_"/^'_:/$_K7&I&WO_9>$!6B)ZL;?C(W=<50(T M] ,F.7S .$+XS"26-*D2J&VB5\?2SJ=MKA5WZ;FCQ!8YHJ@"5@$ M+ )6?%K-X-XH!"P"%@$KN_E7Z0%V]"NWE_"'1XXE(YE,LPH&H::YS:#+@I#\ M@:&XEJ9@:*" 'J&"4$$V@M! :" ;D:M%'VJ3\9H,,]GL]*470[N@IK?S?$M] M"[X]:KV65;N@381Y%)NF4NPSHZ0:HD>BQXSHL;//G:.)'8D=B1V)'0O#CE9C MGRW9B!Z)'HD>B1X+0X]9Y"\02QJ/4)8D^V$I#OG&!D4?XY8CCN$4P5BT:8838U04^ M2@>F*VKFG)GO8EDCI=DJ":- MN(:XAKB&N(:XAKB&N*8L7$.3IZR#.66*V61<9'_@7L:FL=5HF-M(^"W1E 5B M^4-3[LSUL<(I\[0J0A6AZNA014:*X$1P(B-U>%31-@.TS<#!Q6TX0'3LI1!6 MK6TPOD1%$!0"IU(QXL?R\".5BA%+$DL22Q)+'B9&1?1(]$CT2/18:'HTFL-! M]+AFC/+G$+N]K3P^]3GU7%B"?S;2D3RK7OMQ4=VL]@+HU0\O/47JPG/,@9%. M)4'' U+4W]-W]OQ@S-WY^^ QTPNKQV*V<-WXF%]/:B?J.[PS._F^0NYWSEA( M]ED\L1M_S)?X^,D9A"/X" \>JPJH@$+DKN7.Z=V.MQ&!B7+;\AJ M(^>@NYUXNMFY_*0]J>%:^,QN([K^)[\*0NFRT)5 M=V+"[)7W4MAB?"^"F;0;5H75:Y:QB2>1)2G@*PKX>^2'8L F@6,+1/BK8CW4 M(+F-I1%LS(-O(GR]0N)00SS]*!Z%RZQ-B)%P2[C=5M]NX3;.$$0!@LPC'OP0 MCF7^O13!HXKGY7&0CC>)P*_)Y=AB0JD3H1"A$*&$[R./R&17,FFL32:TO9J! M':'[4HIPI]V@W^2I/4I\7U+.*D\@/\I98+M(^D;Z1OI&^D;Z5G9]*_R2R*XB MN^!RQ,1?D?/(77#0-]F8Q;B,\B$18YF%V3VQZ13 5J_:-/749BQ1/1(G<@*$:$L2?;#4ASR MC2V*/CK\WG$Q,7V7;8I*&?TW:5_* JW\H2AW?@:!@D!!H"!0$"@(% 0* @45 MS*ZC,Q]]'+<(QC "+X018@L7^"@=F*ZHFNCQ5.F:=5$:H(54>'*C)2!">"$QFI MPZ.*MAF@;08.+F[# :)C+X7H-JOUPPOS*&H@* *>402(K$DL22Q M)+%DH5DRNQ 5T2/1(]$CT6.AZ=%H"@?1XYHARI]#;/:V\O@5GW_Y.9)G#YQ/ MWEUS)_B3NY'H2RE"^4EP&05B\,6[P39Q >C?.9>.O ,IG+N^_>VWO__MEZ5S M+QUINSZ>.#M0E=' EQLQ_/7D^K)>L]J_6_^^NSQAS@!^X'9XUJ_W:\UZL]X^ MO[BZA'^WZMU&KV%=6LUV[;Q^V3OY;>%=I.5ZYXR%9)_%$[OQQ_QEODV=CIL. MG(UT[-*JUWY<1)C57N2Y)OQ@Z(6O#IQ>]S_[;#778; MP@_Z2O<&/I/"=1GW M&$?U9W[ )MQ1?P@#[LFA"!AG[G2+"A@F'*NHQ7W6AX B.W##>Q$^">&Q,0^^ MP84F'.G, 1G N,1WVXTDW)'Y0X9229]H^S*4%;C_3%8PR&)1 MN&J,,+1'?%[N#=BC[T9CW482CYX*:BH5N%W_7F*Y'%^^)T@R?MLI!:BH*R4Z M @H@7WV>"GL:.?9H8?SP+O3/Z6OI=QR_8/67$8 #'PY?-* @5HBEIYGP9_4# M>'!X=*PVJ!]AZ.HK31\8WM807M6T.A ON_1*02K_@FN!7JR(8Y*Z>8 +JK&R"<3]QF' MR5^ :[70S/3!FT0IQD%1X1.JZDX6"GOD.7]%J(PHX U:"8%+3/;!8UQA@YB M5+$-G,CA0H$09QH^(T<$/+!'SS$*[]%\*GU[B0#Q;X+#2]070%S&@YM>"U_L M0$@[<.[QS@*TM*(!_%&=8[$1?TS4*]%XT&$_T.H*;U\?V$@?J'6]V*\41:S$ MKZ4GD;[PV5+"GDD1WR!'@;OPZ/+=JP^N_"EF VO$C_3K2>U$?0=GT4Z^QZ-- M/W5SV76?NA$O^"[L)8FL6GA^<@;A2+LF;_JQ\Z[V^@=OMO8-3[V)1[VD1PM/ M/S?UQ)5R W/G;KW>WGWR# ^ZT=QAZ4DS!D-"!M,XOO6>_17YZ# I@R;9*7A8 M [RU&/RDO!FT](E)U50$1L93#ZV-HTS;>D=9:O"ETC9WQ+7529PD8$\.LS ) MC*D/3+$=0_?M=<999WY#X"1P%A.<]5? J3JU.W A#BCT9!A$VD%8PNFJ$V>P M??DJGN^=+5X)?8.Q/Q#NF79Y!C.72()3Z(/+Z&BW2;FBX.@'CPI]0!9'\& M] 5BZ I[SA9/;]!YGTPJT8I'XXG"\^[HR_%T8'6 ;1K&9!BM9"I*HFWA_9@R=U#%8R]N %Z=:G9E9H M!U,IJ^GNZS.K#2AG%7B7:$C)V,$PH?Z>OJCG!V/NSK^7.>K:R)QL$'_6UL"J MP3/%2Q% 22Z?2/$N^?!^<6EAM7F945E[92+Y^N9!CZG9^G%3 S5WOK7CZ;N> M7^C3BSUZ>OBB/'Q!2L-SES0Q'6XC@QTQWY#5"OF\O/CV5WC;[ Q?!MIB%Y)G$,@&I_H9'OW-"N+B]J):G?.Q' M<5P'KN/B_.ZG+)@N"U7=B0FS5]Y/N%PT$W7#JC"\]*I4'7.+!5XEFL_AR+@<9 MA\AS.;:84.I$*$0H1"CA^_1B52X'6 R::Q-)M32PT 70E7]L%,'PC=Y:H\2 MWY>4LRI.RX]R%M@NDKZ1OI&^D;Z1OI5=WPJ_3K*KR"ZX'#'Q5^0\$/[+@G^K6B/\$_X)_T>*_R[9 M?\(_X?]H\9_!YJ5EX0%:(GI):?J/W'%5"9 JON7P >,(X3.36-*D2J"VB5Z] MV6;"I' /V%^B7>UF'A4M"PH+!+CDC!):Y1@4$+ (6 2L^K58UEJ]/P")@ M$; RG'^5'F!'OW*;<0?G@D&H66U0Z()"F%E9FH*A@0)ZA I"!=D(0@.A@6Q$ MKA9]J'_Q:S*DWDH9+48??6^E>LV<]:?>2A3[I-9S1(\EHL<.=7[\# (%@8) 0: @4! H"!0$"BJ874=G/OHX;A&,801> M""/$KB[P43HP75$SET,23\8% _D)UNP0B\E)N*73J+8R%T=9^*A U),[ZTTD M<[PD0S5IQ#7$-<0UQ#7$-<0UQ#5EX1J:/&4=S"E3S";C(OL#]S(VC:U&P]Q& MPF^)IBP0RQ^:NCQ5.F:=5$:H(54>'*C)2!">"$QFIPZ.*MAF@;08.+F[# M :)C+X6P:FV#\24J@J 0.)6*$3^6AQ^I5(Q8DEB26))8\C Q*J)'HD>B1Z+' M0M.CT1P.HL7QJ<^IY\(2_+.1CN19]=J/B^IFM1= KWYXZ2E2 M%YYC#HQT*@DZ'I"B_IZ^L^<'8^[.WP>/F5Y8/1:SA>O&Q_QZ4CM1W^&=V)=\N']XJN?#2H=$)ZI M3WMEI'_]F+(>4[/UX]L*NA)#\3/M>/JNYQ?Z]&*/GAZ^* ]?D-R]W#FUT^$V M,BA9?D-6&SD'W>W$T\W.Y2?M20W7RG<>@ V^D@C,J-/J)=MK[@3L3^Y&@GT2 M7$:!&&/%\Q\2!KV%^YEG$LL$I/H;'OW.">'B]J):GO(Q3$M"R1R/P75NA!LEM+(U@8QY\$^'K%1*'&N+I1_$H7&9M0HR$6\+MMOIV"[=QAB * M$&0>\>"'<"SS[Z4('E4\+X^#=+Q)!'Y-+L<6$TJ="(4(A0@E?!]Y1":[DDEC M;3*A[=4,[ C=EU*$.^T&_29/[5'B^Y)R5GD"^5'. MM%TC?2-](WTC?2M[+K M6^&71'85V067(R;^BIQ'[H*#OLG&+,9EE ^)&,LLS.Z)3:< MGK5IJFG+DNN M7OY(('<&APB@+ 10K_8(_X1_PO^1XK]EL,Z>"( (@ B@8 20025Y67B %HE> M4IK^(W=<5>\S] ,F.7S 2$+XS*2P(SC)R6BC5Y/"/>!N7^UJ._.X:%E06"# MYZ;'?-67_:Z))B MG[0/,-%CB>BQ6^T<7I;$CL2.Q([$CKEC1Y,E4D2/1(]$CT2/):)'ZD16B AE M2;(?EN*0;VQ1]-'A]XZ+B>F[;%-4RNB_2?M2%FCE#T6Y\S,(% 0* @6!@D!! MH"!0$"BH8'8=G?GHX[A%,(81>"&,$%NXP$?IP'1%S5P.23P9%PSD)UBS0RPF M)^&63LW@8EW9ZT0*1#VYL]Y$,L=+,E231EQ#7$-<0UQ#7$-<0UQ3%JZAR5/6 MP9PRQ6PR+K(_<.-BT]BR&N8V$GU+-&6!6/[0E#MS?:QPRCRMBE!%J#HZ5)&1 M(C@1G,A('1Y5M,T ;3-P<'$;#A =>RE$MUFM'UZ81U$#01'PC"+@1(]$CT7U M%HDEB26))8DE"\V2V86HB!Z)'HD>B1X+38]&4SB('M<,4?X<8K.W5NW'15VVV@N,HGY(B?H_D0R=X;-1:=^-L!F>"QP-=V5C$8[\ M@63<&S N932>8(V/9$\B$"R28L!"GPD8Q9B'@H5X+G<"]LC=2#!_R 2W1R @ M.!6_X=\O_#&HT?-T$M5Y+]G0\;AG.]QECB?#(!H++Y05O*$(];W=>/\#1\AW M>Q?O',LWNW"0(8'KKWCX.R>$>]HO!(XON!RIQH0@5Q0-.UN2P3:OFBU=UX:7 M$SA2L#$H\S,;\^";"!FW;>".^$W82$%#(*%0J'>%U M.F&D=*;*V-WL_<.?'D%OX#0/M"5P_$C.WW0(; 5Z-G) @3@HVYA[_.'MZ\/8 M]9EXCN>'; ),Z-CN,PL#/A"#"KN/0C9R9.@'R*3PAQ%_%.Q>" ]^?AC!#ZX# M(AG$XYWI\U2%7Q .W' @L#8.]$Z-$X^]Y]XW"?]&J$03W],8P1&F$, ^]_^$ MV_5=]_5;V%$0P'N"(4[P-B$;<'C'L2@5:-0K"L1 )$#E(3.B*S]8U5K-C-;! MPVH^ 8$I:@!U$D@O[*-X%"ZS8N O*$R FZ/ BWU! ?%)^=B'O_U7X$JF#%&U M-.-XX&KB"X!/RL3!J0-VSEW0(L%N1T+?[)_.H]!G!,)5^7(@6SF"2\*+".-N MH/$+ C6;HZH4LX$JN0X\B%P<#I], O^[8DJ94JN%QYQ*1"[?9R:C>O7X6'"= M9JT[*_OR8-2]#1'NU=)XYP' EQ]1<9_@,@J0020:Y;\B'Q4X9@<@;%LHH&O5 MG:#2P5&HY6PW<"O'L]T(&!I//_D"0PUB'CC9#,C'!XS7$GS-J+\IAV,V MTA>E9+&V'*\283T+B/T0F3RLYR 8X$#&49@%^!.,2#P M&H\XGQJ),V6R08=GHYNW&-,[I!XE]K#2Y?1H;^)+37@ +4!C6#MP$O[5EUF MN]+K^ML;$.3[RWZLYV-P<^'"OOU->><).@6ZMT M8T7K@'OX30$+1&%DJ]?0=L&; M]82M7NN3$XZ4+?O$[4ODI0'KVV!YP8&%/\?T-2>8%:(8 1.I^8H$79'H.RS- M59)Y1"SN%1=QI*:F*2_BX<"^_EAH3Q5G[FJXD9"QS@0,UH4M8GK.!(Q6]:2J'4:>\9'"_C;PDJVKU?C2CU?APXOL$WJ9( MV'\F\ E_U@X0?#:#RG:M:AB6,.6U(U?Y3?JU [L$_GW"*IIOX8\)3L%*2ZG MJW0!9\B@V>E3X! ?)N-XTE2[D\F,!G^B76,.[S4:)]<.>?"@G<.+$0<.E(F? MMZS&:Q FNI!ZBAB[D+<"Q.8]P-Q,V",/Y_H5!N?!\:Z>?@[ *W# (FOCC&\5 M?,LY;W/F8]Z&\)_IR_TRB>^*@[^))XM(=GB>'.%0-(]IK%7@?JCR 3C3\$CH M$\2?XULM@<",VAO2>3M^.PNO)IX:3",6FE9@EC&/8$-(J!L&PHH7%ZOE"^^, M%^NM5108<28&PX/7I_@IA5HP(.$3VA C=^O6#/*K&3'6# VILJ/^FU'_AFGU M+]$:A5K30>5^!&N [C*: <\&/9_.H%0D5CPXGJ=,GC?UU>YU[$#',O H(](- M1X%0,=QP)/%.8F &'4:N\HD']FBV5MZP*N"H6FTS(T0QID-!T_@1#^?,NJ=? M$TSN]5N0X(YJ?T2"TJCP+MQ]A>?)3G7 JO'3_M:!;('3[QEQ+;F* M@V$K_3T]%@\][9I"V%%C)4<>@#GE^!J! M!\6EP"0*[L89#E*$H1M[O3O$G>;&)J/)"^(%*;U?B@'-KM*>A.HBIY9VJ>%" MF[SJC;9-,?F&2[9?"FU#67+S>1=P3PY%@ 8T]..\PP;9SRS0=-2@R9$=W0>: M_$@E5F6()S);9+:V-UM6<9&V.BAX-;=T;$R3,JDU/J9(UKH"+'I$:Z\;*QQ9 M9.OE N$BY2"GF]F7)/%, 46*:6B%"IA!0R] ME'&RRB *DK16(R,XVI2AXF>B32LW<7E/[V?=F.7LJB^%/I3V?4ED,17WB5_)*XS(L MA(/-@^ 9_Q87MF B:;SYQ6!%V<*JO2YFI0P#<:^K"&T^P0PGP)[*-;^'Y]/5 M!1FG.+XDNL(E-&:0K6BUC:0K-@^U0X\%(<7\ZB#E:F^FLA?QW&S=.=-> M!_?GAKF">T")L= ^0:@L$)K%=/*EJJ2-QZB-1.A$Z 2A/1-ZV3+NEE.1TA'L M,_7+3)*[YF;\<7O)/OLA+B,/(H$;@!EKI$85;E3AMO(TJU+K6M5>YN(ZBE2@ M C%=[JPTT1?1U^:"ZC7JU4VRUHF\B+R(O(B\VO>RB+Z(OHB^B+Z*1E^] M9IM\K[S4R1U!>.SJCYN%\!C5?X?O&[UZU5B8L"QXRA]TM&NZT4?/%OO>!:!E M,(F"H$70(FA-H67U:.2H:' S6H!,<" X%AT.W0]:!X$!PF,&!TFY,S$1R-///0];;P@R% MJI+6DEVC3DFH%(S+E3TK#;2:!A-,"5H$+8+6%%I6@Y:0"%H$K2P<0HN6D+*= MN!W;_.S*"T<@639T/)B=P7V9Z_![ZHT4Y]0V*1Y"X4$*#Q(<" X$AR4X&)SH M$!P(#@2'TL&!%H]VT:@+/G&P'Q)(7PKFW\,X>.CXGLPD2. ' Q$DHK,FWYGT M76? _D]-_:\T0826P<#WMB(K"[P+A.3BFL'C ::QMH($3 (F 9,L)@&3@%EJ M8)+%S-%J6>T0,U(CVJ2^/0DUH'O?'>CKW/DP^Y66Q%[$7LM3??R[+,[;-+[$7L1>Q%[+4_W\OJD>^565SLYY##XZ\Z M/D.B2(G)=3QQ-M)1*JM>^W%13ZWV O;5#RGA_B>2H3-\-BK?"QX$SY@W_LC= M2$@V"8047B@&C-\#SS+'L]UH(%CD\;$/:O9?^ L<,W:BL:RP@2-M/_)"R;@W M8 -Q'S)'RHA[M@"=D:&L%EHX=R/!AKX+I@8E-!;AR!_H1^7PE..)2F9A3R( M^4@03.@S :,8\U"P$,_E3J %R_RA^N7"'P..GK7R=.M6Y[UDKH^/A!75*,!W M>Y?8G/UI=N=2@':2H?Z*A[_#/"#'?B%0^W$J@$O4H ^>#(-H#%JXG"BTS0B6 M[L>,7';NP=1USW:]KAX=:)V<5G1P%R XE0?CH&ICP644@+I%$M7RK\A'N(YY M\$V$@$W'!ACS4*E;("8(6CAJ@#HYCMS0F;@.''[_K YX"'PIF9V0 & ^*#N36?,#8;03767PF!9+DB3Z*1^&R.APTB=ZBD.3S M+S]'\NR!\\F[:P#=GWBY2QB,ZZ.HY!UH_;GKV]]^^_O??EDZ\&-<,N,(^2F6 M[1?O1MA1$,!PSKETY!^>?R]%\(@6Y ,."_[LP^MQ'971-KT^/*6'$+L1PU]/ MKB_K-:O]N_7ON\L3Y@S@!VZ'9_V+[O5YOP=_J36M6K/=..\U>PWKTFJV:[WS M3O_DMP6@IQ7GSAF#\#^+)W;CC_G+KF^QF%499E C_]%!W>*@>6GI)OIX+QX< MSU-Z"MHE/!PQN^$RP7J*",@#$>! +S 7T82[R0&9K!MY"J?>&"/9OY' MPZHP5#0S(T0QIM$Y91N@E+0]\_1KTAB!MP @B>$K06F<(3BDAG_R@Y]/JER=G$([@:)!6[.C;V+9L(L6[Y,/[ M1<=]-N[T$O+4^6^NS!58?Q%:#ZG;^O'MV<7*>4[\2#N>WMCK[0M:Q3K3M^YV M5-]]V4V:,=>I]C(J1=Q?R*4XTN M"0P4-W*"CQ),;*#,ZA93Z.-4X2797L_L8&P>M:W=M$[MEAX,0WYS@6) M(PY^D'(W9U/9;:QPR4I_Z[2I>-D\ '/*\34"#XI+(2M,C&7N\. M<:>YLIMFDA*>L]C,#-!TU:')D1_>!)C]22ZX9XHG,%IFM M[;Z2Y5FDS,.=YL.=->?# MVPP,L],"H7,>C5S0\\V,:[(8IO"#N2B%2EC1Z6XZ6640JL5=O9LI(JYVH?W[YD&8;/5=CV_T*<7>_2%>OB"!+=GO+%#IM!"%N(. M3A!E.;XZ3\P^O>NK"(9HM-X*XQQJ?+>^&VVZY7'.()>[:FO"P\OZUG\('#MR MPRC@+B/E(^7;I_)MM.$>+0RNO5QQ*6PQOA=!DL9L+'A,.;>4<[LZ(;!B-3L& MMZ(XZK3; I%:[LPMT1?1U^:"LBK=3I.J!HB^B+Z(OHI'7\U*K6Y5>T1?)NBK M(('M[AV&I752&@3]FW/XK#H^/+7VV,^\+'C*,HQ8 MMG[FVVUE?)A=2[*=R^0G$^7-W3=V2%7)239*O5)OF$\"C!EE%!' M5$94]D9><*_7KM8.+S*B,J(RHC*BLNV%U:S4FQWRRHK0*'B;@15BAZ2YUL&X M(Q)N*S1T/"<49Z[S* :X3W2\_Q9VS!6X#5L(%V7AB'O3_9,J<6]1U9Q*AACI M$.ZS:OH8<*!J/L9-W9[X3CO-SX;^0Z/32?;A,')!M2&^H:&U:X:'%N9__SAS M\DL*I9<&NEPQOZ'RQL7YE]G*NENVFR(=HEY M/A(0V#;=EAOY"/[L!&ICMJ27<0@' 0U-]VY#W7N;MHK]KC\LL;",[O\#>HS2 MB-LXZT:[M'U=7K:OJ[>-;%]G=0JU"YGATP^\=Q\].ST[/3L]>PF?O?"Y?!EN M'TFI(R2?C%-K+"O?N35Y[>M,.D8ZMKZ.;;WOWC%;1_T-C\YH.^2]ZZ0Q(6>O ML?^K?A #QD$\_$&P2(IAY#+7&0IV^BQX8$[4Q)5YVPQV_?U\#JVG_U1]>"[B M!:1UHXS[W4E9]_G ^'!2MW/U73<%R1>"C.WB1/ J"[SZMAV-([7@D5=LS=8< M &&Y'"2AGE!?*-1_%B$[]_UON423:OB6+P@12HX1)<5Q/Y+O M2:@_-M27Q_>DC0U?*CFXB"0,403,=>1&^Q@>4G19['&^I+$[E]C6JL9Z.N5( M%7-'[\9M([5C.()V#%:EWMH'0(^B'0/1%]$7T=<^Z>NT6S.X+]%;PII![4#B M,ZQFYC)3B-B(V(C8C/IE5F$/?) M QZ>#TEAV56S[8P[RUPS)3)^I>W&6J_4:@8W\2T+T1(BCA81IY;5,P>(K69< M^;"U5-M,8'G;N^]V.V0^"!&$B*E#56_7J,,](8(0D3A4S6:MVB2'BAPJ LLZ M#I7)^H6RF ^J(WI)8>ZF71U,Z4P^Q68^0%HW9Y1R)++B,K51(1YR!E#?PW)7 M68B=D$7(6G\FT:AV]J98QSS!(-01ZF:.4GL>I,\14(6(2L# M3[&UQ\D]>8J$.D*=]A2-Y1R6WIX=?2[O9]^#5SN>B% P_A (@:U%S46QL^CY MGM]H=LM\RAHQ]QK,G866'9+!S66NO"F:LA YX8GP].(\I%8UUDYM;=D<\WR$ MP':\8+,,[LQ%QHOP1'@B9Y#P1'@RZ R:6T@E9Y# 1F![S7B96P Z%N.5999U MK;#!:O5MJ0W&G1]R=V\:EJ-EMDQSLEM5RYA,\R.RW%F%_5N"C)?S\K.=T\Y( M-N^>F3:MC4J]N\^X9NF7@HG*B,J(R@XR):_7&GE@,IJM$\L1RQ'+9>6PU3H& M=^DAAXVHC*B,J.PP5-;JFJR:(2HC*B,J(RH[Q-RSW3#92Y#FGL1RQ'+$L8558O68MQX"W MN1OCWH 9N1(,:3E7;)L+5=3C7_ACT/9G%@@; 31@?.P#O/[+0\?WF/@^$9X4 M##XZ7LB]!P<1Q:44H63^T,P3_=!N5IL,#G/AECF3]@^-7K5K=&P5$+6<"#MT M'H7[7'T=W/'G7WZ.Y-D#YY-W__3]P1.,IN\-/DQ?2%^]CTM'VJXOHT#< 7+. M7=_^]MO?__9+<*< ?S M[?#LHG?=NKCH=>J]NG51[]0:W7ZKU[ NK6:G<7%UW3_Y;0'T:7G<.6,AV6?Q MQ&[\,7_9<]F%,^K-3#E#?5W*]?GP^>++IRMVU_]_5[=E94,C6J\H=>9DEI]; M'04W%O+O4Q(-,3',E$!_L+KY)18X\,O?Q>W7A PQFR&9XJ M[,F/W '\,HALD8XQK734P3[U;3N( (@.UHP(&:HW!5,F[H;./*6]@ELXT]S$ M*K_([51;!-V"0'=^FIJ"R$N:;M#KKN55@VO5AMFAK44/\:PA%929!/ZC(]&M M2CQ<(\-1;K*9!RN8KYW'(-P*-+ZL([8R6\HG1LL%'Y]-P;%F&H_HLRNE]N\G/Q")=/I H\Z+F>IAG7&3NAFE4H;#SRP/$CR?X3!8X< M.+;ZPZ9+$Z\M,,PO1#S"Q 7FG-LM1-2OKB^M6KW6;+6ONU;?JEL7-;T0T;ZH M]_K-8UV(^//J\]V7FP\%7X= B([Y?X"2<>+I>[CQ)RJLDRB-]O0X!B9P.BS? MK9FYLO.#KZ$JP M_OX!>DB=QH]OYV*LS B)'VG'TW<]O]"G[_?VA=_BN+L=T743 E='OP,;[#KV M8@;>J0Y4*PURDWS&Z3,U-MK9Q9I\9])WG4&6&R&_+N2E;2-V%?.2G5SA M N.E5V4WK72-:;^A.54EK32BE1N$):@-ZH9IIM>.Y\@13.<>?']@;!-YH\G+ ML<8K%W!)W?,A17.9S3LD+F'AK,[$%C#I_/7"#ZRIVU)?(B\MJ" MO)JU/6RS=A3D5?@9[JZZ]+]^\ UGL)/ MX7V?2@FT\VC!8[506F.0/ M$;DSY66%0]U@]^"RP(&F\2]IRPU_8F,>PI^Y*]5BLXPF$]<1F5B6TO1=[/2H MD3!-./-DI4H#K6;78/%ZV:%E8#K4+:P!6QWT5_O$SQ(;*IBP;TR?,ME\XY@B M/>L*L. 1G[95WV/KF:.(_-"4EKB+N&L/W-7":@CB+MI"Z%#)JA^P/-+SA,J7 M9D]..&)?71X._6#\#SE-JN;V7Y$C5:6IU'ON8$FG6,AJY9CN90>"2]R#)XQK M5)/T=3;@<>9VZFI8\A"(H0N'L"%W GW=*F/75-%@8KAYK&@PD="G3]6J);,[YG8QY\.XLFAK<7JADO-#58OFYX;+MMR?9: M/5.Z[NFS>.K;-F9VPYO]&O@>?+0UEWP%?K&?];\WJ86ZJC>NZ[6VU>_7^^UF MX^+JJG<=;\K6:O0;O8/70F7,0>KK4F#M1F#&KOO,^@-_@J2-JO<5O Y$U.P5 ML/EW4%0>UE_3Y00O2074%.CB.O#':-/" #1(:J_U H;DCT4@V>F=/W%LUJZU MERL.C+P<,QQPQL#W[D\"QU5&0M/F=?_VG#E2XEX"_=L_U%_.K%J%G1AYE.62 MC0]8V 6O4BF3"-#O5]NS?+F'%QW[!:A['QU02 E'+5/+-@]_HBM9.:CM0+LB MJIAY(&!Z!1[&$":WVFC$1<_CB:M47/_Z$($K@Z,("W'CNXLTSL-]FQ9JD'][WI]UC3 M7"4*$=?TP95Q]A)Q%Z\#SE28E.E.1^FD-XW 4NTAL"P<_PP322U=54SOC!F< M[O@#\,3$@^.I!^-#W!DG,=G)AJX=/1(X'QZ+(T6@6.#LL1,"6RQ4[>/]XRUX MX(JQ//'YE$F&OX*F%=:'6Y<[4!CPVK0"G8$3C.9I[L>8-SI6=V?>T#2A$*XW MXGT#X;5>A@@?([1BAQ\F"U> )?]9"'8+$PAQ=JZ<_J_\&0](F9:L< [3%N]! M[ZG"9W8L# 0/U0A2>R%@:?N3XPV&W'5UNL0(?$G\AE7BTK<==:2"@E0/HV
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�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end